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CD23  (FcCRII),  the  low  affinity  receptor  for  IgE,  is  a  single  chain,  45kDa,  type  11 
transmembrane  glycoprotein  and  member  of  the  C-type  lectin  superfamily.  CD23  is  a 
multifunctional  receptor/ligand  and  cytokine,  playing  a  role  in  antigen  presentation, 
macrophage  activation  and  cell  adhesion.  Human  CD23  exits  as  two  distinct  isoforms, 
CD23a  and  CD23b,  that  differ  only  by  a6  or  7  amino  acid  region  located  at  their 
extreme  cytoplasmic  N-teimini.  CD23a  is  constitutively  and  cell  type-specifically 
expressed  on  B  cells,  whereas  CD23b  can  be  expressed  on  B  cells,  monocytes  and  other 
cells  of  the  haematopoietic  lineage  when  activated  by  stimuli  including  IL-4  and  IL-13. 
The  two  CD23  isoforms  appear  to  be  linked  to  both  different  intracellular  trafficking 
pathways  and  to  distinct  intracellular  signalling  pathways.  It  is  the  issues  of  isoform- 
specific  trafficking  and  signalling  that  are  the  focus  of  the  research  discussed  in  this 
thesis. 
Early  evidence  suggests  two  distinct  roles  for  CD23,  one  being  a  stage-dependent 
involvement  in  B-cell  growth  and  differentiation,  the  second  involving  the  effector 
phase(s)  of  IgE-mediated  immunity,  including  allergy  and  response  to  parasitic 
infection.  The  patterns  of  CD23  gene  expression  and  functional  diversity  has  led  to  the 
assumption  that  CD23a  and  CD23b  are  involved  in  B  cell  function  and  IgE-mediated 
immunity,  respectively.  More  recently  studies  by  Yokota  et  al,  suggest  that  the  two 
isoforms  are  internalised  via  distinct  pathways,  with  CD23a  having  been  shown  to  enter 
the  cell  via  a  receptor-mediated  endocytic  pathway  in  y2  cells,  and  CD23b  showing  a 
more  phagocytic  route  of  cellular  entry  in  a  macrophage-like  cell  line  (J774). 
In  the  research  described  in  this  thesis,  the  trafficking  of  each  CD23  isofonn  was 
studied  in  detail,  in  both  wild-type  and  mutant  CD23  proteins,  using  an  identical  cell 
system  and  the  same  method  of  CD23  ligation  for  both  isoforms.  Confocal  microscopic 
analysis  demonstrated  intracellular  sorting  differences  to  exist  between  the  two 
isoforms,  with  CD23a  utilising  the  endocytic  pathway,  and  CD23b  following  both  the 
endocytic  and  phagocytic  pathways  in  a  B-cell  line.  Site-directed  mutagenesis  was  used 
to  investigate  a  number  of  potentially  key  residues  present  in  the  unique  N-terminal  tail 
of  each  isoform.  The  serine  groups  at  positions  7  and  5  in  the  CD23a  and  b  isoforms, respectively,  and  the  NNP  tri-peptide  motif  in  the  b  isoform  were  found  to  be  necessary 
for  accurate  trafficking  of  these  proteins.  The  discovery  that  the  CD23  isoforms  utilise 
different  trafficking  pathways  corroborates  the  hypothesis  that  CD23a  and  CD23b  may 
have  functionally  different  roles. 
Current  models  of  human  CD23  signalling  link  the  CD23a  isoform  to  a  cAMP- 
generating  pathway  and  the  CD23b  isoform  to  stimulation  of  inositol-1,4,5- 
trisphosphate  production  and  calcium  mobilisation.  The  ability  of  CD23  to  transmit  a 
signal  within  various  cells  and  the  fact  it  has  a  very  short  cytoplasmic  tail,  of  only  23 
amino  acids  and  bereft  of  catalytic  motifs,  strongly  suggests  that  CD23  may  associate 
with  other  molecules  involved  in  signal  transduction.  The  divergence  in  the  signalling 
pathways  associated  with  each  CD23  isoforni  has  been  attributed  to  the  unique  amino 
acids  at  the  N-terminal  cytoplasmic  tails,  as  the  remainder  of  the  proteins  are  identical. 
However,  there  is  no  definitive  evidence  to  link  directly  CD23  to  any  of  these  individual 
signalling  pathways.  The  research  presented  in  this  thesis  utilises  the  yeast  two-hybrid 
assay  to  investigate  binding  partners  for  the  N-terminal  tail  of  CD23.  Filamin  A  was 
identified  as  a  potential  interacting  protein,  and  was  found  to  interact  with  both  the 
CD23a  and  CD23b  isoforms.  It  is  hypothesised  that  CD23  interacts  with  filamin  A, 
which  functions  as  an  adaptor  protein,  to  enable  downstream  responses  to  CD23 
through  connections  to  the  appropriate  signalling  pathways  in  an  isoform-specific 
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INTRODUCTION 1.1  THE  IM31UNE  SYSTEM 
The  environment  contains  a  huge  variety  of  infectious  microbes,  such  as  viruses,  fungL 
protozoa  and  muticellular  parasites.  These  agents  can  cause  disease  and  if  left 
uncontrolled  can  multiply  and  pose  a  serious  threat  to  the  survival  of  their  host.  The 
body's  natural  defence  against  such  attacks  is  the  immune  system,  consisting  of  a  highly 
complex  network  of  cells,  collectively  known  as  leukocytes  (white  blood  cells)  and  a 
variety  of  soluble  factors.  The  immune  response  involves  two  phases;  firstly 
'recognising'  the  pathogen  or  foreign  material  and  then  secondly,  mounting  an  effector 
phase  reaction  to  eliminate  it  from  the  body.  The  different  types  of  immune  response  fall 
broadly  into  two  categories;  innate  (or  non-adaptive)  and  acquired  (or  adaptive). 
1.1.1  INNATE  IMMUNITY 
Innate  immunity  is  the  body's  first  line  of  defence  and  is  present  prior  to  the  arrival  of 
the  infectious  agent(s).  The  innate  immune  system  relies  on  a  set  of  germ-line  encoded 
receptors  that  recognise  conserved  molecular  patterns  found  only  in  micro-organisms. 
Innate  immunity  is  mediated  by  phagocytic  cells  such  as  mononuclear  phagocytes  and 
polymorphonuclear  leukocytes.  These  cells  utifise  primitive,  non-specific  recognition 
systems,  enabling  the  internalisation  and  subsequent  destruction  of  foreign  particles. 
Granulocytes  make  up  60-70%  of  the  total  normal  blood  leukocytes  and  play  an 
important  role  in  acute  inflammation  providing  protection  against  micro-organisms.  The 
importance  of  these  cells  is  clear  from  individuals  with  reduced  cell  numbers  as  they 
show  dramatically  increased  susceptibility  to  infection.  Granulocytes  can  be  divided 
into  neutrophils,  eosinophils  and  basophils,  on  the  basis  of  how  the  cytoplasmic 
granules  respond  to  different  types  of  staining  agent  when  prepared  for  microscopy 
Paneway  &  Travers,  1997].  The  three  types  of  cell  have  distinct  effector  functions. 
Neutrophils;  are  the  most  numerous  (>90%  of  circulating  granulocytes)  and  constitute 
the  majority  of  leukocytes  in  the  bloodstream.  Polymorphonuclear  cells  (PMNs)  migrate 
in  response  to  chemotactic  agents  such  as  protein  fragments  released  when  complement 
is  activated  (C5a),  and  the  products  of  other  leukocytes,  platelets  and  certain  bacterial 
products,  facilitating  localisation  at  the  site  of  infection.  These  cells  ingest  micro- 
2 organisms  within  phagosornes,  which  can  then  fuse  with  lysosomes  initiating  the 
neutralisation  and  breakdown  of  the  infectious  agent. 
Eosinophils  comprise  2-5%  of  blood  leukocytes  in  healthy,  non-allergic  individuals  and 
although  not  their  primary  function,  are  also  capable  of  phagocytosing  and  killing 
ingested  micro-organisms.  Eosinophils  are  thought  to  be  primarily  involved  in  the 
defence  against  parasitic  infections,  and  are  attracted  by  the  products  released  by  T 
cells,  mast  cells  and  basophils.  Certain  stimuli  can  cause  degranulation,  enabling  these 
cells  to  use  their  granule  armament  against  large  targets  that  cannot  be  phagocytosed. 
The  stimulus  for  eosinophil  or  mast-cell  degranulation  is  often  an  allergen,  and  to  be 
effective  the  allergen  must  cross-link  IgE  molecules  bound  to  the  surface  of  the  cell  via 
the  cells  high  affinity  receptors  for  IgE  (FccRI).  CD23  is  also  expressed  on  certain 
populations  of  cosinophils  and  monocytes,  and  in  this  capacity  is  thought  to  be  an 
important  mediator  in  allergic  reactions  and  in  the  immune  response  to  parasitic 
infection  [Capron  &  Dessaint,  1986]. 
Basophils  are  found  in  very  small  numbers  in  the  circulatory  system,  and  make  up  less 
than  0.2%  of  leukocytes.  The  function  of  basophils  is  thought  to  be  similar  to  that  of 
mast  cells,  and  they  are  believed  to  play  a  part  in  protecting  the  mucosal  surfaces  of  the 
body  with  degranulation  releasing  substances  affecting  vascular  permeability. 
1.1.2  ADMYrIVE  INUYftMTY 
Acquired  or  adaptive  immunity  is  induced  or  stimulated  after  exposure  to  the  foreign 
antigen,  is  highly  specific  for  a  particular  pathogen  [Male  et  al.,  1993]  and  illustrates 
immunological  memory  whereby  responses  significantly  improve  upon  subsequent 
encounters  with  the  same  antigen  [Zinkernagel  et  al.,  1996].  Lymphocytes,  making  up 
20%  of  the  leukocyte  population  in  adult  circulation,  are  responsible  for  adaptive 
immune  responses  and  the  specific  recognition  of  antigens.  Two  basic  categories  of 
lymphocytes  exist:  B  cells  and  T  cells.  Both  B  and  T  lymphocytes  develop  and 
differentiate  from  pluripotent,  self-renewable  stem  cells  in  the  primary  lymphoid 
organs,  the  adult  bone  marrow  (or  foetal  liver)  and  thymus  respectively,  acquiring  the 
ability  to  recognise  antigen  through  the  development  of  specific  cell  surface  antigen 
3 receptors.  The  cells  then  migrate  to  the  secondary  lymphoid  tissues,  where  they  can 
respond  to  antigen.  The  functioning  of  the  adaptive  immune  system  is  based  upon  its 
ability  to  generate  a  vast  array  of  antigen  receptor  specificities  by  somatic  mechanisms 
of  gcnc  rearrangement  and  several  additioral  processes  of  receptor  diversification. 
B  lymphocytes  represent  approximately  5-15%  of  the  circulating  lymphoid  pool,  and 
are  classically  defined  by  the  presence  of  particular  surface  immunoglobulins  (1g)  that 
act  as  specific  antigen  receptors  [Mellman  &  Kotch,  1988].  The  majority  of  circulating 
human  B  cells  express  two  Ig  isotypes  on  their  surface,  IgM  and  IgD.  Very  few  B  cells 
in  circulation  express  IgG,  IgA  or  IgE,  although  these  are  present  in  large  numbers  in 
specific  locations,  for  example,  IgA-bearing  cells  in  the  intestinal  mucosa.  The 
transmembrane  segments  of  surface  IgM  is  associated  with  disulphide  bonded 
heterodimers  of  Iga  (CD79a)  and  IgR  (CD79b)  on  the  B  cell  surface  forming  the  B  cell 
antigen  receptor  complex  (BCR).  Most  B  cells  display  MHC  class  II  antigens,  important 
for  co-operative  interactions  with  T  cells,  and  complement  receptors  CRI  (CD35)  and 
CR2  (CD21)  are  also  commonly  expressed. 
T  cells  also  play  an  important  role,  not  only  in  the  activation  of  B  cells,  as  highlighted  in 
section  1.23A,  but  also  in  their  own  right  as  immunologically  reactive  cells.  As 
mentioned  previously  T  cells  are  derived  from  bone  marrow  stem  cells  that  differentiate 
as  they  pass  through  the  mature  thymus  [Shortman  &  Wu,  1996;  van  EwiJk,  1991].  T 
lymphocytes  recognise  antigen  and  MHC  molecules  via  the  definitive  T-cell  lineage 
marker,  the  T-cell  antigen  receptor  (TCR),  a  receptor  molecule  distinct  from,  but  related 
to  the  BCR  and  indeed  all  immunoglobulin  molecules.  This  receptor  consists  of  an 
antigen-binding  portion  formed  by  two  different  disulphide  linked  polypeptide  chains 
(y,  8  or  a,  P)  associated  with  a  set  of  five  polypeptides  known  as  the  CD3  complex, 
givmg  the  T-cell  receptor  complex  (TCR-CD3  complex)  [Clevers  et  al.,  1988].  T  cells 
can  be  further  divided  into  subpopulations,  distinguished  by  their  expression  of  either 
CD4  or  CD8,  which  determines  whether  they  'see'  antigen  in  association  with  major 
histocompatibility  complex  (MHQ  class  I  or  class  11  molecules.  CD4+  T  cells  act 
primarily  as  helper  T  cells  (TH)  and  can  be  subdivided  into  THI  and  TH2  cells  based  on 
the  cytokines  they  secrete  (either  IL-2  &  IFN-y  or  IL-4,  IL-5  IL-6  &  IL-10, 
respectively).  THI  cells  are  important  for  combating  intracellular  pathogens  whereas 
4 TH2  cells  are  more  effective  at  stimulating  B  cells  to  proliferate  and  produce  antibody, 
functioning  primarily  to  protect  against  free-living  micro-organisms  (hurnoral 
immunity).  CD8+  (cytotoxic)  T  cells  are  mainly  associated  with  the  cytotoxic 
destruction  of  virally-infected  cells. 
Both  T  and  B  cells  are  activated  on  binding  their  specific  antigens.  T  cells  need  to 
recognise  antigens  in  the  context  of  MHC  molecules  on  antigen-  presenting  cells 
(APCs),  whereas  B  cells  can  bind  to  free  antigen,  but  generally  require  T  cell  help  to 
become  activated.  Antigen-induced  activation  and  proliferation  generally  occurs,  in  the 
lymphoid  tissues  and  leads  to  the  production  of  cytokines  and  cytokine  receptors  which 
together  drive-  proliferation  of  the  selected  clones  to  maturation  and  -the  production  of 
effector  or  memory  cells.  Memory  cells  re-circulate  and  ultimately  lodge  in  areas  of  the 
lymphoid  tissues  where  they  remain,  ready  to  respond  if  the  same  antigen  is 
encountered  again.  Many  B  cell  blasts  mature  into  antibody  forming  cells  (AFC's), 
exclusively  devoted  to  the  production  of  secreted  antibody.  Circulating.  antibodies  are 
structurally  identical  to  the  primary  B  cell  antigen  receptors,  lacking  the  transmembrane 
and  intracytoplasmic  sections,  with  huge  diversity  associated  with  the  antigen-binding 
region.  Antibodies  are  mediators  of  the  hunioral  immune  response,  binding  to  specific 
antigens  and  aiding  in  their  elimination.  These  target  antigens  can  either  be  a  molecule 
on  the  surface  of  a  pathogen  particle,  or  a  toxin  that  it  produces.  The  basic  structure  of 
all  immunoglobulin  molecules  is  a  unit.  consisting  of  two  identical  light  polypeptide 
chains  and  two  identical  heavy  polypeptide  chains,  linked  together  by  disulphide  bonds. 
The  class  and  subclass  of  each  immunoglobulin  is  determined  by  its  heavy  chains.  Each 
immunoglobulin  molecule  is  bi-functional:  the  variable  region  is  primarily  concerned 
with  antigen  binding  and  mediates  the  neutralisation  of  soluble  antigen  and  opsonisation 
of  particulate  matter.  The  constant  (Fc)  region  mediates  the  so-called  effector  functions 
enhancing  phagocytosis  and  antibody-dependent-cell-mediated  cytotoxicity  (ADCC)  as 
well  as  activation  of  the  classical  complement  pathway  through  interactions  with 
receptors  on  the  host  tissues.  AFCs  can  progress  in  vivo  into  terminally  differentiated 
plasma  cells,  (comprising  less  than  0.1%  of  the  total  lymphocyte  population),  and  tend 
to  be  restricted  to  the  secondary  lymphoid  organs,  producing  antibodies  of  one 
specificity  and  immunoglobulin  class. 
5 1.2  B  LympHopolESIS 
The  B  cell  clearly  plays  a  central  role  in  the  immune  system.  B  lymphocyte 
development,  also  known  as  B  lyrnphopoiesis,  the  process  by  which  B  cells  differentiate 
from  haematopoietic  stem  cells,  proliferate  and  mature  into  functional  cells,  is  a  highly 
regulated  and  complex  process.  Briefly,  in  the  primary  lymphoid  organs  the 
lymphocytes  attain  their  repertoire  of  speciflc  antigen  receptors  to  deal  with  the 
antigenic  challenges  they  will  receive  during  their  lifespan  before  migrating  to  the 
peripheral  secondary  lyinphoid  tissues.  The  majority  of  B  cells  (over  75%)  maturing  in 
the  bone  marrow  do  not  reach  the  circulation  but  undergo  apoptosis  and  are 
phagocytosed  by  bone  marrow  macrophages.  Many  B  cells  die  at  the  pre-B  cell  stage, 
due  to  non-productive  rearrangements  of  antibody  receptors.  The  B  cells  arc  also 
stringently  selected  for  tolerance  to  auto-antigens,  minimising  the  production  of  cells 
with  reactivity  to  self  when  in  the  periphery.  The  secondary  lyinphoid  tissues 
(comprising  of  the  spleen,  lymph  nodes  and  mucosa-associated  tissues)  provide  an 
environment  in  which  lymphocytes  can  interact  with  each  other,  with  accessory  cells 
and  with  antigen  and  disseminate  the  immune  response. 
The  stages  of  primary  B  cell  development  are  defined  by  cell  size,  the  expression 
pattern-  Qf  a  variety  of  B-cell-restricted  markers,  growth  properties  and  the 
rearrangement  status  of  the  immunoglobulin  (Ig)  genes  [Melchers  &  Rolink,  1998]. 
Figure  1.1  illustrates  the  general  features  of  antigen-independent  B  cell  development. 
The  progenitor  B  (pro-B)  cells,  the  first  identifiable  stage  of  B  cell  development, 
express  B220  (CD45)  a  marker  expressed  by  all  cells  committed  to  B  lyrnphopoiesis,  as 
well  as  CD43  [Hardy  et  al.,  1991;  Melchers  et  al.,  1995;  Li  &  Wasserman  et  al.,  1996]. 
As  progenitors  progress  through  the  pro-B  stage  they  express  terminal  deoxytransferase 
(TdT),  RAG-1,  RAG-2,  surrogate  light-chain  genes,  X5  and  Vpre-B,  CD19,  Iga  and 
IgP,  and  rearrange  their  heavy  chain  Igh  genes. 
The  following  pre-B  cell  stage  is  identified  by  a  decrease  in  surface  expression  of 
CD43,  a  lack  of  TdT  expression,  the  successful  rearrangement  of  the  Igh  locus,  and  the 
appearance  of  the  pre-B  cell  receptor  complex  (pBCR)  [Karasuyama  et  al.,  1994].  Early 
stage  cycling  or  dividing  pre-B  cells  show  a  decrease  in  RAG-1  and  RAG-2  expression 
6 [Grawunder  et  al.,  1995;  Li  &  Dordai  et  al.,  1996].  As  differentiation  continues  the 
RAG  gene  expression  is  induced  and  Ig  light  chain  rearrangements  begin,  the 
completion  of  antigen  independent  B  cell  development  is  marked  by  successful 
rearrangement  of  the  fight  chain  genes  and  expression  of  surface  IgM.  The  cells  then 
exit  the  bone  marrow  and  migrate  to  the  periphery  as  immature  B  cells. 
The  B220  (CD45)  molecule  is  a  phosphotyrosine  phosphatase  (PTPase)  which  appears 
to  regulate  B  cell  receptor  signalling  by  dephosphorylation  -of  the  src  family  tyrosine 
kinases  such  as  lyn,  Igcc  and  Igo  [Satterthwaite  &  Witte,  1996].  It  has  been  assumed  that 
CD45  integrates  signals  during  development  although  it  is  not  actually  required  for  B 
lymphopoiesis  [Kishihara  et  al.,  1993].  CD19  is  also  thought  to  be  important  for  B  cell 
signalling  and  has  been  shown  to  interact  with  a  number  of  tyrosine  kinases 
[Satterthwaite  &  Witte,  1996].  It  should  be  noted  however  that  the  role  of  this  protein  in 
B  cell  development  is  unclear  as  CD194-  mice  are  still  able  to  generate  B  cells. 
Appropriate  expression  of  the  surrogate  light  chain  proteins  p,  Iga,  and  Igo  is  essential 
for  B  cell  development  as  it  is  these  molecules  that  form  the  pBCR  on  the  cell  surface 
during  pro-B  cell  stage  development  [Karasuyama  et  al.,  1994;  Melchers  et  al.,  1994; 
Rajewsky,  19961.  The  pBCR  has  been  shown  to  associate  with  non-receptor  kinases  and 
provide  critical  signals  for  both  progression  to  the  pro-B  cell  stage  and  establishing  Igh 
alleUc  exclusion  [Loffert  et  al.,  1996].  Indeed,  gene  targeting  experiments  have 
confirmed  that  individual  components  of  the  pBCR  are  required  for  normal  B  cell 
differentiation.  Mice  lacking  Igo  are  blocked  at  the  pro-B  cell  stage  of  development 
[Gong  &  Nussenzweig,  1996],  while  %5-1-  and  ýý  mice  have  been  shown  to  be  restricted 
at  the  early  pre-B  cell  stage  [Kitamura,  et  al.,  1991;  Kitamura,  et  al.,  1992]  and  mice  with 
non-functional  Igot  have  significantly  lower  numbers  of  peripheral  B  cells.  The  finding 
that  bcl-2  and  bcl-x  genes,  involved  in  protecting  cells  against  apoptosis,  are 
differentially  expressed  during  B  cell  development  [Grillot  et  al.,  19961  is  consistent 
with  the  hypothesis  that  the  role  of  pBCR  signalling  in  lymphopoiesis  may  reflect  cell 
fate  decisions  at  the  pro/pre-B  transition. 
Additional  molecules  involved  in  signalling  and  having  a  role  in  B  cell  development 
include  JAK3,  with  knockout  mice  lacking  B220+/CD45+  progenitors  [Grillot  et  al., 
1996]  this  munics  y,  4-  mice  giving  an  X-SCID  phenotype;  flk2,  a  receptor  tyrosine 
7 kinase  that  appears  to  influence  progenitor  B  cell  development  [Mackarehtschian  et  al., 
19951;  syk,  a  tyrosine  kinase  that  appears  to  be  essential  for  the  generation  of  pre-B 
cells  [Cheng  et  al.,  1995;  Turner  et  al.,  1995];  lyn,  a  kinase  related  to  src,  seems  to 
affect  the  maturation  of  immature  B  cells  [Hibbs  et  al.,  1995;  Nishizumi  et  al.,  1995] 
and  Bruton's  tyrosine  kinase  [BTK],  as  mutations  of  this  gene  are  shown  to  be 
associated  with  X-linked  immunodeficiency  in  mice  and  X-linked 
a-gammaglobulinemia  in  humans  [Satterthwaite  &  Witte,  19961. 
Additional  proteins  that  display  B  cell-restricted  functions  include  integrin  proteins, 
necessary  for  mediating  both  cell-cell  and  cell-extracellular  matrix  interactions  and  the 
IL-7  receptor,  required  for  pro/pre  B-cell  generation  [Li  et  al.,  1993;  Arroyo  et  al., 
1996;  Candeias  et  al.,  1997]. 
1.2.1  EXPRESSION  AND  REARRANGEMENT  OF  Ig  GENES 
Correct  expression  of  both  the  Ig  heavy  and  light  chains  is  essential  for  B  cell 
development,  and  the  transcriptional  regulation  and  recombination  events  involved  have 
been  extensively  characterised  [Tonegawa,  1983;  Ernst  &  Smalc,  1995;  Henderson  & 
Calme,  1995;  Slcckman  et  al.,  1996].  In  general,  Ig  genes  are  regulated  by  an  array  of 
tissue-specific  cis-acting  promoters  and  enhancers,  these  elements  being  regulated  by  a 
combinatorial  mechanism  that  involves  both  tissue-specific  and  ubiquitous  transcription 
factors. 
V(D)J  recombination  is  known  to  occur  at  specific  times  during  B  lymphopoiesis 
[Tonegawa,  1983],  with  recombination  beginning  in  the  pro-B  cell  stage  when  cells 
undergo  DJH  recombination  [Reth  &  Alt,  1984].  Expression  of  cytoplasmic  11, 
characteristic  of  the  pre-B  cell,  occurs  after  successful  rearrangement  of  a  VII  segment 
to  the  previously  joined  DJH-  Successful  rearrangement  of  V  and  J  elements  at  one  light 
chain  locus  in  the  pre-B  cell  signifies  the  final  stage  of  primary  B  cell  development. 
V(D)J  recombination  is  regulated  by  at  least  two  mechanisms;  expression  of  the  RAG 
genes  and  accessibility  of  the  Ig  genes  to  recombinase  activity,  both  of  which  are 
transcription  dependent  [Sleckman  et  al.,  19961.  Components  of  the  V(D)J 
8 recombination  machinery  include  ubiquitously  expressed  DNA  repair  proteins  such  as 
DNA-dependent  protein  kinase  complex  and  lymphoid-specific  components  consisting 
of  RAG-1  and  RAG-2,  which  together  are  sufficient  for  recognition  of  recombination 
signal  sequences  and  mediation  of  cleavage  [McBlane  et  al.,  1995;  Difilippantonio  et 
al.,  1996;  Sleckman  et  al.,  1996;  Van  Gent  et  al.,  1996,  Ramsden  et  al.,  1997;  Eastman 
et  al.,  1996].  Deficiencies  in  V(D)J  recombination  win  result  from  defects  in  either  of 
these  components  [Shinkai  et  al.,  1992;  Mombaerts  et  al.,  1992].  Expression  of  RAG 
genes  is  primarily  restricted  to  developing  lymphocytes  undergoing  rearrangement  of 
their  antigen  receptor  genes,  and  is  highly  regulated  during  B  lymphopoiesis.  RAG-1 
and  RAG-2  mRNA  can  be  detected  in  pro-B  cells,  but  both  are  down-regulated  in  large 
pre-B  cells  upon  completion  of  IgH  gene  rearrangements  [Grawunder  et  al.,  1995;  Lin 
&  Desiderio,  19981.  The  RAG  genes  are  then  transcribed  again  in  small  pre-B  cells, 
enabling  fight  chain  gene  rearrangement  [Grawunder  et  al.,  1995]. 
D- 
Receptor  editing  is  the  process  by  which  immature  bone  marrow  B  cells  become 
tolerant  to  self  [Gay  et  al.,  1993;  Radic  el  al.,  1993;  Tiegs  et  al.,  1993].  These 
rearrangements  are  induced  by  encounter  with  autoantigens,  and  receptor  editing  that  is 
stimulated  by  an  autoreactive  receptor  is  geared  to  promote  continued  secondary  Ig  L 
gene  rearrangements  until  the  offending  receptor  is  either  eliminated  or  altered  for 
specificity  to  non-self  Receptor  editing  has  been  shown  to  occur  frequently  in  normal  B 
cell  development  [Retter  &  Nemazce,  1998]. 
1.2.2  ROLES  OF  TRANSCRIPTIONAL  PROTEINS 
The  development  of  committed  B  lineage  cells  from  multipotent  progenitors  requires 
the  co-ordinated  activity  of  many  transcriptional  factors.  Recent  findings  regarding  the 
function  and  target  genes  for  seven  transcription  factors  necessary  for  proper 
development  of  early  B  lineage  cells  shall  be  detailed  briefly. 
Transcriptional  factors  that  are  essential  for  B  cell  development  appear  to  block 
differentiation  primarily  at  two  stages;  prior  to  commitment  to  B  lymphopoiesis  and  at 
the  pro-B/pre-B  cell  transition  when  VIIDJII  recombination  is  beginning.  PU.  1  seems  to 
be  required  prior  to  the  first  developmental  checkpoint,  whereas  E2A,  EBF  and  BSAP 
9 appear  to  act  at  the  second  developmental  checkpoint  [Urbanek  et  al.,  1994;  Dorshkind, 
1994;  Singh,  1996]. 
PU.  l 
PU.  1  is  a  member  of  the  els  family  of  transcription  factors,  that  is  expressed  exclusively 
in  haematopoietic  cells,  with  expression  being  highest  in  macrophages,  but  is  also 
detected  in  neutrophils,  B  and  early  T  lymphocytes.  [KIemsz  et  al.,  1990,  Anderson  et 
al.,  1999].  The  importance  of  PW  in  the  development  of  these  lineages  was  confirmed 
by  generating  mutant  PU.  1  mice  [Scott  et  al.,  1994;  McKercher  et  al.,  1996].  Scott  et 
al.,  report  a  mutation  resulting  in  mice  that  die  at  embryonic  day  18,  lacking 
macrophages,  neutrophils  and  lymphocytes  but  containing  normal  erythrocytes  and 
megakaryocytes.  The  PW  mutation  produced  by  McKercher  et  al.,  results  in  mice 
surviving  for  48  hours  after  birth,  but  that  subsequently  die  from  bacterial  infection. 
These  mice  lack  macrophages,  neutrophils  and  lymphoid  cells  at  birth.  These  findings 
suggest  that  PW  is  required  for  the  development  of  multipotential  progenitor  cells 
common  to  both  the  lymphoid  and  myeloid  lineages.  DeKoter  and  Singh  suggest  PUI 
expression  levels  to  be  important  in  determining  whether  multi-potent  progenitors 
commit  to  differentiation  down  the  B  lymphocyte  or  macrophage  lineage  [DeKoter  & 
Singh,  2000]. 
IKAROS 
The  Ikaros  gene  encodes  a  set  of  proteins,  generated  by  alternative  splicing,  that  contain 
kruppel-like  zinc  fingers  organised  in  two  functional  domains;  one  for  DNA  binding 
and  a  second  for  dimerisation  [MoInar  &  Georgopoulos,  1994,  Hahm,  et  al.,  1994J. 
Ikaros  gene  expression  appears  to  be  present  throughout  B  cell  development 
[Georgopoulos,  et  al.,  1992,  Georgopoulos,  et  al.,  1997,  Morgan  et  al.,  1997],  and  while 
it  appears  to  increase  as  B  cells  mature,  the  relevance  of  absolute  versus  relative  levels 
of  Ikaros  proteins  is  not  understood  [Georgopoulos,  et  al.,  1997].  Gene  targeting 
experiments  introducing  an  Ikaros  null-mutation  in  mice  [Wang,  et  al.,  1996]  illustrate 
its  role  in  lymphopoiesis  with  these  animals  lacking  fetal  lymphocytes  and  adult  B  cells, 
with  B  cell  development  block  being  very  early,  prior  to  the  pro-B  cell  stage. 
10 E2A 
The  E2A  gene  encodes  two  proteins,  E12  and  E47,  members  of  the  basic  helix-loop- 
helix  (bHLH)  family  of  transcription  factors  [Murre  et  al.,  1994].  The  E2A:  4* 
homozygous  mice  die  shortly  after  birth  [Bain  et  al.,  1994;  Zhuang  et  al.,  1996],  whilst 
in  the  heterozygotes  B  lymphocytes  fail  to  develop  and  T  cell  development  is 
significantly  perturbed  [Bain  et  al.,  1994;  Zhuang  et  al.,  1996;  Bain  et  al.,  1997].  The 
bone  marrow  and  fetal  liver  of  E2A-deficient  mice  lack  CD19+  cells,  and  rearrangement 
of  the  19H  loci  cannot  be  detected.  In  addition  few  B-lineage-associated  genes  are 
expressed,  with  the  exception  of  germline  IgH  transcripts  and  B29/lgp  [Bain  et 
al.,  1994;  Bain  et  al.,  1997].  The  E2A  proteins  have  been  shown  to  be  involved  in  the 
expression  and  re-arrangernent  of  the  Igh  and  Igic  gene  loci,  and  are  thought  to  be 
required  for  the  correct  expression  of  the  recombinase  activating  genes  [RAGs] 
[Schlissel  et  al.,  1991;  Bain  et  al.,  1997).  E2A  and  early  B  cell  factor  (EBF)  are 
necessary  and  function  together  to  promote  the  development  of  B  lineage  cells  at 
subsequent  stages  [O'Riordan  &  Grosschedl,  1999]. 
Mice  lacking  E12  alone  have  defects  at  later  developmental  stages,  suggesting  E12  and 
E47  have  an  overlapping,  yet  distinct  influence  on  B  cell  development  [Bain  et  al., 
1997].  There  is  also  a  noted  gene  dose  effect  with  E47  proteins,  with  E47+1' 
heterozygotes  showing  exactly  half  the  number  of  mature  B  cells  relative  to  control 
mice  [Zhuang  et  al.,  1994]. 
E2A  may  also  play  a  role  in  later  B  cell  differentiation  as  it  is  upregulated  in  germinal 
centre  cells  with  class  switching  to  some  isotypes  inhibited  in  B  cell  lines  that  over- 
express  Id  (inhibitor  of  development),  implying  a  role  for  bHLH  family  factors  in 
terminal  differentiation  [Goldfarb  et  al.,  1996]. 
EBF 
Early  B  cell  factor  (EBF),  as  the  marne  suggests,  has  been  shown  to  regulate  early  events 
in  B  cell  differentiation.  EBF  is  expressed  throughout  B  cell  differentiation,  with  the 
exception  of  terminally  differentiated  plasnia  cells  [Hagnian  et  al.,  1993].  In  mice 
ablation  of  EBF  results  in  a  block  in  the  B  cell  differentiation  at  the  early  pro-B  cell 
11 stage.  Pro-B  cells  from  these  animals  lack  DJH  rearrangements,  Iga,  lgP,  surrogate  fight 
chain,  RAG-1  and  -2,  although  they  do  express  Igýt  and  IL-7F,  leading  to  the  proposal 
that  developmental  arrest  occurs  after  commitment  to  the  B  lineage  [Lin  &  Grosschedl, 
1995]. EBF  and  E2A-deficient  mice  present  with  defects  at  similar  stages  in  B  cell 
development,  suggesting  these  proteins  may  act  co-operativeIy  to  regulate  a  conunon 
set  of  genes.  Indeed  ectopic  expression  of  EBF,  together  with  E47  dimers,  was  shown 
to  induce  expression  of  VpreB  and  X5  B  cell-specific  genes  suggesting  functional 
synergy  between  the  EBF  and  E47  proteins  [Sigvardsson  et  al.,  1997]. 
BSAP/PAX-5 
B  cell  specific  activating  protein  (BSAP),  the  product  of  the  Pax-S  gene,  is  expressed  in 
all  B  lineage  cells  with  the  exception  of  plasma  cells  [Barberis  et  al.,  1990].  Mice  that 
carry  a  targeted  deletion  of  the  Pax-S  gene  lack  pre-B,  B  and  plasma  cells  [Urbanek  et 
al.,  1994].  These  mice  lack  CD19+  cells  and  VHDJ,  4  recombination  is  significantly 
reduced  [Urbanek  et  al.,  1994;  Nutt  et  al.,  1997].  In  addition,  most  B-lineage  associated 
genes  are  expressed  normally  with  the  exception  of  CD19,  N-myc,  mb-l/Iga  and  LEF- 
1,  which  have  all  been  shown  to  be  Pax-5  -responsive  target  genes  [Nutt  et  al.,  1999].  In 
the  absence  of  Pax-5,  progenitors  do  not  become  committed  to  the  B  lineage,  even 
although  they  have  the  phenotype  of  committed  B  lineage  progenitors  [Nutt  et  al.,  1999; 
Rolink  et  al.,  1999].  In  the  absence  of  Pax-5  the  cells  continue  to  express  a  number  of 
genes  associated  with  non-B  lineage  cells,  indicating  an  ability  of  Pax-5  to  repress  the 
expression  of  genes  that  function  in  the  differentiation  of  alternative  cell  lineages. 
LEF-I 
Lymphoid  enhancer-binding  factor  (LEF-1)  is  a  member  of  the  T-cell-specific 
transcription  factor  (TCF)/LEF  family.  LEM  is  expressed  in  both  pro-B  and  pre-B 
cells,  but  not  immature  or  mature  B  cells  [Reya.  et  al.,  2000].  In  the  absence  of  LEF-  IB 
lymphocyte  differentiation  appears  to  be  normal,  although  fewer  pro-B  and  pre-B  cells 
develop,  as  a  result  of  a  decrease  in  proliferation  and  survival  of  early  B  lineage 
progenitors.  Recently  LEF-I  has  been  shown  to  be  the  target  of  the  Wnt  signalling 
pathway.  Signal  transduction  in  response  to  Wnt  binding  to  its  receptor,  Frizzled,  leads 
to  the  stabilisation  of  cytosolic  P-catenin,  which  then  accumulates  in  the  nucleus  and 
12 functions  as  a  co-activator  for  LEF-I  transcriptional  responses  [Behrens  et  aL,  19961. 
This  signal  transduction  pathway  is  very  important  in  a  number  of  developmental 
processes  and  in  many  forms  of  cancer  [Polakis,  2000].  Wnt  signalling  may  also  be 
involved  in  the  development  of  some  forms  of  pre-B-acute  lymphoblastic  leukaemia 
(ALL),  as  Wnt16  was  identified  as  a  target  of  the  E2A-PbxI  oncoprotein  which  is 
associated  with  a  subset  of  pre-B  ALL  [McVVhirter  et  aL,  1999]. 
NF-icB 
The  NF--KB/rel  family  of  transcriptional  factors  illustrate  a  high  degree  of  homology  in  a 
shared  300  amino  acid  rel  domain.  This  region  is  essential  for  DNA  binding, 
dimerisation  between  rel  proteins  and  interactions  with  other  transcriptional  factors. 
There  are  at  least  five  rel  family  members  which  may  be  involved  in  B  cell 
development,  these  include  ReIA  (p65),  Rel-c,  ROB,  NF-xBI  (pIO5)  and  NF-KB2 
(plOO).  p105  and  plOO  generate  precursor  proteins  processed  by  proteolyic  cleavage  to 
generate  p50  and  p52  subunits.  These  subunits  can  generate  hetero-  and  homodimers, 
that  bind  DNA.  NF-O,  whose  activity  is  regulated  by  interaction  with  IkB  inhibitory 
proteins  is  proposed  to  regulate  several  genes  important  in  B  cell  differentiation, 
including  the  Ig  light  chains  [Baeuerle  &  Henkel,  1994].  Studies  have  suggested  a 
hierarchy  of  NF-r.  B  dirners  during  B  cell  development;  pre-B  cells  primarily  have 
p50/P65  dimers,  mature  B  cells  have  Rel-c/p50  dirners  and  plasma  cells  have  p52/RelB 
dimers  [Liou  et  al.,  1994;  Miyarnoto  et  al.,  1994]. 
1.2.3  STAGES  OF  ANTIGEN-DEPENDENT  DEVELOPMENT 
Developmental  events  and  altered  patterns  of  gene  expression  that  occur  after  the  B  cell 
encounters  antigen  are  summarized  in  Fig  1.2.  The  naYve  B  cell,  is  initially  activated 
following  the  first  encounter  of  the  BCR  with  cognate  antigen,  inducing  proliferation 
and  stimulating  uptake,  processing,  and  presentation  of  thyinus-dependent  (TD) 
antigens  and  altered  patterns  of  gene  expression. 
13 1.2.3A  B  LympHoCYTE  ACTIVATION  BY  CONTACT-MEDIATED 
INTERACTIONS  WITH  T  LywHoCYTES 
B  lymphocytes  can  bind  many  biologically  active  soluble  molecules  such  as 
lymphokines  and  chemokines,  however  the  development  of  affinity  maturation  and  a 
highly  effective  humoral  memory  response  requires  the  receipt  of  contact-mediated 
signals  from  an  activated  T  lymphocyte.  Bystander  polyclonal  activation  of  B  cells  by 
activated  T  cells  does  occur,  but  is  not  widespread  in  the  normal  immune  response.  This 
fact  suggests  that  the  cognate  interactions  between  B  cells  that  can  present  specific 
antigen,  and  activated  T  cells  that  are  specific  for  that  antigen-MHC  complex,  increase 
the  efficiency  of  the  delivery  of  non-cogmte  signals  between  the  two  cell  types  [Bishop 
et  al.,  1995;  Macaulay  et  al.,  1997;  Kalberer  et  al.,  1997].  Three  mechanisms  are 
thought  to  contribute  to  this  increased  efficiency;  first,  signalling  through.  the  BCR 
primes  the  B  cell  to  become  more  responsive  to  T  cell  activation  signals  and  also 
stimulates  enhanced  expression  of  surface  molecules  contributing  to  antigen 
presentation,  e.  g.  MHC  class  II  molecules.  Second,  the  ability  of  the  cells  to  interact 
directly  through  MHC-TCR  binding  enhances  physical  proximity,  assisting  in  the 
delivery  of  contact-mediated  signals  as  well  as  soluble  molecules.  Third,  signals 
delivered  to  the  B  cell  via  engagement  of  the  MHC  class  II  molecules  have  been  shown 
to  enhance  both  antigen  presentation  and  B  cell  activation,  and  are  thought  to  co-operate 
with  both  BCR  signals  and  other  contact-dependent  signals. 
The  requirement  for  contact-mediated  signals  in  antigen-specific  B  cell  activation 
appears  to  serve  two  important  roles;  to  enhance  the  effectiveness  of  the  adaptive 
humoral  response  and  to  decrease  the  potential  for  activation  of  auto-reactive  B  cells, 
with  recent  reports  highlighting  the  importance  of  contact-mediated  signals  in  the 
development  of  autoimmunity  [Korganow  et  al.,  1999;  Kyburz  et  al.,  1999].  Through 
use  of  a  TCR  transgenic  mouse  strain  that  develops  a  disease  resembling  human 
rheumatoid  arthritis  (RA),  Korganow  and  colleagues  showed  that  autoreactive  T  cells 
and  B  lymphocytes  secreting  auto-antibody  are  both  necessary  for  disease  development, 
suggesting  the  close  co-operation  of  cellular  and  humoral  immune  responses  in  the 
development  of  certain  autoirnmune  diseases.  Kyburz  and  colleagues  demonstrate  the 
Potentially  important  role  for  CD40-CD154  interactions  in  the  pathogenesis  of  RA.  This 
14 interaction  is  discussed  in  more  detail  in  the  section  devoted  to  the  TNF  and  TNF- 
receptor  family  members. 
It  was  originally  believed  that  T  cell  cytokine  production  was  both  necessary  and 
sufficient  to  mediate  the  full  activation  of  antigen  specific  B  cells.  However  when  more 
stringent  cell  separation  procedures  were  employed  it  was  shown  that  contact-mediated 
signals  from  T  cells  were  also  required.  Historically,  purified  B  cell  samples  would  have 
stiff  contained  contaminating  T  cells,  facilitating  the  generation  of  these  essential 
signals,  unbeknown  to  the  investigator.  A  variety  of  receptor-ligand  pairs  are  now 
thought  to  contribute  to  T  cell  contact-mediated  B  cell  activation,  these  interactions  are 
discussed  briefly  below. 
MHC  CLASS  11  MOLECULES 
The  first  such  signal  to  be  identified  was  that  from  MHC  class  II  molecules  [Palacios  et 
al.,  1983;  Bishop  &  Haughton,  1986a].  This  interaction  has  been  well  charactcrised 
now,  with  engagement  of  class  Il  molecules  on  B  cells  reported  to  stimulate  early 
biochemical  signalling  events  as  well  as  later  effector  functions,  such  as  B  cell 
proliferation  and  differentiation  [Scholl  &  Geha,  1994].  Indeed  many  of  these 
interactions  have  been  investigated  and  it  is  reported  that  both  the  cytoplasmic  and 
transmembrane  domains  of  the  molecule  contribute  to  these  signalling  events  [Wade  et 
al.,  1989;  Harton  et  al.,  1995].  Work  with  class  Il  deficient  mice  has  shown  that  B  cell 
activation  can  occur  in  the  absence  of  class  II  expression  [Markowitz  et  al.,  19931. 
However,  class  11  engagement  has  been  shown  to  enhance  both  BCR  and  CD40 
signalling  [Bishop  el  al.,  1995],  and  is  thought  to  contribute  to  the  activation  of  CD40- 
deficient  B  cells  [Schrader  et  al.,  1996].  These  data  suggest  that  class  Il  signalling  may 
promote  the  preferential  activation  of  cognate  antigen-presenting  B  cells  by  T  cells 
through  enhancing  the  effectiveness  of  other  B  cell  activation  signals.  Class  11  signalling 
has  recently  been  shown  to  be  partly  regulated  by  two  BCR  co-receptors,  CD19  and 
CD22  [Bobbitt  &  Justement,  2000],  a  finding  consistent  with  this  suggested  role. 
15 ADHESION  MOLECULES 
Both  B  and  T  lymphocytes  express  a  variety  of  transmembrane  intercellular  adhesion 
molecules.  Both  cell  types  express  CD54  (ICAM-  1)  and  CD  II  a-CD  18  (LFA-  1),  which 
can  bind  to  each  other  and  mediate  both  hornotypic  and  heterotypic  adhesion 
interactions.  Signalling  to  the  B  cell  via  these  molecules  is  not  well  understood, 
however  enhanced  adhesiveness  between  B  and  T  cells  can  amplify  the  activation 
signals  from  one  cell  type  to  the  other.  Preliminary  studies  indicated  that  both  CD  II  a- 
CD18  and  CD54  may  directly  transmit  activation  signals  to  B  cells  [Bishop  & 
Haughton,  1986b;  Owens,  1991],  and  it  was  later  shown  that  such  signals  are  able  to 
contribute  to  enhanced  B  cell  antigen-presentation  [Moy  &  Brian,  1992]  and  work 
together  with  CD40-mediated  signalling  [Poudrier  &  Owens,  1994].  More  recently, 
CD54-mediated  upregulation  of  class  II  expression  on  aB  cell  line  has  been  shown  to 
correlate  with  the  activation  of  the  Src  family  kinase,  Lyn,  and  the  mitogen-activated 
protein  kinases  [Holland  &  Owens,  1997].  Further  investigation  is  needed  to  elucidate 
the  physiological  circumstances  in  which  CD  11  a-CD  18  and  CD54  signal  to  B  cells  and 
how  these  signals  co-ordinate  with  other  T  cell  mediated  signals. 
CD22,  an  immunoglobulin  family  member  that  modulates  BCR  signalling  [Cornall  et 
al.,  2000],  is  another  adhesion  molecule  capable  of  signalling  to  B  cells.  A  vast  number 
of  potential  binding  partners  exist  for  CD22,  including  a  variety  of  cell-surface 
glycoproteins  and  glycolipids  demonstrating  its  natural  ligand  of  N-linked 
oligosaccharides  containing  cc2fi-linked  sialic  acids,  many  of  which  are  expressed  on  T 
lymphocytes.  The  physiologically  important  ligands  in  vivo  remain  unclear.  CD22  has 
been  shown  to  be  a  receptor  for  CD45/13220  [Sgroi  et  al.,  1995]. 
CD81,  a  tetraspanin  family  member,  has  also  been  implicated  in  adhesion  and  T  cell 
dependent  B  cell  activation  [Maecker  &  Levy,  1997;  Maecker  et  al.,  1998],  but  as  yet 
no  natural  ligand  has  been  isolated  so  its  effect  on  T  and  B  cell  interactions  is  not  yet 
known. 
16 CD72 
Antibody-mediated  engagement  of  CD72  on  B  cells  has  been  shown  to  stimulate 
proliferation,  enhance  B  cell  survival  and  upregulation  of  MHC  class  II  expression 
[Amakawa  et  al.,  1996].  However  until  recently'the  ligand  for  CD72  had  remained 
elusive.  CD100,  a  class  IV  sernaphorin  expressed  on  both  B  and  activated  T  cells,  was 
identified  as  the  natural  ligand  for  CD72  [Kumanogoh  et  al.,  2000]  an  interaction  shown 
to  enhance  B  cell  activation  mediated  by  CD40.  Results  also  indicate  that  CDlOO- 
mediated  CD72  signals  are  important  for  antigen  presentation  and  may  be  responsible 
for  inducing  the  dissociation  of  SHP-1  phosphatase  from  CD72  [Kumanogoh,  et  al., 
2000,  Shi  et  al.,  2000]. 
TNF  AND  TNF-RECEPTOR  FAmiLy  PROTEINS 
Signals  delivered  through  membrane-bound  members  of  the  TNF  and  TNF  receptor 
(TNF-R)  family  of  proteins  are  some  of  the  most  biologically  important  signals  that  B 
ceUs  receive  from  the  cogmte  activated  T  ceH. 
CD40 
CD40  was  one  of  the  first  TNF  family  members  shown  to  be  of  major  importance  in  T 
cell-dependent  B  cell-activation.  CD40  is  a  45-5OkDa  glycoprotein  [Paulie  et  al.,  19891 
expressed  on  B  cells  as  well  as  T  cells  and  follicular  dendritic  cells  (FDCs) 
[Banchereau,  et  al.,  19941.  CD154  or  CD40L,  the  ligand  for  CD40,  is  a  39kDa  member 
of  the  TNF  family  and  is  expressed  as  a  membrane-bound  trimer  on  activated  T 
lymphocytes,  as  well  as  mast  cells  and  basophils.  T  cell  CD40L  expression  levels  have 
been  shown  to  increase  as  the  cells  mature  [Nonoyama,  et  al.,  1995]. 
Bricfly,  CD40  engagement  on  B  lymphocytes  is  well  characterised,  resulting  in  B  cell 
proliferation,  antibody  secretion,  cytokine  production,  upregulation  of  various  surface 
molecules  involved  in  antigen  presentation,  isotype  switching,  development  of  germinal 
centers  and  a  humoral  memory  response,  recently  reviewed  in  [van  Kooten  & 
Banchereau,  2000;  Calderhead  et  al.,  2000].  Dendritic  cells  have  been  shown  to  be 
superior  to  B  cells  with  respect  to  antigen  presentation  in  many  situations,  however 
recent  studies  have  shown  that  B  cells  can  be  important  antigen-presenting  cells  for  T 
17 cell  activation  and  that  CD40  signalling  to  the  B  cell  plays  a  critical  role  in  this  function 
[reviewed  by  Korganow  et  al.,  1999;  Constant,  1999]. 
B  cell  CD40-T  cell  CD40L  interaction  is  also  involved  in  the  rescue  of  B  cells  from 
apoptosis  [Holder,  et  al.,  1993],  and  the  promotion  of  IgE  synthesis  and  CD23 
expression  on  uncommitted  nSfve  B  cells  requires  a  minimum  of  two  signals,  the  first 
from  IL-4  (or  IL-13)  and  the  second  through  the  CD40-CD40L  interaction  [Bonnefoy, 
et  al.,  1995].  Enhanced  CD23  expression  is  noted  when  B  cells  are  co-induced  with 
both  sCD40L  and  IL-4  [Burlinson,  et  al.,  1996].  This  increase  in  CD23  is  thought  to  be 
due  to  the  ability  of  IL-4  to  elevate  CD40  levels  in  B  cells,  thus  increasing  the  number 
of  receptors  available  for  engaging  sCD40L. 
The  molecular  mechanism  by  which  CD40  signals  to  B  cells  has  not  been  established. 
The  carboxy-terminal  domain  of  CD40  has  been  shown  to  bind  to  a  cytoplasmic  family 
of  adapter  molecules,  called  'TNF-R-associated  factors'  (TRAFs)  [Arch  et  al.,  1998]. 
TRAFs  play  important  roles  in  CD40  signalling,  however  it  is  not  yet  clear  how  they 
regulate  CD40  function. 
CD27 
CD27  is  a  TNF-R  family  member  expressed  by  a  subpopulation  of  B  lymphocytes,  its 
ligand,  CD70,  is  expressed  by  T  lymphocytes  relatively  late  in  their  activation  [11intzen 
et  al.,  1993].  CD27  signals  have  been  shown  to  be  important  in  the  terminal 
differentiation  of  B  cells  into  antibody-secreting  plasma  cells  [Agematsu  et  al.,  1998; 
Jacqout  et  al.,  1997;  Nagumo,  et  al.,  1998]  and  like  other  TNF-R  family  members, 
signalling  by  CD27  is  mediated,  at  least  in  part,  by  TRAF  molecules  (TRAF-2,  -3  and  - 
5)  [Arch  et  al.,  1998].  CD27  does  mediate  the  activation  of  NF-icB  and  c-Jun  kinase,  in 
common  with  CD40  signalling  [Akiba  et  al.,  1998;  Gravestein  et  al.,  1998],  but 
additional  unidentified  signals  and  the  timing  of  CD27  expression  are  thought  to 
contribute  to  its  unique  activities  in  B  cell  differentiation  [Bishop  &  Hostager,  20011. 
18 CD30  AND  CD153 
CD30  and  its  figand  CD153  have  been  proposed  as  negative  regulators  of  the  humoral 
immune  response,  as  signalling  through  either  molecule  on  B  lymphocytes  has  been 
shown  to  inhibit  isotype  switching  and  limit  the  magnitude  of  the  immune  response  and 
the  activation  of  low  affinity  B  cells  [Cerutti  et  al.,  1998;  Cerutti  et  al.,  2000].  Like 
many  of  its  relatives,  CD30  mediates  its  signalling  through  TRAF  proteins  [Arch  et  al., 
1998]  and  can  stimulate  NF-KB  activation  [Ansieau  et  al.,  1996],  presumably  delivering 
other  unique  'negative'  signals  that  are  yet  to  be  identified.  Signal  transduction  through 
CD153  is  even  less  well  understood,  with  its  engagement  resulting  in  the  loss  of  Blimp- 
I  (B-lymphocyte-induced  maturation  protein  1)  mRNA  expression  and  enhancement  of 
BSAP  (13-cell-specific-activator  protein)  repressor  binding  to  the  immunoglobulin  3' 
enhancer  [Cerutti  et  al.,  2000]  although  the  proximal  signalling  events  leading  to  these 
phenomena  have  not  been  elucidated. 
CD134  LIGAND  AND  CD137  LIGAND 
Early  studies  demonstrated  that  CD134  ligand  (CD134L),  expressed  on  activated  B 
cells,  may  send  signals  to  B  cells  to  promote  proliferation  and  differentiation  [StUber  et 
al.,  1995;  Stilber  &  Strober,  1996].  CD134L-deficient  mice  have  been  shown  to  have  a 
reduced  number  of  switched  immunoglobulin  isotypes  [Murata  et  al.,  2000]  but 
germinal  centre  formation  is  not  affected  [Stilber  &  Strober,  1996],  suggesting  these 
signals  are  more  important  for  normal  production  of  a  strong  secondary  antibody 
response,  rather  than  for  the  development  of  memory  B  cells.  More  recently,  CD134 
stimulation  of  B  cells  has  been  shown  to  enhance  the  rate  of  IgG  production  stimulated 
through  CD40,  IL-4  and  IL-  10  [Morimoto  el  al.,  2000]. 
CD  13  7,  expressed  on  activated  T  cells,  interacts  with  CD  13  7L  expressed  on  B  cells  and 
this  interaction  has  been  shown  to  provide  important  co-stimulatory  signals  to  the  T  cell 
[as  reviewed  by  Vinay  &  Kwon,  1994],  however  a  clear  role  in  B  cell  signalling  has  not 
been  demonstrated  in  vivo.  Early  in  vitro  studies  observed  stimulation  with  CD137  to 
enhance  the  B  ceR  proliferative  response  to  anti-p  antibody  [PoHock  et  al.,  19941.  A 
more  recent  study  suggests  that  CD137L  serves  prinmrily  to  stimulate  CD137  signalling 
in  T  cells,  rather  than  to  deliver  critical  signals  to  the  B  cell  [DeBenedette  et  al.,  19991. 
19 BCMA  AND  TACI 
B-cell  maturation  antigen  (BCMA)  is  a  member  of  the  tumour  necrosis  factor  (TNF) 
receptor  family  and  is  expressed  on  B  lymphocytes.  Two  recently  identified  TNF- 
related  proteins,  BAFF  [Schneider  et  al.,  1999]  (also  known  as  BlyS  [Moore  et  al., 
1999]  or  TALL-I  [Shu  et  al.,  1999]),  and  APRIL  ('a  proliferation-inducing  ligand') 
[Hahne  et  al.,  1998],  have  been  shown  to  be  able  to  augment  B  cell  growth  and 
differentiation  by  signalling  through  either  BCMA  or  transmembrane  activator  and 
CAML-interactor  (TACI).  BCMA  and  TCAI  are  both  expressed  on  resting  B  cells 
[Schneider  et  al.,  1999].  Both  BAFF  and  APRIL  compete  for  receptor  binding,  binding 
BCMA  and  TACI  with  equivalent  affinity  [Yu  et  al.,  2000].  BAFF  is  known  to 
stimulate  B  cell.  proliferation  and  immunoglobulin  secretion  [Schneider  et  al.,  1999],  as 
well  as  modulating  the  survival  of  peripheral  B  cells  [Batten  et  al.,  2000;  UAW  & 
Strasser,  2000].  APRIL  has  also  been  shown  to  stimulate  B-cell  proliferation  [Yu  et  al., 
2000].  Recent  studies  in  mice  have  suggested  a  functional  redundancy  of  BCMA  in  13- 
cell  physiology,  probably  due  to  the  presence  of  TACI  [Xu  &  Lam,  2001].  The  role  of 
APRIL  and  BAFF  in  T  cell  contact  dependent  B  cell  activation  is  yet  to  be  confirmed. 
Both  molecules,  primarily  sourced  from  myeloid  cells,  are  type-II  transmembrane 
proteins  and  may  have  the  potential  to  be  proteolytically  cleaved  from  the  cell  surface; 
therefore,  they  may  be  more  important  as  soluble  molecules. 
1.2.3B  REGULATION  OF  GERMINAL  CENTER  B  CELL  DIFFERENTIATION 
The  complex  developmental  events  that  occur  in  the  germinal  centre  (GQ  depend  upon 
mtirmte  associations  between  the  B  cells  and  T  helper  cells  (T11)  and  follicular  dendritic 
cells  (FDC's),  initiating  proliferation,  somatic  hypermutation,  selection  for  cells 
expressing  high-affinity  antibodies,  isotype  switch  recombination  and  negative  selection 
[MacLennan,  1994;  Kelsoe,  1995;  Kelsoe,  1996;  Tsiagbe,  et  al.,  1996;  Ferguson,  et  al., 
1996].  Predictably  a  number  of  gene  products  involved  in  B  cell-T  cell  interactions  are 
required  for  GC  formation;  CD28,  CD40,  CD40L,  CD19  and  B7-2. 
Centroblasts  that  form  the  dark  zone  proliferate  rapidly  and  express  high  levels  of  c- 
Myc,  required  for  rapid  cell  division  [Cutrona  et  al.,  1997].  Somatic  hypennutation 
takes  place  in  GC  [Kuppers  et  al.,  1996]  in  centroblasts  prior  to  isotype  switch 
recombination  [Liu  et  al.,  1996  a,  b&  cl  although  GC  formation  has  been  shown  not  to 
20 be  strictly  required  for  somatic  hypermutation  [Stall  et  al.,  1996,  Matsumoto  et  al., 
1996].  Receptor  editing  of  immunoglobulin  light  chains  and  re-expression  of  RAG-1 
and  -2  also  occur  in  GC  centroblasts  [Han  et  al.,  1996]. 
Signalling  via  CD40/CD40L  induces  expression  of  B7,  CD23  and  other  surface 
molecules  in  GC  cells  [Barrett  et  al.,  1991;  Ranheim.  &  Kipps,  1993;  Kennedy  et  al., 
1994].  If  GC  cells  fail  to  receive  signals  from  FDC  or  T  cells  they  undergo  spontaneous 
Fas-dependent  cell  death  [Laman  et  al.,  1996;  Choe  et  al.,  1996;  Koopman  et  al.,  1997]. 
If  the  BCR  is  engaged  by  soluble  antigen  or  in  the  presence  of  T  cell  help,  the  cells  also 
undergo  apoptosis  independent  of  Fas  and  CD40L  [Pulendran  et  al.,  1995;  Shokat  & 
Goodnow,  1995;  Galibert  et  al.,  1996;  Han  et  al.,  1995],  which  presumably  deletes 
auto-reactive  B  cells  [Han  et  al.,  1995;  Billian  et  al.,  1997]  thus  eliminating  the 
possibility  of  generating  high  affinity  auto-reactive  mutants. 
B  cell  antigen  receptors  that  fail  to  bind  adequately  to  low  levels  of  antigen  presented  by 
FDCs  within  the  GC  can  trigger  yet  another  mechanism  for  optimising  the  B  cell 
immune  response  -  receptor  revision  [Wilson  et  al.,  2000;  Nemazee  &  Weigert,  2000]. 
Receptor  revision  refers  to  a  process  similar  to  receptor  editing  (yet  differently 
triggered)  as  it  occurs  in  the  peripheral  lymphoid  organs,  such  as  the  spleen,  lymph 
node  and  gut.  Whilst  editing  minimises  autoreactivity  in  immature,  preimmune  cells  by 
specifically  replacing  auto-reactive  receptors,  revision  occurs  during  antigen-driven 
immune  responses  and  is  suppressed,  rather  than  induced,  by  slg  cross-linking. 
Successful  antigen  receptor  revision  in  peripheral  B  cells  results  in  the  expression  of  a 
surface  Ig  molecule  that  binds  antigen  with  an  affinity  higher  than  that  of  the  parent  Ig 
molecule,  and  therefore  contributes  to  selection  of  an  Ig  repertoire  of  the  best  fit 
[Nemazee,  20001. 
Following  successive  rounds  of  somatic  hypermutation,  receptor  editing,  isotype  switch 
recombination  and  selection,  GC  B  cells  are  signalled  to  proliferate,  exit  the  germinal 
center  and  differentiate  into  either  memory  (able  to  make  a  robust  secondary  immune 
response)  or  plasma  B  cells  (secreting  high  affinity  antibody).  These  cells  lose  their 
apoptotic'  phenotype  by  downregulating  Fas  [Choe  et  al.,  1996]  and  increasing 
expression  of  bcl-2,  bcl-xL,  and  cyclin-dependent  kinases  4  and  6  [Ishida  et  al.,  19951. 
21 They  switch  from  an  autocrine  to  a  paracrine  dependence  on  IL-6  by  downregulating 
IL-6  expression  and  upregulating  IL-6R  expression  [Koopman  et  al.,  1997]. 
CD40  signalling  also  induces  expression  of  a  number  of  transcription  factors,  including 
jun  via  JNK  [Berberich  et  al.,  1996;  Li  &  Baccam  et  al.,  1996],  NF-KB  [Berberich  et 
al.,  1994],  and  NF-AT  [Choi  et  al.,  1994].  CD40  signalling  is  probably  required  for  the 
generation  of  both  memory  and  plasma  cells  [Lagresle  et  al.,  1995;  Holder  et  al.,  1993]. 
The  timing,  strength,  and  interplay  of  signals  from  BCR,  CD40,  B7-1/2,  and  cytokines 
appears  to  determine  cell  fate  [Grouard  et  al.,  1995;  Arpin  et  al.,  1995;  Malisan  et  al., 
1996;  Maliszewski  et  al.,  1993;  Urashima  et  al.,  1996].  Little  is  known  about  gene 
expression  in  memory  cells,  although  human  memory  cells  are  CD38CD20+CD39+  and 
can  be  re-stimulated  to  proliferate  in  response  to  CD40L  [Arpin  et  al.,  1995]. 
Plasmablasts  exiting  the  GC  are  still  proliferating,  but  outside  the  GC  they  become  non- 
dividing  plasma  cells  with  a  life  span  of  approximately  I  month.  IL-6  protects  plasma 
cells  from  apoptosis  [Kawano,  et  al.,  1995],  induces  immunoglobulin  and  Oct-2 
expression  [Natkunarn  et  al.,  1994],  and  leads  to  activation  of  cyclin-dependent  kinase 
inhibitor  p18,  which  blocks  cell  division  [Morse  et  al.,  1997].  Plasma  cells  have 
immense  levels  of  Ig  and  J  chain  mRNA,  and  transcription  factor  Blimp-  I  is  induced 
when  B  cells  differentiate  into  plasma  cells  [Turner  et  al.,  1994].  Expression  of  many 
genes  is  decreased  in  plasma  cells,  including  CD23,  CD22,  possibly  CD19,  class  II 
MHC,  c-Myc,  BSAP,  early  B  cell  factor  (EBF),  and  CIITA  [Henderson  &  Calame, 
1998]. 
1.3  MOLECULAR  SORTING 
All  eukaryotic  cells  exhibit  protein  transport  both  out  from  and  into  the  cell.  Pathways 
that  transport  material  out  of  the  cell  are  termed  exocytic  or  secretory  pathways, 
whereas  pathways  that  bring  material  into  the  cell  are  termed  endocytic  pathways.  One 
of  the  areas  addressed  by  the  research  presented  and  discussed  within  this  thesis  is 
CD23  intracellular  trafficking  from  the  plasma  membrane  into  the  cell,  the  endocytic 
molecular  sorting  pathways  are  therefore  of  particular  importance  in  this  work.  Figure 
22 1.3  iflustrates  an  overview  of  the  common  intraceHular  compartments  and  transport 
pathways  which  exist  in  eukaryotic  cells. 
1.3.1  GENERAL  MODELS  OF  INTRACELLULAR  SORTING 
For  the  most  part  transport  of  materials  between  intracellular  compartments,  and  indeed 
between  the  plasma  membrane  and  intracellular  compartments,  occurs  via  vesicles  and 
requires  several  steps,  namely  vesicle  formation,  targeting,  docking  and  fusion.  A 
general  model  of  vesicular  transport  exists  that  has  been  found  to  be  conserved  in  all 
eukaryotic  organisms  from  yeast  to  man.  Briefly,  transport  is  initiated  from  one 
membrane  compartment  by  the  recruitment  of  cytosolic  coat  proteins  resulting  in  the 
formation  of  coated  pits  that  can  then  deform  the  membrane  into  coated  bud  structures. 
These  buds  then  undergo  scission  to  form  mature  coated  transport  vesicles.  The 
membrane-bound  coat  proteins  must  then  be  released  into  the  cytosol  before  the  vesicle 
can  then  fuse  with  its  target  compartment.  Fusion  is  directed  by  protein  complexes, 
derived  from  components  that  reside  in  both  the  cytosol  and  membranes  of  the  vesicle 
and  target  compartment,  serving  to  bridge  the  interaction  between  the  membranes  of  the 
vesicle  and  those  of  the  target  compartment/membrane  [Rothman  &  Wieland,  1996; 
Schekman  &  Orci,  1996]. 
Transport  vesicles,  whether  or  not  they  are  selective  in  the  way  they  pick  up  cargo  from 
the  donor  compartment,  must  be  highly  selective  with  respect  to  their  target  in  order  to 
fuse  with  the  correct  membrane,  enabling  transport  to  the  correct  compartment  within 
the  cell.  The  SNARE  hypothesis,  suggests  fusion  is  mediated  by  specific  v-SNAREs  on 
the  vesicle  membrane  that  recognise  and  dock  with  t-SNARES  on  the  target  membrane, 
and  is  an  attractive  hypothesis  describing  how  membrane  specificity  may  be  achieved 
[Sollner  et  al.,  1993].  The  v-SNAREs  are  thought  to  be  co-packaged  with  coat  proteins 
during  budding  of  the  transport  vesicle,  and  remain  associated  with  the  vesicle  as  it 
moves  to  the  target  membrane.  It  is  interesting  to  note  that  the  v-SNAREs  are  also 
transported  back,  from  the  target  compartment  to  their  original  compartment,  in  an 
inactivated  form,  after  the  fusion  event  [Rothman  &  Warren,  1994;  Pfeffer,  1996].  It  has 
been  demonstrated  that  SNAREs  are  regulated  by  the  Rab  family  of  GTPases 
[Brennwald  et  al.,  1994].  The  cognate  pairs  of  v-  and  t-SNAREs  were  originally 
thought  to  be  sufficient  for  both  vesicle  targeting  and  fusion,  however  it  has  recently 
23 become  clear  that  the  SNAREs  mediate  the  fusion  event,  whilst.  Rab  proteins  mediate 
the  SNARE-mediated  fusion  indirectly  by  modulating  a  more  upstream  process  that 
docks  the  vesicle  to  its  proper  target  compartment  [Barlowe,  1997;  Lupashin  et  al., 
1996]. 
Three  types  of  coated  vesicles  exist,  and  figure  1.4  summarises  these  proteins  and  the 
pathways  they  serve  in.  Two  groups  of  coatarner  proteins  termed  COPI  and  COPII 
(COP  for  Coat  Protein)  are  involved  in  the  ER-to-Golgi,  intra-Golgi  and  Golgi-to-ER 
pathways  [Rothman  &  Wieland,  1996;  Schekman  &  Orci,  1996],  whilst  clathrin  coated 
vesicles  are  involved  in  plasma  membrane-to-early  endosorne,  TGN-to-late  endosome 
and  TGN-to-lysosome  transport.  The  clathrin  coat  complex  consists  of  six  subunits. 
Two  of  them  are  termed  clathrin  heavy  and  light  chains.  These  molecules  are  known  to 
assemble  in  trimeric  pairs  forming  the  clathrin  triskelions  (Figure  1.4,  section  2). 
Triskelions  assemble  into  a  cage-Eke  hexagonal  lattice  which  attaches  to  membranes 
through  the  four  other  members  of  the  clathrin  coat,  the  adaptor  proteins  (AP)  or 
adaptins  [Brodsky,  1997;  Schmid,  1997].  The  adaptins  demonstrate  specificity  for 
different  membranes,  and  thus  enable  clathrin  coat  proteins  to  form  coated  vesicles  for 
more  than  one  transport  pathway.  For  example,  clathrin  with  AM  adaptins  form 
vesicles  that  transport  from  the  TGN  to  the  late  endosome  whilst  clathrin  with  AP-2 
adaptins  form  vesicles  that*  transport  from  the  plasma  membrane  to  the  early  endosome 
[Kirchhausen  et  al.,  1997;  Trowbridge  et  al.,  1993].  A  third  adaptin  complex  has  been 
identified,  AP-3  [DeU'Angefica  et  al.,  1997;  Simpson  et  al.,  1997]  and  has  been  shown 
to  mediate  transport  from  the  TGN  to  the  lysosome  [Cowles  et  al.,  1997;  Simpson  et  al., 
1997]. 
It  should  be  noted  that  endocytosis  can  also  occur  via  non-clathrin  coated  vesicles, 
however  this  is  less  understood  and  poorly  characterised.  One  class  of  non-clathrin 
coated  endocytosis  can  be  defined  pharmacologically  as  its  action  is  unaffected  by 
cytosolic  acidification  and  potassium  depletion,  two  factors  which  characteristically 
affect  clathrin-mediated  transport  [Sandvig  &  van  Deurs,  1994].  Another  class  is 
identified  by  the  involvement  of  morphologically  distinct  structures  termed  caveolae 
[Parton,  1996].  Reconstitution  studies  suggest  that  a  predicted  multi-spanning 
membrane  protein  termed  caveolin  is  essential  for  the  organisation  of  the  membrane 
24 into  the  structures  characteristic  of  caveolae  [Fra  et  al.,  1995].  Isoforms  of  caveoUn  that 
have  tissue  specific  distribution  have  been  identified  [Scherer  et  al.,  1996;  Tang  et  al., 
1996]  but  this  protein  is  absent  in  lymphocytes  accounting  for  the  lack  of  caveolae  in 
these  cells  [Fra  et  al.,  1994;  Gorodinsky  &  Harris,  1995]. 
1.3.2  SECRETORY  PATHWAYS 
Briefly,  the  endoplasmic  reticulum  (ER)  is  the  port  of  entry  for  an  proteins  transported 
through  the  secretory  pathways.  Nascent  proteins  targeted  to  the  ER  contain  an  amino- 
terminal  stretch  of  hydrophobic  residues  known  as  the  signal  peptide  [Blobel  & 
Dobberstein,  1975]. A  protein  complex  termed  the  signal  recognition  particle  (SRP) 
binds  to  the  signal  peptide  and  targets  the  nascent  protein  to  another  complex  on  the  ER 
membrane.  The  target  complex  on  the  ER  contains  the  binding  site  for  the  SRP,  the  SRP 
receptor  and  a  channel  that  translocates  the  nascent  protein  across  the  ER  membrane. 
Proteins  proceed  from  the  ER  to  the  Golgi  complex  where  they  can  be  sorted  into 
several  different  routes  [Mellman  &  Simons,  1992];  some  are  retained  in  the  Golgi, 
others  are  sorted  for  retrograde  transport  back  to  the  ER,  whilst  others  continue  in  the 
anterograde  direction,  through  the  Golgi  stacks  to  reach  the  trans-Golgi  network  (TGN), 
from  where  they  can  be  transported  directly  to  the  cell  surface  or  diverted  towards  the 
endosomaYlysosomal  system  [Griffiths  &  Simons,  1986].  Depending  on  the  cell  type, 
secretion  can  either  be  a  constitutive  process  or  it  may  be  regulated,  as  occurs  in 
specialised  cells,  where  by  proteins  are  concentrated  and  stored  until  an  extracellular 
signal  stimulates  their  release. 
1.3.3  ENDocyTic  PATHwAys 
Endocytosis  has  been  defined  traditionally  as  the  transport  processes  that  brings 
materials  into  the  cell,  and  is  characterised  by  the  continuous  and  regulated  formation  of 
large  numbers  of  membrane  vesicles  at  the  plasma  membrane.  Endocytotic  vesicles 
exist  in  several  different  varieties,  ranging  from  actin-dependent  formation  of 
phagosomes  involved  in  larger  particle  uptake  or  phagocytosis,  to  smaller  clathrin- 
coated  vesicles  often  responsible  for  the  internalisation  of  extracellular  fluid  and 
receptor-bound  Hgands  via  endocytosis. 
25 There  are  characteristic  differences  between  endocytosis  and  phagocytosis,  with  the 
main  one  being  that  phagocytosis  can  bring  much  larger  material  into  the  cell.  The 
initial  step  of  each  pathway  is  also  different,  with  vesicular  transport  involving  a 
localised  inward  curvature  of  the  membrane,  forming  buds,  whereas  the  initial  step  of 
phagocytosis  involves  local  reorganisation  of  the  submembranous  actin-based 
cytoskeleton,  enabling  the  cell  surface  to  envelope  the  structure  that  is  to  be  internalised 
[Swanson  &  Baer,  1995].  It  should  be  noted  that  although  endocytosis  was  originally 
used  to  include  both  these  types  of  transport,  the  usage  of  the  term  endocytosis  now 
often  implies  only  to  transport  other  than  phagocytosis,  and  this  is  the  case  herein. 
1.3.3A  ENDOCYTOSIS 
Proteins  at  the  cell  surface  are  internalised  into  endosomes  by  a  process  termed 
endocytosis  [Goldstein  et  al.,  1985;  Helenius  et  al.,  1983;  Pastan  &  Willingham,  1983]. 
Endosomes  can  be  divided  into  functionally  distinct  compartments;  internalised  proteins 
are  first  transported  to  the  early  endosome,  which  can  be  further  divided  into  the  sorting 
endosome,  where  membrane-associated  proteins  can  be  sorted  for  either  further 
transport  into  the  cell  or  return  to  the  cell  surface  via  the  recycling  endosome  [Geuze  et 
al.,  1983;  Griffiths  et  al.,  1989].  Proteins  that  are  taken  further  into  the  cell  reach  the 
late  endosome  [Salzman  &  Maxfield,  1988;  Schmid  et  al.,  1988],  where  they  can  be 
either  transported  to  the  lysosome  and  degraded  or  transported  to  the  TGN  to  join  the 
ex0cytic  pathway  [Geuze  et  al.,  1988].  The  endosomal  system  involves  a  pH  gradient 
that  becomes  progressively  more  acidic  from  early  endosomes  (pH  5.5-6.0)  to 
lysosomal  compartments  (pH  4.5-5.0)  [Mellman  et  al.,  1986].  The  acidic  pH  is  known 
to  serve  at  least  two  major  purposes;  firstly,  playing  a  critical  role  in  the  dissociation  of 
ligands  from  their  receptors  and  secondly  activating  hydrolases  that  reside  within 
lysosomes.  Collectively  this  enables  receptor  recycling  via  endosomes,  as  well  as  the 
degradation  of  proteins  within  the  lysosomal  compartments.  In  many  cases  the  unbound 
receptor  is  then  free  to  be  recycled  back  to  the  cell  surface  and  perform  finther  rounds 
of  ligand  uptake  [Dautry-Varsat  et  al.,  1983;  Klausner  et  al.,  1983].  There  are  four 
general  fates  for  ligand  receptor  complexes  and  these  are  detailed  below,  with  examples 
of  each  case; 
1)  Both  receptor  and  ligand  are  recycled,  e.  g.  the  transferrin  receptor, 
26 2)  Both  receptor  and  Hgand  are  degraded  e.  g  the  epidenml  growth  factor  (EGF) 
receptor, 
3)  Receptor  is  recycled  whilst  the  Ugand  is  degraded  e.  g.  the  low  density 
lipoprotein  (LDL)  receptor 
4)  Both  receptor  and  ligand  are  transported  elsewhere,  e.  g.  the  immunoglobulin  Fcy 
receptor  family. 
A  good,  extensively  understood  example  is  the  transferrin  receptor  and  its  ligand 
ferrotransfeffin.  In  this,  case  the  low  PH  causes  the  release  of  Fe  31  from  the  ligand, 
which  remains  bound  to  the  transferrin  receptor  and  together  they  recycle  back  to  the 
plasma  membrane,  where  the  apotransferrin  dissociates  from  the  receptor  at  the  neutral 
PH,  leaving  the  transferrin  receptor  free  to  bind  another  ferrotransferrin  molecule  and 
repeat  the  process  again.  Each  cycle  is  thought  to  take  about  15-20  minutes  to  complete 
and  an  individual  receptor  may  complete  the  process  up  to  100  times. 
Most  of  the  known  membrane  receptors  are  internalised  from  the  cell  surface  through 
specialised  structures  of  the  plasma  membrane  ternied  coated  pits,  characterised  by  the 
presence  of  a  coat  on  the  cytosolic  side  of  the  plasma  membrane.  The  receptors 
undergoing  endocytosis  are  first  recruited  and  concentrated  into  coated  pits  and  then 
internalised  as  a  result  of  progressive  invagination  of  the  coated  pits  that  pinch  off  from 
the  membrane  giving  coated  vesicles  [Smythe  &  Warren,  1991]. 
Endocytosis  has  been  studied  most  extensively  for  transport  by  clathrin-coated  vesicles 
Activation  of  many  cell  surface  receptors  induces  their  association  with  clathrin  AP-2 
adaptins  and  results  in  the  endocytosis  of  the  activated  receptors  at  distinct  areas  along 
the  plane  of  the  cell  membrane  [Pearse  &  Robinson,  1990;  Schmid,  19971.  The  AP-2 
adaptin  complex  plays  a  central  role  in  both  the  organisation  and  function  of  plasma 
membrane  coated  pits  [Kirchhausen,  1993].  AP-2  is  composed  of  two  large  chains,  the  y 
andP2  adaptins,  a  medium  sizedI12  chain  and  a  small  a2  chain.  y  adaptin  is  necessary 
for  targeting  to  the  plasma  membrane  and  seems  to  modulate  AP-2  function  through 
interactions  with  phosphoinositides  [Beck  &  Keen,  1991],  whilst  theP2adaptin  binds  to 
clathrin  [Gallusser  &  Kirchhausen,  1993;  Shih  et  al.,  19951.  ji2has  been  demonstrated  to 
27 bind  to  tyrosine-based  sorting  signals  present  in  the  cytoplasmic  tail  of  many 
endocytosed  receptors  [Boll  et  al.,  1996;  Ohno  et  al.,  1995  &  19961.  There  is  evidence 
to  suggest  that  other  proteins  can  act  as  functional  homologues  of  AP-2,  for  example  0- 
arrestin  can  cause  the  endocytosis  of  adrenergic  receptors  by  physically  coupling  the 
receptors  to  clathrin  triskelions  [Goodman  et  al.,  1996]. 
1.3.3B  PIIAGOCYTOSIS 
Within  the  immune  system,  the  ability  to  internalise-  large  particles  is  most  often 
associated  with  phagocytic,  leukocytes,  e.  g.  macrophages  and  neutrophils.  Phagocytic 
uptake  is  generally  triggered  by  the  binding  of  opsonised  particles  to  cell  surface 
receptors,  capable  of  transducing  a  phagocytic  stimulu&  to  the  cytoplasm,  resulting  in  the 
localised  polyinerisation  of  actin  at  the  site  of  particle  attachment.  The  completion  of 
phagocytosis,  results  in  a  compartment  termed  the  phagosome  that  can  then  evolve  into  a 
phagolysosome  after  the  incorporation  of  lysosomal  proteases  as  a  result  of  the 
phagosome  fusing  with  a  lysosomal  compartment  [Desjardins  et  al.,  1994]. 
In  mammals  phagocytosis  serves  as  the  first  line  of  defence  against  microorganisms,  as 
well  as  providing  an  important  component  of  the  humoral  immune  response  by  allowing, 
the  processing  and  presentation  of  pathogen-derived  peptides  to  antigen-specific  T- 
lymphocytes  via  MHC  class  II  molecules  [Harding  &  Geuze,  1992].  Receptors  that 
mediate  phagocytosis  in  leukocytes  include  members  of  the  IgG  Fcy  receptor  fan-dly  as 
well  as  some  integrins  (e.  g.  complement  receptor  3,  CR3)  and  lectins  (e.  g.  mannose 
receptor)  [Kielian  &  Cohn,  1980;  Mellman  et  al.,  1983;  Wright  &  Silverstein,  1983; 
Ezekowitz  et  al.,  199  1;  Isberg  et  al.,  19941. 
1.3.4  ANTIGEN  PRESENTATION  BY  MHC  CLASS  11  MOLECULES 
Antigen  presentation  by  MHC  class  11  molecules  represents  one  of  the  most  complex 
examples  of  co-ordinated  protein  assembly  and  transport  [reviewed  by  Cresswell, 
1994].  Mature  MHC  class  11  molecules  on  the  cell  surface  consist  of  a  and  P 
heterodirners  with  bound  peptide  in  the,  peptide-binding  groove.  Briefly,  upon  their 
synthesis  in  the  EP,  class  11  heterodimers  assemble  with  a  third  subunit,  termed  the 
invariant  chain  (H).  The  h  molecule  covers  the  peptide-binding  cleft  of  the  class  11 
28 heterodimers  and  prevents  them  from  acquiring  peptide  antigens  in  the  ER.  During 
transport  through  the  secretory  pathway,  the  cytoplasmic  tail  of  li  possesses  a  dileucine- 
based  motif  that  diverts  the  nonameric  complexes  from  the  TGN  to  the  endosomal 
pathway.  Hydrolases  that  are  activated  by  the  acidic  environment  of  the  endosomal 
pathway  degrade  U,  except  for  a  peptide  portion,  termed  CLIP  that  remains  in  the 
peptide-binding  groove  of  the  a/P  heterodimer.  At  the  same  time,  protein  antigens  from 
the  extracellular  environment  are  endocytosed  into  the  endocytic  pathways,  where  they 
are  degraded  into  peptides.  An  MHC-like  molecule,  termed  HLA-DM  in  humans, 
catalyses  the  release  of  the  CLIP  peptide  from  the  peptide-binding  groove  so  that 
exogenously-derived  peptides  can  be  transferred  into  the  cleft.  The  assembled  class  11 
molecules  are  then  transported  to  the  cell  surface,  where  they  present  their  bound 
peptides  to  T  cells  [Cresswell,  1994].  Both  MHC  class  II  molecules  and  phagocytosed 
antigens  are  present  in  phagosomes  [Harding  &  Geuze,  1992].  The  phagosomes  may 
receive  the  MUC  class  II  molecules  following  fusion  with  vesicles  from  the  trans-golgi 
network  that  contain  newly  synthesised  MEC  class  II  molecules  or  by  fusion  with 
endocytic  organelles  [Rabinowitz,  1992].  Binding  of  antigen  to  the  MHC  may  take 
place  in  the  phagosome  [Lang  et  al.,  1994]  or  alternatively,  partially  or  fully  processed 
antigens  from  the  phagosome  may  be  transported  to  the  endocytic  pathway  for  further 
processing,  and  transportation  to  the  cell  surface  [Pitt  et  al.,  1992;  Tjelle  et  al.,  1998]. 
1.3.5  INTRACELLULAR  SORTING  SIGNALS 
A  variety  of  intracellular  sorting  signals  have  been  identified  within  the  cytoplasmic 
domain  of  a  number  of  transmembrane  proteins  and  collectively  these  have  lead  to  the 
elucidation  of  a  variety  of  consensus  motifs  found  to  be  involved  in  several  of  the 
intracellular  transport  pathways.  The  first  class  of  endocytic  sorting  signals  are 
characterised  by  an  essential  tyrosine  residue  which  is  either  part  of  the  motif  NPXY  (X 
representing  any  amino  acid)  as  initially  described  for  the  LDL  receptors  signal 
(NPVY),  or  in  the  context  of  YXXý  (where  ý  is  an  amino  acid  with  a  bulky 
hydrophobic  side  chain  such  as  leucine/isoleucine  or  phenylalanine),  as  exemplified  by 
the  internalisation  signal  of  the  transferrin  receptor  (YTRF).  Interestingly,  in  some  cases 
the  internalisation  signal  is  also  functional  with  phenylalanine  replacing  tyrosine,  e.  g. 
the  LDL  receptor  [Chen  et  al.,  1990].  The  second  class  of  internalisation  motifs 
typically  contains  a  di-leucine  sequence  LL;  in  some  cases  one  of  the  leucines  may  be 
29 replaced  by  isoleucine,  valine,  alanine  or  methionine.  Both  tyrosine-based  [Glickman  et 
al.,  1989;  Ohno  et  al.,  19951  and  di-leucine-based  [Heilker  et,  al.,  19961  motifs  are 
recognised  by  clathrin  with  AP-2  adaptins,  enabling  proteins  with  these  motifs  to  be 
transported  from  the,  cell  surface  to  the  early  endosome  [Letourneur.  &  Klausner,  1992*, 
Lobel  et  al.,  1989].  A  dilysine  motif  KXKXX  has  also  been  associated  with  the 
transport  of  proteins  from  the  plasma  membrane  to  early  endosornes,  although  the 
adaptin  molecule  involved  has  not  been  identified.  The  determinants  for  lysosomal 
sorting  also  generally  involve  typical  tyrosine  or  dileucine  motifs  [Hunziker  &  Geuze, 
1996],  although  the  precise  sequence  requirements  are  not  exactly  the  same.  The 
lysosomal  tyrosine  motifs,.  for  example,  are  immediately  preceded  by  a  glycine  (e.  g. 
larnp-1,  GYQTI),  which  is  important  for  direct  lysosomal  traffic  but  not  necessary  for 
endocytosis  [Harter  &  Mellman,  1992]. 
Fe  receptor-mediated  phagocytosis  of  IgG-coated  particles  by  macrophages  is 
associated  with  localised  tyrosine  phosphorylation  of  a  variety  of  cytoplasmic  proteins 
[Greenberg  et  al.,  1993;  Greenberg,  1995].  Two  cytoplasmic  tyrosine  residues  of  FcyRs 
that  undergo  phosphorylation  are  arranged  into  a  short  domain,  YxxL(X)7yXxL  or 
YxxL(x)12YxxL,  termed  ITAM  (immunoreceptor  tyrosine-based  activation  motit) 
[Samelson  &  Klausner,  19921.  The  phagocytic  abilities  of  FCYRs  depend  on  ITAM,  as 
indicated  by  studies  of  COS  cells  transfected  with  wild-type  or  mutant  FcyRs  [Mitchel 
et  al.,  1994;  Indik,  et  al.,  19941.  This  reflects  the  recruitment  of  cytosolic  src-fan-ffly 
kinases  to  the  Fc  receptor  cytoplasmic  domain  via  its  consensus  tyrosine-containing 
ITAM  motif  [Greenberg  et  al.,  1994;  Greenberg,  et  al.,  19961.  Transfection  of  Fc; 
receptor  cDNAs  into  normally  non-phagocytic  cells  can  also  result  in  phagocytosis,  as 
long  as  the  appropriate  src-family  kinases  are  co-expressed  [Greenberg  et  al.,  1996]. 
ITAMs  are  also  present  in  other  receptors  of  the  Ig  gene  superfamily,  such  as  the  BCR 
and  TCP,  which  share  common  signalling  motifs  with  the  FcyRs. 
The  cytoplasmic  domain  of  CD23,  shown  in  figure  1.6,  does  not  contain  any  of  these 
characteristic  tyrosine  or  di-leucine-based  motifs.  However,  CD23a  does  contain  a 
cryptic  tyrosine  motif  (YSEI),  utilising  both  "unique"  and  "common7'  elements  of  the 
CD23a  cytoplasmic  tail  sequence  that  is  similar  to  the  tyrosine  motif  found  in  lamp-I 
(GYQTI).  The  lack  of  the  important  preceding  glycine  residue  however,  suggests  that 
30 this  motif  may  favour  endocytic  rather  than  lysosomal  uptake  of  CD23a.  Recently,  an 
acidic  dipeptide  motif  (EE)  has  been  demonstrated  to  be  important  for  intracellular 
sorting  of  HIV-  I  Nef  protein  [Piguet  et  al.,  1999].  Mutation  of  the  EE  diacidic  motif  of 
HIV-  I  Nef  abrogates  its  ability  both  to  target  CD4  from  the  early  to  the  late  endosomal 
compartment  and  to  interact  with  P-COP,  yet  is  does  not  affect  AP  binding  or  indeed 
Nef-induced  CD4  endocytosis.  Both  CD23  isoforms  contain  an  EE  acidic  dipeptide 
motif  in  their  N-terminal  cytoplasmic  tails.  There  is  also  a  dileucine  motif  present 
within  the  transmembrane  region  of  CD23,  however,  this  is  unlikely  to  be  available  for 
sorting  purposes  when  it  is  retained  within  the  Hpid-bilayer. 
1.4  CD23  (FccRll) 
Human  CD23  is  a  45kDa  leukocyte  cell  surface  antigen  that  is  expressed  on  a  variety  of 
cells  of  haematopoietic  lineage  [Capron  et  al.,  1986,  Sarfati  et  al.,  1986,  Bieber  et  al., 
1989  and  Billaud  et  al.,  1989].  CD23  is  known  to  exist  in  two  membrane  bound 
isoforms,  each  of  which  can  be  proteolytically  cleaved  from  the  cell  surface  to  generate 
soluble  CD23.  The  principal  function  of  CD23,  in  its  membrane-associated  form,  is  to 
act  as  the  low  affinity  receptor  for  IgE  (FccRII)  [Bonnefoy  et  al.,  1987;  Yukawa  et  al., 
1987]  and  the  majority  of  the  immunological  functions  of  CD23,  such  as  IgE-dependent 
cellular  toxicity,  antigen  focusing,  processing  and  presentation  of  IgE-containing 
immune  complexes,  are  a  reflection  of  this  property. 
1.4.1  DISCOViERY  OF  CD23 
The  CD23  molecule  was  initially  identified  in  human  B  lymphocytes  as  FccRII,  a  low 
affinity  receptor  for  IgE  [Gonzalez-MoUna  et  al.,  1976]  and  was  shown  to  be  distinct 
from  FccRI,  the  high  affinity  IgE  receptor  which  had  previously  been  identified  on  mast 
cells  and  basophils  [Carson  et  al.,  1975;  Conrad  et  al.,  1976].  A  panel  of  monoclonal 
antibodies  able  to  precipitate  a  45kDa  glycoprotein  from  the  surface  of  Epstein-Barr 
virus-transformed  B  cells  was  described,  so  the  molecule  was  named  EBV  cell  surface 
antigen,  or  EBVCS  [Kintner  &  Sugden,  1981].  The  same  molecule  was  later  shown  to 
be  expressed  on  the  surface  of  both  normal  and  activated  B  cells,  and  was  now  referred 
to  as  aB  cell  activation  antigen  (Blast-2),  and  was  demonstrated  to  have  a  rapid 
turnover  from  the  cell  surface  of  transformed  B  cells  as  a  result  of  proteolysis  [Thorley- 
31 Lawson  et  al.,  1985].  It  was  eventually  demonstrated  that  antibodies  within  the  CD23 
cluster  (including  Blast-2)  reacted  with,  and  specifically  precipitated,  the  45kDa  protein 
product  of  cDNA  encoding  the  low  affinity  IgE  receptor,  demonstrating  that  CD23, 
EBVCS,  Blast-2  and  FccRII  were  in  fact  the  same  molecule  [Yukawa  et  al.,  1987; 
Bonnefoy  et  al.,  1987]. 
1.4.2  CELLULAR  DISMRIBUTION  AND  REGULATION  OF  CD23  EXPRESSION 
CD23  is  expressed  on  numerous  human  cell  types  including  B  and  T  lymphocytes, 
natural  killer  cells,  macrophages,  eosinophils,  a  subset  of  platelets,  follicular  dendritic 
cells,  epidermal  Langerhans  cells  and  some  epithelial  cells  [Capron  et  al.,  1986;  Sarfati 
et  al.,  1986;  Bieber  et  al.,  1989;  Billaud  et  al...  1989].  Expression  of  CD23  is  tightly 
regulated  in  a  tissue  specific  manner  with  the  two  CD23  isotypes  having  different 
cellular  distribution  patterns.  CD23a  illustrates  constitutive,  but  ceff-type  specific,  low 
level  expression  on  B  cell  lineage  cells,  whereas  CD23b  is  detectable  on  B  cells  and  a 
variety  of  other  cell  types,  usually  after  stimulation  by  cytokines  such  as  IL-4 
[DeFrance  et  al.,  1987;  Bonnefoy  et  al.,  1988]. 
B  LymPHOCYTES 
CD23  is  a  differentiation  antigen  for  B  cells,  being  restricted  to  certain  stages  of  B  cell 
development.  CD23  is  selectively  expressed  on  slgWslgD  double-positive  mature  B 
cells,  but  not  immature  bone  marrow  cells,  and  is  thought  to  be  involved  in  the 
regulation  of  growth  and  differentiation  of  B  cells.  CD23  is  generally  lost  after  the  Ig 
isotype  switch  [Kitutani  et  aL,  1986]  and  during  B  cell  differentiation  into  Ig  secreting 
cells,  regardless  of  isotype  switch  [Snapper  et  aL,  1991]. 
CD23  has  also  been  shown  to  be  spatially  associated  with  HLA-DR  molecules  on  the  B 
cell  surface  [Bonnefoy  et  aL,  1988].  This  interaction  facilitates  a  well  characterised 
function  of  membrane  bound  CD23  in  B  cells,  the  enhancement  of  the  IgE-dependent 
antigen  presentation  to  T  cells  [Kehry  el  al.,  1989;  Pirron  et  al.,  1990;  van  der  Heijden 
et  al.,  1993;  Santamaria  et  al.,  1993;  Squire  et  al.,  1994;  Gustavsson  et  al.,  1994; 
Fujiwara  et  al.,  1994;  Mudde  et  al.,  1995;  Westman  et  al.,  1997;  Oshiba  et  al.,  1997; 
Karagiannis  et  al.,  2001].  This  requires  the  binding  of  antigen-IgE  antibody  complexes 
32 to  CD23,  internalisation  of  the  complexes  and  transport  to  compartments  of  the 
endosomal  network  containing  proteolytic  enzymes  and  major  histocompatibility 
(MHC)  class  11  antigens.  After  digestion  of  the  antigen,  restricted  peptides  are  loaded 
onto  MHC  class  II  antigens  and  returned  to  the  cell  surface  for  presentation  to  T  cells. 
Antigen  presentation  also  requires  interaction  between  CD23  and  CD21  at  points  of 
contact  on  the  B-  and  T-cell  surfaces  [Flores-Romo  et  al.,  1990;  GrosJean  et  al.,  1994]. 
Recent  data  have  also  suggested  that  CD23a  and  MHC  class  11  molecules  can  be  co- 
internalised  and  co-localised  to  endocytic  compartments  in  a  human  B  cell  line 
[Karagiamis  et  al.,  2001]. 
Another  function  of  membrane-associated  CD23,  the  negative  feedback  regulation  of 
IgE  receptors  [Sarfati  et  al.,  1988;  Sheff  et  al.,  1989;  Saxon  et  al.,  1991;  Yu  et  al., 
19941,  may  well  be  related  to  the  endocytosis  of  antigen-IgE  complexes  and  the 
degradation  of  IgE  within  B  ceUs. 
Conflicting  data  exist  as  to  the  effect  of  engagement  of  CD23  on  B  cells,  some 
publications  reporting  enhancement  [Gordon  et  al.,  1986],  others  inhibition  [Luo  et  al., 
1991]  of  B  cell  progression  from  G,  to  S  phase  in  the  cell  cycle.  However,  the  definite 
involvement  of  CD23  in  the  regulation  of  B  cell  growth  is  underlined  by  its  abnormal 
expression  and  dysregulation  in  two  malignant  diseases  resulting  from  the  clonal 
expansion  of  slgWslgD  mature  B  cells;  namely  chronic  lymphocytic  leukaemia  (CLL) 
and  small  lymphocytic  lyrnphoma  [Sarfati  et  al.,  1988].  CD23  disease  association  is 
discussed  in  more  depth  in  section  1.3.9. 
T  LymPHOCYTES 
In  situ  hybridisation  reveals  that  CD23  niRNA  is  expressed  in  the  subcapsular  region 
(outer  cortex)  of  the  thymus,  a  region  known  to  contain  very  early  thymocytes.  Both 
membrane  associated  and  soluble  CD23  were  suggested  to  play  an  accessory  role  in  T 
cell  response  to  mitogens  and  allogenic  or  autologous  B  cells  [Armitage  et  al.,  1989]. 
More  recent  observations  demonstrated  that  mitogen-induced  proliferation  of  CD4+  T 
cells,  known  to  require  interactions  with  HLA-DX'  accessory  cells,  could  be  inhibited 
by  the  binding  of  anti-CD23  monoclonal  antibodies  [Bertho  et  al.,  19911,  these  data 
suggesting  a  role  for  CD23  in  T  cell  activation. 
33 OTHER  LEUKOCYTIC  CELLS 
CD23  on  macrophages,  eosinophils  and  platelets  has  been  found  to  mediate  IgE- 
dependent  cytotoxicity  and  to  promote  phagocytosis  of  IgE-coated  particles  on 
monocytes  [Spiegelberg,  1984;  Capron  et  aL,  1986].  As  monocytes  and  eosinophils 
have  been  shown  to  express  only  CD23b  these  effects  must  be  mediated  by  this  isoform. 
CD23b  has  thus  been  concluded  to  have  a  role  in  protective  immunity  against  parasites 
and  in  IgE-mediated  inflammatory  responses. 
Follicular  dendritic  cells  (FDQ  are  crucial  in  the  generation  and  maintenance  of 
adaptive  immune  responses  via  their  ability  to  retain  immune  complexes  for  long 
periods  of  time,  thus  contributing  to  the  generation  of  memory  B  cells.  FDCs,  located 
exclusively  in  the  germinal  centres  of  secondary  lymphoid  tissues,  have  been  shown  to 
exhibit  CD23  protein  (although  CD23  mRNA  appears  to  be  absent).  The  function  of 
this  high  level  of  CD23  expression  on  FDCs  is  still  unknown.  Theories  include  the 
possibility  of  these  cells  being  involved  in  the  generation  of  IgE-rnernory  B  cells,  with 
them  also  being  a  potential  source  of  signals  which  may  rescue  germinal  centre  B  cells 
from  apoptosis  [Liu  et  al.,  199  1  ]. 
REGULATION  OF  CD23  ExPRESSION 
IL-4,  a  15-19kDa  cytokine  is  amongst  the  most  potent  inducers  of  CD23  expressim 
(particularly  CD23b)  and  can  act  on  all  cell  types  capable  of  expressing  CD23.  IL-4  is  a 
highly  pleiotropic  cytokine  involved  in  the  regulation  of  B  cell  growth  and 
differentiation  as  well  as  playing  a  pivotal  role  in  the  control  of  IgE  responses  via 
induction  of  IgE  isotype  switching  [Lebman  &  Coffinan,  1988].  The  enhancing  effects 
of  IL-4  on  B  cells  has  been  found  to  be  inhibited  by  interferon-y  (IFN-y),  IFN-a.  TGF-P 
and  glucocorticoids  via  a  protein  kinase-C  (PKC)  independent  pathway  [Delespesse  et 
al.,  1991;  Delespesse  et  al.,  1992,  Lee  et  al.,  1993].  Regulation  of  CD23  expression  on 
monocytes  is  different  to  that  on  B  cells,  with  IFN-y  enhancing  CD23  expression,  while 
the  effects  of  glucocorticoids  and  TGF-P  are  the  same.  Engagement  of  CD40  may 
override  the  suppressive  effects  of  IFNs  and  TGF-P  on  IL-4-induced  CD23  expression 
[Gordonetal.,  1991]. 
34 1.4.3  STRUCTURE  OF  CD23 
Human  CD23  is  a  single  chain,  45kDa  type  11  transmembrane  glycoprotein  containing  I 
chain  of  N-linked  complex  carbohydrates,  several  O-linked  carbohydrates  and  sialic; 
acids  residues  [Letellier  et  aL,  1988].  No  similarities  have  been  shown  to  exist  between 
the  amino  acid  sequence  of  human  CD23  and  any  of  the  subunits  of  the  high  affinity 
IgE  receptor.  Figure  1.5  illustrates  a  schematic  representation  of  the  structural  features 
of  these  two  molecules.  CD23  has  also  been  found  to  be  both  structurally  and 
functionally  unique  in  comparison  to  other  immunoglobulin  (1g)  receptors.  CD23  has 
since  been  shown  to  be  a  type  11  transmembrane  glycoprotein,  such  that  the  amino 
terminus  lies  within  the  cell  and  the  carboxy  terminus  outside,  effectively  the  opposite 
orientation  to  other  Ig  receptors. 
1.4.3A  CD23  IS  A  MEMBER  OF  THE  C-TYPE  LECTIN  SUPERFAMILY 
Extensive  homology  was  discovered  to  exist  between  CD23  and  the  super-family  of 
animal  C-type  lectins,  [Kikutani  et  aL,  1986;  Suter  et  aL,  1987;  Ludin  et  aL,  1987]  a 
family  of  proteins  found  to  bind  carbohydrates  in  a  calcium-dependent  manner 
[Drickarner,  1988].  This  region  of  homology  Res  between  Cys,  163  and  Cys  282  in  the 
CD23  molecule  and  contains  four  highly  and  two  partially  conserved  cysteine  residues, 
at  positions  191,259,273,282  and  positions  163  and  174,  respectively  [Kikutani  et  aL, 
1986;  Ludin  et  aL,  1987].  These  data  illustrate  that  CD23,  unlike  all  the  other  Fc 
receptors  that  belong  to  the  Ig  super-family,  actually  belongs  to  the  C-type  lectin  super- 
family. 
Two  subgroups  within  the  C-type  lectin  superfamily  with  different  domain 
organisations,  soluble  collectins  [Epstein  et  al.,  1996],  and  the  macrophage  mannose 
receptor  [Ikeda  et  al.,  1987;  Tenner  et  al.,  1995],  are  believed  to  be  involved  in  the 
innate  immune  response.  Selectins  serve  in  the  adaptive  immune  response  and  have 
been  shown  to  mediate  transient  interactions  between  leucocytes  and  endotheliurn 
[Lasky,  1995;  Rosen  &  Bertozzi,  1996].  NK  cells  display  a  set  of  cell  surface  receptors 
containing  the  C-type  lectin-like  domains  that  may  be  involved  in  protein-protein 
interactions  rather  than  the  protein-carbohydrate  interactions  classical  of  the  C-type 
35 lectin  superfamily  members.  The  C-type  carbohydrate  recognition  domain  (C-type 
CRD)  is  identified  as  a  conunon  feature  of  several  different  calcium-dependent  animal 
lectins  and  illustrates  the  sequence  motif  characteristic  of  the  sugar-binding  domain 
from  these  proteins  [Drickamer,  19931.  The  module  has  been  used  to  identify 
structural1y  related  regions  in  other  proteins  [Taylor,  1997].  One  of  the  largest  groups  of 
proteins  containing  C-type  CRD's  are  the  type  11  transmembrane  proteins  [Nakayama  et 
al.,  1996],  including  CD23,  that  have  C-ten-ninal  CRD-like  sequences  linked  by  neck 
regions.  of  various  lengths  to  signal-anchor  sequences  and  N  terminal  cytoplasmic  tails. 
These  molecules  are  thought  to  have  distinct  functional  mechanisms  to  the  classical  C- 
type  lectin  superfamily  members. 
1.4.3B  STRUCTuRAL  DomAiNs  OF  HumAN  CD23 
Human  CD23  has  been  shown  to  contain  several  domains  [Beavil  et  al.,  1992],  these  are 
summarized  in  the  schematic  diagram  in  Figure  1.6.  The  extracellular  portion  of  CD23 
contains  two  domains,  namely  a  stalk  region  and  a  C-type  lectin-like  domain.  The  stalk 
region  is  thought  to  be  involved  in  oligomerisation  of  CD23  molecules  at  the  cell, 
surface.  CD23  also  contains  a  leucine  zipper  motif,  located  between  the  transmembrane 
domain  and  the  lectin-like  domain.  This  region  consists  of  3  short  consensus  repeats  of 
21  amino  acids,  including  5  heptadic  repeats  of  leucines  or  isoleucines.  The  heptad 
repeats  illustrate  an  cc-helical  coiled-coil  secondary  structure  [Beavil  et  al.,  1992] 
separating  the  lectin  heads  from  the  cell  membrane,  with  the  tertiary  conformation  being 
a  common  motif  present  in  other  members  of  the  C-type  lectin  family.  This  stalk  region 
has  been  suggested  to  provide  a  possible  mechanism  for  oligomerisation  of  CD23  on  the 
cell  surface  [Beavil-  et  al.,  19951,  a.  structural-  feature  important  for  IgE  binding  [Dierks, 
et  al.,  19931.  This  theory  has  been  verified  by  protein  chemical  cross-linking  studies 
where  human  CD23  has  been  shown  to  exist  in  both  dimer  and  trimer  surface 
complexes  [Beavil  et  al.,  1995]. 
The  so-called  lectin-like  domain  has  been  finther  characterised  by  mutational  analysis 
and  demonstrated  to  contain  the  IgE-binding  site  [Bettler  et  al.,  19891.  IgE  has  been 
shown  to  bind  CD23  via  protein-protein  interactions  fVercelli  et  al.,  1989],  as  de- 
glycosylation  of  IgE  does  not  eradicate  binding.  This  interaction  has  also  been  shown  to 
be  calcium  dependent  [Richards  &  Katz,  1990]  and  it  can  be  inhibited  by  fucose-l- 
36 phosphate  [Delespesse  et  al.,  1992].  Further  investigation  has  shown  the  cytokine 
activity  of  CD23  to  be  mediated  by  an  epitope  overlapping,  yet  distinct  from  the  IgE 
binding  domain  [Mossalayi  et  aL,  19921,  these  cytokine  effects  are  discussed  more  fully 
in  section  1.4.5. 
CD23  has  an  extended  C-terminal  tail  containing  a  DGR  (inverse  RGD)  sequence  (a 
common  recognition  triad  in  receptors/ligands,  for  integrin  molecules)  which  seems  to 
be  involved  in  binding  class  II  MHC  molecules  [Kijimoto-Ochiai  &  Noguchi,  20001. 
CD23  contains  a  single,  transmembrane  hydrophobic  domain  (residues  24-44)  and  a 
short,  largely  hydrophilic  cytoplasmic  domain  thought  to  be  involved  in  signal 
transduction  (residues  1-23).  The  two  membrane-associated  CD23  isoforms  differ  only 
in  this  region,  and  these  differences  are  discussed  further  in  section  1.4.6. 
1.4.4  SOLUBLE  CD23 
Similar  to  other  Fc  receptors,  full  length  CD23  can  be  cleaved  to  produce  a  number  of 
soluble  (sCD23)  fragments,  with  all  cleavage  sites  located  in  the  stalk  region  of  full 
length  CD23.  Intact/45kDa  CD23  is  initially  cleaved  to  release  the  37kDa  species, 
containing  the  lectin-like  domain  and  a  large  portion  of  the  stalk  region  [Lettelier  et  al., 
1989;  Marolewski  et  al.,  1998].  This  species  can  be,  and  frequently  is,  sequentially 
cleaved  into  smaller  fragments  of  33,29,25  and  l6kDa,  each  of  which  has  been 
demonstrated  to  have  cytokine  activity  in  vitro  [Liu  et  al.,  1991].  The  25kDa  species, 
conventionally  known  as  sCD23,  has  been  identified  as  the  most  stable  of  all  the  soluble 
products  [Letellier  et  al.,  1989]  and  the  one  most  readily  available  for  use.  All  the 
soluble  fragments  retain  the  lectin-like  domain  and  studies  with  anti-IgE  antibodies 
have  demonstrated  that  they  also  all  retain  their  ability  to  bind  IgE  [Delespesse  et  al., 
1992].  The  l6kDa  species  binds  IgE  with  much  lower  affinity,  a  property  believed  to  be 
due  to  the  monomeric  nature  of  this  form  [Bettler,  et  al.,  1989],  as  the  avidity  of  CD23 
for  IgE  is  determined  by  oligomerisation  [Dierks,  et  al.,  1993].  The  25kDa  and  larger 
fragments  enhance  IgE  synthesis,  while  the  l6kDa  fragment  has  been  found  to  inhibit 
the  synthesis  of  IgE  by  B  cells. 
37 The  binding  of  IgE  has  been  shown  to  protect  CD23  from  cleavage  [Lee  et  aL,  1987] 
with  the  amount  of  cleavage  also  significantly  reduced  in  the  presence  of  anti-CD23 
antibodies.  However,  in  contrast  to  this,  cleavage  is  increased  after  the  use  of  agents  that 
prevent  CD23  glycosylation  [Delespesse,  et  al.,  1989]  indicating  that  the  carbohydrate 
chain  exerts  a  stabilising  effect  on  CD23.  Studies  with  highly-purified  37kDa  and 
29kDa  soluble  CD23  proteins  have  shown  these  products  to  be  able  to  cleave  the  full 
length,  membrane-bound  CD23  into  the  soluble  25kDa  fragment  [Lettelier  et  al.,  1990]. 
These  data  have  been  used  as  evidence  to  suggest  CD23  can  be  cleaved  in  an 
autocatalytic  manner,  although  CD23  does  not  show  homology  to  any  known 
proteolytic  enzymes  [reviewed  by  Bonnefoy  et  al.,  1997].  A  recent  publication  refutes 
this  however,  reporting  that  CD23  release  from  human  RPNU  8866  cell  membranes  is 
mediated  by  a  metalloprotease  distinct  from  substrate  CD23  and  that  the  cleavage 
process  can  be  repressed  by  specific  protease  -inhibitors  [Marolewski  et  al.,  1998].  The 
same  group  subsequently  suggested  that  the  proposal  of  auto-proteolysis  was  a  result  of 
the  co-purification  of  the  metalloprotease  with  CD23,  and  speculate  that  there  may  be  a 
whole  family  of  metalloproteases  that  mediate  the  cleavage  of  CD23.  Clearly  the  details 
of  this  cleavage  process  have  still  to  be  elucidated. 
1.4.5  CYTOKm  EmCTS  OF  sCD23 
Human  CD23  and  its  soluble  products  display  a  variety  of  biological  functions  in 
addition  to  their  ability  to  bind  IgE.  Soluble  CD23  may  exert  several  regulatory  effects, 
either  alone  or  in  synergy  with  other  cytokines,  on  a  variety  of  heniatopoietic  cells, 
including  the  differentiation  of  prothymocyte  and  myeloid  precursors  [Mossalayi  et  al., 
1990a  &  1990b],  inhibition  of  monocyte  migration  [Flores-Romo  et  al.,  19891, 
induction  of  CD3  positive  thymocytes  [Mossalayi  et  al.,  1990]  and  stimulus  of  antigen 
presentation  by  both  B  cells  and  monocytes  to  T  cells  [Bertho  et  al.,  1991].  Signal 
transduction  of  sCD23  is  closely  dependent  upon  the  cell  subset  and  ligands  involved  as 
well  as  the  functional  co-factors  required. 
1.4.6  CD23  ISOFORMS 
Early  evidence  suggested  two  distinct  roles  for  CD23,  one  being  a  stage-dependent 
involvement  in  B  cell  growth  and  differentiation  [Gordon,  et  aL,  1987;  Kolb,  el  aL, 
38 1990],  the  second  involving  the  effector  phase(s)  of  IgE-mediated  immunity,  including 
allergy  and  the  response  to  parasitic  infections  [Kehry  &  Yamashita,  1989;  Luo,  et  aL, 
1991].  Two  species  of  human  CD23  were  originally  hypothesised  by  Yokota  and 
colleagues  and  then  later  identified  and  termed  CD23a  and  CD23b  [Yokota  et  al, 
1988].  These  isoforms  have  been  demonstrated  to  differ  only  in  a  short  amino  acid 
stretch  in  the  cytoplasmic  tail  region  where  the  N-terminal  7  an-dno  acids  of  CD23a 
(MEEGQYS)  are  distinct  from  the  alternative  6  amino  acids  of  CD23b  (MNPPSQ), 
Figure  1.6. 
The  human  CD23  gene  (EMBL  accession  number:  M30447)  spans  approximately  13kb 
and  has  been  specifically  mapped  to  an  II  exon  gene  located  on  chromosome  19, 
encoding  both  the  CD23  isoforms  [Ludin,  et  aL,  1987;  Suter  et  al.,  1987;  Wendel- 
Hansen  et  aL,  1990].  Southern  and  Northern  blot  analysis  of  the  CD23  genomic  gene 
and  the  receptor-specific  mRNA  was  carried  out  using  fragments  of  CD23  cDNA  as 
probes.  A  novel  exon,  specific  for  CD23b  was  found  to  be  located  between  exons  2  and 
3  of  the  CD23a  mRNA.  Primer  extension  studies  then  revealed  it  was  in  fact  the 
initiation  site  for  CD23b  transcription.  Three  species  of  CD23  rnRNA  have  been 
identified  which  differ  only  within  their  5'  regions.  Two  mRNAs  code  for  CD23a  and 
their  sequences  differ  by  only  four  nucleotides  in  the  5'untranslated  region  [Kikutani,  et 
aL,  19861,  which  is  thought  to  be  due  to  differential  splicing.  The  third  mRNA  codes 
for  CD23b  and  is  completely  different  from  the  other  two  in  the  5'  upstream  region,  in  a 
position  that  corresponds  to  the  exon  2-3  boundary  of  CD23a  mRNA.  It  was  concluded 
that  these  two  transcripts  are  generated  from  different  initiation  sites  and  thus  alternative 
splicing  patterns  of  the  same  gene  [Yokota  et  aL,  1988].  These  data  are  summarized  in 
Figure  1.7. 
The  promoter  regions  of  each  CD23  isoform  have  been  shown  to  possess  distinct 
response  elements.  The  CD23a  promoter  region  contains  two  IL-4  response  elements 
(IL-4RE),  an  NFxB  site,  a  glucocorticoid  response  element  (GRE)  and  aB  cell  activator 
protein  (BSAP)  or  Pax-5  binding  site.  In  contrast,  the  CD23b  promoter  region 
comprises  two  IL-4RE  sites  surrounding  an  NFKB  site,  and  two  activated  protein  I  (AP- 
1)  binding  sites.  CD23a  is  expressed  constitutively  and  cell  type-specifically  in  B  cells, 
whereas  CD23b  is  expressed  on  several  cell  types  of  haernatopoietic  lineage  following 
39 activation  with  various  stimulants  (IL-4,  IL-13,  anti-CD40,  anti-ýt  chain,  PMA). 
Reporter  vector  construct  studies  of  the  CD23a  and  CD23b  promoters  revealed  that  the 
CD23a  promoter  was  activated  by  IL-4  alone,  but  that  the  CD23b  promoter  was 
initiated  with  IL-4,  anti-CD40,  anti-ýt  and  PMA  [Ewart  et  al.,  in  press].  The  presence  of 
both  cell  type-specific  and  stimulus-specific  expression  of  the  two  CD23  variants 
suggests  that  each  isoform  has  a  different  cellular  function,  despite  having  identical 
extracellular  domains. 
The  highly  regulated  manner  of  CD23  gene  expression  suggests  that  CD23a  and  CD23b 
are  involved  in  B  cell  function  and  IgE  mediated  immunity,  respectively.  Further 
investigations  illustrated  the  slight  amino  acid  differences  of  the  two  isoforms  to  be 
responsible  for  their  separate  functions  [Yokota  et  aL,  1992].  Early  studies  of  CD23a 
and  CD23b  indicated  that  the  two  isoforms  were  internalised  via  distinct  pathways,  with 
CD23a  entering  the  cell  via  receptor-mediated  endocytosis  and  CD23b  showing  a  more 
phagocytic  route  of  cellular  entry.  CD23-mediated  endocytosis,  was  observed  only  in  the 
CD23a-expressing  cells.  Site-directed  mutagenesis  revealed  that  the  aromatic  tyrosine 
residue  at  position  6  in  CD23a  was  important  for  this  process.  It  should  be  noted  that 
these  data  are  in  good  agreement  with  many  other  studies  where  cytoplasmic  aromatic 
amino  acids  have  been  illustrated  to  be  particularly  important  for  endocytotic  functions 
in  many  different  receptor  molecules;  namely  the  low  density  lipoprotein  receptor 
[Davis,  et  aL,  1987],  mannose-6-Phosphate  receptor  [Lobel,  et  al.,  1989]  and  transferrin 
receptor  [Jing,  et  al.,  1990].  IgE-dependent  phagocytosis  was  observed  only  in  the 
CD23b-expressing  cells  with  the  Asn-Pro  residues  at  positions  2-4  found  to  be 
necessary.  These  findings  suggest  endocytosis  and  phagocytosis  to  be  separate  functions 
that  appear  to  be  attributable  to  distinct  amino  acid  residues. 
Divergence  in  the  signalling  pathways  coupled  to  the  two  membrane-bound  CD23 
iSOfOrMS  must  be  related  to  the  first  6/7  amino  acids  of  the  cytoplasmic  N-terminal  tail, 
as  the  remainder  of  each  protein  is  identical.  Current  understanding  generally  links  the 
CD23a  isofonn  to  a  cAMP  pathway  with  the  CD23b  isoform,  thought  to  function 
generally  via  inositol-l,  4,5-trisphospb%e  and  CP  mobilisation  [as  reviewed  by 
Mossalayi  et  aL,  1997].  The  abiliýy  of  . ý1)23  to  transmit  a  signal  to  various  cells  and  the 
fact  it  has  a  very  short  cytopl4smic  tail  strongly  suggest  that  CD23  may  be  associated 
40 with  other  molecules  involved  in  signal  transduction.  Further  research  is  obviously 
required  to  gain  a  comprehensive  understanding  of  the  signalling  pathways  employed 
by  each  isoform  and  this  was  one  of  the  general  aims  of  the  work  presented  herein. 
1.4.7  LIGANDS  FOR  CD23 
1.4.7A  CD21 
CD21  was  identified  as  a  figand  for  CD23  after  CD23  Eposomes  were  shown  to  bind 
specifically  to  cells  transfected  with  recombinant  CD21  [Aubry  et  al.,  1992].  CD21  is  a 
145kDa  membrane  glycoprotein  expressed  on  a  variety  of  cell  types,  including  B  cells, 
T  cells  and  FDCs,  and  is  also  known  as  the  complement  receptor-2  (CR2)  [Weis  et  al., 
1984].  CD21  has  also  been  identified  as  a  receptor  for  the  gp350/220  envelope  protein 
of  EBV  (EBV-R)  [Tanner  et  al.,  1987]  and  a  receptor  for  IFN-a  [Declayre  et  al.,  1991]. 
CD21  exists  within  a  molecular  complex  on  B  cells,  in  association  with  CD12,  Leu  13 
and  TAPA-1  [Bradbury  et  al.,  1992]. The  extracellular  domain  of  CD21  contains  16 
short  consensus  repeats  (SCRs)  [Weis  et  al.,  1988]. 
Characterisation  of  the  CD21-CD23  interaction  has  showed  that  it  is  a  calcium- 
dependent  interaction,  [Pochon  et  al.,  1992]  involving  two  sites  on  the  CD21  molecule 
[Aubry  et  aL,  1994].  A  lectin  type  interaction  occurs  at  SCRs  5-8,  as  tunicamycin 
treatment  inhibits  this  binding  [Aubry  et  al.,  1994].  Tunicwnycin  served  to  inhibit  N- 
glycosylation  during  protein  biosynthesis  [Sarfati  et  al.,  1992].  SCRs  1-2  were  also 
found  to  be  involved  in  CD21-CD23  binding,  but  via  a  protein-protein  interaction 
[Aubry  et  al.,  1994].  Soluble  forms  of  CD21  shed  from  B  and  T  cells  have  also  recently 
been  shown  to  interact  with  recombinant  oligomeric  soluble  CD23  [Fremeaux-Bacchi  et 
aL,  19961.  Collectively  the  data  on  this  interaction  indicate  that the  IgE  promoting 
effects  of  CD23  are  most  probably  exerted  through  CD21. 
CD23  is  known  to  be  highly  pleiotropic  with  many  studies  describing  non-IgE-mediated 
effects  and  others  demonstrating  that  CD23  expression  is  increased  in  several  diseases 
not  linked  to  IgE.  It  was  quite  correctly  hypothesised  that  not  all  of  these  activities 
could  be  attributed  to  the  interaction  of  CD23  with  IgE  and/or  CD21.  Ibis  has  fuelled 
further  research  into  discovering  other  novel  ligands  for  CD23. 
41 1.4.7B  02  Integrins 
CD23  was  found  to  interact  with  the  (x  chain  of  two  of  the  A  integrins,  CD  IIb  (I  7kDa) 
and  CD11c  (15kDa)  on  monocytic  cells  [Lecoanet-Henchoz  et  al.,  19951.  These 
integrins  are  adhesion  molecules  which  participate  in  many  cell-cell  and  cell-matrix 
interactions  [Springer,  1990].  The  cc  chains  exist  as  heterodimer  with  a  common  P 
subunit  known  as  CD18,  forming  the  CDllb-CD18  (Mac-1)  and  CDllc-CD18  (p150, 
95)  glycoprotein  receptors  [Corbi  et  al.,  1988;  Kurzinger  &  Springer,  1982].  The 
functional  significance  of  CD23  binding  to  CDllb/c  was  demonstrated  by  triggering 
CD  IIb  and  CD  IIc  on  monocytes  with  either  recombinant  CD23  bound  to  liposomes  or 
anti-CD11b  and  anti-CD11c  MAbs.  CD23  binding  caused  a  marked  increase  in 
production  of  nitrite,  oxidative  products  and  pro-inflammatory  cytokines  [Lecoanet- 
Henchoz  et  al.,  1995],  suggesting  a  physiological  role  for  CD23  in  the  activation  of 
monocytic  cells.  Furthermore,  CD23  engagement  has  been  demonstrated  to  elicit  an 
increase  in  the  production  of  interleukin  la  (IL-la),  IL-1p,  interferon-y  (IFN-y),  IL-6 
and  tumour  necrosis  factor  cc  (TNF-a).  Collectively  these  data  support  the  theory  that 
CD  IIb  and  CD  IIc  are  functional  receptors  for  CD23,  and  that  CD23  is  clearly  a  pro- 
inflammatory  mediator  [Lecoanet-Henchoz  et  al.,  1995]. 
IgE  binding  to  CD23  was  shown  to  inhibit  CD23  binding  to  monocytes  and  the 
presence  of  EDTA  was  also  found  to  decrease  binding  of  CD23  to  CD  I  lb/c  [Lecoanet- 
Henchoz  et  al.,  1995],  indicating  that  CD23  may  be  acting  as  a  C-type  lectin  with  the 
CD23  -CD  II  b/c  interaction  being  C2+-dependent  and  involving  both  lectin  and  protein- 
protein  interactions.  These  findings  are  similar  to  those  associated  with  the  interaction 
of  CD23  and  CD21,  where  CD23  acts  as  a  C-type  lectin  recognising  structures  that  have 
both  sugar  and  protein  components  [Pochon  et  al.,  1992;  Aubry  et  al.,  1994].  As 
discussed  previously  the  CD23  molecule  contains  a  DGR  motif,  which  in  the  reverse 
orientation  is  known  to  be  a  common  recognition  site  for  integrin  receptors.  This 
sequence  was  found  not  to  be  involved  in  the  CD11b  and  CD11c  interactions 
[Lecoanet-Henchoz  et  al.,  1995]. 
42 1.4.7C  VITRONECTiN  RECEPTORS 
avP3 
A  recent,  publication  suggests  the  vitronectin  receptor,  avP3,  to  be  a  novel  receptor 
component  for  CD23  in  monocytes  [Hermann  et  aL,  1999].  This  study  has  demonstrated 
that  the  trimolecular  complex  (VnR/a,  P3  &  CD47)  mediates  pro-irdlammatory  cytokine 
synthesis  via  interaction  with  CD23.  The  (XvP3  integrin  is  a  ubiquitous  receptor  known 
to  interact  with  a  number  of  figands,  incluaing  vitronectin  (Vn),  fibronectin  (Fn), 
osteopontin  and  the  matrix  metalloproteina.  se  MMP-2  [Felding-Habermann  &  Cheresh, 
1993].  avP3  plays  an  important  role  in  the  phagocytosis;  of  apoptoic  cells,  tumour  cell 
invasion  and  angiogenesis  [Glasdson  &  Cheresh,  1994]  and  is  usually  found  physically 
associated  with  CD47,  a  multi-spanning  transmembrane  receptor  molecule. 
avps 
On  B  cells,  the  most  likely  receptor  for  CD23  is  the  CD21  molecule  [Pochon  et  al, 
1992;  Aubry  et  al.,  1992],  although  CD21  is  only  expressed  from  the  late  pre-B  cell 
stage.  White  and  colleagues  initially  suggested  the  possibility  of  a  novel,  or  previously 
undefined,  receptor  for  CD23  to  exist  on  SMS-SB  cells  [White  et  al.,  1997],  a  human 
pre-B  cell  line  derived  from  a  female  patient  presenting  with  acute  lymphocytic 
leukaemia  (ALL)  [Smith,  1984].  This  receptor  was  demonstrated  to  be  involved  in  the 
rescue  of  these  cells  from  apoptosis,  possibly  by  influencing  the  expression  of  Bcl-2 
[White  et  al.,  1997].  BlAcore  studies  have  demonstrated  SMS-SB  cell.  extracts  to  bind 
immobilised  sCD23  and  analysis  by  flow  cytometry  has  demonstrated  that  these  cells 
do  not  express  any  of  the  common  CD23  receptors,  namely  CD21,  CDIlb-CD18  or 
CDIIc-CD18  [White  et  al.,  1997].  Data  have  also  shown  that  SMS-SB  cells  do  not 
express  membranous  CD23  protein  nor  do  they  contain  any  RNA  message  for  this 
receptor,  strong  evidence  that  sCD23  cannot  function  in  an  autocrine  fashion  in  this 
model. 
The  CD23  binding  entity  expressed  on  the  model  pre-B  cell  line  (SMS-SB)  has  recently 
been  identified  as  a,  P5  [Matheson  et  al.,  2001]  and  it  has  been  reported  that  a  number  of 
pre-B  ceH  lines  also  bind  CD23  via  this  receptor.  aP5  has  indeed  been  shown  to  be 
present  on  all  ALL  samples  analysed  [Matheson  &  Borland,  et  al.,  paper  in  press]  but  is 
43 not  expressed  by  B  chronic  lymphocytic  leukaemia  cells  (B-CLL).  In  vitro  studies  using 
purified  proteins  demonstrate  that  soluble  CD23  interacts  specifically  with  the  aP5 
vitronectin  receptor  isoform,  both  by  ELISA  and  by  surface  plasmon  resonance  studies 
[Matheson  &  Borland  et  al.,  in  press]. 
1.4.8  DISEASE  ASSOCIATION 
CD23  has  been  implicated  in  a  variety  of  pathological  conditions,  with  data  from  many 
laboratories  suggesting  elevated  soluble  CD23  serum  levels  are  a  useful  prognostic 
indicator  in  a  range  of  allergic  [Yanagihara  et  al.,  1990],  inflammatory  [Bansal  et  al., 
1992],  autoinimune  [Hellen  et  al.,  1991]  and  neoplastic  conditions  [Sarfati  et  al.,  1996; 
Mossalayi  et  al.,  1997]. 
ATopic  DiSEASES 
Atopic  disease  usually  describes  the  clinical  presentation  of  type  I  hypersensitivity 
reactions,  and  includes  conditions  such  as  asthma,  hay  fever,  atopic  eczema  and 
anaphylaxis.  These  allergic  conditions  can  be  defined  as  an  inappropriate  response  of 
the  immune  system  to  an  otherwise  harmless  environmental  allergen,  for  example 
pollen  [Robinson,  et  al.,  1997].  These  conditions  are  dependent  upon  the  specific 
triggering  of  IgE-sensitised  mast  cells  by  (generally  low  levels  oo  environmental 
allergen.  The  initial  contact  of  an  allergen  with  the  mucosa  is  followed  by  a  complex 
series  of  events  leading  to  the  production  of  IgE.  This  is  a  local  event,  occurring  at  the 
site  of  allergen  entry  into  the  body.  The  locally  produced  IgE  first  sensitises  local  mast 
cells  before  excess  IgE  can  then  enter  the  circulation  and  bind  to  specific  receptors  on 
both  circulating  basophils  and  tissue  fixed  mast  cells  throughout  the  body.  IgE,  when 
cross-linked  with  allergen,  binds  to  both  basophils  and mast  cells  via  the  FccRI 
receptor,  stimulating  the  release  of  pharmacological  mediators,  producing  the 
inflammatory  responses  leading  to  the  allergic  symptoms  [Mudde  et  al.,  1990].  Several 
cytokines  are  also  released  as  a  result  of  IgE-mediated  mast-cell  activation  [Dugas  et 
al.,  1992].  It  should  be  noted  that  Th2-type  cytokines  play  an  important  role  in  atopic 
disease,  particularly  in  atopic  asthma.  Development  of  atopic  disease  is  linked  to 
increased  circulating  levels  of  IgE  [Burrows  et  al.,  1989;  Sears  et  al.,  1991;  Naclerio  et 
al.,  1993]. 
44 Serum  CD23  levels  tend  to  be  significantly  higher  in  atopic  compared  to  normal 
individuals,  with  these  levels  thought  to  be  weakly  but  significantly  correlated  with  IgE 
levels.  It  is  thought  that  both  membrane-bound  and  soluble  forms  of  CD23  contribute  to 
the  pathogenesis  of  atopic  disease  by;  (i),  regulating  IgE  production  [Sarfati  et  aL,  1984 
&  1988];  (ii),  direct  interaction  with  CD21  to  induce  histamine  release  from  basophils 
[Bacon  et  aL,  1993];  (iii),  IgE-dependent  release  of  inflammatory  mediators  by 
monocytes  and  eosinophils,  etc  and  (iv),  activation  of  monocytes  and  macrophages  via 
CD  II  b/c-CD  18  integrins  [Lecoanet-Henchoz  et  aL.,  1995].  In  late  allergic  reactions,  IL- 
4  also  induces  CD23b  expression  on  various  cells,  thus  enabling  the  release  of  more 
inflammatory  cytokines.  The  CD23-triggered  histamine  release  from  basophils,  clearly 
suggests  CD23  may  have  a  direct  role  in  mediator  release. 
INFLAMMATORY  DISEASES 
Increased  levels  of  CD23  have  been  reported  in  various  chronic  inflammatory  diseases 
including  rheumatoid  arthritis  (RA)  [Hellen,  et  al.,  1991],  systemic  lupus  erythernatosus 
(SLE)  [Bansal,  et  al.,  1992]  and  inflammatory  bowel  disease  [KaiserHan,  et  al.,  1993]. 
RA  is  a  long-term  inflammatory  disease  resulting  in  swelling  and  joint  pain.  Patients 
with  RA  have  been  found  to  have  elevated  levels  of  circulating  CD23-positive  B  cells 
[Kumagais  et  al.,  1989],  as  well  as  increased  levels  of  circulating  sCD23  in  both  their 
serum  and  synovial  fluid  [Ikizawa  et  al.,  1993].  Furthermore,  CD5+  B  cells  are 
specifically  activated  in  these  individuals,  leading  to  the  constitutive  expression  of 
CD23a  mRNA  and  accelerated  release  of  sCD23  [Ikizawa  et  al.,  1993].  The  levels  of 
serum  sCD23  in  RA  patients  are  related  to  disease  status,  as  demonstrated  by  a  large 
study  on  identical  twins  discordant  for  RA  [Bansal  et  al.,  19941.  Pro-inflammatory 
cytokines,  such  as  TNF-a  and  IL-  IP  have  also  been  found  to  be  present  in  the  synovial 
fluid  of  these  patients  [Brennan  et  al.,  1989]  and  subsequent  studies  have  shown  a 
marked  reduction  in  disease  severity  and  tissue  destruction  after  the  neutralisation  of 
these  cytokines  [Williams  et  al.,  1992].  Pro-inflammatory  cytokines  have  thus  been 
postulated  to  play  a  role  in  the  destruction  of  tissues  within  the  arthritic  joints  [Elhot  et 
al.,  1993].  IgE  is  not  implicated  in  RA  therefore  it  has  been  proposed  that  CD23  must 
bind  other  ligands  in  order  to  induce  the  production  of  these  pro-inflammatory 
cytokines.  As  has  been  previously  described  in  section  1.4.7,  CD23  is  capable  of 
binding  to  either  CD11b  or  CD11c,  with  the  result  of  increased  nitric  oxide  and 
45 inflammatory  mediators  [Lecoanet-Henchoz  et  al.,  19951.  Recent  evidence  also  links 
the  binding  of  CD23  to  avP3  to  pro-inflanumtory  immune  responses  [Hermann  et  al., 
1999]. 
LEUKAEMIC  DISORDERS 
Chronic  lymphocytic  leukaemia  (CLL)  is  characterised  by  the  accumulation  of  long- 
lived  and  slowly  dividing  malignant  CD5+  B  cells  co-expressing  slgM,  sIgD  and  CD23 
antigens,  which  have  escaped  programmed  cell  death  and  are  arrested  in  the  Go/Gi  stage 
of  the  cell  cycle  [Fournier  et  al.,  1992;  O'Brien  et  al.,  1995].  B-CLL  accounts  for  -30- 
40%  of  all  the  reported  cases  of  leukaemia  in  Western  Europe  and  North  America 
[Sarfati  et  al.,  1988].  The  CD23  protein  is  over-expressed  and  abnormally  regulated  in 
B-CLL  [Fournier  el  al.,  1992],  with  a  selective  increase  in  CD23  (mainly  CD23b)  in  B- 
CLL  lymphocytes  provoking  entry  of  these  cells  into  S  phase  of  the  cell  cycle  [Fournier 
et  al.,  1994].  B-CLL  sera  have  been  reported  to  have  between  3  to  500  fold  more  sCD23 
than  control  sera  [Sarfati  et  al.,  1988]  and  a  level  of  >575U/ml  sCD23  has  been  shown 
to  be  correlated  with  disease  progression  and  a  poor  prognosis  [Sarfati  et  al.,  1996]. 
sCD23  levels  have  also  been  shown  to  reliably  reflect  disease  activity  [Reinisch  et  al., 
1994]  and  correlate  significantly  with  tumour  load  [Beguin  et  al.,  1993]. 
Acute  lymphocytic  leukaernia  (ALL)  is  the  most  common  pediatric  malignancy  and  also 
accounts  for  a  significant  proportion  of  adult  lymphoid  neoplasms  [Greaves,  1999; 
Chessells,  2000].  B-ALL  is  successfully  treated  in  the  great  majority  of  pediatric  cases 
by  combination  chemotherapy  leading  to  complete  ren-dssion  and  disease-free  survival 
[Chessells,  2000].  The  prognosis  in  adult  B-ALL  is  less  encouraging  with  blast  crisis, 
an  overwhelming  number  of  neoplastic  cells  in  the  bloodstream,  being  a  frequent  and 
life-threatening  event  in  the  disease  progression.  In  the  leukaemic  phase,  sCD23  in  the 
blood  may  be  able  to  provide  a  signal  to  the  neoplastic  cell,  but  there  are  no  reports  of 
elevated  sCD23  in  the  plasma  of  ALL  patients  with  any  form  of  the  malignancy.  This 
may  be  due  to  the  fact  that  B-ALL  neoplastic  cells  are  derived  from  B  cell  precursors, 
where  the  CD23  gene  is  silent.  C45,  a  receptor  for  CD23,  is  expressed  on  all  B-ALL  cell 
samples  analysed  in  our  laboratory  [Matheson  et  al.,  in  Pres.  ].  CD23  is  expressed  on 
bone  marrow  stromal  cells  [Fourcade  et  al.,  1992],  and  may  serve  to  provide  transient 
anti-apoptotic  signals  to  B  cell  precursors  at  a  particular  window  in  antigen-independent 
46 differentiation.  This  does  not  explain  the  overt  proliferation  of  leukaemic  cells,  a 
function  thought  to  be  dependent  upon  a  chromosomal  translocation  or  other  event  that 
takes  place  within  the  transformed  cell.  The  precise  function  of  CD23  in  the  regulation 
of  normal  and  neoplastic  B  lymphoid  differentiation  remains  to  be  defined. 
1.4.9  MuRwE  CD23 
Murine  CD23  has  been  shown  to  be  very  similar  to  its  human  counterpart.  It  is  a  49kDa 
glycoprotein,  has  two  (instead  of  one)  N-linked  glycosylation  sites,  no  DGR  motif 
[Bettler  et  aL,  1989],  and  four  (instead  of  three)  consensus  repeats.  Controversial  data 
have  in  the  past  suggested  that  murine  CD23,  like  its  human  equivalent,  existed  as  two 
isoforms,  however  the  majority  of  groups  now  believe  there  to  be  only  one  murine 
CD23  form  (likened  to  the  human  CD23a  isoform)  at  the  protein  level.  Evidence 
suggests  that  murine  CD23  can  also  form  oligomers  at  the  cell  membrane  [Dierks  et  aL, 
1993],  and  there  is  evidence  to  support  the  hypothesis  that  IgE  requires  at  least  dimers 
of  the  murine  CD23  to  bind  to  cells  and,  further,  that  this  binding  stabilises  the 
oligomerisation. 
1.4.10  CD23  TRANSGENIC  MOUSE  STUDIES 
Numerous  groups  have  generated  a  wide  variety  of  mouse  models,  utifising  gene 
knockout  and  transgenic  technology  in  an  attempt  to  determine  the  in  vivo  function  of 
CD23  in  relation  to  IgE  synthesis.  The  resultant  phenotypes  and  observations  obtained 
have  been  deemed  by  most  to  be  more  controversial  than  informative. 
Mice  genetically  deficient  for  CD23  were  generated  using  homologous  recombination 
in  embryonic  stem  (ES)  cells,  targeting  the  exons  encoding  the  transmembrane  domain 
of  CD23  thus  ensuring  the  eradication  of  all  forms  of  this  protein,  whether  they  be  the  a 
or  b  isoform  or  the  membrane-associated  or  soluble  form  [Yu  et  al.,  1994].  Except  for 
the  lack  of  CD23  proteins  the  rest  of  the  immune  system  was  shown  to  be  the  same  as 
that  of  the  control  mice  with  regards  to  cell  number,  distribution  and  surface  riwker 
expression.  The  knockout  mice  were  reported  to  have  a  single  abnormal  phenotype; 
they  were  found  to  make  more  IgE  than  control  animals  [Yu  et  al.,  1994].  These 
animals  were  shown  to  have  two-fold  higher  serum  IgE  levels  than  their  littermate 
47 controls,  and  mount  a  10-100-fold  higher  specific  IgE  response  upon  challenge  with 
thymus-dependent  antigens.  Immune  response  to  helminths  was  unaffected.  This 
phenotype  indicates  that  CD23  negatively  regulates  IgE  production  in  vivo  [Yu  et  al., 
1994]. 
Two  other  CD23-deficient  mouse  strains  were  made  using  the  gene  targeting  technique, 
[Stief  et  al.,  1994;  Fujiwara  et  al.,  1994]  and  these  confirmed  the  lack  of  major 
disturbances  to  the  normal  immune  system.  However  neither  strain  was  found  to 
corroborate  the  enhanced  IgE  responses  found  by  Yu  and  colleagues.  Heyman  and 
colleagues  [Heyman  et  al.,  1993]  reported  that  IgE-antigen  complexes  could  augment 
immune  responses  by  interacting  with  CD23,  supported  by  the  findings  that  this 
augmentation  was  not  present  in  the  CD234-  animals  [Fujiwara  et  al.,  1994].  The 
general  conclusion  from  these  data  was  that  CD23  acts  as  a  negative  regulator  for  IgE 
production,  however  it  was  also  noted  that  the  absence  of  CD23  resulted  in  only  a 
modest  phenotype. 
Texido  and  colleagues  produced  a  transgenic  stain  whereby  CD23  transgenic  expression 
was  controlled  by  the  Thyl.  1  promoter  [Texido  et  al.,  1994].  Mice  transgenic;  for  the 
membrane-associated  form  of  CD23,  but  not  those  for  the  soluble  form,  were  found  to 
have  about  a  50%  suppression  of  IgE  production,  thus  demonstrating  an  impaired  IgE 
immune  response.  Expression  of  the  transgene  was  mainly  restricted  to  T  lymphocytes, 
however  backcrossing  onto  the  CD234"  phenotype  did  demonstrate  some  expression  on 
B  cells  [Texido  et  al.;  1994].  These  studies  indicate  CD23  expression  on  T  cells  has  a 
modest  effect  on  IgE  production,  however  they  do  not  address  its  role  on  B  cells,  where 
CD23  is  more  typically  expressed  at  high  levels. 
More  recently  a  new  transgenic  model  in  which  CD23  was  over-expressed  using  the 
murine  MHC  class  I  promoter,  H-2Kb,  in  conjunction  with  an  IgH  enhancer  was 
reported  [Payet  et  al.,  1999].  This  strain  resulted  in  the  clearly  enhanced  expression  of 
CD23  on  both  resting  and  stimulated  B  lymphocytes,  (an  advantage  over  the  Texido 
report),  and  T  lymphocytes.  Expression  of  the  transgene  was  not  observed  on  non- 
lymphoid  tissue.  The  serum  IgE  half-life  was  found  to  be  similar  in  control  and 
transgenic  animals.  The  transgenics  were  also  tested  for  in  vitro  and  in  vivo  regulation 
48 of  IgE,  demonstrating  a  consistently  strong  suppression  of  IgE  synthesis  in  both  primary 
and  secondary  responses  against  antigen/alum  immunisation,  Nippostrongylus 
brasiliensis  (Nb)  infections  and  anti-IgD  injection  models.  Furthermore,  enzyme-linked 
immunospot  analysis  of  activated  B  lymphocytes  revealed  a  reduced  number  of  IgE 
antibody-forming  cells.  The  hurnoral  Ig  levels  were  mildly  dampened  after 
immunisation,  suggesting  that  the  transgene  affected  production  of  all  isotypes, 
potentially  through  interactions  of  CD23  with  an  alternate  ligand,  possibly  CD21  [Payet 
et  al.,  1999].  The  dramatic  suppression  of  IgE  responses  further  supports  the  concept 
that  CD23  can  regulate  IgE  levels. 
It  was  hypothesised  that  the  high  levels  of  CD23  expression  on  B  cells  was  responsible 
for  the  suppression  of  the  IgE  response  in  these  transgenic  mice.  However,  in  vitro 
culture  of  the  transgenic  B  cells  revealed  IgE  production  to  be  normal.  Furthermore, 
adoptive  transfer  of  transgenic  lymphocytes  into  normal  mice  further  confirmed  that  B 
lymphocytes  alone  were  not  sufficient  to  cause  suppression.  No  functional 
abnormalities  were  observed  in  the  transgenic  T  cells  either.  Suppression  of  the  IgE 
response  was  therefore  concluded  to  be  most  likely  dependent  on  a  cell  type  other  than 
B  or  T  cells  and  follicular  dendritic  cells  (FDCs)  were  thought  to  be  the  most  likely 
candidates.  The  adoptive  transfer  experiments  detailed  in  this  report  highlight  the 
importance  of  the  host  environment  and  the  high  levels  of  CD23  expression  in  the 
germinal  center,  where  FDC  reside  and  the  recall  responses  are  initiated,  suggest  CD23 
expression  on  FDCs  is  playing  a  role  in  the  phenotype  observed  [Payet-Jamroz  et  al., 
20011.  This  concept  was  supported  by  the  demonstration  that  IgE  synthesis  was 
significantly  reduced  by  culturing  B  cells  in  the  presence  of  transgenic  FDC,  in 
comparison  to  culture  with  normal  FDC. 
]Because  both  membrane  and  soluble  CD23  levels  are  enhanced  in  the  transgenic  mice, 
the  observed  phenotype  could  be  attributable  to  either  membrane  or  soluble  CD23  (or 
both).  Soluble  CD23  transgenic;  mice  had  no  observable  phenotype  [Texido  et  al.,  1994] 
therefore  membrane-associated  CD23  is  favoured  as  being  responsible  [Payet-Jamroz  et 
al.,  20011.  The  current  model  for  CD23  predicts  that  three  monomers  interact  with  each 
other  to  form  a  functional  trimer  on  the  cell  surface.  This  model  is  based  on  the  noted 
heptad  repeat  pattern  found  in  the  stalk  region  of  the  molecule  [Beavil  et  al.,  1992]  and 
49 chemical  cross-Iffiking  studies  [Dierks  et  al.,  1993].  CD23  is  cleaved  by  an  as  yet 
unknown  metalloprotease  [Marolewski  et  al.,  1998]  and  the  cleaved  monomeric  product 
interacts  with  only  a  single  IgE  with  low  affinity.  Development  of  anti-CD23  antibodies 
raised  against  the  stalk  region,  having  the  potential  to  inhibit  CD23  ofigomerisation, 
may  have  more  potential  to  investigate  this  further,  however  these  antibodies  are  not 
available  yet. 
Transgenic  and  knockout  mouse  models  have  provided  new  insights  into  the 
immunological  functions  of  CD23,  however  there  are  a  number  of  limitations.  There  are 
marked  differences  between  CD23  in  mouse  and  CD23  in  humans.  At  the  molecular 
level,  there  is  only  57%  homology  between  the  CD23  proteins.  Furthermore,  human 
CD23  exists  in  two  distinct  isoforms  (1.4.6),  each  protein  displaying  different  cellular 
expression  patterns  and  hypothesised  to  have  differential  functions,  whereas  mice  are 
generally  believed  to  have  only  a  single  CD23  protein,  likened  to  human  CD23a, 
expressed  on  mature  B  cells,  T  cells  and  FDCs.  In  humans  most  of  the  regulatory  effects 
of  CD23  are  ascribed  to  its  IgE  binding  capacity,  with  the  mouse  CD23  having  been 
shown  to  not  retain  the  same  extent  of  IgE  binding  [Bartlett  et  al.,  1995].  The  relevance 
of  the  observations  discussed  in  this  section  to  the  human  system  is  therefore 
ambiguous.  However  as  in  vivo  experimentation  in  humans  is  not  an  option,  the  mouse 
model  is  still  the  most  practical  experimental  tool  for  studying  CD23  function  in  vivo.  In 
summary,  a  certain  amount  of  care  must  be  used  when  extrapolating  results  from  one 
system  to  the  other. 
1.5  AREAS  OF  RESEARCH  INTEREST 
As  previously  discussed  there  are  two  distinct  CD23  isofonns,  CD23a  and  CD23b 
[Yokota  et  al.,  1992],  with  both  species  derived  from  a  single,  II  exon  gene  [Suter  et 
al.,  1987;  Wendel-Hansen  et  al.,  1990]  and  differing  only  by  6/7  amino  acids  at  the  very 
N-terminus  of  their  short  intracytoplasmic  tails.  Early  studies  employing  radioiodinated 
anti-CD23  MAb  to  probe  endocytic  function  and  IgE-coated  erythrocytes  for  assay  of 
phagocytosisj  indicated  that  the  two  CD23  isoforms  were  internalised  via  distinct 
pathways,  with  CD23a  entering  the  cell  via  receptor-mediated  endocytosis  and  CD23b 
showing  a  more  phagocytic  route  of  cellular  entry  [Yokota  et  al.,  1988].  Individual 
amino  acids  residues,  a  tyrosine  at  position  6  in  CD23a  and  the  asparagine-proline- 
50 proline  residues  at  positions  2-4  in  CD23b,  were  also  identified  as  being  responsible  for 
these  differences.  Two  separate  cell  types  were  used  to  analyse  the  trafficking  pathways 
of  each  isoform  using  two  sets  of  separate  experimental  conditions.  Unoccupied  CD23 
trafficking  could  not  be  studied  due  to  the  nature  of  the  assays  utilised. 
The  research  presented  herein  employs  identical  systems  for  ligating  both  CD23a  and 
CD23b,  namely  chimaeric,  hapten-specific  IgE  and  a  haptenated  protein  antigen  for 
cross-finking  purposes.  The  wild-type  proteins  were  analysed  initially  before  being  used 
to  generate  GFP-CD23  fusion  proteins  to  enable  direct  analysis  of  each  isoform.  in  a 
basal,  ligated  and  crosslinked  state  in  HEK  293  cells.  A  small  panel  of  specifically 
designed  GFP-tagged  mutant  CD23  proteins  were  then  generated  in  an  attempt  to 
identify  the  essential  amino  acids  involved  in  CD23  isoform  receptor  trafficking  in  the 
same  system.  CD23  is  expressed  primarily  in  haematopoietic  tissues,  and  it  is  in  these 
cells  that  many  of  the  biologically  important  functions  of  CD23  take  place.  One  of  the 
aims  of  this  research  was  to  utilise  the  GFP-CD23  fusion  proteins  and  the  NIP  system 
discussed  above  to  visualise  the  intracellular  trafficking  of  CD23  in  a  natural  host  cell. 
Present  knowledge  of  the  downstream  signalling  pathways  employed  by  the  CD23 
isoforms  is  somewhat  preliminary  and  incomplete  to  say  the  least.  However,  it  is 
generally  believed  that  these  isoforms  utilise  unique  trafficking  and  signalling 
pathways.  CD23a  has  been  linked  to  a  cAMP  pathway  whilst  CD23b  is  thought  to 
function  via  inositol-1,4,5-trisphosphate  and  calcium  mobilisation.  However  no  studies 
have  been  performed  to  address  the  question  of  what  actually  binds  to  CD23  in  order  to 
initiate  either  of  these  pathways,  or  indeed  any  other  signalling  pathways  which  may  be 
involved  in  CD23  function.  The  cytoplasmic  tail  of  CD23  is  small,  in  comparison  to 
other  cell  surface  receptors,  and  does  not  contain  any  of  the  more  commonly  recognised 
protein  binding  motifs,  such  as  NPXY  or  YXXý  [Heilker  et  al.,  1999].  It  therefore 
seems  likely  that  CD23  may  bind  to  an  adaptor-like  protein  in  order  to  facilitate  the 
recruitment  of  the  necessary  signalling  component(s)  required  for  its  function.  This 
hypothesis  was  addressed  in  the  fmal  section  of  research,  where  the  cytoplasmic  N- 
terminal  tail  of  CD23  was  used  as  bait  to  screen  for  potential  binding  partners  in  a 
human  leukocyte  cDNA  library,  using  the  yeast  two-hybrid  technique.  The  aim  of  this 
51 study  was  to  identify  interacting  protein  species  with  the  goal  of  elucidating  the  first 
step  in  the  signalling  cascade  employed  by  CD23. 
52 FIGURE  1.1  SCHEmATic  DIAGRAM  ILLUSTRATING  THE  ANTIGEN- 
INDEPENDENT  STAGES  OF  B  CELL  DEVELOPMENT 
This  diagram  illustrates  the  characteristic  cell  surface  markers  and  gene  expression 
patterns  present  at  each  stage  of  antigen-independent  B  cell  development.  The 
transcription  proteins  important  at  each  stage  are  shown  in  pink.  The  black  'up'  arrows 
indicate  induction  of  gene  expression,  whereas  the  black  'down'  arrows  represent 
repression  of  gene  expression.  No  arrow  indicates  gene  expression  occurs  but  is  not 
altered  from  the  previous  stage.  Components  of  the  pBCR  include  surrogate  light 
chains,  ýt,  and  Iga/p,  the  components  of  the  BCR  are  identical  except  that  the  light 
chain  genes  are  associated  with  g. 
Abbreviations:  GL  -  Germ  line,  SL  -  Surrogate  light  chain,  go  -  Sterile  [i  transcript. 
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uuuu FIGURE  1.2  SCHEMATic  DIAGRAm  DETAILING  THE  ANTIGEN-DEPENDENT 
STAGES  OF  B  CELL  DEVELOPNtENT 
The  diagram  illustrates  the  stages  of  antigen  dependent  B  cell  development.  The 
anatomical  location,  types  of  B  cell,  developmental  events  and  expression  patterns  for 
genes  known  to  increase  (up  arrows)  or  decrease  (down  arrows)  are  all  indicated.  Cell 
status  is  colour  coded,  blue  indicates  resting,  indicates  cycling  whilst 
indicates  quiescent  stage  cells. 
54 
-I -  a. 
coo 
w 
(D 
9. 
cu 
12. 
C..  ) 
Z 
1.01 
i-- 
Z.  0  = 
'Z  räo 
`d 
.  00 
>  zi 
J--  Z  0- 
< 
.0  Z 
C) 
u  C)  0  <j 
U 
:  i:  .- 
ce  Co  0  E  in 
Z  OIM 
E  .Z  u  um  ta 
(A  ul 
=.  E  :Z 
CA 
.  Z:  ý  Q) 
CU 
+ 
cl) 
Ö 
04  (1)  (1)  <  CL 
CN  U)  <  LL 
>,  co  m 
C)  C)  M  Lu 
cu 
L 
E 
Cý 
04 
1 
06 
CN  x 
-L  -L  cn  U0  cu  < 
Li- 
0) 
C14 
cn  -L  cu  0 
U- 
C14 
06 
<5 
CN 
U)  0 
-j  C%4 
Cl)  q  -,  I<W 
LL  I-) 
CU  co  L)  Z0 FIGURE  1.3  SCHEmATic  DIAGRAM  ILLUSTRATING  THE  COMMON 
MOLECULAR  SORTING  PATHWAYS  PRESENT  IN  EUKARYOTIC  CELLS 
This  diagram  illustrates  the  main  compartments  present  in  most  eukaryotic  cells  and  the 
common  sorting  pathways  that  facilitate  protein  trafficking  between  these 
compartments.  The  pathways  of  particular  interest  to  the  work  presented  in  this  thesis 
are  the  endocytic  pathways  (blue  arrows)  and  phagocytosis  (purple  arrow). 
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Nuclear  envelope FIGURE  1.4  COAT  PROTEINS  ]REGULATE  PROTEIN  TRANSPORT  BETVVEEN 
SPECIFIC  COMPARTMENTS  WITHIN  THE  CELL 
Three  types  of  coat  proteins  are  known  to  exist  in  eukaryotic,  cells  and  these  are  detailed 
in  table  1.  Clathrin  is  the  best  characterised  and  figure  2  illustrates  how  the  clathrin 
heavy  and  light  chains  assemble  into  the  clathrin  triskelion.  The  triskelions  assemble 
into  a  cage-like  hexagonal  lattice  which  attached  specifically  to  membranes  through  the 
coat  proteins.  Three  coat  proteins  have  been  identified  and  the  subunits  of  each  are 
shown  in  figure  3.  Figure  4  illustrates  receptor-mediated  uptake  from  clathrin  coated  pit 
with  a  membrane  into  clathrin  coated  buds. 
56 Name  Subunits  Transport  Pathway 
Clathrin  Triskelion  Heavy  chain,  Light  chain 
AP-  I  adaptins  7,01,  ý11'  (YI  TGN-to-late  endosornes 
AP-2  adaptins  (x,  P2,  ý0,  a2  PM-to-early  endosomes 
AP-3  adaptins  8,03,  ý0,  c73  TGN-to-lysosomes 
Early  endosome-to-? 
COPI  ()C,  P"P,  7,8,  F,  C  ER-to-Golgi 
intra-Golgi 
Golgi-to-ER 
COPII  Sec3lp,  Sec24p,  Sec23p,  Secl3p  ER-to-Golgi 
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I"0-0  lw FIGURE  1.5  STRUCTURAL  COMPARISON  OF  THE  HIGH  AND  Low  AFFINITY 
RECEPTORS  FOR  IgE,  FCcRI  AND  FccRII 
The  high  affinity  receptor  for  IgE  (FccRI)  is  a  tetramer  consisting  of  one  (x  chain  With 
two  disulphide-finked  immunoglobulin-like  loops,  aP  chain  and  two  y  chains.  The  p 
chain  has  two  extracellular  and  one  intracellular  loop  and  is  located  close  to  the  two  Y 
chains,  which  are  linked  by  a  single  disulphide  bond.  The  cc  chain  contains  the  igE 
binding  site. 
The  diagram  of  the  low  affmity  receptor  for  IgE  (FccRII  or  CD23)  is  a  proposed  model 
based  upon  sequence  data  and  similarity  with  animal  Jectins.  CD23  is  a  single  chain, 
type  Il  transmembrane  glycoprotein,  lying  in  the  opposite  orientation  to  the  other  Fe 
receptors.  The  IgE  binding  site  is  located  within  the  lectin-like  domain.  Proteolytic 
cleavage  of  the  full-length  form  can  release  several  soluble  CD23  fragments,  each 
retaining  the  ability  to  bind  IgE. 
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This  diagram  illustrates  the  proposed  structure  of  the  human  CD23  molecule,  detailing 
the  location  of  each  of  the  domain  regions  referred  to  within  the  text  of  the  introduction 
chapter.  CD23  is  a  45kDa  type-II  transmembrane  glycoprotein.  CD23  has  a  short 
cytoplasmic  tail  and  a  single  hydrophobic  transmembrane  domain  with  the  remainder  of 
the  protein  located  outwith  the  cell.  The  stalk  region  contains  the  leucine  zipper  motif 
and  a  number  of  heptad  repeats,  thought  to  be  involved  in  the  oligomerisation  of  these 
molecules  on  the  cell  surface.  The  IgE  binding  site  is located  within  the  lectin  domain. 
DGR  represents  the  amino  acid  sequence  Aspartate,  Glycine,  Arginine. 
The  two  CD23  isoforms  differ  only  by  the  six  or  seven  amino  acids  at  the  very  N- 
terminus  of  the  short  cytoplasmic  tail,  with  these  differences  being  highlighted  in  red  in 
the  box  at  the  base  of  this  figure.  The  black  and  purple  letters  represent  the  amino  acids 
common  to  each  isoform,  with  the  purple  letters  representing  the  amino  acids  located 
within  the  transmernbrane  domain.  The  coloured  boxes  highlight  the  location  of  two 
potential  sorting  motifs  within  the  CD23  N-terminal  tail.  These  motifs  are  discussed  in 
section  1.3.5. 
This  figure  has  been  adapted  from  Marolewski  et  aL,  (1998). 
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S-S 
(aa  163-321) 
S-S 
25  kDa 
Proteolytic 
29  kDa  cleavage 
(aa  82-157)  sites  generating 
<  33  kDa  soluble  CD23 
fragments 
4  37  kDa 
Extracellular  spa, 
ransine  ii 
Domain  (aa  23-44) 
CD23a  ME.  FIGQ  YSEI  EE  LPRRRCCRRGTQ1  Vl,  l  I 
CD23b  MNPPSQEI  EE  LPRRRCCRRGTQ1  Vl,  l  I 
Na  or  Nb FIGURE  1.7  CD23A  AND  CD23B  ISOFORMS  ARE  GENERATED  FROM 
ALTERNATIVE  SPLICING  OF  THE  SAmE  GENE. 
Human  CD23  is  encoded  by  an  II  exon  gene  located  on  chromosome  19.  The  two 
CD23  isoforms  are  generated  using  distinct  transcriptional  initiation  sites  and 
differential  RNA  splicing.  The  diagram  illustrates  which  exons  are  incorporated  into 
wlAch  isoform  The  5'  untranslated  (IJTR)  re&n  of  each  isoform  is  indicated  by  the 
pale  blue  and  green  boxes,  and  the  sequence  provided  by  exon  III  is  indicated  by  the 
yellow  box.  The  unique  regions  of  the  CD23a  and  CD23b  isoforms  are  shown  in  pink 
and  dark  blue  respectively. 
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MATERIALS  AND  METHODS 
60 2.1  MATERIALS 
GENERAL  CHEMICALS  AND  MATERIALS 
All  general  chemicals  and  reagents,  unless  otherwise  stated  below,  were  purchased  from 
Sigma-Aldrich  or  BDH  Chemicals,  both  Poole,  Dorset,  UK.  All  reagents  were  of 
'AnalaR'grade. 
Chemical/Reagent  Supplier 
Kaleidoscope  and  Broad-range  protein  molecular  Amersharn  Life  Science  Ltd. 
weight  markers.  Buckinghamshire,  UK. 
Hybond  Tm  ECL  nitrocellulose  membrane 
Bio-Rad 
TM  Protein  Assay  Bio-Rad  Laboratories  Ltd. 
40%  Acrylamide/Bis  solution,  29:  1  Hertfordshire,  UK. 
X-(x-Gal  (5-Bromo-4-chloro-3-indoly-a-D-  Clontech  Laboratories  UK  Ltd. 
galactopyrano  side)  Chromogenic:  substrate  Hampshire,  UK 
KC8  Electrocompetent  E.  coli 
Drop  Out  Supplement 
Peptone 
Mowiol*  used  for  mounting  coverslips  onto  slides  CN  Biosciences,  UK. 
Sheep  Red  Blood  Cells  Diagnostics  Scotland. 
Lanarkshire,  UK. 
TRIM  *Reagent  Gibco  BRL,  Life  Technologies 
Ltd. 
Paisley,  UK. 
Bacto-agar  Oxoid  Ltd.  Hampshire,  UK. 
Bacto-tryptone 
Yeast  Extract 
Restriction  Endonucleases  and  Buffers  Promega  UK  Ltd.  Southampton, 
Taq  DNA  polymerase  UK. 
T4  DNA  ligase 
T4  Polynucleotide  kinase 
JM109  E.  coli 
Epicurian  Coh  XL  I  -Blue  Supercompetent  Cells 
Agarose  MP  (multi-purpose)  Roche  Diagnostics,  UK. 
DNA  molecular  weight  marker  X  (0.07-12.2  kbp) 
Restriction  Endonucleases  and  Buffers 
dNTP's  (PCR  grade) 
Cloned  Pfu  DNA  Polymerase  Stratagene  Ltd,  Cambridge,  UK. 
61 2.1.2  CELL  AND  TISSUE  CULTURE  REAGENTS  &  MATERIALS 
Reagent/Material  Supplier 
Disposable  plastic  graduated  pipettes  Bibby  Sterlin  Ltd.  Staffordshire,  UK. 
Tissue  culture  Flasks  Coming  Costar.  Buckinghamshire,  UK. 
50  ml  centrifuge  tubes 
6  well  plates 
Gene  Pulser  Electroporation  Cuvettes  Bio-Rad  Laboratories  Ltd.  Hertfordshire,  UK. 
Dulbecco's  Modified  Eagles  Medium  Gibco  BRL,  Life  Technologies  Ltd.  Paisley, 
RPMI-1640  Medium  UK. 
Foetal  Calf  Serum 
Penicillin/Streptomycin/Glutaniine 
Cryovials 
Haernocytometer  Phillip  Harris  Scientific.  Lanarkshire,  UK. 
G418  antibiotic  Promega  UK  Ltd.  Southampton,  UK. 
Cell  Dissociation  Media  Sigma-Aldrich.  Dorset,  UK. 
Trypan  Blue 
2.1.3  CELL  LINES 
Cell  Line  Supplier 
COS  7-  SV40  Transformed,  African  Gift  from  Prof  G  Milligan,  Department  of 
Green  Monkey  Kidney  Cells.  Biochemistry  &  Molecular  Biology,  University  of 
Glasgow,  UK. 
EDR  -  EBV  Transformed  Mature  Gift  from  Prof.  C  Watts,  University  of  Dundee, 
Human  B  Lymphoblastoid  Cell  Line  UK. 
HEK  293  -  Human  Embryonic  Laboratory  Stocks 
Kidney  Cells 
Raji  &  Raji  A-  Human  EBV-  European  Collection  of  Animal  Cell  Cultures, 
negative  Burkitt's  lymphoma  Cell  CAMR,  Wiltshire,  UK. 
Line 
SMS-SB  -  Human  Pre-BlI  Acute  Gift  from  Prof.  Brad  Ozanne,  CRC  Beatson 
Lymphoblastic  Leukaemia  Cell  Line  Laboratories,  Glasgow,  UK. 
P3HRI  -  Mature  Human  Burkitt's  Laboratory  Stocks 
Lymphoma  B  Cell  Line 
II 
2.1.4  PLASMIDS  &  TRANSFECTION  REAGENTS 
Plasmid/Reagent  Supplier 
Gene  Pulser  Electroporation  Cuvettes  Bio-Rad  Laboratories  Ltd.  Herts,  UK. 
62 DOTAP  'I'm  Boehringer  Manheim  Ltd.  Herts,  UK. 
_  Human  Leukocyte  MATCHMAKER  cDNA  Clontech  Laboratories  UK  Ltd. 
Library,  GAL  4  AD  vector,  pACT2  Hampshire,  UK. 
GAL  4  DNA-BD  vector,  pGBKT7 
pcDNA3.1  Invitrogen,  Netherlands. 
Full  length  enhanced  green  fluorescent  protein,  Gift  from  Brad  Ozanne,  CRC  Beatson 
pEGFP-N  I  Laboratories,  Glasgow,  UK. 
2.1.5  ANTIBODIES 
Antibody  Supplier 
p-Tyr  (pho  sphotyro  sine)  mouse  Autogen  Bioclear.  Wiltshire,  UK. 
monoclonal  IgG 
anti-human  CD23-R-phycoerythrin 
(RPE)  conjugate  (B-G6)  IgG  I 
anti-HA  mouse  monoclonal  IgGa2 
Protein-A,  with  horseradish  Amersham  Life  Science  Ltd.  Bucks.,  UK. 
peroxidase  (HRP)  conjugate 
Anti-Human  CD23  (Bu38)  IgGI  ImmunoKontact,  AMS  Biotechnology  (Europe) 
Ltd.,  Oxon,  UK. 
CD  19  R-phycoerythrin  (RPE)  DAKO  Ltd.  Cambridgeshire,  UK. 
(HD37)  Isotype  IgGI 
CD19-FITC  (HD37)  Isotype  IgGI 
CD23-FITC  (MHM6)  Isotype  IgGI 
CD21  -FITC  (IF8)  Isotype  IgG  I 
CD3-FITC  (UCHTI)  Isotype  IgGI 
Rabbit-anti-human  CD23  (Rb55)  Gift  from  Dr  J-Y  Bonnefoy,  Geneva  Biomedical 
Research  Institute,  Switzerland 
Mouse-anti-human  CD23  Gift  from  Prof.  J  Gordon,  University  of 
Birmingham,  UK. 
Mouse-anti-GFP  Gift  from  Prof.  Brad  Ozanne,  CRC  Beatson, 
Glasgow,  UK. 
Anti-HLA  DR  (Class  11)  Gift  from  Dr  H  Jorgenson,  Academic  Transfusion 
Medicine  Unit,  Glasgow  Royal  Infirmary, 
Glasgow,  UK. 
Chimeric  Human  IgE  anti-NIP  Serotec,  UK. 
Mouse-anti-human  CD23 
Anti-Rabbit  IgG,  with  HRP  Scottish  Antibody  Production  Unit  (SAPU). 
conjugate  Lanarkshire,  UK. 
Anti-Mouse  IgG,  with  HRP 
conjugate 
63 2.1.6  FLUORECENT  PROBES 
Reagent  Supplier 
Transferrin-modified  Texas  Red  Molecular  Probes,  USA. 
(Tf-TxR) 
LysoTracker  Red 
Phalloidin-modified  Texas  Red  Gift  from  Brad  Ozanne,  CRC  Beatson  Laboratories, 
(P-TxR)  Glasgow,  UK. 
2.1.7  COMMERCIAL  KITS 
Kit  Supplier 
ECL  Western  Blotting  Detection  System  Amersharn  Life  Sciences  Ltd. 
Buckinghamshire,  UK. 
GAL  4  Yeast-2-Hybrid  MATCHMAKER  3 
System 
Clontech  Laboratories  UK  Ltd. 
Hampshire,  UK. 
OptEIATm  Human  sCD23  ELISA  Pharmingen.  San  Diego,  CA,  USA. 
Wizard  PlusSVTm  DNA  Mini  Preps 
RT-PCR  System 
Promega  UK  Ltd.  Southampton,  UK. 
Qiagen  Plasmid  Giga,  Mega  &  Maxi  DNA 
Purification  Kits 
Qiagen  QlAquickTm  Gel  Extraction  Kit 
Qiagen  Ltd.  West  Sussex,  UK. 
QuikChangeTM  Site-Directed  Mutagenesis  Stratagene  Ltd.  Cambridge,  UK. 
QuickStepTM  PCR  Purification  Kit  Vh  Bio  Ltd.  UK. 
2.1.8  OLIGONUCLEOTIDES 
All  oligonucleotides  were  synthesized  and  purified  by  MWG  Biotech,  to  PSF  purity.  The 
Iyophilised  oligonucleotides  were  resuspended  in  nuclease  free  water  at  a  concentration 
of  I  OOpmol/gl  and  stored  at  -200C.  The  sequences  of  each  of  the  oligonucleotides  used 
are  detailed  in  the  appropriate  figures. 
64 2.2  METHODS 
The  composition  of  all  the  solutions  and  buffers  referred  to  in  the  following  sections  are 
detailed  in  the  appendix. 
2.2.1  CELL  CULTURE 
2.2.1A  CULTURE  OF  NON-B CELL  LINES 
COS7  and  HEK  293  cells  were  routinely  cultured  in  Dulbecco's  Modified  Eagles 
Medium  (DMEM),  supplemented  with  0.05mg/ml  penicillin,  2mM  L-glutamine  and  10% 
(v/v)  fbetal  calf  serum  Ccomplete  medium!  ).  Cells  were  generally  cultured  in  75cmý 
flasks  at  37'C  in  a  humidified  5%  C02  incubator  and  manipulated  aseptically  in  Laminar 
flow  hoods.  Cells  were  split  1/3  every  2-3  days.  HEK  293's  were  bashed  from  the  flask 
whilst  cell  dissociation  fluid  (Signia)  was  used  to  detach  the  COS7  cells. 
2.2.111  CULTURE  OF  HumAN  B  CELL  LINES 
RAJI,  RAN  A,  SMS-SB,  EDR  and  P3HRI  cells  were  routinely  cultured  in  RPMI-1640 
medium  supplemented  with  2mM  L-glutamine,  0.05mg/ml  penicillin  and  10%  (v/v) 
heated  inactivated  fetal  calf  serum.  Cells  were  propagated  in  75crr?  flasks  at  37'C  in  a 
humidified  5%  COz  incubator  and  sub-cultured  aseptically  in  laminar  flow  hoods  every 
2-3  days  as  necessary. 
2.2.1C  DETERMINATION  OF  CELL  VIABILITY 
Cell  viability  was  determined  using  trypan  blue  dye.  Dead  cells,  after  losing  the  integrity 
of  their  plasma  membrane,  become  stained  as  a  result  of  the  trypan  blue  entering  into  the 
cell.  Numbers  of  live  and  dead  cells  were  counted  using  a  Neubauer  haernocytometer. 
The  total  number  of  cells  in  the  twenty-five  grid  squares  was  multiplied  by  104  and  also 
the  dilution  factor  in  order  to  estimate  the  number  of  cells  per  nil  of  culture. 
%  viability  =  number  of  live  cells  x  100 
total  number  of  cells 
65 2.2.1D  FROZEN  CELL  STOCKS 
Frozen  sample  stocks  of  each  cell  line  were  maintained  in  liquid  nitrogen.  Cells  were 
removed  from  logarithmically  growing  cultures,  centrifuged  and  resuspended  in  ice-cold 
freezing  media,  90%  (v/v)  heat-inactivated  FCS  and  10%  (v/v)  dimethyl  sulphoxide 
(DMSO)  at  approximately  IX  106  cells/ml.  Cells  were  transferred  to  pre-chilled  Nunc 
cryovials,  each  sample  was  then  frozen  at  -70'C  overnight  before  being  placed  into  liquid 
nitrogen  for  long  term  storage. 
Cell  samples  removed  from  liquid  nitrogen  storage  were  rapidly  thawed  in  lukewarm 
water  and  immediately  washed  in  9ml  of  the  appropriate  incomplete  medium  in  order  to 
remove  residual  traces  of  DMSO.  The  cells  were  harvested  at  10OOrpm,  re-suspended  in 
5ml  of  complete  medium,  transferred  to  a  25crr?  flask  and  incubated  in  a  37'C  incubator 
with  5%  C02  allowing  recovery  before  further  manipulation. 
2.2.2  FLOW  CYTOMETRIC  ANALYSIS 
A  Becton-Dickinson  FACScan  Flow  Cytometer  fitted  with  an  argon  laser  was  utilised 
for  the  analysis  of  all  cell  samples,  and  each  sample  was  prepared  in  a  6n-d  Falcon  tube. 
Samples  were  analysed  using  CeUQuestTm  software. 
Flow  cytometers  measure  and  analyse  the  optical  properties  of  single  cells  passing 
through  a  focused  laser  beam  and  can  analyse  hundreds  of  cells  per  second,  providing  a 
statistically  significant  picture  of  the  samples,  physical  and  biochemical  make  up.  When 
cells  pass  through  the  laser  beam  they  disrupt  and  scatter  the  laser  light  (detected  as 
forward  and  side  scatter).  Forward  scatter  (FSC)  relates  to  the  size  of  the  cell,  whilst 
side  scatter  (SSQ  is  an  indicator  of  the  cells  internal  complexity.  In  addition  to  scatter 
the  cytometer  also  measures  fluorescence  (FL)  parameters  (FLI-FL3).  Cells  can 
therefore  be  stained  with  fluorescent  dyes  or  fluorochromes.  The  fluorochromes  absorb 
the  laser  fight  and  emit  a  portion  of  this  absorbed  fight  in  different  regions  of  the 
spectrum.  With  fluorochromes  coupled  to  MAbs  directed  against  cell  surface  antigens, 
the  relative  amount  of  each  dye  on  an  individual  cell  can  be  determined,  generating 
information  about  the  molecular  properties  of  these  cells.  The  flow  cytometer  then 
66 processes  the  electronic  signals  resulting  from  each  cell,  creating  numeric  values  for  each 
parameter.  It  assigns  each  value  a  channel  number  and  passes  these  values  to  the 
computer  system  for  display  and  analysis.  Cell  size,  shape,  internal  complexity  and  in  this 
case  any  cell  component  or  surface  molecule  that  can  be  detected  by  a  fluorescent 
compound  can  therefore  be  examined  and  analysed  by  flow  cytometric  techniques. 
Figure  2.1  shows  a  schematic  representation  of  the  beam  path  of  a  typical  flow 
cytometer  and  a  brief  explanation  of  its  operation. 
2.2.2A  ANALYSIS  OF  CELL  SURFACE  PROTEINS 
Flow  cytometry  was  used  to  analyse  the  surface  expression  of  a  variety  of  proteins  on  a 
number  of  cell  lines  as  well  as  transiently  and  stably-transfected  HEK  293  and  RAJI-A 
cells.  Cells  to  be  analysed  were  harvested  from  culture  and  washed  twice  in  ice-cold 
PBS.  Approximately  5x  10'  cells  were  incubated  with  Igg  of  the  appropriate 
fluorescein  isothiocyanate  (FITC)  or  R-phycoerythrin  (RPE)  conjugated  antibody  for  45 
minutes  on  ice  protected  from  light.  After  incubation  the  cells  were  washed  twice, 
resuspended  in  0.5ml  ice-cold  PBS  and  analysed.  Indirect  staining  was  used  initially  to 
detect  cells  expressing  green  fluorescent  protein-CD23  fusion  proteins  (GFP-CD23). 
I  ýtg  of  biotinyl-anti-CD23  was  added,  excess  washed  off  as  described  previously  and  any 
MAb  binding  was  then  detected  using  streptavidin-Quantum  Red  (SA-QR).  Cells  were 
washed  and  resuspended  in  ice-cold  PBS  as  before.  FL-1/525mn  was  used  to  detect 
green  fluorescence  emitted  from  either  FITC  or  (GFP).  FL2/575tun  was  used  to  detect 
red  fluorescence  from  RPE.  Unstained  cells  were  also  analysed,  and  used  as  a  control, 
testing  for  auto-fluorescence.  In  all  cases  a  minimum  of  10'  events  were  collected. 
Propidium  iodide  (PI)  was  added  to'  certain  samples,  at  a  final  concentration  of  - 
5gg/ml,  in  order  to  highlight  the  dead  cell  population  within  any  given  cell  sample. 
2.2.213  FLOW  CYTOMETRIC  CELL  SORTING 
GFP-CD23b  expressing  HEK293  cells  were  sorted  using  a  Becton-Dickinson  FACStar 
Flow  Cytometer  fitted  with  an  argon  laser.  Cells  were  analysed  in  the  FLI/530nm 
cytometer  channel,  detecting  fluorescence  from  expression  of  the  GFP  protein  itself. 
Cells  registering  fluorescence  above  a  certain  level  were  selected  from  the  remainder  of 
the  population  and  subsequently  returned  to  cell  culture,  thus  selecting  cells  expressing  a 
67 minimum  level  of  GFP-CD23  fusion  proteins.  This  process  was  used  to  generate  a  stock 
of  HEK  293  cells  expressing  a  useful  level  of  GFP-CD23b  proteins,  since  the  signal  was 
initially  very  low  and  the  original  sample  was  not  comparable  to  the  GFP-CD23a  sample. 
2.2.3  NUCLEIC  ACIDS 
2.2.3A  SMALL  SCALE  PREPARATION  OF  DNA  (MINI-PREPS) 
The  Promega  Wizard  SV  Mini  plasmid  purification  kit  was  used  according  to  the 
maufacturer's  instructions.  Briefly,  a  5ml  overnight  Escherichia  col!  (E.  coli)  bacterial 
culture  expressing  the  required  plasmid  DNA  was  harvested  by  centrifugation  at  13,500 
xg  for  I  minute.  The  cell  pellet  was  fully  resuspended  in  250ýd  of  Resuspension 
solution.  250[il  of  Lysis  solution  was  added,  samples  mixed  by  inversion  and  incubated 
at  room  temperature  for  5  minutes.  10[il  of  protease  solution  was  then  added,  samples 
were  incubated  again  for  5  minutes  at  room  temperature.  350gl  of  Neutralization 
solution  was  added,  samples  were  mixed  by  inversion  and  immediately  spun  at  13,500  x 
g  in  a  desktop  microfuge  for  10  minutes.  The  supernatants  were  transferred  to  a  Wizard 
SV  mini  prep  resin  column,  and  spun  at  13,500  xg  for  I  minute  permitting  the  DNA  to 
bind  the  resin.  The  columns  were  then  washed  with  Wash  buffer  and  the  DNA  was 
collected  in  an  eluate  of  approximately  100[d  of  nuclease  free  dH20,  Samples  were 
assayed  for  concentration  and  purity,  as  per  section  2.2.3c,  and  stored  at  -20T. 
2.2.311  LARGE  SCALE  PREPARATION  OF  DNA 
Modification  of  the  alkali  lysis  method  proposed  by  Sambrook  et  al.,  1989,  was  used  to 
extract  plasmid  DNA  from  bacterial  cultures.  Cells  from  a  200ml  overnight  culture  of 
Ecoli  expressing  the  desired  plasmid  were  harvested  by  centrifugation  at  5,500  xg  for 
15  minutes  at  4'C.  The  supernatant  was  removed  and  the  pellet  fully  resuspended  in 
10ml  of  Solution  1.10ml  of  Solution  2  was  added,  the  sample  inverted  four  times  to 
facilitate  mixing,  and  incubated  on  ice  for  5  minutes.  7.5ml  of  Solution  3  was  added,  the 
sample  mixed  as  before  and  incubated  on  ice  for  10  minutes.  The  samples  were  then 
centrifuged  at  15,000  xg  for  15  minutes  at  4C  to  collect  the  cellular  debris.  The 
supernatant,  containing  the  nucleic  acids,  was  filtered  using  Whatman  3MM  filter  paper 
and  incubated  with  0.6  volumes  of  isopropanol  for  15  minutes  at  room  temperature.  The 
68 samples  were  centrifuged  at  350  xg  for  15  minutes  at  4'C  and  the  supernatant 
discarded.  The  pellet  was  resuspended  in  2ml  of  TE  buffer  and  incubated  with  2n-d  5M 
LiCI/5OmM  Tris-HCI,  pH  8.0,  for  10  minutes  on  ice,  serving  to  precipitate  the  RNA. 
The  RNA  was  then  separated  from  the  sample  by  centrifugation  at  350  xg  for  5  minutes 
at  4*C.  The  DNA  content  was  precipitated  from  the  sample  supernatant  using  two 
volumes  of  ethanol  and  a  15  minute  incubation  on  ice.  The  resultant  DNA  pellet  was 
collected  by  centrifugation  at  1200  xg  for  15  minutes  at  4T  in  a  Beckman  bench-top 
centrifuge.  The  pellet  was  dissolved  in  5001A  of  TE  buffer  and  300gg  of  RNase  added. 
The  sample  was  incubated  at  37T  for  I  hour,  serving  to  remove  any  contaminating 
RNA.  The  nucleic  acid  content  was  then  purified  using  two  phenoVehloroform  and 
chloroform  extractions.  The  aqueous  phase,  containing  the  DNA  was  incubated  with 
50%  volume  of  ammonium  acetate  and  two  volumes  of  ethanol  for  10  minutes  at  -70T 
serving  to  precipitate  the  final  DNA  preparation.  The  supernatant  was  removed  and  the 
DNA  pellet  resuspended  in  500gl  of  TE  or  dH20.  Concentration  and  purity  were 
assayed  as  per  section  2.2.3C,  and  the  samples  stored  at  -200C.  The  pellet  was 
resuspended  in  a  small  volume  of  sterile  dH20  and  stored  at  -200C. 
The  Qiagen  Maxi  and  Giga  plasmid  purification  kits  were  also  occasionaRy  used  for 
large  scale  DNA  purification  in  accordance  with  the  manufacturers  instructions. 
2.2.3C  DNA  CONCENTRATION  AND  PURITY 
DNA  concentration  and  purity  was  measured  using  a  Helios  y  spectrophotometer.  The 
DNA  sample  to  be  measured  was  diluted  1/100  and  11500  in  dH20  and  the  absorbance 
at  260nm  and  280nm  recorded.  The  concentration  of  DNA  was  calculated  by 
manipulating  the  A26o  reading  as  shown  in  the  equation  below,  where  50  is  the 
multiplication  factor  for  DNA  (40  for  RNA). 
DNA  Concentration  =  A260  x  50  x  Dilution  Factor  x  mg/ml 
1000 
The  A260:  A2so  ratio  provided  an  estimation  of  the  purity  of  the  DNA  sample,  with  values 
between  1.8  and  2.0  indicating  a  quality  DNA  preparation  containing  minimal  impurities. 
69 2.2.3D  RESTRICTION  ENDONUCLEASE  DIGESTION  OF  DNA 
I  unit  of  the  appropriate  restriction  enzyme  was  used  per  [Ig  of  plasmid  DNA,  each 
sample  reaction  being  carried  out  in  the  appropriate  reaction  buffer,  supplied  by  the 
enzyme  manufacturer.  Samples  were  incubated  for  at  least  I  hour  at  an  appropriate 
temperature,  the  reaction  was  terminated  by  the  addition  of  loading  buffer  and  the 
samples  were  separated  on  a  0.8%  agarose  gel,  section  2.2.3F. 
2.2.3E  LIGATION  OF  DNA  VECTOR  AND  INSERT  FRAGMENTS 
5gl  of  each  of  the  vector  and  insert  samples  to  be  ligated.  were  run  out  on  a  0.8% 
agarose  gel  along  with  a  known  amount  of  DNA  markers,  facilitating  an  estimation  of 
the  amount  of  DNA  in  each  preparation.  The  ligation  reaction  was  assembled  as  follows; 
50ng  vector  DNA,  200ng  insert  DNA,  I  gI  T4  DNA  figase,  2ýd  10  x  Ligase  buffer  and 
dH20  to  a  final  reaction  volume  of  20[d.  The  mixture  was  incubated  at  16*C  overnight, 
and  then  used  to  transform  competent  cells,  see  section  2.2.6. 
2.2.3F  AGAROSE  GEL  ELECTROPHORESIS 
Non-denaturing  0.8%  (w/v)  agarose  gels  were  used  to  visualize  DNA  fragments  of 
>100bp.  Higher  percentage  gels  (2%)  were  used  to  visualise  small  fragments,  i.  e.  PCR 
products.  Agarose  was  dissolved  in  60ml  (mini-gel)  or  100ml  (maxi-gel)  of  Ix  TAE 
buffer  for  fragment  resolution  or  DNA  purification  respectively.  Ethidium  bromide  was 
added  to  a  final  concentration  of  0.4mg/ml,  and  the  gels  were  set  at  room  temperature. 
Prior  to  loading,  the  DNA  samples  were  mixed  with  2pl  of  I  Ox  DNA  loading  buffer  and 
electrophoresed  along  with  the  appropriately  sized  DNA  markers  at  IOOV  in  Ix  TAE 
buffer.  The  DNA  fragments  were  visualized  on  a  UV  transilluminator  and  the  results 
recorded  as  a  photographic  image  of  the  gel. 
2.2.3G  PURIFICATION  OF  DNA  RESTRICTION  FRAGMENTS  FROM  LOW  MELTING 
POINT  AGAROSE  GELS. 
The  Qiagen  QIAquick  Gel  Extraction  kit  was  used  to  purify  DNA  fragments  from  low 
melting  point  TAE  agarose  gels.  The  appropriate  DNA  fragment  was  excised  from  the 
70 gel  using  a  sterile  scalpel  and  transferred  to  an  eppendorf  tube.  The  gel  slice  was 
weighed,  3  volumes  of  QA  added  (i.  e.  100pl/lOOpg)  and  incubated  at  50T  for  10 
minutes  to  melt  the  gel.  I  volume  of  isopropanol  was  added  to  each  sample  and  the  mix 
loaded  onto  the  resin  purification  column.  After  microcentrifugation  at  high  speed  for  I 
minute,  the  resin  bound  with  DNA  was  washed  twice  with  QF  or  wash  solution,  the 
second  spin  serving  to  remove  all  residual  wash  solution.  The  bound  DNA  was  then 
eluted  from  the  column  with  the  addition  of  30ýil  of  dH20  at  room  temperature  for  I 
minute  and  the  eluate  was  collected  by  nucrocentrifugation  for  I  minute.  Purified 
fragments  were  analysed  by  gel  electrophoresis  and  stored  at  -20'C. 
2.2.31-1  "BIG  DYE"  TERMINATOR  SEQUENCING  (ABI  373A) 
The  DNA  to  be  sequenced  (200-500ng  for  double  stranded  DNA)  was  mixed  with  3.2 
pmoles  of  primer  to  a  final  volume  of  12pi  with  dH-,  O.  Table  2.1  lists  the  ng  amount  of  a 
variety  of  oligonucleotide  lengths  equivalent  to  3.2pmoles.  8ýd  of  kit  reaction  premix 
was  added  and  PCR  amplification  was  carried  out  in  a  Perkin  Elmer  Cetus  DNA 
Thermal  Cycler  as  follows;  2  minutes  at  96'C  for  I  cycle  to  denature  the  dsDNA,  10 
seconds  at  96'C,  5  seconds  at  500C  and  4  rninutes  at  600C  for  25  cycles. 
Table  2.1  Conversion  table  - 
ng  of  Oligonucleotides  equivalent  to  3.2pmoles 
Oligonucleotide  Size  (No.  bases)  ng  equivalent  to  3.2  pmoles 
15  15.85 
16  16.90 
18  19.00 
20  21.12 
22  23.23 
24  25.34 
2[d  of  3M  sodium  acetate  (pH  4.5)  and  50ýil  of  ethanol  were  then  added  and  each 
sample  incubated  at  700C  for  15  minutes.  Samples  were  centrifuged  on  high  in  a 
microfuge  and  the  supernatants  removed.  Pellets  were  washed  in  I  00pl  70%  ethanol  and 
then  air-dried.  Samples  were  resuspended  in  loading  dye/forman-dde  and  denatured  in  a 
hotplate  at  900C  for  2  minutes  prior  loading  on  the  sequencing  gel.  The  samples  were 
71 run,  generally  overnight  and  the  resultant  sequence  data  analysed  using  the  ABI  Prism 
software. 
2.2.4  POLYMERASE  CHAIN  REACTION  (PCR) 
All  PCR  reactions  were  carried  out  in  accordance  with  the  method  of  Saiki  et  al  (1985) 
in  0.5n-d  microcentrifuge  tubes  and  performed  in  a  Techne  Genius  PCR  machine. 
Optimal  conditions  and  components  were  determined  for  each  primer  set,  and  the  PCR 
annealing  temperature  was  set  at  least  5*C  below  the  melting  temperature  (T  ..  )  of  the 
primer  with  the  lowest  T,,,.  Typical  reaction  mixtures  and  example  PCR  cycle  parameters 
are  shown  in  the  table  2.2  and  2.3,  respectively. 
Table  2.2  Typical  PCR  Reaction  Components 
Component  Final  concentration 
Template  DNA  I  Ong/pI 
Upstream  Primer  50pmol 
Downstream  Primer  50pmol 
dNTP  mix  0.2mM 
10  x  Taq  Reaction  Buffer  Ix 
25mM  magnesium  1.25mM 
Taq  DNA  Polymerase  0.025u/ýd 
Table  2.3  PCR  Cycle  Parameters 
Temperature  Time  (minutes)  No.  of  Cycles 
95*C  2  1 
95*C 
(T,,  -5'C) 
72*C 
I 
1.5 
1.5 
35 
72  C  7  1 
4'C  Hold  - 
Following  the  PCR  reaction,  2x  loading  buffer  was  added  and  the  samples  were  analysed 
by  agarose  gel  electrophoresis,  gel-purified,  digested  and  cloned  into  the  appropriate 
vector. 
72 2.2.4A  RNA  ISOLATION  WITH  TRIZOL 
Suspension  cells  of  interest  were  pelleted,  by  centrifugation  at  1200  xg  for  5  minutes, 
transferred  to  disposable  polypropylene  tubes  and  lysed  in  TRIzolS  reagent  (Iml  per  5- 
10  X  106  cells).  Cells  grown  in  monolayers  were  harvested  by  adding  the  TRIzol(& 
directly  into  the  culture  dish  (Iml/10cm)  and  passing  the  cell  lysate  through  a  pipette 
several  times.  The  homogenized  sample  was  incubated  at  room  temperature  for  5 
minutes.  0.2ml  of  chloroform  was  added  per  I  nil  of  TRIzolV  reagent.  The  sample  tubes 
were  capped  and  shaken  vigorously  by  hand  for  15  seconds  and  incubated  at  room 
temperature  for  2-3  minutes.  The  samples  were  centrifuged  at  12,000  xg  for  15  minutes 
at  4'C,  separating  the  mixture  into  a  lower  red  phenol-chloroform  phase,  an  interphase 
and  a  colourless  upper  aqueous  phase.  The  RNA  sample,  remaining  exclusively  in  the 
upper  aqueous  phase,  was  transferred  to  a  fresh  polypropylene  tube.  The  RNA  was 
precipitated  by  the  addition  of  iso-propanol  (Iml/In-A  TRIzolg)  and  incubated  at  room 
temperature  for  10  minutes.  Samples  were  centrifuged  at  12,000  xg  for  10  minutes  at 
4'C.  The  supernatant  was  removed  and  the  RNA  pellet  washed  once  with  70%  ethanol 
(again,  at  least  In-d  for  every  Iml  of  TRIMS  added  initially).  The  samples  were 
vortexed  and  centriftiged  at  7,500  xg  for  5  minutes  at  4'C.  The  pellet  was  briefly  air- 
dried  at  room  temperature  for  5  minutes  before  being  resuspended  in  DEPC-treated 
water.  Each  sample  was  incubated  at  550C  for  10  minutes  to  aid  complete  dissolution  of 
the  RNA.  The  concentration  and  purity  of  the  samples  were  assayed  as  per  section 
2.2.3C  and  the  RNA  stored  at  -200C. 
2.2.411  REVERSE  TRANSCRIPTASE  POLMERASE  CHAIN  REACTION  (RT-PCR) 
The  reaction  mix  was  prepared  by  combining  all  the  reagents  listed  in  Table  2.4  below  in 
a  thin-wafled  0.5ml  reaction  tube  on  ice,  with  the  enzymes  being  added  last. 
Table  2.4  RT-PCR  Sample  Components 
Reagent  Volume  Final  Concentration 
RNA  sample/control  1-5ýd  500ng 
Tfl  DNA  Polymerase  (5u/ýtl)  I  [LI  0.1  u/gl 
AMV  Reverse  Transcriptase  (5u/ýtl)  I  ý11  0.1  U/ýd 
25mMM9SO4 
I 
2gl  IMM 
73 Upstream  Primer  (15  pM)  50pmol  I  [LM 
Downstream  Primer  (I  5[tM)  50pmol  I  [LM 
dNTP  Mix  (I  OmM  each  dNTP)  I  [LI  0.2mM 
AMV/Tfl  5x  Reaction  Buffer  I  O[LI  Ix 
The  sample  tubes  were  gently  vortexed  for  10  seconds  to  mix  the  components.  All 
additions  were  carried  out  using  RNase-free  pipette  tips  and  separate  tips  were  used  for 
every  addition.  The  tubes  were  placed  in  a  controlled  temperature  heat  block 
equilibrated  to  48'C  and  incubated  for  45  minutes.  Thermal  cycling  was  performed  in  a 
Techne  Genius  PCR  machine,  see  Table  2.5,  to  facilitate  second  strand  cDNA  synthesis 
and  amplification.  The  resultant  PCR  products  were  analysed  by  agarose  gel 
electrophoresis  on  a  2%  gel.  Reaction  products  were  stored  at  -20'C. 
Table  2.5  Reverse  Transcriptase  (RT)  and  PCR  Cycling  Profile 
Temperature  Time  No.  of 
(minutes)  Cycles 
Synthesis  of  first  strand  of  cDNA  48'C  45  1 
(Reverse  transcription) 
AMV  RT  inactivation  94'C  2  1 
RNA/cDNA/primer  denaturation 
Synthesis  of  second  strand  of  cDNA  72*C  7  1 
PCR  amplification,  denaturation  94*C  0.5 
Annealing  Tm  -  5'C  1  40 
Extension  68*C  2 
Final  extension  68'C  - T7 
1 
2.2.5  CD23  N-TERMINAL  TAIL  MUTAGENESIS 
In  vitro  site  directed  mutagenesis  is  an  invaluable  technique  for  studying  protein 
structure-  function  relationships  and  for  identifying  amino  acids  that  may  mediate  these 
ftinctions.  Several  methods  for  performing  this  technique  have  appeared  in  the  literature, 
but  these  protocols  generally  require  single  stranded  DNA  templates  [Kunkel,  1985; 
Vandeyar  et  al.,  1988;  Sugimoto  et  al.,  1989;  Taylor  et  al.,  19851  and  can  often  be 
labour  intensive.  The  QuikChange  site-directed  mutagenesis  kit  was  used  to  make 
74 specific  point  mutations  in  the  cYtoPlasmic  N-termhW  tail  section  of  both  CD23 
isofornis,  using  a  typical  dsDNA  cloning  vector. 
Briefly,  the  oligonucleotide  primers,  each  complementary  to  opposite  strands  of  the 
vector,  extend  during  temperature  cycling  by  means  of  PfuTurbo  DNA  polymerase 
generating  mutagenised,  nicked  circular  strands.  The  methylated,  non-mutated  parental 
DNA  template  was  then  digested  with  Dpn  I  and  the  circular  nicked  dsDNA 
transformed  into  XLI-Blue  supercompetent  cells.  Figure  2.2  illustrates  an  overview  of 
this  process. 
2.2.5A  PRIMER  DESIGN 
Both  mutagenic  primers  contained  the  desired  mutation  and  were  designed  to  anneal  to 
corresponding  sequences  on  opposite  strands  of  the  plasmid  DNA.  Primers  were 
between  25  and  45  bases  in  length,  with  a  melting  temperature  (T.  )  of  78"C  or  more. 
The  following  formula  was  used  to  estimate  the  T.  of  each  primer.  Where,  N=  the 
length  of  each  primer,  measured  in  base  pairs. 
Tm  =  81.5  +  0.41(%GC)  -  675  -%  mismatch 
N 
The  desired  mutation  (deletion  or  insertion)  was  designed  to  be  in  the  center  of  the 
primer,  with  10-15  bases  of  correct  sequence  present  on  either  side.  Each  of  the  primers 
were  designed  to  have  a  minimum  GC  content  of  40%  and  terminated  in  one  or  more 
single  G  or  C  bases. 
2.2.5.11  STPATAGENE  QUICKCHANGE  MUTAGENESIS  PCR  REACTION 
Each  set  of  swnple  reactions  were  set  up  using  both  I  Ong  and  25ng  of  dsDNA  template 
concentrations,  whilst  the  primer  concentration  was  kept  constant  (125ng  of  each).  The 
control  reaction  contained  lOng  of  pWhitescriptTm  4.5kb  control  plasmid  and  125ng  of 
each  of  the  control  primers.  2.5  units  of  PfuTurbo  DNA  polymerase  was  added  to  each 
reaction. 
75 specific  point  mutations  in  the  cytoplasmic  N-terminal  tail  section  of  both  CD23 
isofornis,  using  a  typical  dsDNA  cloning  vector. 
Briefly,  the  oligonucleotide  primers,  each  complimentary  to  opposite  strands  of  the 
vector,  extend  during  temperature  cycling  by  means  of  PfuTurbo  DNA  polyinerase 
generating  mutagenised,  nicked  circular  strands.  The  methylated,  non-mutated  parental 
DNA  template  was  then  digested  with  Dpn  1  and  the  circular  nicked  dsDNA 
transformed  into  XLI-Blue  supercompetent  cells.  Figure  2.2  illustrates  an  overview  of 
this  process. 
2.2.5A  PRIMER  DESIGN 
Both  mutagcnic  primers  contained  the  desired  mutation  and  were  designed  to  anneal  to 
corresponding  sequences  on  opposite  strands  of  the  plasmid  DNA.  Primers  were 
between  25  and  45  bases  in  length,  with  a  melting  temperature  (T.  )  of  780C  or  more. 
The  following  formula  was  used  to  estimate  the  T.  of  each  primer.  Where,  N=  the 
length  of  each  primer,  measured  in  base  pairs. 
Tm  =  81.5  +  0.41(%GC)  -  675  -%  mismatch 
N 
The  desired  mutation  (deletion  or  insertion)  was  designed  to  be  in  the  center  of  the 
primer,  with  10-15  bases  of  correct  sequence  present  on  either  side.  Each  of  the  primers 
were  designed  to  have  a  minimum  GC  content  of  40%  and  terminated  in  one  or  more 
single  G  or  C  bases. 
2.2.5.11  STRATAGENE  QUICKCHANGE  MUTAGENESIS  PCR  REACTION 
Each  set  of  sample  reactions  were  set  up  using  both  I  Ong  and  25ng  of  dsDNA  template 
concentrations,  whilst  the  primer  concentration  was  kept  constant  (125ng  of  each).  The 
control  reaction  contained  lOng  of  pWhitescriptTm  4.5kb  control  plasmid  and  125ng  of 
each  of  the  control  primers.  2.5  units  of  PfuTurbo  DNA  polymerase  was  added  to  each 
reaction. 
75 The  cycling  parameters  detailed  in  Table  2.6  were  used  for  the  generation  of  all  ten  of 
the  CD23  N-terminal  point  mutations  (The  N-terminal  tail  deletion  mutant  was 
generated  independently  from  the  Stratagene  mutagenesis  kit,  using  a  simple  cloning 
strategy). 
Table  2.6  PCR  Parameters  for  the  Generation  of  the  Ten 
CVtODIasmic  N-Terminal  CD23  Mutants 
Purpose  Temperature  Time  (minutes)  No.  of  Cycles 
Denaturation  of  dsDNA  95'C  0.5  1 
Denaturation  950C  0.5 
Annealing  Tm  -  5'C  1  16 
Elongation  68  OC  14 
The  amplification  process  was  checked  by  running  10ýfl  of  each  sample  on  a  0.8% 
agarose  electrophoresis  gel.  The  remaining  sample  was  digested  with  10  units  of  Dpn  I 
at  37'C  for  one  hour  to  digest  the  parental,  i.  e.  non-mutated,  super  coiled  dsDNA- 
2.2.5C  TRANSFORMATION  OF  EPICURIAN  COLI  XL-1  BLUE  SUPERCOMPETENT 
CELLS 
Epicurian  Coh  XL-l  Blue  Supercompetent  cells  were  thawed  on  ice  and  50ýtl  aliquots 
transferred  into  pre-chilled  labeled  microfuge  tubes.  I  pl  of  the  Dpn  I  treated  PCR 
reaction/control  sample  was  added  to  each  tube,  the  cell  suspension  mixed  by  flicking, 
and  the  samples  incubated  on  ice  for  30  minutes.  The  samples  were  then  heat-shocked  at 
42'C  for  45  seconds  and  allowed  to  recover  on  ice  for  2  minutes.  500ýtl  of  pre-warmed 
NZY'  broth  was  then  added  to  each  sample  and  the  tubes  transferred  to  an  orbital  shaker 
and  incubated  at  37'C  for  more  than  I  hour.  At  the  end  of  the  60  minute  incubation  the 
entire  volume  of  each  sample  was  spread  onto  individual  LB  amp  agar  plates.  250ýd  of 
the  control  transformation  reaction  and  5ýd  of  the  pUC18  control  reaction  was  spread 
onto  an  LB  Amp  X-gal  IPTG  plate.  All  plates  were  incubated  at  37'C  overnight  to  allow 
colonies  to  develop.  Random  colonies  were  chosen,  grown  up  and  the  plasmid  DNA 
extracted  and  analysed  using  endonuclease,  restriction  digestion.  Clones  found  to  contain 
an  appropriately  sized  insert  were  sequenced  (section  2.2.3H)  in  order  to  confirm  that 
76 mutagenesis  had  occurred  correctly  without  incorporating  any  unwanted  changes  into 
the  remainder  of  the  CD23  or  vector  sequence.  Once  the  sequences  had  been  confirmed 
to  be  correct,  large-scale  DNA  preparations  were  made  for  each  mutant  construct  and 
the  DNA  was  stored  at  -200C. 
2.2.6  TRANSFECTION  &  TRANSFORMATION  OF  CELLS 
2.2.6A  DoTAP  TRANsFECTION  OF  HUMAN  CELL  LINES 
Cells  were  harvested  and  seeded  onto  6-well  plates.  5ýtg  plasmid  DNA  was  added  to 
30[d  DOTAP  and  100gl  filter-sterilized  20mM  Hepes,  pH  7.2  and  incubated  at  room 
temperature  for  15  minutes  in  a  sterile  universal.  The  DNA-DOTAP  suspension  was 
then  added  to  the  cell  mono-layer  in  2ml  of  fresh  complete  DMEM  and  the  cells  were 
incubated  over  night  as  normal.  Next  day  the  medium  was  replaced  with  complete 
DMEM  supplemented  with  700ýtg/ml  G418.  Cells  were  gently  sub-cultured  for  4-6 
weeks  before  a  stable  population  of  G418-resistant  cells  emerged. 
2.2.6B  ELECTROPORATION  OF  RAii-A  CELLS 
RAJI-A  cells  were  grown  in  cell  culture  in  complete  RPMI  medium  and  sub-cultured  the 
day  prior  to  use.  The  cells  were  harvested  in  serum  free  RPMI  medium  and  centrifuged 
at  350  xg  for  5  minutes.  The  cell  pellet  was  resuspended  in  a  known  volume  of  serum- 
free  RPMI  medium  and  cell  viability  measurements  (section  2.2.1C)  were  made.  The 
cells  were  resuspended  in  RPNH  medium  to  a  final  concentration  of  6.25  x  106  cell/mI. 
0.8n-A  of  this  mix  was  transferred  to  a  pre-chilled,  0.4cm  gap  electroporation  cuvette  and 
the  40pg  of  the  appropriate  DNA  plasmid,  added.  The  cells  were  electroporated  using  a 
Biorad  Gene  Pulser.  The  capacitance  was  set  to  960ý&  and  the  voltage  set  to  0.25kV. 
Cells  were  allowed  to  recover  on  ice  for  5  minutes  before  being  transferred  to  pre- 
warmed  complete  RPMI  medium  and  returned  to  the  37*C  incubator  with  5%CO2. 
Stable  cells  lines  were  selected  by  culturing  the  cells  in  complete  RPMI  medium  with  the 
addition  of  700jig/mI  G418  after  the  first  24  hours  recovery  period.  Stable  G418- 
resistant  cell  lines  were  usually  obtained  after  around  6-10  weeks  in  selection. 
77 2.2.6C  RUBIDIUM  CHLORIDE  METHOD  FOR  MANUFACTURE  OF  TRANSFORMATION 
COMPETENTE.  COLI 
250n-A  of  Psi  broth  was  inoculated  using  Iml  of  overnight  culture  and  incubated  at  37C 
with  aeration  to  A550  =0.48.  Cells  were  chilled  on  ice  for  15  minutes  and  centrifuged  at 
3-50OOg  for  5  minutes.  The  supernatant  was  discarded  and  the  cell  pellet  resuspended  in 
100ml  of  TfbI  and  incubated  on  ice  for  a  further  15  minutes.  Cells  were  pelleted  as 
before,  resuspended  in  10ml.  of  TfbII  and  incubated  on  ice  for  15  minutes.  The  cells  were 
either  used  immediately  or  quick-frozen  in  ethanol-dry  ice  prior  to  storage  at  -70T. 
2.2.6.1)  TRANSFORMATION  OF  COMPETENT  CELLS 
Competent  Exo1i  cells  (either  DH5a  or  JM109)  were  thawed  on  ice  and  25ýd  volumes 
aliquoted  into  pre-chilled  eppendorf  tubes.  I[Il  of  the  appropriate  DNA  plasmid  was 
added  and  the  cell  samples  were  incubated  on  ice  for  a  further  20  minutes.  The  cells 
were  then  heat-shocked  at  42T  for  45  seconds,  incubated  for  a  further  2  minutes  on  ice 
and  resuspended  in  500pl  of  pre-warmed  SOC  medium  and  incubated  at  37T  for  30 
minutes.  An  appropriate  dilution,  or  indeed  the  entire  sample,  was  then  plated  onto 
antibiotic  selection  agar  and  incubated  overnight  at  37'C.  Representative  colonies  were 
selected,  used  to  inoculate  5ml  of  LBroth  (containing  the  appropriate  antibiotic 
selection),  and  amplified  by  overnight  incubation  in  an  orbital  shaker  at  37'C. 
2.2.7  PROTEIN  ANALYSIS 
2.2.7A  PREPARATION  OF  WHOLE  CELL  "RIPAII  LYSATES 
Cells  were  isolated  from  culture,  washed  twice  with  serum-free  medium,  re-suspended  in 
ice-cold  PBS  at  approximately  5x  106  cells  per  n-A  and  washed  by  centrifugation  at  350 
xg  for  5  minutes.  Cells  were  resuspended  in  3001il  of  RIPA  buffer  (SOmM  Tris-HCI  (pH 
7.4),  1%  (v/v)  NP40,  ImM  Na  Deoxycholate,  150m.  M  NaCl,  ImM  EGTA,  IMM 
Na3V04,  ImM  NaF,  ImM  PMSF,  2pghnL  Leupeptin,  0.5MM  DTT)  and  lysed  by 
pipetting.  Cells  were  further  lysed  by  incubation  on  ice  for  30  min.  Cellular  debris  was 
removed  by  centrifugation  at  13,500  xg  for  15  min  at  40C.  The  supernatant  was  retained 
and  the  protein  concentration  of  each  sample  determined  by  Biorad  protein  assay, 
followed  by  storage  of  allquoted  samples  at  -70*C. 
78 2.2.711  BioRAD  PROTEIN  CONCENTRATION  ASSAY 
BSA  standards  were  made  at  concentrations  of  0.2,0.4,0.6,0.8,1.0,1.2,1.4,1.6,1.8 
and  2.0  mg/ml.  BioRad  assay  buffer  was  diluted  1:  5  in  dH20,,  filtered  through  Whatmann 
filter  paper  and  Iml  aliquots  transferred  to  labelled  eppendorf  tubes.  Samples  were 
routinely  measured  at  dilutions  of  1:  10  and  1:  20.  -  20gl  of  the  appropriate 
standard/sarnple  was  added  to  each  designated  tube  containing  the  Iml  sample  of 
BioRad  assay  buffer,  mixed  and  left  for  5  minutes  at  room  temperature.  The  absorbance 
of  each  sample  at  595nm  was  analysed  on  a  Helios  y  spectrophotometer.  The  results 
obtained  for  the  standards  were  used  to  plot  a  calibration  curve,  from  which  the 
unknown  protein  concentrations  of  the  samples  could  be  determined. 
2.2.7C  PREPARATION  OF  IMMUNOPRECIPITATES 
Cells  were  isolated  from  culture,  washed  twice  in  incomplete  medium  and  resuspended 
at  IxIO7  cells/ml  in  complete  medium.  The  cells  were  then  treated  as  described  in  the 
appropriate  results  section,  and  recovered  by  centrifugation  for  5  minutes  at  350  x  g. 
Cells  were  subsequently  lysed  by  the  addition  of  400pt  of  OGP  buffer  (50MM  HEPES- 
KOH,  pH  7.4,5mM  CaC12,140mM  NaCl,  1%  octyl-p-D-glucopyranoside,  IMM  PMSF, 
ImM  Aprotinin,  ImM  Leupeptin)  and  incubated  on  ice  for  30  minutes,  after  which  cell 
membranes  were  disrupted  by  repeated  aspiration  through  a  21-gauge  needle.  Cellular 
debris  was  pelleted  by  centrifugation  at  1000  xg  at  4'C  for  5  minutes,  and  the 
supernatant  transferred  into  fresh  tubes.  In  accordance  with  the  method  described  by 
Harlow  and  Lane  [Harlow  &  Lane,  1988],  the  protein  solution  was  then  pre-cleared  for 
2  hours  by  rotation  with  101A  of  50%  slurry  of  Protein-G  agarose  in  OGP  buffer  and  the 
pre-clearing  Protein-G  removed,  prior  to  the  addition  of  I  Vg  of  appropriate  antibody 
and  subsequent  incubation  at  40C  for  4  hours  on  a  rotating  table.  Samples  were  finally 
rotated  overnight  with  25gl  of  Protein-G  agarose  at  4'C,  in  order  to  allow  the 
immunoprecipitates  to  be  captured.  Immunoprecipitates  were  then  collected  by 
centrifugation  at  350  xg  for  5  minutes,  washed  twice  with  OGP  buffer  and  re-suspended 
in  50pl  of  Laemmli/protein  loading  buffer.  Each  sample  was  denatured  by  boiling  for  3 
minutes,  centrifuged  gently  to  pellet  the  Protein-G  agarose  and  loaded  on  to  an 
appropriate  percentage  SDS-PAGE  gel. 
79 2.2.7D  SDS-PAGE  GEL  ELECTROPHORESIS 
Acrylamide  separating  gels  were  prepared  as  described  by  Laemmli  [Laemmli  et  aL, 
1970]  using  a  Biorad  mini-gel  rig.  The  gels  were  set  at  30'C  with  an  isopropanol 
overlay,  before  the  5%  (w/v)  acrylamide  stacking  gel  was  poured.  Gel  compositions  are 
detailed  in  the  appendix.  Appropriate  sample  volumes  were  added  to  the  gel  and 
electrophoresed  at  15mA  in  Ix  running  buffer  through  the  stacking  gel.  The  current  was 
increased  to  25mA  after  the  samples  had  entered  the  separating  gel,  and  run  until  the  dye 
front  reached  the  bottom  of  the  separating  gel  layer.  If  two  gels  were  run  simultaneously 
using  the  same  gel  rig  the  gels  were  run  at  35-4OmA. 
Following  SDS-PAGE,  separated  proteins  were  often  transferred  onto  nitrocellulose 
membrane  to  facilitate  immuno-detection  of  particular  proteins  of  interest.  Following 
electrophoresis  the  glass  gel  plates  were  separated  facilitating  removal  of  the  separating 
gel.  The  gel  was  transferred  to  a  Scotlab  wet  blotting  apparatus  in  a  sandwich  of 
nitrocellulose  membrane  and  filter  paper.  The  protein  sarnpleswere  then  transferred  to 
the  nitrocellulose  membrane  in  protein  transfer  buffer  at  250mA  for  45  minutes. 
2.2.7E  IMMUNOBLOTTING 
After  transfer,  the  nitrocellulose  membrane  was  incubated  in  blocking  buffer  for  either 
30  minutes  at  room  temperature  or  overnight  at  40C,  serving  to  prevent  any  non-specific 
antibody  binding.  The  membrane  was  then  rinsed  in  phosphate  buffered  saline 
(PBS)/0.05%  (v/v)  Tween-20  and  subsequently  incubated  with  primary  antibody 
prepared  at  1/1000  in  "Blotto"  for  I  hour  at  room  temperature.  The  nitrocellulose 
membrane  was  washed  3x  15  minutes  in  Blotto  and  incubated  with  the  secondary 
antibody  (1/1000  in  Blotto)  for  45  minutes  at  room  temperature.  Finally  the 
nitrocellulose  was  washed  3x  15  minutes  in  MAO%  (v/v)  Tween-20. 
2.2.7F  ECL  DETECTION  SYSTEM 
The  Arnersharn  Enhanced  Chemiluminescence  (ECL)  kit  was  used  in  accordance  to  the 
manufacturer's  instructions  to  develop  all  immunoblots.  Briefly,  2ml  volumes  of  the  two 
ECL  solutions  were  mixed,  poured  over  the  nitrocellulose  and  incubated  for  I  minute. 
80 Excess  ECL  reagent  was  removed  with  a  tissue  and  the  nitrocellulose  membrane 
wrapped  in  saran  wrap.  The  nitrocellulose  membrane  was  exposed  to  Fuji  RX  film  for  an 
appropriate  time  interval  (from  I  second  to  20  minutes,  depending  on  signal  strength) 
and  developed  using  an  X-omat  developer. 
2.2.7G  SILVER  STAIN 
Protein  gels  were  initially  fixed  in  40%  methanol/10%  acetic  acid  (v/v)  for  30  minutes 
with  shaking  before  being  transferred  into  fresh  10%  ethanol/5%  acetic  acid  (v/v)  fixer 
for  two  15  minutes  incubations.  The  gels  were  subjected  to  oxidizer  (0.02g  sodium-thio- 
sulphate  in  I  OOn-d  dH20),  for  5  minutes  and  then  washed  in  dH20.  The  silver  stain  (0.2g 
AgN03,75gl  formaldehyde  in  I  OOn-A  dH20).  was  then  added  and  the  gels  incubated  for 
20  minutes.  The  gels  were  washed  in  dH20  for  I  minute  to  remove  any  excess  silver 
reagent  before  being  placed  into  developer  (6g  sodium  carbonate,  4mg  sodium-thio- 
sulphate,  50gl  formaldehyde  in  100ml  dH20).  The  reaction  was  stopped  at  an 
appropriate  time  point  by  submerging  the  gel  in  5%  acetic  acid  stop  solution.  Stained 
gels  were  dried  onto  Whatman  3MM  filter  paper  for  storage. 
2.2.7H  SCD23  ELISA 
Each  of  the  wells  on  the  96  well  ELISA  plate  to  be  used  were  coated  with  IOOPI  of 
capture  antibody  and  incubated  overnight.  Each  well  was  aspirated  and  washed  3  times 
with  wash  buffer  and  then  blocked  with  200pt  of  assay  diluent  for  I  hour.  The  wells 
were  aspirated  and  washed  3  times  with  wash  buffer.  100pl  of  sample  or  standard  was 
then  added  to  each  well  and  incubated  for  2  hours.  Each  well  was  aspirated  and  washed 
5  times  before  100pl  of  Detector  Solution  was  added  and  incubated  for  I  hour.  The 
wells  were  aspirated  and  washed  7  times  with  wash  buffer  before  I  00pl  of  Substrate  was 
added  to  each  well  and  incubated  for  30  minutes  in  the  dark.  50[d  of  Stop  Solution  was 
added  to  each  well  and  the  plate  was  read  at  450nn-4  within  30  minutes.  All  incubations 
were  carried  out  at  room  temperature.  Standards  used  were  50,25,12.5,6.3,3.1,1.6, 
and  0.8ng/ml.  All  antibody  and  buffer  details  are  listed  in  the  appendix. 
81 2.2.8  CONFOCAL  ANALYSIS 
2.2.8A  DIALYSIS  OF  FITC  CONJUGATED  ANTI-CD23  ANTIBODY9  REMOVAL  OF 
SODIUM  AZIDE  CONTAMINATION 
Dialysis  tubing  was  boiled  in  I  m.  M  EDTA  for  5  minutes  and  allowed  to  cool.  Two  knots 
were  tied  in  one  end  of  the  tubing  and  the  antibody  sample  was  carefully  added  to  the 
tube.  The  open  end  was  then  tied  with  two  knots  and  the  tubing  was  submerged  in 
dialysis  buffer,  exactly  the  same  as  the  buffer  the  antibody  was  stored  in  minus  sodium 
azide.  In  this  case,  0.05M  Tris-HCI,  pH  7.2  with  1%  (w/v)  BSA.  The  sample  was 
dialysed  against  a  total  of  3  litres  of  buffer  in  a  conical  flask  at  4C  with  continual 
stirring,  protected  from  any  light  source.  The  buffer  was  replaced  three  times,  every  10- 
14  hours.  The  antibody  sample  was  collected  from  the  dialysis  tubing  and  stored  at  40C 
protected  from  light. 
2.2.811  PREPARATION  OF  NIP-CONJUGATED  BSAANSULIN 
BSA  was  derivatised  with  4-hydroxy-3-iodo-5-nitrophenylacetic  acid  (NIP)  using 
established  procedures.  Briefly,  5-10mg  NIP-OSu  was  dissolved  in  2000  of 
dichloromethane  and  added  to  15-20mg  of  BSA  protein  in  sodium  carbonate  buffer,  pH 
9.5  (Iml  volume).  The  mixture  was  incubated  at  room  temperature,  with  occasional 
mixing  for  16  hours,  and  then  dialysed  against  several  litres  of  PBS,  pH  7.2. 
NIP-Insulin  was  generated  using  a  slightly  modified  protocol  as  the  an-dno  terminus  had 
to  be  blocked  in  order  to  enable  only  a  single  NIP  molecule  to  bind  to  each  insulin 
molecule  [Roth  et  al.,  1981].  Briefly,  insulin  was  dissolved  in  carbonate  buffer  to 
generate  a  0.7mM  solution.  5pl  of  citraconic  anhydride  was  added  and  the  sample  was 
incubated  for  30  minutes  at  room  temperature.  The  sample  was  dialysed  against  2  fitres 
of  carbonate  buffer  at  4*C  for  24  hours  each.  5-10mg  NIP-OSu  was  dissolved  in  200ýd 
of  dichloromethane,  added  to  the  dialysed  insulin  sample  and  incubated  for  I  hour  at 
room  temperature  with  occasional  mixing.  The  sample  was  then  dialysed  against  PBS 
(pH  7-2)  overnight  at  4*C.  The  blocked  amino  group  was  then  unblocked  by  sequential 
dialysis  against  dH20  for  2  hours  at  room  temperature,  I  OmM  HCI  for  6  hours  at  room 
temperature  and  then  PBS  (pH  7.2),  for  18  hours  at  40C.  A  small  sample  of  the  end 
82 products  were  run  on  an  SDS-PAGE  gel,  transferred  to  nitrocellulose  and 
inanunoblotted  with  NIP-specific  IgE  antibody  to  check  conjugation  had  taken  place 
successfully.  The  derivatisation  ratio  was  worked  out  by  measuring  the  A2&0  for  the  NIP- 
conjugated  protein,  calculating  the  molar  concentration  of  BSA  and  then  relating  this  to 
the  molar  extinction  co-efficient  for  NIP  thus  calculating  the  number  of  NIP  molecules 
per  molecule  of  BSA.  The  derivatisation  ratio  was  calculated  to  be  approximately  10 
NIP  molecules  per  molecule  of  BSA  or  a  1:  1  ratio  for  NIP-insulin.  Protein-hapten 
conjugates  were  filter-sterifised  and  stored  at  -200C. 
2.2.8C  PREPARATION  OF  CELL  SAMPLES 
Glass  cover  slips  were  submerged  in  concentrated  hydrochloric  acid  for  I  hour,  washed 
in  copious  amounts  of  dH20,  transferred  to  metal  cover  slip  racks,  wrapped  in  tin  foil 
and  sterilized  by  autoclaving  at  1260C  for  II  minutes.  Stably-transfected  HEK  293  cells 
were  harvested  from  culture  and  seeded  onto  glass  cover  slips  coated  with  0.01%  Poly- 
D-Lysine  (PDL)  and  incubated  at  370C  in  a  humidified  5%C02  incubator  for  36-48 
hours.  Stably-transfected  Raji  A  cells  were  harvested  from  culture  and  seeded  directly 
onto  glass  cover  slips  with  no  need  for  the  addition  of  the  PDL  coating. 
All  cell  samples  were  washed  in  KRH  buffer  prior  to  analysis  on  a  Zeiss  LSM  410 
confocal  microscope.  GFP  and  FITC  fluorescence  were  excited  using  a  488nm 
argon&rypton  laser  and  emission  fluorescence  was  detected  with  a  515-540  band  pass 
filter.  Co-localisation  studies  utilized  Transferrin-modified  Texas  Red,  LysoTracker  and 
Phalloidin-modified  Texas  Red  dyes,  each  of  which  was  excited  at  543mn  and  emission 
fluorescence  detected  with  a  570nm  long  band  pass  filter.  Figure  2.3  shows  a  schematic 
representation  of  the  beam  path  of  the  LSM  410  microscope  and  the  table  lists  each  of 
the  abbreviations  used  in  the  diagram. 
2.2.8D  LIVE  CELL  CONFOCAL  ANALYSIS  OF  Nff  CD23  AND  GFP-CD23  FUSION 
PROTEINS 
Analysis  of  CD23  movement  in  transfected  cells  was  performed  using  a  Zeiss  confocal 
microscope.  Individual  cover  slips  were  transferred  to  the  five  cell  chamber,  kept  at  37C 
83 using  a  heated  stage  facility  and  imaged  in  KRH  buffer.  Images  were  collected  using  the 
63  x  magnification  lens,  at  the  time  points  indicated  in  the  individual  figure  legends.  Each 
data  set  is  representative  of  at  least  three  separate  experiments.  Experiments  examining 
unmodified  WF  CD23a/b  proteins  were  monitored  by  the  addition  of  IýLg  of  FITC- 
conjugated  anti-CD23  monoclonal  antibody.  Movement  of  GFP-CD23a/b  fusion  protein 
was  directly  monitored  via  the  GFP  tag,  and  evaluated  in  several  contexts  (see  Figure 
3.5).  Images  were  collected  from  untreated  cells  (basal),  from  ceRs  exposed  to  I  [Ig  of 
NIP-specific  Chimeric  IgE  (loaded)  and  finally,  cells  treated  with  NIP-specific  IgE  and 
then  cross-linked  with  I  gg  of  NIP-BSA. 
2.2.8E  LivE  CELL  ANALYSIS  OF  CD23  Co-LOCALISATION  WfrH  TRANSFERRIN- 
MODIFIED  TEXAS  RED  OR  LYSOTRACKER  DYES. 
In  five  cell  co-localisation  experiments,  cells  were  exposed  to  Transferrin-modified 
Texas  Red  (Tf-TxR)  or  LysoTrackerTm  for  20  minutes  at  37'C,  at  a  final  concentration 
of  lOgghnl  and  5OnM  respectively.  Any  further  additions  (FITC  anti-Human  CD23 
antibody  or  NIP-specific  IgE  and/or  NIP-BSA)  were  subsequently  added  prior  to  a  final 
wash  in  KRH  buffer  before  the  cells  were  analysed  on  the  confocal  microscope  using  a 
heated  stage  facility,  as  described  in  2.2.8D. 
2.2.8F  ANALYSIS  OF  Nff  CD23  AND  GFP-CD23  FusloN  PROTEINS  UNDER  FIXED 
CONDITIONS 
Cells  were  harvested  and  seeded  onto  glass  cover  slips,  as  described  above.  WT  CD23 
samples  were  bathed  in  250[d  of  KRH  buffer  and  treated  with  Iýtg  FITC-conjugated 
anti-CD23  MAb  for  5  minutes  at  room  temperature  before  being  washed  in  KRH  buffer. 
Each  swnple  was  incubated  at  370C  in  a  humidified  S%C02  incubator  for  the 
appropriate  time  period.  All  samples  were  washed  in  KRH  buffer,  transferred  into  4% 
formaldehyde  in  ice  cold  PBS  and  fixed  for  15  minutes.  The  cover  slips  were  then 
washed  in  ice  cold  PBS  and  mounted  onto  glass  microscope  slides,  using  l5pl  of 
Mowiol.  The  slides  were  stored  at  4*C  and  visualized  on  the  Zeiss  Confocal  microscope 
within  5  days  of  preparation. 
84 2.2.9  PREPARATION  OF  THE  MATCHMAKER  cDNA  LIBRARY 
2.2.9A  TITRATION  OF  MATCHMAKER  CDNA  LIBRARY 
A  10111  aliquot  of  the  Clontech  leukocyte  cDNA  library  sample  was  added  to  10111  of 
LBroth.  2[il  of  this  solution  was  transferred  into  Iml  of  LBroth  in  a  1.5ml  eppendorff 
and  the  tube  vortexed  to  mix  (Dilution  A,  1/103)  .AI  gl  aliquot  was  removed  from 
Dilution  A  and  added  to  Iml  of  LBroth  in  a  1.5ml  eppendorf  and  the  tube  vortexed 
(Dilution  B,  1/106).  1  lit  of  Dilution  A  was  added  to  50ptl  of  LBroth,  mixed  and  the  entire 
sample  spread  onto  a  pre-warmed  LB/ampicillin  agar  plate.  5  01A  and  I  OOgI  of  Dilution  B 
were  spread  onto  2  separate  LB/ampiciffin  agar  plates.  AR  plates  were  incubated  at  370C 
for  30-48  hours  to  allow  colonies  to  grow.  The  number  of  colonies  on  each  plate  were 
counted,  and  the  titre  determined  using  the  following  formulae,  as  per  the  manufacturers 
instructions; 
Dilution  A,  cfu/mI  =  number  of  colonies  x 
103  X  103 
Dilution  B,  cfu/ml  =  number  of  colonies/plating  volume  x 
103  X  103  X  103 
2.2.9B  AMPLIFICATION  OF  THE  MATCHMAKER  LEUKOCYTE  CDNA  LIBRARY. 
The  Clontech  cDNA  library  sample  had  to  be  amplified  in  order  to  ensure  enough  DNA 
was  available  for  screening  purposes.  This  process  was  carried  out  exactly  as  per  the 
manufacturers  instruction  to  minimise  any  loss  of  clone  representation.  Due  to  the  fact 
that  the  library  was  cloned  into  the  pACT2  vector,  lower  incubation  temperatures  were 
used  (3  0-3  VC),  again  to  aid  maintenance  of  clone  representation.  The  library  was  plated 
directly  onto  LBroth  agar  plates,  containing  50gghnl  arnpicillin,  at  a  high  enough  density 
to  ensure  the  resulting  colonies  would  be  nearly  confluent  (2xW  cfu/150nim  plate)  in 
order  to  obtain  2-3  times  the  number  of  independent  clones  present  within  the  library. 
The  number  of  plates  required  is  dependent  upon  the  size  of  the  library  to  be  amplified, 
with  IX  106  independent  clones  requiring  50  x  150mm  agar  plates.  In  this  case  the 
library  contained  3.5  x  106  independent  clones,  therefore  10.5  X  106  colonies  had  to  be 
plated,  requiring  550  x  150mm  LBroth/ampicillin  agar  plates.  Since  the  library  titre  was 
calculated  to  be  4x  10'  cfu/ml,  26.25[d  of  library  stock  was  required.  26.251d  of  the 
library  stock  was  diluted  in  82.5ml  of  dH20,  the  sample  was  thoroughly  mixed  and 
150gl  spread  onto  each  of  the  550  agar  plates.  The  plates  were  incubated  at  30*C  until 
85 colonies  appeared,  usually  2448  hours  later.  5ml  of  LBroth  was  added  to  each  plate  and 
the  colonies  were  left  to  soak  for  a  few  minutes  before  being  scraped  from  the  plate.  Any 
residual  cells  were  washed  off  in  a  ffirther  2ml  of  LBroth.  Every  colony  was  collected 
and  the  entire  sample  was  pooled  into  a  sterile  3  litre  conical  flask  and  placed  at  300C  for 
a4  hour  incubation  to  maximize  DNA  yield.  A  25%  volume  of  glycerol  was  added  and 
the  stocks  stored  in  the  fridge  overnight.  The  DNA  was  isolated  using  five  Qiagen  Giga 
plasmid  purification  columns,  and  the  concentration  and  purity  of  the  collective  sample 
was  assayed  as  per  section  2.2.3C  and  stored  at  -200C. 
2.2.10  YEAST  Two-HYBRID  STUDIES 
2.2.10A  DNA  ExTRAcTION  FRom  YEAST 
Fresh  colonies  were  used  to  inoculate  5ml  of  SD/-Trp/-Leu,  media  and  incubated  at 
30'C  for  a  minimum  of  20  hours.  4.5n-fl  of  each  culture  was  centrifuged  at  13,500  xg  in 
a  microcentrifuge,  the  supernatant  removed  and  the  cell  pellet  resuspended  in  0.5ml  of  S 
Buffer  and  vortexed  to  facilitate  complete  resuspension.  The  samples  were  incubated  at 
37'C  for  30  minutes,  100gl  of  Lysis  solution  (25mM  Tris-HCI,  25mM  EDTA,  25% 
(w/v)  SDS)  was  then  added  to  each  tube  and  the  samples  were  then  vortexed  and 
incubated  at  65C  for  30  minutes.  166gl  of  3M  potassium  acetate  was  added,  the 
samples  were  incubated  on  ice  for  10  minutes,  centrifuged  at  13,500  xg  in  a  benchtop 
microcentrifuge  for  10  minutes  and  the  supernatant  transferred  to  a  fresh  tube.  The  DNA 
was  precipitated  by  the  addition  of  8001il  of  ice-cold  ethanol,  a  10  minute  incubation  on 
ice  and  a  10  minute  spin  in  the  microfuge  at  13,500  x  g.  The  pellet  was  then  washed  in 
500gl  of  70%  ethanol  and  air  dried  for  15  minutes.  The  final  pellet  was  resuspended  in 
40[d  of  nuclease-free  dH20.  The  isolated  DNA  extracted  from  double  transfection  will 
contain  both  the  DNA-AD  and  DNA-BD  vectors  (and  in  some  cases  more  than  a  single 
DNA-AD  vector  may  be  present).  This  DNA  must  be  used  to  transform  KC8  E.  coli  cells 
should  the  aim  be  to  purify  the  AD  vector  alone,  see  section  2.2.1  OD. 
2.2.1011  TCA  YEAST  PROTEIN  EXTRACTS 
A  2-3  OD6oo  quantity  of  freshly  pelleted  cells,  or  a  match  head  sized  ball  of  yeast  cells 
from  a  fresh  agar  plate,  were  resuspended  in  In-d  of  dH20-  150ýd  of  1.85M  sodium 
86 hydroxide  containing  7.5%  (v/v)  P-mercaptoethanol  was  added,  the  sample  mixed  and 
incubated  on  ice  for  10  minutes.  150ml  of  55%  (w/v)  TCA  mix  was  then  added,  and  the 
sample  incubated  for  a  finther  10  minutes  on  ice.  The  sample  was  then  centrifuged  at 
13,500  xg  in  a  desktop  microfuge  for  15  minutes  at  40C.  The  supernatant  was  removed 
and  the  sample  briefly  spun  again.  The  remaining  supernatant  was  removed  and  the 
precipitated  proteins  resuspended  in  150pl  of  high  urea  buffer  (HU-Buffer).  The  sample 
was  heated  at  650C  for  15  minutes  to  aid  complete  resuspension  of  the  pellet.  If 
necessary,  a  few  microlitres  of  IM  Tris  was  added  neutralizing  the  sample  (returning 
buffer  back  to  blue  from  yellow).  The  samples  were  centrifuged  for  5  minutes  at  13,500 
xg  in  a  microcentrifuge  and  10-15  gl  analysed  by  SDS-PAGE  gel  electrophoresis  and 
western  blotting. 
2.2.10C  PREPARATION  OF  ELECTROCOMPETENT  KC8  ECOM  CELLS 
400ml  of  LBroth  was  inoculated  to  a  cell  density  of  5x  106ceUsln-A  or  an  OD6w  of  0.1 
with  a  stationary  phase  overnight  culture  of  KC8  cells  and  grown  at  37'C  with  250rpm 
shaking  to  an  OD6oo  of  0.4-0.6.  The  culture  mix  was  chilled  on  ice  for  20-30  minutes  and 
the  cells  were  pelleted  by  centrifugation  at  4,300  xg  at  4'C  for  30  minutes.  The 
supernatant  was  removed  and  the  cell  pellet  resuspended  in  a  small  volume  of  ice-cold 
dH20-  500n-A  of  ice-cold  water  was  added  and  the  cells  were  recentrifuged  as  above. 
The  supernatant  was  removed  and  the  cells  washed  again  in  ice-cold  dH20.  The 
supernatant  was  removed  and  the  cells  were  then  resuspended  in  the  remaining  liquid. 
The  cell  suspension  was  transferred  into  a  narrow  bottomed  50n-d  polypropylene  tube 
and  centrifuged  at  4,300  xg  at  4*C  for  10  minutes.  The  pellet  volume  was  estimated  and 
resupended  in  an  equal  volume  of  ice-cold  dH20-  50gl  volumes  of  the  cell  suspension 
were  allquoted  into  pre-chflled  microcentrifuge  tubes.  Frozen  stocks  were  made  by 
resuspending  the  cell  pellet  in  an  equal  volume  of  sterile  10%  glycerol,  transferred  to 
pre-chilled  cryovials,  and  frozen  on  dry  ice.  The  electrocompetent  cells  were  stored  at  - 
80'C. 
87 2.2.10D  TRANSFORMATION  OF  ELECTROCOMPETENT  KC8  E.  COLI  CELLS 
The  yeast  DNA  extractions  detailed  in  section  2.2.10A  were  used  to  transform  KC8 
E.  coli  cells  to  facilitate  selection  of  the  GAL4  AD  plasmids  containing  library  cDNA  of 
interest.  40gl  aliquots  of  electrocompetent  KC8  cells  were  transferred  into  pre-chilled, 
labeled  0.1cm.  gap  electroporation  cuvettes.  21il  of  each  DNA  preparation  was  added 
and  the  cuvettes  tapped  to  mix  the  sample.  I  gl  of  pUC  19  DNA  was  added  to  the  control 
sample.  Each  electroporation  was  carried  out  using  the  following  conditions,  2.4kV 
voltage,  25[tF  constant  capacitance  and  200  Ohms  resistance.  Iml  of  pre-warmed  SOC 
medium  was  added  to  each  sample  immediately  after  the  electroporation  step  and  the 
samples  were  then  transferred  to  universals  and  incubated  at  370C  with  shaking  for  I 
hour.  Each  cell  sample  was  harvested  by  centrifugation  at  1200  xg  for  5  minutes, 
resupsended  in  100ýtl  of  M9  media  and  spread  onto  M9  agar.  The  control  sample  was 
not  centrifuged  but  I  Oýd  of  the  SOC  culture  was  diluted  1/10  in  LBroth  and  spread  onto 
LBroth  agar  containing  ampicillin.  The  plates  were  incubated  at  370C  for  36-48  hours 
until  colonies  appeared  and  the  DNA  was  rescued  using  the  Promega  SV  Wizard 
plasmid.  purification  columns,  as  per  the  manufacturers  instructions,  2.2.3A. 
2.2.10E  LITHium  ACETATE  HIGH  EFFICIENCY  TRANSFORMATION 
All  reactions  were  performed  in  accordance  with  the  method  described  by  Agatep  and 
colleagues,  [Agatep  et  al.,  1998;  Gietz  et  al.,  1997].  2-5nil  of  the  appropriate  media  was 
inoculated  with  the  yeast  sample  (YPDA  for  untransformed  yeast  or  SD/-Trp  for  yeast 
already  containing  the  bait  plasmid)  and  incubated  with  shaking  overnight  at  30T.  50ml 
of  pre-warmed  YPDA  was  inoculated  to  a  cell  density  of  5xI  06  cells/ml  or  OD600  0.  I- 
The  culture  was  incubated  at  30"C  on  an  orbital  shaker  at  200rprn  for  3-5  hours  until  an 
OD600of  0.4-0.6  had  been  reached.  Producing  enough  cells  for  10  transformations,  this 
method  was  scaled  up  or  down  as  required.  The  culture  was  harvested  in  a  sterile  50ml 
centrifuge  tube  at  1200  xg  for  5  minutes.  The  medium  was  removed  and  the  cell  pellet 
resuspended  in  25ml  of  sterile  dH20  and  centrifuged  again.  The  water  was  removed  and 
the  cells  resuspended  in  In-A  of  IOOmM  of  lithium  acetate  (LiAc)  and  transferred  to  a 
1.5n-d  eppendorf  tube.  The  cells  were  pelleted  at  13,500  xg  in  a  benchtop 
microcentrifuge  for  I  minute  and  the  LiAc  removed  with  a  micro-pipette.  The  cells  were 
resuspended  to  a  final  volume  of  500ýtl  in  IOOmM  LiAc.  A  Ind  sample  of  2mg/n-d  single- 
88 stranded  carrier  DNA  (ssDNA)  was  boiled  for  5  minutes  and  chilled  quickly  on  ice.  The 
cell  suspension  was  vortexed  and  50gl  aliquots  were  transferred  into  labeled  eppendorff 
tubes.  The  cells  were  pelleted  and  the  LiAc  removed.  The  transformation  mix  was  then 
added  in  the  following  order,  240gl  polyethyleneglycol  (PEG)  (50%  w/v),  36PI  IM 
LiAc,  50gl  SS-DNA  (2mg/mI),  X[tl  Plasmid  DNA  (0.1-10mg),  34-XjtI  Sterile  dH20,, 
enabling  the  PEG  to  shield  the  cells  from  the  detrimental  effects  of  the  concentrated 
lithium  acetate  solution.  Each  tube  was  vortexed  vigorously,  until  the  cell  pellet  was 
completed  mixed,  and  incubated  at  300C  for  30  minutes.  The  samples  were  then  heat 
shocked  at  420C  for  30  minutes  and  centrifuged  at  6-8000  rpm  for  15  seconds  and  the 
transformation  mix  removed.  The  cells  were  resuspended  in  Iml  of  sterile  water  and  an 
appropriate  volume  plated  onto  appropriate  selection  SD-minus  agar  plates  in  a  final 
volume  of  200gl.  The  plates  were  incubated  at  300C  for  2-15  days  to  recover 
transformants.  Figure  2.4  illustrates  the  screening  stringency  options. 
It  should  be  noted  that  two  sequential  transformation  steps  were  used  to  introduce  the 
bait  plasmid  and  then  cDNA  library  plasmids  separately.  This  maximized  transformation 
efficiency  for  each  plasmid  and  thus  enabled  the  largest  number  of  double  transformants 
to  be  screened  in  each  experiment.  For  library  scale  transformations  the  co- 
transformation  efficiency  was  tested  by  spreading  100gl  of  a  1/1000,1/100  and  1/10 
dilution  onto  SD/-Trp/-Leu  agar.  In  order  to  test  the  transformation  efficiency  of  each 
plasmid.  I  [d  of  the  transformation  mixture  was  diluted  I/  100  with  dH20,  and  I  jil  of  this 
dilution  was  spread  onto  90mm  SD/-Leu  and  SD/-Trp  plates  in  I  00gl  of  the  appropriate 
media. 
2.2.10F  CALCULATION  OF  TRANSFORMATION  EFFICIENCY  &  THE  NUMBER  OF 
CLONESSCREENED 
Transformation  efficiency  was  calculated  by  counting  the  number  of  clones  (cfu) 
growing  on  SD/-Trp/-Leu  plates  with  30-300  cfu. 
cfu  x-total  susnension  volume  (ub  cfu/jig  DNA 
Volume  plated  (pl)  x  dilution  factor  x  amount  of  DNA  used  (pg)* 
*In  co-transformations  this  value  relates  to  the  amount  of  the  limiting  plasmid. 
89 The  total  number  of  colonies  screened  was  estimated  by  multiplying  the  number  of  cfu 
present  by  the  amount  of  DNA  used  in  the  transformation. 
Total  number  of  screened  clones  =  cfu  x  amount  of  DNA  used  (ýtg) 
2.2.10G  DETECTION  OF  a-GALACTOSIDASE  ACTIVITY 
Yeast  colonies  to  be  assayed  for  cc-galactosidase  activity  were  incubated  on  the 
appropriate  SD  media  agar  plates  containing  20mg/L  of  the  X-a-Gal  substrate.  Plates 
were  incubated  at  30'C  until  colony  growth  appeared.  Blue  colonies  indicated  the  ability 
to  activate  the  MELI  reporter  gene,  usually  via  the  interaction  of  bait  and  prey  proteins, 
thus  inducing  cc-galactosidase  activity  and  metabolism  of  the  X-a-Gal  substrate  from 
colourless  to  blue  [Aho  et  al,  19971. 
2.2.10H  AmPLIFICATION  AND  ANALysis  OF  PLASMID  INSERTS  BY  PCR 
DNA  extracts  were  made  from  yeast  cells  expressing  the  plasmids  of  interest  (see  section 
2.2.10A).  PCR  was  then  used  to  amplify  the  cDNA  inserts  encoding  proteins  initially 
found  to  interact  with  the  N-terminal  tail  of  CD23.  These  fragments  were  then  subjected 
to  endonuclease  restriction  analysis  to  eliminate  colonies  expressing  the  same  cDNA 
inserts.  Oligonucleotides  specific  for  the  AD  vector  (sequence  details  fisted  in  Table 
2.1.8c)  were  used  to  amplify  the  insert  fragments  from  these  plasmids.  PCR 
amplification  was  carried  out  using  30  cycles  of  the  following  conditions;  90'C  for  30 
seconds,  62"C  for  2  minutes  and  VC  for  I  minute.  The  samples  were  incubated  for  5 
minutes  at  72'C  to  ensure  full  extension  of  any  incomplete  DNA. 
The  PCR  products  were  then  analysed  by  agarose  gel  electrophoresis  (2.2.3F)  to  identify 
any  clones  containing  multiple  AD  plasmids.  10ýd  of  the  PCR  product  was  also 
subjected  to  endonuclease  restriction  analysis  (2.2.3D)  with  Hae  III  and  Alu  I  for  2  hours 
at  37'C.  The  samples  were  again  analysed  by  agarose  gel  electrophoresis  to  identify 
clones  with  similarly  sized  fragments. 
90 2.2.101  SEQUENCE  ANALYSIS  OF  LIBRARY  CLONES  FOUND  TO  INTERACT  WITH 
CD23 
The  primers  used  to  sequence  the  library  clones  were  as  follows; 
Forward  Primer  5'-ctattcgatgatgaagataccccaccaaaccc-3' 
Reverse  Primer  5'-aagtgaacttgcggggtttttcagtatctacg-3'. 
Sequence  analysis  was  performed  as  per  section  2.2.3H.  Sequences  were  checked  and 
manipulated  using  the  Macintosh-based  Edit  View  and  Gene  Jockey  programs 
respectively.  Library  sequence  homology  searches  were  performed  by  comparison  with 
sequences  listed  in  the  GenBank,  EMBL  and  other  databases  using  BLAST  searches  on 
the  world  wide  web  (http:  //www.  ncbi.  nlm.  nffi.  gov/BLAST)  to  identify  interacting  library 
cDNAs. 
91 FIGuRE  2.1  THE  BEAM  PATH  OF  A  TYPICAL  FLOW  CYTOMETER 
The  diagram  illustrates  the  beam  path  of  the  Becton-Dickinson  FACScan  Flow 
Cytometer.  Every  flow  cytometer  consists  of  a  laser  fight  source,  collection  optics, 
electrics  and  a  computer,  facilitating  the  respective  generation,  collection  and  translation 
of  the  signals  into  data.  The  cell  suspension  enters  the  system  at  the  interrogation  point 
shown  at  the  base  of  the  diagram  and  passes  through  the  beam  of  the  laser,  which  emits 
coherent  light  at  a  specified  wavelength.  The  cells  cause  the  laser  light  to  scatter,  and 
the  resultant  pattern  is  collected  by  two  lenses,  one  set  directly  in  front  of  the  light 
source  (forward  scatter,  FSQ  and  one  set  at  right  angles  to  it  (side  scatter,  SSQ. 
FITC/GFP  and  PE  fluorochromes  absorb  blue  laser  fight  (488nm)  enabling  their 
excitation  and  thus  emission  of  signals  around  530nm  and  585nm,  respectively. 
Specified  wavelengths  of  fluorescence  are  measured  by  a  series  of  optics,  beam  splitters 
and  filters.  The  FLI  and  FL2  detectors  receive  emissions  of  around  530nm  and  585nm, 
detecting  FITC  or  GFP  and  PE,  respectively.  The  dichroic  mirror  allows  fight  of  less 
than  560nm  to  pass  straight  through  to  the  FLI  detector  whilst  it  reflects  fight  above  this 
frequency  towards  the  FL2  detector.  This  enables  the  cytometer  to  separate  and 
distinguish  between  the  fluorescence  emitted  from  green  (FITC  or  GFP)  and  red  (PE) 
fluorochromes,  enabling  accurate  collection  of  data  from  dual  staining  experiments. 
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DIRECTED  MUTAGENESIS  PROTOCOL 
The  basic  procedure  utilises  a  supercoiled,  double-stranded  DNA  (dsDNA)  vector 
containing  the  insert  of  interest  and  two  synthetic  oligonucleotide  primers.  The  primers 
are  complimentary  to  opposite  strands  of  the  vector  with  each  containing  the  desired 
mutation.  Primer  extension  and  amplification  occurs  during  temperature  cycling, 
generating  nicked  plasmids  encoding  the  desired  mutation(s).  The  parental,  non-mutated 
dsDNA  is  digested  with  DpnI  (specific  for  methylated  and  hemi-methylated  DNA) 
allowing  transformation  of  the  nicked  vectors  into  E.  coli  cells.  Mutated  plasmids  are 
detected  as  blue  colonies  on  LB/ampicillin  selection  agar  containing  IPTG  and  X-gal. 
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repaired  by  XL  I  -Blue  cells FIGuRE  2.3  BEAM  PATH  OF  THE  ZEiss  LSM  410  INvERT  CoNFocAL 
MICROSCOPE 
This  diagram  illustrates  the  beam  path  of  the  Zeiss  LSM  410  Confocal  Microscope,  the 
machine  used  to  analyse  all  live  and  fixed  cell  samples  discussed  in  chapters  3  and  4. 
The  table  lists  the  definition  for  all  the  abbreviations  used  within  the  diagram. 
The  internal  laser  was  a  HeNe  543mn  laser  enabling  the  excitation  of  red 
fluorochromes,  in  this  case  either  Tf-TxR  or  LysoTracker  Red.  The  external  laser  was 
an  Argon/Krypton  488nm  laser  used  for  the  excitation  of  green  fluorochromes,  in  this 
case  GFP  or  FITC.  The  dichroic  beam  splitters  used  were  the  FT510  for  single 
excitation  of  the  Ar/Kr  line,  the  FT560  for  the  single  excitation  of  the  NeHe  line  and  the 
DBSP  488/543  or  double-banded  beam  splitter  for  the  simultaneous  excitation  of  both 
488  and  543  stimulated  fluorochromes. 
The  emission  filters  used  were  a  BP  515-525,  a  special  bandpass  filter  for  blue-488 
fluorescence,  detecting  emission  after  excitation  with  the  Ar/Kr  488nm  laser.  An  LP 
570,  a  long-pass  filter  was  used  to  detect  emission  after  excitation  with  the  HeNe  543 
laser.  These  filters  allowed  simultaneous  detection  of  both  green  (488nm)  and  red 
(543run)  emission  signals.  The  LP  590  filter  was  also  available  for  use  if  the  green 
emission  was  found  to  bleed-through  in  double  fluorescence  experiments  using  the  LP 
570  filter. 
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The  schematic  diagram  (adapted  from  the  MATCHMAKER  GAL4  Two-Hybrid  System 
3&  Libraries  User  Manual)  illustrates  the  options  for  altering  the  stringency  at  which  a 
yeast  two-hybrid  screen  is  performed.  This  is  primarily  controlled  through  growth  on 
nutritional  selection  media  with  additional  stringency  also  being  incorporated  by  the 
addition  of  the  X-cc-Gal  substrate  to  the  agar  plates.  Obviously  lower  stringency 
methods  increase  the  number  of  false  positives  but  may  aid  in  the  identification  of  weak 
or  transient  interactors,  whilst  high  stringency  can  result  in  false  negatives,  (loss  of  real 
interactors  due  to  the  interaction  being  too  weak  or  transient  and  thus  going  undetected). 
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. *-  wo CHAPTER  3 
GENERATION  AND  ANALYSIS  OF  WILD  TYPE  CD23  OR  GFP 
CD23  FuSION  PROTEINS  IN  STABLY-TRANSFECTED  HEK  293 
CELL  LINES. 
96 3.1  INTRODUCTION 
Two  species  of  the  low  affinity  human  Fc  receptor  for  IgE  exist,  FccRIla  (CD23a)  and 
FccRIIb  (CD23b)  [Kikutani,  et  al.,  1986;  Yokota,  et  al.,  1988].  As  previously  discussed 
these  two  isoforms  have  been  found  to  differ  only  by  a  short  stretch  of  amino  acids  at 
the  N-terminal  cytoplasmic  tail,  and  -result  from  different  transcription  initiation  sites, 
leading  to  the  incorporation  of  distinct  5'  exons  in  the  CD23a  and  CD23b  mRNAs  (see 
Figures  1.6  &  1.7)  [Yokota  et  al.,  1988]. 
CD23  is  expressed  on  numerous  cell  types  with  the  two  isoforms  having  been  observed 
to  have  distinct  cellular  expression  patterns;  CD23a  shows  constitutive,  but  cell  specific 
expression  on  B  cells  [Yokota,  et  al.,  1988],  whereas  CD23b  is  inducible  in  a  range  of 
haernatopoietic  cell  types,  usually  following  stimulation  by  cytokines  such  as  IL-4 
[DeFrance  et  al.,  1987;  Bonnefoy  et  al.,  1998].  CD23  has  also  been  shown  to  have  a 
variety  of  different  functions  including  those  as  an  adhesion  molecule  and  involvement 
in  IgE-mediated  allergic  responses  and  protective  immunity  against  parasites.  The  two 
isoforms  appear  to  be  linked  to  both  separate  intracellular  signalling  pathways  [as 
reviewed  by  Mossalayi  et  al.,  1997]  and  to  distinct  intracellular  trafficking  pathways 
[Yokota  et  al.,  1992]  and  it  has  been  suggested  that  the  slight  amino  acid  differences 
between  the  two  isoforms;  may  be  responsible  for  these  distinct  differences,  although  the 
molecular  evidence  for  this  is  incomplete. 
A  potential  complication  for  studying  the  cellular  trafficking  of  CD23  in  native  cells  is 
the  simultaneous  presence  of  both  endogenous  CD23  isoforms,  making  it  difficult  to 
follow  accurately  the  independent  molecular  movement  of  the  two  CD23  isoforms. 
Green  fluorescent  protein  (GFP)  obtained  from  the  jellyfish  Aquorea  vitoria  [Prasher  et 
al.,  1992;  Tsien,  1998]  has  been  utilised  in  many  systems  as  a  means  to  generate  fusion 
proteins  whose  fates  can  be  followed  by  immunohistochemistry,  flow  cytometry  or  in 
real  time  by  laser-scanning  confocal  microscopy  [Milligan,  1999;  Tsien,  1998].  In  this 
study  fusion  proteins  of  GFP  and  each  of  the  CD23  isofornis  were  generated,  with  a 
view  to  visualising  the  movement  of  these  molecules  in  real  time  in  living  cells. 
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3.2.1  GENERATION  OF  cDNAS  AND  PLASMIDS  EXPRESSING  EACH  OF  THE 
CD23  CONSTRUCTS. 
Prior  to  the  initiation  of  this  project,  plasmids  encoding  each  of  the  human  CD23 
isoforms  were  generated  by  Dr.,  Clare  Bradshaw.  CD23  coding  sequences  were 
vectorially  cloned  into  the  Bam  HIINot  I  site  of  pcDNA3.  I+  using  the  ofigonucleotides 
detailed  in  Table  3.1,  to  generate  the  pCD23a  and  pCD23b  plasmids.  Constructs 
encoding  GFP-CD23  ftision  proteins  were  generated  using  a  sin-iilar  cloning  strategy 
and  the  synthetic  oligonucleotides  (see  Table  3.1)  coffesponding  to  the  distinct  5'  and  3' 
ends  of  the  enhanced  green  fluorescent  protein  (eGFP)  coding  sequence,  and  containing 
an  additional  flanking  restriction  site,  were  used  to  introduce  Kpn  I  and  Bam  HI  sites  at 
the  ends  of  the  eGFP  coding  sequence  by  PCR.  The  resultant  DNA  fragments  were 
directionally  sub-cloned,  in-frame,  into  the  pcDNA3.1+  plasmids  already  containing  the 
appropriate  CD23  isoform  (pCD23a  or  pCD23b,  respectively),  generating  cDNAs 
encoding  a  fusion  protein  comprising  GFP  ftised.  via  a  tetra-peptide  linker  sequence  to 
the  extreme  N-terminus  of  CD23a  or  CD23b.  The  schematic  diagram  in  Figure  3.1 
illustrates  these  pGFP-CD23a  or  pGFP-CD23b  constructs,  and  automated  DNA 
sequencing  was  used  to  confinn  the  correct  cloning  of  each  isoform  (data  not  shown). 
Table  3.1  illustrates  the  sequence  of  each  oligonucleotide,  with  the  additional  restriction 
sites  shown  in  red. 
Table  3.1  Oligonucleotide  sequences  used  to 
generate  the  pCD23  and  pGFP-CD23  plasmids. 
Primer  Oligonucleotide  Sequence 
CD23a  Forward  5'  -  gtag.  gatccaccgccatggaggaaggtc  -3' 
CD23b  Forward  5'  -  gtaggatccagcataatgaatcctccaagccaggagatcgaggagcttcccagg  -  3' 
CD23  Reverse  5'  -  gtagcggccgctcaagagtggagaggggcag  -  3' 
GFP  Forward  5'  -  cggggtaccgccaccatgagtaaaggagaagaac  -  3' 
GFP  Reverse  5'  -  cgcggatcctgatttgtatagttcatccatgg  -  3' 
98 3.2.2  WILD  TYPE  CD23  AND  GFP-CD23  FusION  PROTEINS  ARE 
ExPRF,  SSED  AT  THE  PLASNU  MEMBRANE  OF  STABLY-TRANSFECTED 
HEK  292  CELLS. 
The  principal  function  of  CD23  as  a  membrane  protein  is  as  the  low  affinity  receptor  for 
IgE.  In  order  for  the  GFP-CD23  fusion  system  to  be  of  practical  value  in  probing  CD23 
function,  the  fusion  proteins  must  be  accurately  targeted  to  the  plasma,  membrane, 
correctly  folded  and  displayed  in  a  manner  analogous  to  the  endogenous  CD23  proteins. 
The  ability  of  transfected  cells  to  express  CD23  and  GFP-CD23  fusion  proteins  at  the 
cell  membrane  was  tested  by  transfection  of  plasmids  containing  the  appropriate  cDNAs 
into  HEK  293  cells.  After  5-6  weeks  in  selection  G418-resistant  cell  lines  eventually 
emerged  and  these  were  characterised,  firstly  by  Western  Blotting  (Figure  3.2)  and  then 
by  flow  cytometric  (FACS)  analysis  (Figure  3.3).  Collectively  these  results  indicate  that 
both  the  wild  type  CD23  and  GFP-CD23  fusion  proteins  are  firstly  being  properly 
synthesised  and  secondly  being  correctly  targeted  to  and  expressed  on  the  plasma 
membrane  in  HEK  293  cells.  The  flow  -  cytometric  data  also  demonstrates  that  the 
addition  of  the  GFP  tag  does  not  prevent  the  expression  and  targeting  of  these  fusion 
proteins.  The  extracellular  domain  of  the  fusion  proteins  must  also  be  correctly  folded  at 
the  plasma  membrane,  as  once  on  the  cell  surface,  they  are  readily  recognised  by  the 
anti-CD23  antibodies. 
3.2.3  VISUALISATION  OF  CD23  IsoFoRm  RE-DISTRIBUTION  IN  HEK  293 
CELLS. 
Stably-transfected  HEK  293  cells  expressing  individual  wild  type  CD23  isoforms,  were 
assessed  by  laser  scanning  confocal  microscopy.  In  each  case  live  cells  were  studied  and 
CD23  receptor  protein  trafficking  was  monitored  over  a  fixed  time  interval.  Figure  MA 
illustrates  two  representative  stills,  detailing  the  typical  initial  staining  pattern  observed 
for  CD23a  and  CD23b  respectively,  after  the  addition  of  FITC  anti-CD23  antibody.  In 
agreement  with  flow  cytometric  data  in  Figure  3.3,  these  pictures  illustrate  that  at  an 
initial  time  point  (i.  e.  relatively  soon  after  the  addition  of  the  anti-CD23  antibody)  the 
majority  of  CD23a  or  CD23b  is  localised  to  the  plasma  membrane.  In  order  to  probe 
99 movement  of  the  CD23  protein  isoforms  appropriate  cell  samples  were  monitored  on  a 
heated  stage  facility  for  a  ftirther  30-45  minute  period.  Specific  fields  of  view  were 
chosen  and  data  were  collected  from  these  at  defined  time  intervals.  When  the  data 
pictures  were  then  run  together  as  a  'movie'  it  was  evident  that  re-distribution  of 
fluorescence  was  occurring,  both  along  the  plane  of  the  membrane  and  within  the  cell, 
indicating  that  both  isoforms  show  a  certain  level  of  re-cycling  after  the  addition  of 
FITC  anti-CD23  antibody.  It  is  impossible  in  this  experimental  configuration  to  tell 
whether  or  not  this  re-cycling  would  still  occur  if  the  receptor  were  unoccupied/cross- 
linked  by  antibody. 
Figure  3.4B  illustrates  representative  confocal  microscopic  images  of  HEK  293  cells 
expressing  either  GFP-CD23a  or  GFP-CD23b  proteins  and,  as  per  the  wild  type  protein 
data  (Figure  3.4A),  a  distinct  plasma  membrane  localisation  is  evident.  These  data  are 
consistent  with  the  flow  cytometric,  cell  surface  expression  data  illustrated  in  Figure 
3.3,  and  again  confirm  that  the  GFP-CD23  fusion  proteins  are  correctly  targeted  to  and 
expressed  upon  the  cell  membrane.  Movement  along  the  membrane  and  a  low  level  of 
"re-cycling"  of  these  proteins  was  observed  when  time-lapse  images  were  collated  as  a 
'movie',  indicating  that  GFP-CD23a  and  GFP-CD23b  proteins,  and  presumably  wild- 
type  CD23  proteins  do  indeed  illustrate  basal  re-cycling  movement. 
3.2.4  GFP-FUSION  PROTEiNs  FACILITATE  THE  STUDY  OF  CD23 
ISOFoRm  TRAFFICKING  IN  "BASAL"g  "LIGATED99  AND  "CROSS- 
LUSKED"  CONDITIONS. 
Figure  MA  and  the  associated  time-lapse  movies  (data  not  shown)  illustrate  that  CD23a 
and  CD23b  proteins  can  be  driven  to  internalise  upon  antibody-mediated  cross-linking. 
This  system  does  not  however  facilitate  the  analysis  of  CD23  isoform  re-distribution  in 
the  unligated  state  as  the  addition  of  fluorophore-conjugated  and  intact  anti-CD23 
antibodies,  by  definition,  move  the  system  from  resting  to  cross-linked.  Philosophically, 
therefore,  the  addition  of  the  probe  has  in  itself  perturbed  the  experiment.  These  and 
previous  studies  of  CD23  trafficking  [Yokota  et  al.,  1992]  have  been  unable  to  address 
the  issues  of  movement  in  the  unoccupied,  basal  state  or  in  the  state  where  CD23 
molecules  are  occupied  by  IgE  but  are  not  cross-finked  by  antigen.  GFP-CD23  fusion 
100 proteins  allow  these  questions  to  be  addressed  directly.  Figure  3.5  illustrates  GFP-CD23 
fusion  proteins  and  NIP-specific  chimaeric  human  IgE  antibody  being  utilised  to 
investigate  the  potential  trafficking  differences  between  CD23  in  an  unligated  or  "basar' 
state,  CD23  "loaded"  with  its  natural  ligand  IgE  (NIP-specific)  and  following  the 
addition  of  NIP-BSA  to  cells  pre-loaded  with  IgE,  to  evaluate  "cross-linked"  CD23. 
Initial  time-lapse  studies  in  the  basal  state  show  that  both  GFP-CD23a  and  GFP-CD23b 
proteins  move  within  the  plane  of  the  plasma  membrane  and  illustrate  modest  uptake 
into  the  cell  to  a  peri-nuclear  compartment  and  movement  back  out  to  the  plasma 
membrane  (data  not  shown).  Figure  3.4B  shows  two  representative  'snapshot'  time 
point  pictures  illustrating  this  for  both  GFP-CD23  isoforms.  The  rate  of  this  re-cycling 
movement  appeared  to  be  slightly  increased  when  the  CD23  molecules  were  loaded 
with  IgE,  as  demonstrated  by  comparison  of  the  time-lapse  movies  (Data  not  shown). 
Pre-loading  the  cells  with  NIP-specific  IgE,  followed  by  the  addition  of  NIP-BSA 
stimulates  distinct  receptor  internalisation,  initially  demonstrated  by  punctate 
fluorescence  on  the  plasma  membrane,  followed  by  the  appearance  of  multiple  discrete 
foci  of  fluorescence  within  the  cell.  Figure  3.6  shows  a  diagrammatic  representation  of 
this  process  and  illustrative  confocal.  images  demonstrating  the  consequent  localisation 
of  receptor  staining  at  each  stage. 
3.2.5  CD23A  BuT  NOT  CD23B  PROTEINS  ARE  INTERNALISED  VIA  THE 
EARLY  ENDocyTic  PATHwAy. 
Co-localisation  studies  were  carried  out  using  five  HEK  293  cells  expressing  either 
CD23a  or  GFP-CD23a  proteins.  The  cells  were  exposed  to  Transferrin-modified-Texas 
Red  dye  (Tf-TxR)  for  20  minutes  at  37'C,  (,  wild  type  proteins  were  then  labelled  with 
FITC  anti-CD23  antibody  for  5  minutes  at  room  temperature)  and  then  analysed  on  the 
confocal  microscope  using  the  heated  stage.  Images  were  recorded  over  a  45-minute 
period  (unless  otherwise  stated). 
Figure  3.7  illustrates  a  single  data  set  representative  of  the  many  CD23a  experiments 
recorded.  The  results  indicate  that  MAb  cross-linked  CD23a  isofonn  appears  to  move 
101 into  endosomal  compartments,  denoted  by  the  yellow  signal,  resulting  form  the  co- 
localisation  of  CD23a  (green)  and  Tf-TxR  (red).  GFP-CD23a  was  also  found  to  co- 
localise  with  Tf-TxR,  but  only  under  "cross-linked"  conditions  where  the  CD23 
proteins  were  loaded  with  19E  and  then  cross-linked  with  'antigen'.  The  results  of  the 
wild  type  CD23a  study  support  these  findings  for  the  GFP-CD23a  proteins,  and 
reconfirms  that  the  addition  of  anti-CD23  antibody  moves  the  system  from  a  basal  to 
cross-linked  state. 
The  same  experiments  were  also  carried  out  for  HEK  293  cells  expressing  either  CD23b 
or  GFP-CD23b  proteins.  Figure  3.8  shows  a  single  data  set  representative  of  the  many 
CD23b  experiments  recorded.  Co-localisation  of  Tf-TxR  with  either  the  wild  type 
CD23b  or  GFP-CD23b  fusion  proteins  was  not  observed  under  any  of  these 
experimental  conditions.  This  indicates  that  CD23b,  unlike  CD23a,  does  not  move  into 
the  early  endosomal  pathway  within  this  HEK  293  cell  system.  Again  the  results  from 
both  the  wild  type  and  GFP  fusion  proteins  are  similar,  illustrating  the  utility  of  the 
system.  A  difference  between  the  two  isoforms  has  already  been  observed,  reconfmning 
the  usefulness  of  this  cell  system  for  studying  CD23  isoform  trafficking  issues. 
3.2.6  NEITHER  CD23  IsoFoRm  ENTERS  A  PHAGOCYTIC  PATHWAY  IN 
HEK  293  CELLS. 
Co-localisation  studies  with  LysoTracker  Red  dye  were  routinely  carried  out  over  a  45- 
minute  time  period  (and  occasionally  over  75  minutes).  Figures  3.9  and  3.10  illustrate 
single  data  sets  representative  of  many  experiments  recorded  for  CD23a/GFP-CD23a 
and  CD23b/GFP-CD23b  proteins,  respectively.  Co-localisation  was  never  observed  in 
any  of  these  experiments  indicating  that  neither  CD23  isoform.  was  found  to  enter  the 
lysosomal  pathway  in  HEK  293  cells. 
3.2.7  HEK  293  CELLS  Do  NOT  UTELISE  CLASSICAL  PHAGOCYTOSIS. 
The  data  of  Figures  3.9  and  3.10  indicate  that  neither  of  the  CD23  protein  isoforms  were 
found  to  co-localise  with  LysoTracker  dye,  suggesting  that  neither  protein  appeared  to 
undergo  classical  phagocytosis.  Before  drawing  too  many  conclusions  about  the 
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phagocytic  capability  of  HEK  293  cells.  A  phagocytic  assay  was  carried  out  utilising 
opsonised  sheep  red  blood  cells  (SRBC). 
A  Iml  suspension  of  sheep  red  blood  cells  (SRBC)  was  spun  down  and  exposed  to  5mg 
of  FITC  dissolved.  in  101A  of  DMSO  and  then  resuspended  in  SOOgI  of  IM  carbonate 
buffer,  pH  7.2.  The  mixture  was  incubated  in  the  dark  at  room  temperature  for  several 
hours  with  occasional  gentle  mixing.  Finally  anti-SRBC  stromal  antibodies  were  added 
to  the  mixture,  generating  opsonised  SRBC.  The  antibody-coated  cell  suspension  was 
then  presented  to  HEK  293  cells  at  37'C  for  30  minutes  and  the  results  analysed  under  a 
fluorescent  microscope.  Engulfed  SRBC  could  be  located  either  by  their  FITC 
fluorescence  or  by  simple  bright  field  analysis.  No  SRBC  were  found  within  any  HEK 
293  cells  (Figure  3.11),  indicating  that  HEK  293  cells  cannot  be  used  to  study  the 
trafficking  of  proteins  via  the  classical  phagocytic  pathway,  as  these  cells  do  not  in  fact 
use  this  method  of  uptake.  Figure  3.11  also  illustrates  a  control  test  indicating  that 
U937s,  a  macrophage-like  cell  line,  can  take  up  the  opsonised  SRBC  probably  mediated 
through  FcyRl  and  FcyRII.  Neither  cell  was  observed  to  engulf  non-opsonised  SRBC- 
HEK  293  cells  may  not  have  Fc  receptors  therefore  the  use  of  a  non-opsonised  target 
may  have  been  a  better  positive  control  in  this  case. 
3.2.8  HEK  293  CELLS  Do  NOT  EXPRESS  MHC  CLASS  11  MOLECULES 
'Rxecent  data  suggests  that  CD23a  and  MEC  class  II  molecules  can  be  co-internalised 
and  co-localised  into  endocytic  compartments  in  a  human  RPMI-8866  B  cell  fine 
[Karagiannis  et  al.,  2001],  as  demonstrated  by  the  endosomal  uptake  of  any  anti-CD23, 
anti-HLA-DR  or  IgE/antigen  complexes.  These  experiments  raise  the  question  as  to 
which  of  the  molecules  present  within  the  ternary  complex  provides  the  sorting  signals 
for  movement  of  the  complex  into  the  cell.  It  is  a  distinct  possibility  that  the  HLA-DR 
molecules  may  provide  the  necessary  sorting  signals  for  uptake  and  that  these 
experiments  may  report  more  on  HLA-DR  trafficking  rather  than  CD23  trafficking. 
Flow  cytometric  analysis  of  HEK  293  cells  was  performed  to  investigate  whether  or  not 
this  cell  fine  expressed  endogenous  HLA-DR  molecules.  The  results  demonstrate  that 
103 HEK  293  cells  do  not  express  HLA-DR  molecules,  but  that  the  Raji  A  hmature  B  cell 
fine,  used  as  a  positive  control,  did  express  MEC  class  11  molecules  (Figure  3.12).  The 
absence  of  MHC  class  II  antigen  expression  in  HEK  293  cells  enables  investigation  of 
CD23  trafficking  independently  of  any  contribution  which  the  HLA-DR  molecules  may 
have  provided.  The  protein  motifs  responsible  for  CD23  trafficking  in  the  experiments 
described  in  this  chapter,  are  therefore  most  likely  to  be  intrinsic  to  the  CD23  isoforms 
themselves,  since  the  HEK  293  cell  line  does  not  express  MUC  class  II  antigens. 
3.3  DISCUSSION 
The  studies  presented  herein  employed  identical  cell  systems  and  methods  for 
assessment  of  the  trafficking  of  both  CD23a  and  CD23b  molecules;  namely  BEK  293 
cells  and  chfimeric,  hapten-specific  IgE  and  a  haptenated  protein  antigen  for  cross- 
linking  purposes.  The  use  of  GFP-tagged  proteins  has  enabled  visualisation  of  CD23  in 
both  the  unoccupied  or  "basar'  state  and  in  the  state  where  CD23  molecules  are 
occupied  by  IgE  but  not  cross-linked  by  antigen,  two  scenarios  never  previously 
visualised.  Another  strong  advantage  of  this  system  is  the  ability  to  study  five  cells  and 
collect  real-time  images  as  each  individual  experiment  progresses. 
The  data  presented  in  this  chapter  demonstrate  that  CD23a  and  CD23b  molecules  show 
a  degree  of  re-cycling  in  the  basal,  unligated  state.  CD23a  cross-linked  with  FITC  anti- 
CD23  MAb  and  GFP-CD23a  fusion  proteins  loaded  with  IgE  and  then  cross-linked  with 
'antigen'  were  both  found  to  show  rapid  co-localisation  with  Tf-TxR  in  the  early 
endosomal  pathway.  GFP-CD23a  fusion  proteins  in  the  basal  or  loaded  state  were  never 
observed  to  co-localise  with  TPTxR.  Neither  CD23b  nor  GFP-CD23b  fusion  proteins  in 
any  of  the  three  states  were  found  to  co-localise  into  the  endosomal  pathway.  Neither 
isoform  was  found  to  traffic  to  the  lysosomal  pathway  under  any  of  the  experimental 
conditions  tested. 
In  contrast  to  these  results,  earlier  studies  [Yokota  et  al.,  1992]  employed  radio- 
iodinated  anti-CD23  MAb  to  probe  endocytic  function,  and  IgE-coated  erythrocytes  to 
probe  phagocytosis,  using  separate  cell  types  to  analyse  each  protein  trafficking 
104 pathway.  J774  macrophage  cells,  a  cell  line  with  extremely  high  phagocytic  capability, 
were  used  to  probe  the  possible  uptake  of  CD23  into  the  lysosomal  pathway.  y2  cells 
were  used  to  analyse  endocytic  uptake  of  CD23.  At  this  point  it  is  necessary  to  say  that 
the  Yokota  studies  indicated  that  the  CD23  isoforms  were  internalised  via  distinct 
routes;  CD23a  was  observed  to  enter  y2  cells  via  receptor-mediated  endocytosis 
whereas  CD23b  was  shown  to  illustrate  phagocytic  uptake  into  J774  cells.  The  findings 
from  these  studies  will  be  discussed  at  greater  length  in  the  general  discussion  chapter. 
The  results  presented  within  this  chapter  support  these  previous  findings  for  CD23a  and 
CD23b  trafficking  in  the  context  of  endocytic  pathways,  but  are  unable  to  provide  any 
information  on  the  trafficking  methods  employed  by  CD23b  with  respect  to 
phagocytosis,  other  than  to  suggest  that  receptor-mediated  endocytosis  is  not  the 
internalisation  route  of  choice  for  this  isoform. 
In  summary,  these  studies  clearly  demonstrate  that  GFP-CD23  fusion  proteins  are  a 
viable  and  informative  means  of  probing  the  cell  biological  properties  and  intracellular 
trafficking  of  the  CD23  isoforms.  The  limitations  of  this  system  He  with  the  cell  line 
chosen  since  HEK  293  cells  have  subsequently  been  shown  to  be  unsuitable  for  the 
analysis  of  phagocytic  routes  of  trafficking.  HEK  293  cells  are  a  typical  choice  for  this 
type  of  expression  work  as  they  benefit  from  ease  of  transfection  with  a  plasmid  of 
choice,  and  generation  of  stable  cell  lines  producing  the  required  protein  at  a  reasonable 
expression  level.  Their  adhesion  properties  are  also  an  important  benefit,  facilitating 
analysis  of  cells  attached  to  glass  cover  slips  by  confocal  microscopy.  HEK  293  cells 
are  routinely  used  as  a  model  system  to  study  receptor-mediated  endocytic  trafficking 
by  many  research  groups  and  no  doubt  will  continue  to  be  used  for  this  type  of  work  in 
the  future.  HEK  293  cells  have  also  been  used  to  analyse  the  endocytic  trafficking 
capacity  of  a  small  library  of  GFP-CD23  N-terminal  mutant  fusion  proteins.  This  work 
is  presented  and  discussed  in  chapter  4  of  this  thesis. 
105 FIGuRE  3.1  GENERATION  OF  WILD-TYPE  CD23  AND  GFP-CD23 
FuSION  PROTEINS 
Human  CD23  was  amplified  by  RT-PCR  from  aB  lymphoblastoid  cell  line  and 
directionally  cloned  into  the  Bam  HI  -  Not  I  sites  in  the  multiple  cloning  region  of 
pcDNA3.1+,  generating  pCD23a  and  pCD23b  plasmids.  Enhanced  green  fluorescent 
protein  (eGFP)  was  then  subcloned  into  the  Kpn  1-  Bam  HI  sites,  generating  cDNAs 
encoding  a  fusion  protein  comprising  eGFP  fused  via  a  tetra-peptide  linker  sequence  to 
the  extreme  N-terminus  of  CD23a  and  CD23b,  generating  pGFP-CD23a  and  pGFP- 
CD23b  plasmids. 
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pGFP-CD23a  pGFP-CD23b FIGuRE  3.2  HEK  293  CELLS  STABLY  EXPRESS  CD23  AND  GFP-CD23 
FUSION  PROTEINS 
30pg  of  total  RIPA  cell  lysate  protein  from  HEK  293  cells  stably  transfected  with 
pCD23a,  pCD23b,  pGFP-CD23a  or  pGFP-CD23b  were  separated  on  10%  SDS-PAGE, 
transferred  to  nitrocellulose  membrane  and  immunoblotted  with  polyclonal  rabbit  anti- 
CD23  antibody  (Rb55,  Geneva  Biomedical  Research  Institute)  and  detected  with  an 
anti-rabbit  IgG  secondary  antibody  for  45  minutes  at  room  temperature.  The  blots  were 
visualised  using  the  Biorad  ECL  detection  kit.  Untransfected  HEK  293  cells  have  been 
included  as  a  control,  and  these  samples  have  been  run  in  lane  one  of  each  gel.  Figure 
(i)  illustrates  the  results  for  the  wild-type  CD23  proteins,  with  figure  (H)  showing  the 
results  for  the  CD23a  isoform  in  its  untagged  and  GFP-tagged  state.  Data  for  GFP- 
CD23b  not  shown.  A  band  was  observed  at  approximately  75kDa  in  all  HEK  293  cell 
lysate  samples.  Although  this  species  was  not  identified  during  the  course  of  this 
research,  it  is interesting  to  note  that  is  was  not  observed  in  CD23  producing-bacterial 
cell  lysates  and  may  therefore  be  specific  to  the  HEK  293  cell. 
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45  kl)a  m>  gunum FIGURE  3.3  HEK  293  CELLS  STABLY  EXPRESS  CD23  AND  GFP-CD23 
FUSION  PROTEINS  AT  THE  PLASMA  MEMBRANE 
G418-resistant  HEK  293  cells  stably  transfected  with  pCD23a,  pCD23b  (Panel  A)  or 
pGFP-CD23a,  pGFP-CD23b  (Panel  B)  were  subjected  to  flow  cytometry.  Panel  A- 
The  green  line  represents  the  presence  of  CD23,  as  detected  by  a  FITC  anti-CD23 
antibody.  The  black  line  represents  the  negative  control  illustrating  the  results  for 
untransfected  HEK  293  cells  with  the  addition  of  the  anti-CD23  antibody.  Panel  B- 
The  presence  of  CD23  was  detected  by  an  anti-CD23  PE  antibody  (FL-2),  whilst  the 
presence  of  the  GFP  tag  was  directly  detected  from  its  green  fluorescence  (FL-1).  The 
data  has  been  presented  as  a  number  of  dot-plots  enabling  the  percentage  of  double 
positive  cells  to  be  calculated. 
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FUSION  PROTEINS  IN  HEK  293  CELLS 
G418-resistant  HEK  293  cells  stably  transfected  with  pCD23a,  pCD23b  (Panel  A)  or 
pGFP-CD23a,  pGFP-CD23b  (Panel  B)  were  propagated  for  48  hours  on  poly-D-lysine 
(PDL)  coated  coverslips  before  being  harvested,  washed  in  KRH  buffer  and  sub  ected  to  j 
Confocal  analysis.  Wild-type  CD23  was  visualised  by  the  addition  of  FITC-anti-CD23 
antibody  for  5  minutes,  prior  to  rinsing  and  then  subjected  to  confocal  analysis. 
109 4ý  m FIGURE  3.5  SCHEMATIC  DIAGRAM  ILLUSTRATING  ME  NIP  SYSTEM 
BSA  was  conjugated  with  4-hydro)cy-3-iodo-5-nitrophenylacetic  acid  (NIP)  and  used  in 
con  unction  with  NIP-specific  IgE  antibody.  The  NIP-BSA  preparation  had  an  average  j 
derivatisation  ratio  of  approximately  10  NIP  molecules  per  each  BSA  molecule.  GFP- 
CD23  fusion  proteins  were  stably  expressed  in  HEK  293  cells  and  their  trafficking 
patterns  assessed  in  an  unoccupied  or  "Basd'  state,  a  "Loaded"  state  following  the 
addition  of  NIP-specific  chimaeric  IgE  antibody  and  a  "Cross-finked"  state  following 
the  addition  of  NIP-BSA  to  cell  pre-loaded  with  NIP-specific  IgE.  The  green  star  in 
each  instance  represents  the  GFP  tag  at  the  N-terminus  of  each  CD23  fusion  protein. 
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Basal FIGuRE  3.6  TYPICAL  PATTERNS  OF  RECEPTOR  INTERNALISATION 
Many  cell  surface  receptors  are  ubiquitously  expressed  on  the  plasma  membrane  until  a 
stimulus  causes  them  to  cluster  at  particular  points  on  the  cell  surface  prior  to  their 
internalisation  or  entry  into  the  cell.  Panel  (i)  shows  a  schematic  diagram  illustrating  the 
steps  of  receptor  internalisation.  Panel  (H)  shows  three  confocal  microscope  images  of 
GFP-tagged  CD23  illustrating  the  main  stages  of  receptor  internalisation,  with  the 
es  demonstrating  the  classical  punctate  morphology  referred  to  when  discussing 
the  confocal  results  herein. 
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MODIF71ED  TExAs  RED  (TF-TxR)  iN  HEK  293  CELLS 
Coverslips  bearing  G418-resistant  HEK  293  cells  expressing  CD23a  or  GFP-CD23a 
were  pre-incubated  with  20pg  Tf-TxR  prior  to  confocal  analysis.  The  wild  type  CD23a 
proteins  were  visualised  after  the  addition  of  FITC-anti-CD23  antibody.  The  GFP- 
CD23a  fusion  proteins  were  exposed  to  no  stimulus,  Igg  NIP-specific  IgE  or  to  Igg 
NIP-specific  IgE  followed  by  the  addition  of  I  gg  NIPjo-BSA  and  examined  by  confocal 
microscopy  over  a  45  minute  period.  The  pictures  illustrate  the  results  for  wild  type 
CD23a  at  a  (i)  zero  and  (H)  20  minute  time  point  and  GFP-CD23a  in  the  (iii)  basal,  (iv) 
loaded  and  (v)  cross-linked  states  respectively.  Co-localisation  was  observed  in  the  wild 
type  situation  after  the  addition  of  FITC-anti-CD23  antibody.  GFP-CD23  fusion 
proteins  were  also  found  to  co-localise  with  Tf-TxR,  but  only  after  being  "cross-linked" 
with  antigen. 
112 FIGuRE  3.8  THE  CD23B  ISOFORM  DOES  NOT  CO-LOCALISE  WITH 
TRANSFERRIN-MODIFIED  TExAs  RED  (rF-TxR)  IN  HEK  293  CELLS 
Coverslips  bearing  G418-resistant  HEK  293  cells  expressing  CD23b  or  GFP-CD23b 
were  pre-incubated  with  20pg  Tf-TxR  prior  to  confocal  analysis.  The  wild  type  C1323b 
proteins  were  visualised  after  the  addition  of  FITC-anti-CD23  antibody.  The  GFP- 
CD23b  fusion  proteins  were  exposed  to  no  stimulus,  Igg  NIP-specific  IgE  or  to  Igg 
NIP-specific  IgE  followed  by  the  addition  of  I  gg  NIPlo-BSA  and  examined  by  confocal 
microscopy  over  a  45  minute  period.  The  pictures  illustrate  the  results  for  wild  type 
CD23b  at  a  (i)  zero  and  (H)  20  minute  time  point  and  GFP-CD23b  in  the  (iii)  basal,  (iv) 
loaded  and  (y)  cross-linked  states  respectively.  Co-localisation  was  not  observed  under 
any  of  these  experimental  conditions. 
113 C110 FIGuRE  3.9  THE  CD23A  IsoFoRm  DOEs  NOT  Co-LOCALISE  WITH 
LYSoTRACKER  DYE  iN  HEK  293  CELLS 
Coverslips  bearing  G418-resistant  HEK  293  cells  expressing  CD23a  or  GFP-CD23a. 
were  pre-incubated  with  50nM  LysoTracker  dye  prior  to  confocal  analysis.  The  wild 
type  CD23a  proteins  were  visualised  after  the  addition  of  FITC-anti-CD23  antibody. 
The  GFP-CD23a  fusion  proteins  were  exposed  to  no  stimulus,  I  gg  NIP-specific  IgE  or 
to  Ipg  NIP-specific  IgE  followed  by  the  addition  of  Ipg  NIPIO-BSA  and  examined  by 
confocal  microscopy  over  a  45  minute  period.  The  pictures  illustrate  the  results  for  (i) 
wild  type  CD23a  and  GFP-CD23a  in  the  (ii)  basal,  (iii)  loaded  and  (iv)  cross-linked 
states  respectively.  Co-localisation  was  not  observed  under  any  of  these  experimental 
con  itions. 
114 FIGuRE  3.10  THE  CD23B  IsoFopm  DOEs  NOT  CO-LOCALISE  WrrH 
LYSOTRACKER  DYE  IN  HEK  293  CELLS 
Coverslips  bearing  G418-resistant  HEK  293  cells  expressing  CD23b  or  GFP-CD23b 
were  pre-incubated  with  5OnM  LysoTracker  dye  prior  to  confocal  analysis.  The  wild 
type  CD23  proteins  were  visualised  after  the  addition  of  FITC-anti-CD23  antibody.  The 
GFP-CD23b  fusion  proteins  were  exposed  to  no  stimulus,  1ýtg  NIP-specific  IgE  or  to 
Ipg  NIP-specific  IgE  followed  by  the  addition  of  Igg  NIPjo-BSA  and  examined  by 
confocal  microscopy  over  a  45  minute  period.  The  pictures  illustrate  the  results  for  (i) 
wild  type  CD23b  and  GFP-CD23b  in  the  (H)  basal,  (iii)  loaded  and  (iv)  cross-linked 
states  respectively.  Co-localisation  was  not  observed  under  any  of  these  experimental 
conditions. 
115 FIGuRE  3.11  HEK  293  CELLS  Do  NOT  UTILISE  THE  CLASSICAL 
PRAGOCYTIC  PATHWAY 
A  phagocytosis  assay  was  performed  to  assess  the  phagocytic  ability  of  HEK  293  cells. 
Sheep  red  blood  cells  (SRBC)  were  labelled  with  FITC  dye,  coated  with  anti-SRBC 
stromal  antibody  and  then  presented  to  the  cells  for  30  minutes  at  37'C.  The  top  panel 
shows  the  bright  field  images  for  'each  cell  line,  with  the  bottom  panel  showing  an 
overlay  of  the  bright  field  image  with  the  confocal  fluorescent  image,  recording  the 
location  of  the  green  of  the  FITC-labelled  SRBC.  HEK  293  cells  are  unable  to  engulf 
FITC  labelled  sheep  red  blood  cells  (SRBC)  opsonised  with  antibody,  unlike  the 
macrophage-like  cell  fine  U937. 
116 FIGuRE  3.12  HEK  293  CELLs  Do  NOT  ExPREss  MHC  CLAss  II 
MOLECULES 
Untransfected  HEK  293  were  subjected  to  flow  cytometry,  analysing  whether  or  not 
these  cells  express  MEC  class  11  molecules.  The  thick  gray  fine  represents  the  presence 
of  MIIC  class  11  molecules,  as  detected  by  a  FITC  anti-HLA-DR  (class  II)  antibody. 
The  black  dotted  line  represents  the  negative  control  illustrating  the  results  for 
untransfected  HEK  293  cells  with  the  addition  of  the  anti-CD23  antibody.  The  insert 
histogram  illustrates  the  results  for  the  RaJi  A  cell  line,  indicating  that  these  cells  do 
express  MEC  class  II  molecules  and  thus  serve  their  purpose  as  a  positive  control  for 
this  experiment. 
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GENERATION  AND  ANALYSIS  OF  CD23A  AND  CD23B 
N-TERMINAL  MUTANT  PROTEINS 
118 4.1  INTRODUCTION 
Human  CD23,  as  previously  discussed,  has  been  demonstrated  to  exist  in  two  isoforms, 
[Yokota  et  al.,  1992],  with  these  species  originating  from  a  single  II  exon  gene  located 
on  chromosome  19  [Suter  et  al.,  1987;  Wendel-Hansen  et  al.,  1990],  differing  only  by  a 
few  amino  acids  at  the  very  N-terminus  of  their  short  cytoplasmic  domains  [Yokota  et 
al.,  1988].  Section  1.5  discusses  the  fact  that  the  CD23a  and  CD23b  isoforms,  show 
distinct  patterns  of  cellular  expression  and  are  believed  to  have  discrete  functional  roles. 
Indeed,  it  seems  logical  for  these  two  very  similar,  yet  distinct,  proteins  to  have 
different  functional  roles,  otherwise  why  would  their  individual  production,  sometimes 
on  the  very  same  cell,  be  maintained?  It  also  stands  to  reason  that  any  differences  that 
do  exist  between  these  two  molecules  must  be  attributed  to  the  unique  amino  acid 
sequences  contained  within  the  short  N-terminal  cytoplasmic  tail  regions,  as  the 
remainder  of  the  molecules  are  identical. 
The  two  CD23  isofornis  have  previously  been  associated  with  different  intracellular 
trafficking  pathways,  the  CD23a  isoform.  associated  with.  receptor-mediated  endocytosis 
and  the  CD23b  isoforin  linked  more  to  a  phagocytic  route  of  cellular  entry  [Yokota  et 
al.,  1988].  The  amino  acid  sequences  at  the  extreme  N-termini  of  each  isoform,  may 
partly  explain  this  phenomena;  for  example  the  CD23b  isoform.  contains  an  asparagine 
and  proline  at  positions  2  and  3  that  have  been  suggested  to  be  essential  for 
phagocytosis  of  the  CD23b  isoforni  and  experimental  evidence  suggests  that  mutation 
of  these  residues  results  in  a  severe  reduction  in  phagocytic  uptake  in  J774  cells 
[Yokota  et  al.,  1988].  The  primary  aim  of  this  research  was  to  investigate  the  individual 
amino  acid  differences  that  exist  between  the  two  isoforms,  using  the  same  cell  system 
to  analyse  both  isoforms,  in  an  attempt  to  identify  the  functionally  essential  amino  acids 
involved  in  receptor  trafficking.  The  phosphorylation  state  of  the  molecule  is  often 
important  with  respect  to  function.  This  research  concentrates  on  the  unique  N-terminal 
tail  sections  of  the  CD23  isoforms  with  particular  focus  on  the  serine  and  tyrosine 
residues  which  might  function  as  targets  for  regulatory  kinases. 
A  small  library  of  CD23a  and  CD23b  N-terminal  mutants  have  been  generated  and  the 
properties  of  each  of  the  resultant  CD23  mutant  proteins  assessed  using  flow  cytometry 
and  live  cell  confocal  analysis.  The  results  discussed  within  this  chapter  do  indeed 
119 indicate  that  certain  amino  acids  contained  within  the  unique  N-terminal  tail  region  do 
appear  to  be  essential  for  the  correct  trafficking  and  thus  functioning  of  the  individual 
protein  isoforms. 
4.2  REsuLTs 
4.2.1  GENERATION  OF  CDNAs  AND  PLAsmiDs  ExPREsSING  EACH  OF  THE 
CD23  N-TERMINAL  MUTANT  PROTEINS. 
A  small  library  of  ten  CD23  N-terminal  mutant  constructs,  each  differing  from  one  of 
the  wild-type  CD23  proteins  by  only  one  or  two  amino  acids,  were  generated  using  the 
Stratagene  QickChange  Mutagenesis  kit,  (section  2.2.5  and  according  to  the 
manufacturers  instructions).  Figure  2.2  shows  an  overview  of  the  strategy  employed. 
Briefly,  pairs  of  oligonucleotide  primers,  each  complimentary  to  opposite  strands  of  the 
vector,  were  designed  to  incorporate  the  specific  base  changes  required  to  alter  the 
target  N-terminal  amino  acids.  These  primers  were  extended  during  temperature  cycling 
by  means  of  PfuTurbo  DNA  polymerase,  generating  mutagenic  open  plasmid  strands 
complimentary  to  the  original  plasmid  in  every  way  except  the  mutated  bases  encoded 
within  the  oligonucleotide  sequences. 
The  obvious  residues  targeted  for  change  were  those  amino  acids  that  may  be 
potentially  phosphorylated  or  de-phosphorylated,  serving  to  alter  the  phosphorylation 
state  of  the  receptor  molecule  at  the  cell  surface.  The  NPP  motif  in  the  CD23b  isoform 
was  also  mutated  since  these  amino  acids,  as  previously  discussed,  have  been  suggested 
to  play  a  role  in  targeting  this  molecule  into  the  phagocytic  pathway  in  J774  cells 
[Yokota  et  al.,  1988].  Figures  4.1  and  4.2  show  the  sequences  of  the  oligonucleotides 
used  to  generate  each  of  the  mutants,  together  with  the  resultant  proteins  generated  and 
the  nomenclature  given  to  the  CD23a  and  CD23b  N-terminal  mutants.  The  DNA  and 
amino  acid  sequences  of  the  wild-type  protein  isoforms,  are  also  illustrated  in  each  case. 
Figure  4.3  illustrates  the  side  chains  involved  in  each  of  the  amino  acid  changes. 
Each  mutant  clone  was  subjected  to  automated  DNA  sequencing  to  ensure  the  presence 
of  the  correct  sequence  and  incorporation  of  the  correct  mutation  in  each  instance  (data 
not  shown).  As  previously  described  in  chapter  3;  section  3.2.1,  PCR  was  used  to  insert 
120 a  green  fluorescent  protein  (GFP)  tag  at  the  N-terminus  of  each  of  the  CD23  mutant 
proteins,  facilitating  the  generation  of  constructs  expressing  each  of  the  CD23  mutants 
as  GFP  fusion  proteins.  This  cloning  procedure  was  verified  with  restriction  digestion 
analysis  as  well  as  with  automated  DNA  sequencing  to  ensure  each  construct  was 
expressing  the  GFP-CD23  mutant  fusion  proteins  correctly  (data  not  shown). 
4.2.2  ExPRESSION  OF  GFP-CD23A  AND  GFP-CD23B  MUTANT  PROTEINS 
IN  HEK  293  CELLS 
In  order  to  investigate  the  molecular  differences  between  the  two  CD23  isoforms  the 
proteins  must  be  studied  in  the  same  cell  system,  under  the  same  experimental 
conditions.  Having  previously  proven  the  HEK  293  cell  system  to  be  a  feasible  means 
of  studying  the  endocytic  trafficking  ability  of  each  of  the  wild-type  CD23  proteins  it 
was  postulated  that  the  importance  of  the  amino  acid  differences  between  these  two 
isoforms  could  also  be  studied  using  this  cell  system. 
HEK  293  cells  were  transfected  with  pcDNA3.1+  constructs  encoding  each  of  the  GFP- 
CD23  mutant  fusion  proteins.  After  5-6  weeks,  G418-resistant  cell  lines  emerged  and 
these  were  assessed  for  GFP-CD23  fusion  protein  expression  by  flow  cytometry.  The 
cells  were  analysed  directly  for  GFP  fluorescence  as  well  as  the  presence  of  CD23 
proteins  using  an  anti-CD23-PE  conjugated  antibody  (Figure  4.4).  These  results  indicate 
that  all  the  GFP-CD23  mutant  proteins  are  expressed  to  some  extent  in  HEK  293  cells. 
The  majority  of  the  stable  cell  lines  demonstrate  good  levels  of  protein  expression  and 
the  proteins  appear  to  remain  targeted  to  the  plasma  membrane.  This  is  demonstrated  by 
the  percentage  of  double  positive  cells,  shown  in  the  upper  right-hand  comer  of  each  dot 
plot  (Figure  4.4).  The  GFP-CD23bP3R  mutant  was  not  well  detected  with  the  anti- 
CD23  antibody  although  the  cells  did  demonstrate  GFP  fluorescence,  suggesting  the 
bP3R  protein  is  expressed  but  that  it  may  not  reach  the  plasma  membrane,  either  at  all 
or  in  a  conformation  not  recognised  by  the  anti-CD23  antibody  used. 
With  the  exception  of  the  data  collected  for  the  GFP-CD23bP3R  mutant,  the  FACS  data 
suggest  that  the  incorporation  of  these  amino  acid  changes  does  not  interfere  with  the 
expression  and  initial  targeting  of  these  fusion  proteins  to  the  plasma  membrane.  The 
121 mutant  fusion  proteins  must  also  be  folding  correctly  once  at  the  cell  surface  as  they  are 
being  efficiently  recognised  by  anti-CD23  antibodies,  demonstrating  that  the 
incorporation  of  the  amino  acid  changes  at  the  N-termini  does  not  affect  the 
extracellular  domain  structure  of  CD23. 
4.2.3  REAL  Tiw  VISUALISATION  OF  EACH  GFP-CD23  MUTANT 
PROTEIN  IN  HEK  293  CELLS;  THE  GFP-CD23BP3R  MuTANT 
PROTEIN  is  NOT  TARGETED  TO  THE  PLASMA  MEMBRANE, 
Stably-transfected  HEK  293  cells  expressing  the  individual  GFP-CD23  mutant  isoforms 
were  assessed  by  laser  scanning  confocal  microscopy.  In  each  case  live  cells  were 
examined  and  GFP-CD23  receptor  trafficking  was  monitored  over  a  fixed  time  period. 
Initial  experiments  were  performed  to  establish  if  each  of  the  GFP-CD23  mutant 
proteins  could  be  visualised  at  the  surface  of  HEK  293  cells.  Figure  4.5  illustrates  ten 
representative  images,  detailing  the  typical  initial  staining  pattern  observed  for  each  of 
the  GFP-CD23  mutant  proteins  in  HEK  293  cells.  Images  for  the  wild-type  CD23 
isoforms  have  previously  been  shown  in  Figure  3.4.  In  agreement  with  the  flow 
cytometric  data  reported  in  Figure  4.4,  these  images  illustrate  that  all  the  CD23  mutant 
proteins  are  routed  to  the  plasma  membrane,  with  the  exception  of  GFP-CD23bP3P, 
Confocal  analysis  shows  that  the  bP3R  protein  is  expressed  (as  was  expected  from  the 
flow  cytometry  data  shown  in  Figure  4.4);  however,  it  appears  trapped  within  the 
cytoplasm  of  these  cells,  with  no  evidence  of  plasma  membrane  localisation  ever 
observed. 
The  distribution  of  each  of  the  CD23  mutant  proteins  (with  the  exception  of  the  aY6F 
and  bP3R  proteins)  was  then  assessed  in  the  basal,  loaded  and  cross-linked  states  using 
the  previously  described  NIP  system  (Figure  3.5).  Entry  into  early  endosomes  and  thus 
the  endocytic  pathway  was  identified  by  co-localisation  with  transferrin-Texas  Red  dye 
(Tf-TxR). 
122 4.2.3A  INTERNALISATION  AND  INTRACELLULAR  TRAFFICKING  OF  GFP-CD23A 
MUTANTS;  ROLE  FOR  SERINE  7 
Wild-type  GFP-CD23a,  as  previously  shown  (Figure  3.4B),  demonstrates  a  distinct 
pattern  of  expression  with  the  majority  of  the  protein  being  localised  to  the  cell 
membrane  in  the  basal  and  loaded  states.  GFP-CD23a  was  found  to  co-localise  with  Tf- 
TxF,  only  under  cross-linked  conditions  after  the  receptor  had  been  occupied  with  NIP- 
specific  IgE  and  cross-linked  with  NIPIO-BSA  (Figure  3.7). 
GFP-CD23aS7A  was  observed  to  have  a  more  diffuse  pattern  of  staining,  with  most  of 
the  protein  demonstrating  an  internal  location  throughout  the  cytoplasm  of  the  HEK  293 
cells  (Figure  4.6).  A  comparatively  small  amount  of  this  protein  was  observed  at  the 
plasma  membrane;  however,  the  vast  majority  seemed  to  be  retained  within  the  cell 
cytoplasm.  There  was  evidence  of  concentrated  areas  of  fluorescence  within  the 
cytoplasm  in  the  basal  state.  Cross-linking  studies  were  performed  and  it  was  observed 
that  the  aS7A  proteins  located  at  the  plasma  membrane  could  be  driven  to  internalise 
only  after  the  addition  of  both  IgE  and  NIPIO-BSA,  as  demonstrated  by  the  appearance 
of  distinct  foci  of  fluorescence  along  the  membrane  and  some  areas  of  co-localisation 
within  the  cell  (Figure  4.6).  It  should  be  noted  that  co-localisation  of  this  mutant  with 
Tf-TxR  was  only  observed  after  cross-Iffiking,  with  the  position  of  some  of  the  green 
foci  of  fluorescence  correlating  with  some  of  the  Tf-TxR,  demonstrating  use  of  the 
endosomal  pathway. 
The  initial  distribution  of  the  GFP-CD23aS7D  mutant  in  the  basal  state  was  found  to  be 
comparable  to  that  of  wild-type  CD23a  in  a  loaded  or  cross-linked  state,  as  it  was 
observed  to  have  a  punctate  pattern  of  expression  (Figure  4.7).  The  extent  of  punctation 
was  observed  to  increase  on  loading  and  then  again  on  cross-linking.  Strikingly  this 
mutant  was  observed  to  show  internalisation  as  well  as  co-localisation  with  Tf-TxR  in 
all  three  states,  as  evident  from  the  presence  of  yellow  patches  in  each  of  ihe  three 
merged  images  shown.  Collectively  the  data  recorded  for  these  two  mutants  indicate  a 
role  for  serine  7  in  the  routing  of  the  CD23a  isoform  into  the  endosomal  pathway. 
The  conclusions  that  may  be  drawn  from  the  GFP-CD23aY6F  mutant  are  slightly  more 
ambiguous.  The  DNA  encoding  this  CD23  mutant  was  used  to  transfect  HEK  293  cells 
123 on  a  number  of  occasions  with  the  resultant  stably-transfected  cell  lines  always  found  to 
have  low  expression  levels  of  the  GFP-CD23aY6F  protein.  GFP-CD23aY6F  was 
initially  not  thought  to  reach  the  plasma  membrane,  however  this  was  demonstrated  to 
be  absolutely  the  case  (Figure  4.8).  Bright  field  imaging  was  used  to  record  the  location 
of  the  cells  and  confocal  microscopy  to  image  the  fluorescent  dye  and  thus  the  position 
of  the  GFP-CD23aY6F  proteins  within  these  cells.  These  images  illustrate  that  the  aY6F 
protein  does  appear  to  reach  the  plasma  membrane.  The  protein  expression  levels  were 
not  sufficient  to  enable  any  further  investigation  of  its  trafficking  patterns  following 
loading  and  cross-linking,  although  this  was  attempted  during  the  course  of  a  number  of 
experiments,  as  no  definitive  effects  were  observed  due  to  the  very  low  level  of  protein 
expression.  A  number  of  GFP-CD23aY6F  transfected  cell  lines  were  produced,  each  of 
which  demonstrated  uniformly  low  expression  levels.  Figures  4.5  and  4.8  summarise 
the  limited  data  obtained  for  this  CD23  mutant.  It  appears  that  the  aY6F  mutant  may 
have  a  punctate  expression  on  the  plasma  membrane  in  the  basal  state;  however,  it  is 
dMicult  to  say  so  conclusively  due  to  the  low  expression  levels  and  the  poor  quality 
images  recorded  as  a  direct  result  of  this. 
The  CD23aYS67FA  mutant  demonstrated  targeting  to  the  plasma  Membrane,  and 
concentrated  foci  of  fluorescence  within  certain  areas  along  the  plane  of  the  membrane 
in  the  basal  state  (Figure  4.9).  A  small  proportion  of  generalised  intracellular  staining 
was  also  observed  with  this  mutant  in  the  basal  state,  as  well  as  the  occasional  distinct 
focus  of  fluorescence  within  the  cell.  Loading  and  cross-linking  of  the  CD23aYS67FA 
mutant  did  result  in  an  increase  in  the  amount  of  punctate  distribution  on  the  plasma 
membrane.  The  aYS67FA  mutant  was  found  to  co-localise  with  Tf-TxR  and  this  was 
especially  evident  in  the  loaded  state,  where  much  of  the  co-localisation  was  found  on 
the  plasma  membrane,  presumably  due  to  the  receptor  assembling  into  distinct  areas 
along  the  cell  surface.  Directed  aYS67FA  internalisation  from  the  plasma  membrane 
after  loading  and  cross-finking  was  observed,  as  demonstrated  by  the  presence  of 
distinct  foci  of  fluorescence  within  the  cell.  In  contrast  to  the  bS5F  mutant  (Figure  4.12) 
where  much  of  the  plasma  membrane  protein  was  clearly  internalised,  much  of  the 
aYS67FA  protein  appeared  to  remain  within  the  plane  of  the  plasma  membrane. 
124 The  data  recorded  from  these  two  CD23a  mutants  coffectively  suggests  the  importance 
of  the  tyrosine  residue  at  position  6,  and  suggests  that  the  phosphorylation  state  of  this 
residue  may  play  a  role  in  CD23  trafficking. 
4.2.311  INTERNALISATION  AND  INTRACELLULAR  TRAFFICKING  OF  THE  GFP-CD23B 
MuTANTs;  A  ROLE  FOR  SERINE  5 
As  previously  discussed,  the  wild-type  CD23b  isoform,  as  with  wild-type  CD23a,  was 
shown  to  have  a  predominant  membrane  localisation  in  HEK  293  cells  (Figure  3.4). 
Loading  with  IgE  and  subsequent  cross-linking  with  NIPIO-BSA  did  result  in 
internalisation  of  the  CD23b  protein.  However,  co-localisation  with  Tf-TxR  was  not 
evident  in  any  of  the  experiments,  under  any  of  the  three  basal,  loaded  or  cross-linked 
conditions  (Figure  3.8).  Tbree  mutations  were  made  to  the  serine  located  at  position  5, 
resulting  in  the  generation  of  the  bS5A,  bS5D  and  bS5F  CD23  proteins.  Initial  studies 
demonstrated  that  all  three  of  these  mutants  were  able  to  locate  to  the  plasma  membrane 
(Figure  4-5),  although  characteristic  differences  were  observed  in  the  basal  expression 
patterns  shown  by  each  of  these  mutant  proteins,  both  in  comparison  to  the  wild-type 
CD23b  proteins  as  well  as  with  respect  to  each  other. 
Two  distinct  cell  populations  were  observed  with  the  bS5A  mutant.  The  first  was  found 
to  demonstrate  a  fairly  uniform  expression  throughout  the  cytoplasm  of  HEK  293  cells, 
with  a  limited  amount  of  CD23bS5A  protein  located  at  the  plasma  membrane  (Figure 
4.5  &  4.10A).  Loading  with  IgE  and  subsequent  cross-finking  with  NIPIO-BSA  resulted 
in  the  membrane-localised  staining  assuming  a  more  punctate  distribution,  some  of 
which  was  observed  to  enter  into  the  cell  and  co-localise  with  Tf-TxR  (Figure  4.10A). 
The  second  cell  population  was  observed  to  show  a  more  usual  pattern  of  staining  with 
much  of  the  GFP-CD23bS5A  protein  associated  with  the  cell  membrane,  or  located 
within  distinct  foci  of  fluorescence  within  the  cell.  This  population  was  found  to 
demonstrate  extensive  co-localisation  with  Tf-TxR  in  all  three  basal,  loaded  and  cross- 
linked  states.  Collectively  the  confocal  images  suggest  that  the  bS5A  protein  is  able  to 
undergo  directed  uptake  into  the  cell  and  co-localisation  with  Tf-TxR,  regardless  of 
whether  or  not  the  receptor  is  occupied  with  IgE  and/or  cross-linked  with  NIP-BSA. 
Further  transfection  experiment  would  have  to  be  performed  in  order  to  establish  which 
of  these  two  populations  was  the  true  expression  pattern  of  the  bS5A  mutant. 
125 The  bS5D  mutant  protein  demonstrated  the  presence  of  distinct  foci  of  fluorescence 
along  the  plasma  membrane  in  the  basal  state  (Figure  4.11).  As  observed  with  aS7D,  the 
bS5D  mutant  demonstrated  co-localisation  in  all  of  the  three  basal,  loaded  and  cross- 
linked  conditions,  indicating  that  these  mutants  were  able  to  enter  the  endocytic 
pathway,  regardless  of  whether  or  not  the  receptor  is  occupied  with  IgE  and/or  cross- 
linked  with  NIPio-BSA.  Together  these  proteins  indicate  the  importance  of  the  serine  at 
position  5  and  suggest  that  the  phosphorylation  state  of  this  residue  may  play  a  crucial 
role  in  the  trafficking  of  the  CD23b  isoform.  The  findings  from  the  third  serine 
mutation,  bS5F,  support  this  interpretation  finther. 
CD23  bS5F  showed  a  similar  pattern  of  expression  to  the  bS5D  mutant  and  there  was 
evidence  of  co-localisation  with  Tf-TxR  in  all  three,  basal,  loaded  and  cross-linked, 
states.  In  the  basal  state  there  was  substantial  evidence  of  co-localisation  both  at  the  cell 
surface  and  at  distinct  areas  within  the  cell.  Loading  with  IgE  and  then  cross-linking 
with  NIPIO-BSA  stimulated  an  increase  in  directed  uptake  of  CD23,  as  evident  initially 
by  an  increased  punctate  morphology  at  the  cell  surface  and  then  the  presence  of  more 
foci  of  fluorescence  within  the  cell  (Figure  4.12).  The  majority  of  the  fluorescence, 
originally  located  on  the  cell  surface,  was  observed  to  enter  into  the  cell.  The  results 
obtained  from  each  of  these  three  mutants  collectively  suggest  a  role  for  serine  5 
phosphorylation  in  the  regulation  of  directed  entry  of  CD23b  into  the  cell,  and  in  this 
cell  system,  co-localisation  with  Tf-TxR  in  the  endosomal  pathway.  The  wild-type 
GFP-CD23b  protein  was  never  observed  to  co-localise  with  Tf-TxR  under  any  of  the 
basal,  loaded  or  cross-linked  states  studied. 
4.2.3c  A  ROLE  FOR  THE  NPP  TRI-PEPTIDE  MOTIF 
The  NNP  tri-peptide  motif  in  the  cytoplasmic  tail  of  CD23b  is  believed  to  regulate 
movement  of  this  protein  into  the  phago-lysosomal  pathway  in  J774  cells,  and  for  this 
reason  these  amino  acids  were  also  targeted  in  this  mutagenesis  study.  As  demonstrated 
in  Figure  4.13  incorporation  of  the  bP3R  mutation  prevents  the  CD23b  isoform  from 
reaching  the  plasma  membrane  in  HEK  293  cells,  causing  this  protein  to  remain  trapped 
within  the  cell,  localised  in  distinct  regions  within  the  cytoplasm.  No  co-localisation 
was  observed  with  Tf-TxR  indicating  that  this  protein  is  located  in  areas  or  vesicles 
distinct  from  either  the  early  endosomes  or  indeed  the  endocytic  pathway.  Obviously 
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fact  that  there  was  no  surface  protein  to  be  loaded  or  cross-linked.  These  findings 
suggest  that  this  residue,  unlike  any  of  the  others  studied,  may  be  important  in  the  initial 
targeting  of  the  CD23b  isoform.  to  the  plasma  membrane,  in  so  much  that  mutation  of 
this  residue  actively  prevents  this  from  occurring. 
Unlike  bP3F,  mutation  of  the  neighbouring  proline  residue  to  arghline  (bP4R)  had  no 
effect  on  trafficking  of  the  CD23b  isoform  to  the  cell  membrane,  although  there  was  a 
marked  difference  between  this  protein  and  the  wild-type  GFP-CD23b  protein.  In 
contrast  to  the  wild-type  GFP-CD23b  protein  the  bP4R  protein  was  found  to 
demonstrate  both  concentration  of  fluorescence  on  the  membrane  and  internalisation 
within  the  cell  in  the  basal  state,  (Figure  4.14).  Distinct  foci  of  fluorescence  were  also 
observed  within  the  cell,  indicating  marked  internalisation  in  all  three,  basal,  loaded  and 
cross-linked  conditions.  Co-localisation  was  also  observed  between  this  protein  and  Tf- 
TxR  (unlike  wild-type  GFP-CD23b),  in  all  three,  basal,  loaded  and  cross-linked  states. 
These  results  indicate  this  residue,  like  the  serine  at  position  5,  to  be  important  in  the 
internalisation  and  directed  uptake  of  CD23b  into  the  cell. 
As  has  been  previously  described  for  the  bP4R  protein,  the  bN2K  mutant  was  also 
shown  to  demonstrate  extensive  co-localisation  with  Tf-TxR  in  each  of  the  basal,  loaded 
and  cross-linked  states,  with  internalised  distinct  foci  of  fluorescence  present  in  each  of 
these  conditions.  Punctate  staining  at  the  plasma  membrane  was  increased  on  loading 
with  IgE  and  subsequent  cross-linking  with  NIP  10-13SA  (Figure  4.15). 
The  data  assembled  from  these  three  mutants  collectively  indicate  that  modification  of 
asparagine  2  and  proline  4,  within  the  NPP  putative  phagocytic  targeting  motif,  yields 
CD23  proteins  readily  able  to  enter  a  recycling,  and/or  endocytic  pathway  in  HEK  293 
cells.  These  results  are  in  stark  contrast  to  those  collected  from  the  wild-type  CD23b 
isoform,  as  it  was  never  observed  to  co-localise  with  Tf-TxR  under  any  conditions  in 
HEK  293  cells. 
127 4.2.4  MUTATION  OF  THE  N-TERMINUS  OF  CD23  AFFECTS  PROTEOLYTIC 
CLEAVAGE  FROM  THE  CELL  SURFACE 
Membrane-associated  or  full-length  CD23  can  be  proteolytically  cleaved  from  the  cell 
surface  to  produce  a  number  of  soluble  CD23  fragments  (sCD23),  with  the  enzymatic 
cleavage  sites  located  within  the  stalk  region  of  fiffl-length  CD23.  Binding  of  IgE  has 
been  shown  to  protect  CD23  from  cleavage  [Lee  et  al.,  1987],  as  have  agents  that 
prevent  CD23  glycosylation  [Delespesse  et  al.,  1989].  Having  generated  each  of  the  N- 
termini  mutant  CD23  proteins  for  the  trafficking  studies  it  was  interesting  to  see  if  any 
of  these  had  an  effect  on  CD23  shedding  from  the  cell  surface.  An  OptEIATm  Human 
sCD23  ELISA  kit  (Phanningen)  was  used  to  measure  the  amount  of  sCD23  present  in 
the  sera  collected  from  each  of  the  stably-transfected  HEK  293  cells,  as  per  the 
manufacturer's  instructions  (section  2.2.7H).  The  supernatants  were  collected  from 
nearly  confluent  flasks  of  stably-transfected  cells  that  had  been  cultured  in  the  same 
media  over  a4  day  period.  Figure  4.16  illustrates  the  results.  Firstly,  there  was  a  marked 
difference  in  shedding  patterns  of  the  CD23  isoforms.  The  GFP-CD23a  isoform  was 
shown  to  be  readily  cleaved  from  the  cell  surface,  whilst  the  GFP-CD23b  isoform  was 
observed  to  show  miniml,  if  any,  shedding  from  the  cell  surface.  The  extent  of  release 
of  each  of  the  GFP-CD23  mutants  was  then  compared  to  the  wild-type  GFP-CD23 
protein  isoforms.  The  exact  figures  should  not  be  compared  directly,  but  rather  trends 
drawn  from  the  overall  results. 
Each  of  the  CD23a  mutants  illustrated  a  decrease  in  sCD23  cleavage  in  comparison  to 
the  CD23a  isoform.  The  aS7A  and  aS7D  mutants  illustrated  a  marked  decrease  in 
sCD23  shedding,  and  cannot  be  explained  by.  protein  expression  levels  as  these 
appeared  to  be  comparable  in  each  case.  The  aY6F  mutant  also  indicated  a  marked 
decrease  in  shedding,  however  as  the  expression  levels  of  this  mutant  were  uniformly 
low  it  is  not  surprising  that  little  sCD23  was  detected  in  the  supernatant  collected  from 
these  cells.  The  aYS67FA  protein  was  also  observed  to  have  around  a  50%  decrease  in 
sCD23  shedding.  In  contrast  to  the  CD23a  mutants,  some  of  the  CD23b  mutants  were 
observed  to  demonstrate  a  marked  increase  in  CD23  shedding.  The  most  striking  result 
observed  was  for  the  bS5A  protein,  as  it  showed  a  huge  increase  in  CD23b  shedding 
(115  fold)  from  the  cell  surface.  The  bS5D  mutant  protein  also  demonstrated  a 
noticeable  increase  in  CD23b  cleavage  from  the  cell  surface,  whiIst  the  remainder  of  the 
128 mutants  demonstrated  low-level  cleavage,  very  much  like  the  wild-type  CD23b  isoform. 
The  expression  levels  of  each  of  these  CD23b  proteins  appeared  to  be  generally  similar 
(with  the  exception  of  MR)  and  cannot  therefore  explain  the  vast  differences  in  the 
amounts  of  sCD23  protein  released  from  the  HEK  293  cells.  It  should  be  noted  that  the 
most  interesting  results  were  recorded  primarily  from  those  mutants  illustrating  very 
different  trafficking  patterns  in  comparison  to  the  wild-type  proteins  in  the  confocal 
studies. 
4.2.5  ExPRESSION  OF  GFP-CD23  FusION  PROTEINS  IN  B  LYWHOCYTES 
The  ultimate  goal  of  the  trafficking  studies  discussed  thus  far  was  to  analyse  the 
movement  of  the  CD23  protein  isoforms  in  their  native  cell  type,  the  B  lymphocyte. 
However  B  cells,  as  is  the  case  with  most  mammalian  cell  fines,  are  generally  very 
sensitive  to  manipulation  and  thus  not  the  easiest  cells  to  work  with  when  trying  to 
generate  stably  transfected  cells  expressing  a  particular  protein  of  interest.  The  majority 
of  cultured  B  cell  fines  also  grow  as  free  floating  cells  in  suspension,  posing  a  second 
problem  as  to  how  these  cells  could  be  visualised  using  the  confocal  microscope  should 
any  transfection  method  be  successful. 
The  Raji  A  cell  line  was  chosen  for  this  investigation  for  a  number  of  reasons.  Firstly, 
Raji  A  cells  are  an  adherent,  immature  B  cell  line  isolated  from  a  suspension  culture  of 
an  established  Burkitt's  Lymphoma  cell  line  (Raji)  [Nyormoi,  et  al.,  1972].  These  cells 
express  endogenous  CD23  proteins  and  therefore  must  possess  all  the  necessary 
equipment  and  protein  intermediates  to  enable  the  GFP-CD23  trafficking  to  occur  very 
much  as  CD23  trafficking  would  in  the  real  situation.  Secondly,  the  Raji  A  cell  line  was 
isolated  for  its  adhesion  properties,  enabling  this  cell  line,  unlike  the  parent  Raji  fine,  to 
be  routinely  cultured  in  monolayers.  These  cells  therefore  provide  all  the  advantages  of 
a  normal  B  cell  line  with  the  added  bonus  of  their  ease  of  use  for  investigation  using  the 
confocal  microscope. 
4.2.5A  GENERATION  OF  G418-RESISTANT  RAJI  A  CELLS  EXPRESSING  EACH  OF  THE 
WILD-TYPE  GFP-CD23  FusiON  PROTEIN  ISOFORMS 
A  number  of  transfection  protocols  were  initially  performed  in  an  attempt  to  generate 
stably  transfected  Raji  A  cells  expressing  each  of  the  wild-type  GFP-CD23  proteins. 
129 Electroporation  was  found  to  be  the  only  successful  means  of  transfection,  but  the 
results  obtained  were  by  no  means  ideal,  with  the  technique  often  inducing  upwards  of 
95%  cell  death.  The  cells  subsequently  took  longer  to  recover  and  resume  normal 
growth  rates. 
RaJi  A  cells  were  electroporated  with  pcDNA3.1+  constructs  encoding  each  of  the  wild- 
type  GFP-CD23  protein  isoforms,  as  per  the  protocol  detailed  in  section  2.2.6B.  After  7- 
8  weeks  G418-resistant  cell  fines  finally  emerged  and  these  were  assessed  for  CD23 
protein  expression  by  flow  cytometry.  The  cells  were  analysed  for  GFP  fluorescence 
(FL-1)  as  well  as  the  presence  of  CD23  proteins  using  an  anti-CD23-PE  conjugated 
antibody  (FL-2).  These  results  indicate  that  both  the  GFP-CD23  protein  isoforms  are 
expressed  to  some  extent  in  Raji  A  cells.  Figure  4.17  shows  the  results,  illustrated  as  dot 
plots.  The  stable  cell  line  expressing  GFP-CD23a  demonstrated  lower  levels  of  protein 
expression,  however  the  results  do  indicate  that  both  proteins  did  appear  to  remain 
targeted  to  the  plasma  membrane.  This  is  demonstrated  by  the  percentage  of  double 
positive  cells,  shown  in  the  upper  right-hand  comer  of  each  dot  plot.  The  FL-2  levels  in 
each  instance  were  expected  to  be  higher  than  the  FL-1  levels,  purely  due  to  the 
endogenous  CD23  expressed  at  the  surface,  which  would  also  be  detected  by  the  anti- 
CD23  antibody.  The  cell  fine  expressing  GFP-CD23b  was  found  to  have  a  number  of 
cells  that  were  positive  only  for  GFP.  This  can  be  explained  by  the  fact  that  the  flow 
cytometer  will,  to  some  extent,  detect  the  presence  of  GFP-tagged  proteins  within  the 
cell  as  well  as  those  at  the  cell  surface.  These  cells  may  have  considerably  greater 
amounts  of  GFP-CD23  located  within  the  cell  than  CD23  on  the  cell  surface,  GFP- 
tagged  or  otherwise. 
4.2.511  REAL  TIME  VISUALISATION  OF  THE  WILD-TYPE  GFP-CD23  PROTEINS  IN 
RAji  A  CELLS 
The  stably-transfected  cell  lines  expressing  the  individual  wild-type  GFP-CD23 
isoforms  were  assessed  by  laser  scanning  confocal  microscopy.  Initial  experiments  were 
performed  to  obtain  information  on  the  expression  levels  of  each  protein  and  to  confirm 
that  both  these  GFP-CD23  protein  isoforms,  could  be  visualised  at  the  surface  of  Raii  A 
cells.  Figure  4.18  shows  representative  images,  detailing  the  typical  initial  staining 
patterns  observed  for  each  of  the  wfld-type  GFP-CD23  isoforms.  In  agreement  with  the 
130 flow  cytometric  data  (Figure  4.17),  these  images  demonstrate  the  GFP-CD23b  proteins 
were  routed  to  the  plasma  membrane,  whilst  the  expression  levels  of  GFP-CD23a  were 
too  low  to  confirm  plasma  membrane  expression.  A  bright  field  image  has  also  been 
included  for  the  CD23a  isoform.  in  order  to  identify  the  location  and  indeed  presence  of 
the  RaJi  A  cells,  due  to  the  fact  the  fluorescent  signal  was  weak.  The  results  clearly 
show  that  the  stably-transfected  cell  line  expressing  the  GFP-CD23a  isoform.  had  very 
low  levels  of  GFP-tagged  CD23  protein  (as  was  predicted  to  be  the  case  from  the  flow 
cytometric  data),  and  was  therefore  unsuitable  for  finther  trafficking  studies.  However, 
the  GFP-CD23b  isofonn  was  expressed  at  reasonable  levels  and  this  stably-transfected 
cell  fine  was  subsequently  used  to  monitor  the  intracellular  trafficking  of  GFP-CD23b 
in  Raji A  cells  in  a  basal,  loaded  and  cross-linked  state  using  the  previously  described 
NIP  system  (Figure  3.5).  Another  protein  conjugate  was  also  incorporated  (Figure  4.19) 
serving  to  enhance  the  NIP  system  addressing  the  question  as  to  whether  the  extent  of 
CD23  cross-linking/oligomerisation  at  the  cell  surface  has  an  impact  on  CD23  uptake 
from  the  plasma  membrane.  This  enhanced  NIP  system  was  used  in  the  trafficking 
studies  performed  with  GFP-CD23b  in  Raji  A  cells,  as  discussed  below. 
4.2.5c  GFP-CD23B  UTILISES  THE  ENDOCVTIC  PATHWAY  IN  RAm  A  CELLS  WHEN 
LOADED  WITH  IGE  AND  WHEN  LOADED  AND  SUBSEQUENTLY  CRoSS-LINKED 
WITH  NIP-BSA 
Figure  4.20  shows  the  results  observed  in  the  GFP-CD23b  and  Tf-TxR  co-localisation 
studies  performed  in  Raji  A  cells.  Representative  image  sets  are  shown  for  each 
condition;  (i)  basal,  (H)  loaded,  (iii)  cross-linked  with  NIP10-13SA  and  (iv)  'ligated'  with 
NIP,  -Insulin.  In  the  basal  state  GFP-CD23b  was  found  to  be  predominantly  located  at 
the  Plasma  membrane,  with  some  movement  observed  within  the  plane  of  the 
membrane  when  the  images  were  run  together  as  a  'movie'.  After  loading  with  NIP- 
specific  IgE  antibody,  some  of  the  GFP-CD23b  proteins  were  found  to  localise  towards 
distinct  areas  on  the  plasma  membrane  and  illustrate  directed  uptake  into  the  cell. 
However  it  was  not  until  the  receptor  was  cross-linked  with  NIP,  o-BSA  that  marked 
uptake  of  the  protein  was  observed  from  the  cell  surface.  This  uptake  was  noted  not 
only  as  an  increase  in  the  amount  of  distinct  patches  present  within  the  cytoplasm,  but 
also  as  a  marked  decrease  in  the  amount  of  GFP-CD23b  present  at  the  cell  surface.  In 
contrast  to  this,  cross-linking  with  NIP,  -Insulin  did  not  cause  much  receptor  uptake, 
131 with  much  of  the  CD23  protein  remaining  localised  to  the  plasma  membrane,  however 
areas  of  concentration  along  the  membrane  were  evidence. 
Minimal  co-localisation  of  the  cell  surface  receptor  with  Tf-TxR  was  observed  in  the 
basal  state,  primarily  within  the  cell.  In  the  loaded  state,  there  was  distinct  evidence  of 
yellow  patches  moving  into  the  cell,  suggesting  the  receptor  to  co-localise  with  Tf-TxR 
when  loaded  with  natural  ligand.  Cross-linking  with  NIPjo-BSA  appeared  to  cause  more 
directed  uptake  of  the  GFP-CD23b  protein  into  the  cytoplasm  and  there  was  some 
evidence  of  yellow  patching  within  the  cell  and  extensive  patching  at  the  cell  surface. 
Cross-linking  with  NIP,  -Insulin  was  found  to  result  in  some  uptake  from  the  cell 
surface,  comparable  to  the  loaded  state,  with  much  of  the  CD23  protein  remaining  in 
concentrated  patches  on  the  plasma  membrane. 
4.2.5D  GFP-CD23B  UTILISES  THE  PHAGOCYTIC  PATHWAY  IN  RAil  A  CELLS  WHEN 
LOADED  WITH  IGE  AND  WHEN  LOADED  WITH  IGE  AND  SUBSEQUENTLY 
CROSS-LINKED  WITH  NIP,  O-BSA 
Figure  4.21  shows  the  results  observed  in  the  GFP-CD23b  and  LysoTracker  co- 
localisation  studies  in  RaJi  A  cells.  Representative  image  sets  are  shown  for  each 
condition;  (i)  basal,  (H)  loaded,  (ifi)  cross-linked  with  NIP,  o-BSA  and  (iv)  'ligated'  with 
NIPi-Insulin.  In  the  basal  state  GFP-CD23b  was  found  to  be  predominantly  located  at 
the  plasma  membrane,  with  some  movement  observed  within  the  plane  of  the 
membrane  when  the  images  were  run  together  as  a  'movie.  After  loading  with  NIP- 
specific  IgE  antibody,  the  GFP-CD23b  proteins  were  found  to  localise  towards  distinct 
areas  on  the  plasma  membrane,  showing  regions  of  concentrated  fluorescence,  classical 
of  the  receptor  gathering  into  coated  pits.  Some  evidence  of  cellular  uptake  was  also 
observed.  However  it  was  not  until  the  receptor  was  cross-linked  with  NIPJO-BSA  that 
marked  uptake  of  the  protein  was  observed  from  the  cell  surface.  This  uptake  was  noted 
as  not  only  an  increase  in  the  amount  of  distinct  patches  present  within  the  cytoplasm, 
but  also  by  a  decrease  in  the  amount  of  GFP-CD23b  present  at  the  cell  surface.  In 
contrast  to  this,  cross-linking  with  NIP,  -Insulin  resulted  in  little  receptor  uptake  into  the 
cell,  with  the  vast  majority  of  the  protein  remaining  localised  to  distinct  areas  on  the 
plasma  membrane. 
132 Co-localisation  of  the  cell  surface  receptor  with  LysoTracker  Red  was  observed  in  the 
basal,  loaded  and  cross-linked  (NIPIO-BSA)  states,  primarily  located  within  the  cell.  The 
presence  of  yellow  patches,  both  at  the  cell  surface,  and  within  the  cell,  was  most 
evident  in  the  loaded  state,  suggesting  the  receptor  is  able  to  co-localise  with 
LysoTracker  Red.  Cross-linking  with  NIP,  o-BSA  appeared  to  cause  directed  uptake  of 
the  GFP-CD23b  protein  into  the  cytoplasm  and  there  was  some  evidence  of  yellow 
patching  within  the  cell,  although  some  internalised  patches  did  appear  to  remain  green. 
Cross-linking  with  NIP,  -Insulin  resulted  in  patching  at  the  cell  surface,  but  very  little  (if 
any)  uptake  into  the  cell  with  no  co-localisation  observed.  Collectively,  the  results 
gathered  from  the  two  previous  sections  suggest  that  the  CD23b  isoform.  may  require 
extensive  oligomerisation  at  the  cell  surface,  achieved  in  these  experimental  conditions 
only  after  cross-finking  with  NIPIO-BSA  protein  conjugates,  as  stimulus  for  directed 
uptake  into  the  cell.  No  data  was  available  for  the  GFP-CD23a  isoform  as  the 
expression  levels  were  too  low  to  work  with. 
4.2.6  ANALysis  OF  GFP-CD23  MuTANTs  iN  RAm  A  CELLS 
Each  of  the  CD23  mutant  protein  constructs,  described  in  section  4.2.1,  were  used  to 
transfect  Raji  A  ceRs  in  an  attempt  to  analyse  the  trafficking  of  these  proteins  in  B 
lymphocytes. 
4.2.6A  GENERATION  OF  G418-RESISTANT  RAii  A  CELLS  EXPRESSING  EACH  OF  THE 
GFP-CD23  MUTANT  FUSION  PROTEINS 
Raji  A  cells  were  electroporated  (section  2.2.6B)  with  pcDNA3.1+  constructs  encoding 
each  of  the  mutated  GFP-CD23  proteins  (Figure  4.1  and  4.2).  Aller  7-8  weeks  G418- 
resistant  cell  lines  finally  emerged  and  were  assessed  for  CD23  protein  expression  by 
flow  cytometry.  The  cells  were  analysed  for  GFP  fluorescence  (FL-1)  as  well  as  the 
presence  of  CD23  proteins  using  an  anti-CD23-PE  conjugated  antibody  (FL-2).  Figures 
4.22  and  4.23  show  the  results  for  the  GFP-CD23a  and  GFP-CD23b  mutants 
respectively.  The  results  indicate  that  all  the  wild-type  GFP-CD23  and  mutant  proteins 
are  expressed  to  some  extent  in  RaJi  A  cells,  with  the  majority  of  the  stable  cell  lines 
demonstrating  low  levels  of  protein  expression.  However,  the  proteins  did  appear  to 
remain  targeted  to  the  plasma  membrane  in  the  majority  of  cases,  as  demonstrated  by 
the  percentage  of  double  positive  cells,  shown  in  the  upper  right-hand  comer  of  each  dot 
133 plot.  The  FL-2  levels  in  each  instance  were  expected  to  be  higher  than  the  FL-1  levels, 
due  to  the  endogenous  CD23  expressed  at  the  surface. 
4.2.613  REAL  TIME  VISUALISATION  OF  EACH  GFP-CD23  MUTANT  PROTEIN  IN  RAii  A 
CELLS 
Each  of  the  stably-transfected  ceU  lines  expressing  the  individual  GFP-CD23  mutant 
CD23  proteins  were  assessed  by  laser  scanning  confocal  microscopy.  Initial 
experiments  were  performed  to  obtain  information  on  the  expression  levels  of  each  of 
the  mutant  proteins  and  to  confirm  that  aU  these  GFP-CD23  proteins  could  be  visualised 
at  the  surface  of  Raji  A  ceUs.  Figures  4.24  and  4.25  show  representative  images, 
detailing  the  typical  initial  staining  patterns  observed  for  each  of  the  GFP-CD23a  and 
GFP-CD23b  mutants  in  the  basal  state.  In  agreement  with  the  flow  cytometric  data 
(Figures  4.22  and  4.23),  these  images  illustrate  that  all  the  GFP-CD23  proteins  shown  in 
these  figures  were  indeed  routed  to  the  plasma  membrane.  A  bright  field  image  has  also 
been  included  in  order  to  identify  the  location  and  indeed  presence  of  the  Raji  A  cells, 
due  to  the  fact  the  fluorescent  signal  was  weak  in  many  of  the  stablyý-transfected  cell 
lines. 
The  expression  levels  observed  in  Raji  A  cells  were  generally  much  poorer  than  those 
observed  using  the  HEK  293  cell  system,  however  in  many  cases  the  resultant  initial 
basal  staining  patterns  of  each  mutant  protein  were  similar.  For  example  the  aY6F  and 
aYS67FA  mutants  indicate  a  predominantly  punctate  membrane  distribution,  as  was 
found  to  be  the  case  in  the  HEK  293  cells,  whilst  the  bS5D  and  bS5F  mutants 
demonstrate  the  presence  of  distinct  foci  of  fluorescence  within  both  cell  types  in  the 
basal  state.  The  aS7D,  bP4R  and  bN2K  expression  patterns  are  also  similar  in  both  cell 
types.  The  Raji  A  aS7A  mutant  shows  a  less  diffuse  cytoplasmic  staining  pattern  than 
was  observed  in  the  HEK  293  cells,  whilst  the  Raji  A  bS5A  mutants  illustrate  a  staining 
pattern  more  like  that  observed  in  the  second  cell  population  described  in  Figure  4.10, 
similar  to  that  observed  for  the  bS5D  and  bS5F  mutants  in  both  cell  types. 
Limited  data  were  collected  for  the  GFP-CD23bP3R  mutant  (Figure  4.26),  again  due  to 
low  expression  levels.  It  was  difficult  to  draw  deýinitive  conclusions  concerning  the 
location  of  this  mutant  protein  as  two  expression  patterns  were  observed.  In  most  of  the 
134 cells  analysed  this  mutant  was  predominantly  contained  within  the  cytoplasm  (Figure 
4.26A,  as  was  found  to  be  the  case  in  HEK  293  cells),  with  a  few  Raji  A  cells  shown  to 
express  the  mutant  protein  at  reasonable  levels  at  the  cell  surface  (Figure  4.26  B).  In 
contrast  to  the  results  observed  with  the  HEK  293  cell  system,  these  results  may  be 
explained  as  a  direct  effect  of  the  protein  expression  levels  observed  in  the  Raji  A 
stably-transfected  cells.  Cells  expressing  less  protein  may  simply  have  less  at  the  cell 
surface  and  therefore  demonstrate  very  weak  fluorescence  at  the  plasma  membrane 
rather  than  none  at  all.  This  theory  is  supported  by  the  flow  cytometric;  data  present  in 
Figure  4.23  and  the  confocal  date  presented  in  Figure  4.26A,  however,  further 
investigation  would  be  required  to  clarify  these  findings  in  order  to  unequivocally 
establish  the  true  expression  pattern  of  the  bP3R  mutant  in  Raji  A  cells. 
Initial  attempts  were  made  to  investigate  CD23  trafficking  in  RaJi  A  cells.  Entry  into 
early  endosomes  and  thus  the  endocytic  pathway  was  investigated  by  co-localisation 
studies  with  transferrin-Texas  Red  dye  (Tf-TxR).  Figures  5.27-5-30  summarise  the 
results  obtained.  The  results  indicate  that  the  aS7A,  aS7D,  bS5A,  bS5D,  and  bS5F 
mutants  are  able  to  co-localise  with  Tf-TxR  in  RaJi  A  cells  to  some  extent  in  the  basal 
state.  The  findings  were  less  clear  for  the  aY6F  and  aYS67FA  mutants  due  to  the  poorer 
expression  levels  demonstrated  by  these  proteins.  Loading  and  cross-linking  studies 
were  not  performed  for  these  stably-transfected  Raji  A  cells  expressing  the  GFP-CD23 
mutants  as  the  percentage  of  cells  expressing  good  levels  of  the  GFP-CD23  proteins 
were  generally  very  low.  The  limited  timescale  attached  to  this  project  did  not  permit 
either  the  generation  of  finiher  stably-transfected  cell  lines,  or  the  selection  (via  FACs 
sorting,  2.2.2B)  and  propagation  of  individual  cells  illustrating  reasonable  expression 
levels. 
4.3  DISCUSSION 
The  studies  presented  here,  like  those  already  discussed  in  chapter  3,  demonstrate  the 
usefulness  of  GFP-CD23  fusion  proteins,  the  NIP  system  and  the  HEK  293  cell  line  in 
the  analysis  of  receptor-mediated  (endocytic)  trafficking.  As  a  direct  extension  to  this 
work,  this  chapter  also  details  some  preliminary  studies  of  CD23  trafficking  in  aB  cell 
line.  The  principal  findings  to  emerge  from  the  research  described  in  this  chapter  are  the 
135 importance  of  the  serine  residues  located  at  the  unique  N-terminus  in  each  of  the  CD23 
proteins,  as  well  as  the  NPP  motif  in  the  CD23b  isoform. 
The  trafficking  pathways  of  the  wild-type  CD23  isofonns  were  studied  in  detail  in 
chapter  3.  In  summary,  the  wild-type  CD23  isoforms,  were  found  to  demonstrate 
minimal  (if  any)  co-localisation  with  Tf-TxR  in  either  the  basal  or  loaded  state  (Figure 
3.7  and  3.8),  and  only  the  CD23a.  isoform,  was  found  to  readily  enter  the  endocytic 
pathway  after  cross-linking  with  IgE  and  polyvalent  antigen.  The  CD23b  isoform.  was 
not  found  to  enter  the  endocytic  pathway  in  HEK  293  cells  in  any  of  the  basal,  loaded  or 
cross-linked  states.  In  contrast,  this  chapter  demonstrates  that  many  of  the  N-terminal 
CD23  mutant  proteins  were  found  to  have  very  different  trafficking  patterns,  with  many 
demonstrating  both  internalisation  and  co-localisation  with  Tf-TxR  in  the  basal  state. 
One  plausible  explanation  for  the  data  observed  is  that  the  presence  of  the  aspartate 
residue  mimics  the  effect  of  phosphorylation  of  the  original  serine  residue  and 
stimulates  directed  uptake  of  CD23  into  the  endosomal  pathway,  via  a  means  of 
receptor-mediated  endocytosis.  This  hypothesis  suggests  the  phosphorylation  state  of 
the  CD23  molecule  may  be  an  important  regulator  in  its  sorting  from  the  cell  surface. 
Support  for  this  interpretation  is  provided  by  the  serine  to  alanine  mutations.  These 
mutant  proteins  were  observed  to  demonstrate  a  somewhat  diffuse  cellular  staining 
pattern  throughout  the  cytoplasm  of  HEK  293  cells,  with  the  bS5A  mutant  illustrating 
two  different  expression  patterns.  This  mutation  alters  the  serine  residue,  preventing  its 
possible  phosphorylation.  This  suggests  that  CD23  trafficking  becomes  random  in  the 
absence  of  this  important  serine  residue  at  the  N-terminal  tail  in  both  isoforms  and 
poses  the  question  of  its  importance  in  the  initial  targeting  of  these  proteins  to  the 
plasma  Membrane.  The  images  collected  support  the  interpretation  that  the  majority  of 
the  aS7A  CD23  protein  never  reaches  the  membrane,  but  rather  accumulates  in  the 
cytoplasm  instead.  This  suggests  a  role  for  the  phosphorylation  of  the  serine  residue  in 
the  initial  targeting  of  the  CD23  isoform  to  the  cell  surface.  Although  there  are  no  data 
formally  demonstrating  the  phosphorylation  of  the  N-terminal  serine  residues  in  either 
of  the  two  CD23  proteins,  the  data  from  the  aS7D  and  aS5D  mutants  suggest  that  a 
negatively  charged  moiety  at  these  points  facilitates  movement  into  the  same  pathway 
as  Tf-TxR.  Further  support  for  this  conclusion  is  available  from  the  data  collected  frorn 
136 the  bS5F  mutant  protein.  Traditionally  this  type  of  mutation  (as  is  true  for  the  Y-to-F 
mutation)  mimics  a  constitutively  phosphorylated  receptor  molecule  by  incorporating 
the  large  phenylahmine  side  chain  (although  the  residue  is  not  actually  phosphorylated 
itself).  This  protein  was  demonstrated  to  have  a  very  similar  trafficking  pathway  to  that 
observed  for  the  bS5D  mutant,  only  demonstrating  more  intemalisation  within  the  cell. 
These  data  suggest  that  the  CD23  molecule  may  favour  internalisation  if  the  N-terminal 
serine  residue  remains  phosphorylated.  This  routing  is  presumably  targeted  at  low  pH 
compartments,  or  in  class  II  MIHC+  cells,  towards  vesicles  containing  newly  synthesised 
or  re-cycling  MHC  class  11  proteins.  This  conclusion  assumes  that  both  the  CD23a,  and 
CD23b  isoforms  are  able  to  traffic  via  the  endosomal  pathway,  unless  actively  routed 
via  another  sorting  pathway.  One  consideration  which  must  been  taken  into  account  is 
HEK  293  cells  do  not  possess  a  classical  phagocytic  pathway  therefore  the  CD23b 
mutants  may  have  been  routed  via  the  endosomal  pathway  as  default.  The  only  way  to 
investigate  this  further  would  be  to  perform  similar  experiments  in  a  cell  line  capable  of 
phagocytosis. 
Mutation  of  the  NPP  motif  in  the  CD23b  isoform.  provided  valuable  mutants  (bN2K, 
and  bP4R)  able  to  enter  into  the  endocytic  pathway,  as  determined  by  co-localisation 
with  Tf-TxR,  in  sharp  contrast  to  the  wild-type  CD23b  proteins.  it  may  be  that  these 
CD23b  mutants,  likewise  with  the  bS5D  and  bS5F  proteins,  only  enter  the  endosomal 
pathway  in  this  cell  system  as  a  default  internalisation  pathway,  due  to  the  fact  that  the 
classical  phagocytic  pathway  is  not  available  in  HEK  293  cells.  Ideally,  these  proteins 
should  all  be  expressed  and  tested  in  aB  cell  fine,  enabling  further  investigation  of  the 
functional  importance  of  these  amino  acid  changes  and  the  ability  of  these  mutants  to 
swap  internalisation  pathways  in  a  natural  host  cell  type,  before  this  hypothesis  can  be 
tested  finiher. 
Collectively,  the  results  point  to  the  importance  of  the  phosphorylation  state  of  a 
number  of  key  residues  effecting  CD23  protein  trafficking.  The  question  remains  as  to 
which  kinase  (or  kinases)  may  be  involved  in  the  phosphorylation  of  these  serine 
residues  at  position  7  and  5  in  the  CD23a  and  CD23b  protein  isoforms  respectively. 
This  also  leads  to  the  question  of  how  the  phosphorylation  event,  should  it  take  place, 
be  interpreted  by  the  intracellular  trafficking  machinery.  It  is  likely  that  other  proteins 
137 are  recruited  to  facilitate  the  internalisation  of  the  CD23  proteins  from  the  cell  surface. 
This  proposed  model  is  discussed  further,  in  the  context  of  known  molecular  sorting 
pathways,  in  the  main  conclusion  and  discussion  chapter. 
The  Raji A  cell  line  was  a  natural  choice  in  order  to  take  the  CD23  trafficking  studies 
into  B  lymphocytes  due  to  the  fact  these  cells  are  an  adherent  B  cell  line  (facilitating 
growth  on  glass  cover-slips  and  easy  confocal  analysis)  and  they  also  express 
endogenous  CD23  proteins.  However,  obtaining  stably-transfected  Raji  A  cell  lines 
expressing  each  of  the  GFP-CD23  fusion  proteins  was  somewhat  troublesome,  often 
resulting  in  stables  with  either  uniformly  low  protein  expression  levels  or  mixed 
populations  illustrating  different  levels  of  protein  expression.  These  findings  indicate 
that  the  selection  process  requires  revision,  possibly  incorporating  a  FACs  sorting  step 
to  effectively  'handpick'  cells  expressing  the  desired  level  of  the  fusion  protein  of 
interest.  These  cells  could  then  be  maintained  under  selection  and  cultured  as  usual, 
serving  to  generate  stably-transfected  cell  lines  demonstrating  useful,  and  uniform 
levels  of  protein  expression. 
The  data  collected  from  the  stably-transfected  Raji  A  cell  lines  generated  in  this  work 
was  limited  as  a  direct  result  of  the  poor  expression  levels.  The  wild-type  GFP-CD23b 
isoform  was  found  to  co-localise  with  both  Tf-TxR  and  more  so  with  LysoTracker  Red 
dye,  suggesting  this  isoform  may  use  both  the  endocytic  and  phagocytic  route  of 
cellular  entry  in  Raji  A  cells.  The  GFP-CD23a  isoform  was  not  studied  in  co- 
localisation  experiments  due  to  low  protein  expression  levels.  These  initial  studies 
demonstrate  somewhat  complicated  results,  suggesting  the  CD23b  isoform  to  be  able  to 
utilise  both  the  endocytic  and  phagocytic  pathway  in  Raji  A  cells.  These  findings,  and 
the  rest  of  the  results  presented  in  this  chapter,  are  discussed  further  in  the  main 
conclusion  chapter. 
Basal  trafficking  studies  with  Tf-TxR  were  also  performed  for  each  of  the  mutant 
proteins,  however  this  incomplete  data  set  cannot  neither  fully  support,  nor  refute  the 
information  gained  from  the  same  trafficking  studies  performed  in  HEK  293  cells. 
However,  regardless  of  the  problems  encountered,  many  of  the  results  observed  for  the 
CD23  mutant  proteins  support  those  observed  for  basal  trafficking  of  the  same  mutants 
138 in  HEK  293  cells.  These  findings  indicate  two  things;  firstly  they  provide  ftirther 
evidence  supporting  the  use  of  HEK  293  cells  as  an  initial  model  system  to  study 
receptor-mediated  endocytic  trafficking  and  secondly  they  indicate  the  Raji  A  cells  to  be 
a  useful  system,  should  the  protocol  be  modified  in  such  a  way  to  facilitate  higher 
protein  expression  levels. 
The  information  potentially  available  from  trafficking  studies  performed  in  Raji  A  cells 
is  of  great  significance  due  to  the  fact  that  these  cells  possess  all  the  necessary  sorting 
machinery  and  correct  protein  repertoire  to  process  GFP-tagged  CD23  as  they  would 
naturally  process  their  endogenous  CD23  molecules.  It  is  therefore  a  great  achievement 
to  have  shown  these  cells  to  be  capable  of  producing  stablymtransfected  cell  fines, 
expressing  our  protein  of  interest.  Obviously  this  basic  protocol  requires  some 
modification  to  address  the  issue  of  protein  expression  levels. 
On  a  more  negative  note,  one  possible  disadvantage  of  the  GFP-tagged  approach  could 
be  the  potential  over  expression  of  the  GFP-tagged  protein,  which  may  subsequently 
lead  to  the  saturation  of  certain  accessory  molecules  necessary  for  folding/targeting  or 
signalling  resulting  in  the  presentation  of  false  results.  It  should  also  be  noted  that  the 
microscopic  analysis  discussed  within  could  have  been  strengthened  and  less  subjective 
had  there  been  software  available  to  quantify  various  properties  on  the  recorded  images, 
such  as  the  extent  of  cross-linking  etc.  These  two  points  should  be  addressed  in  the 
future  modification  of  these  experimental  procedures. 
139 FIGuRE  4.1  GENERATION  OF  MuTANT  GFP-CD23A  FusiON  PROTEINS 
Each  of  the  CD23  mutant  constructs  were  generated  using  specifically  designed 
olignucleotides  and  the  Stratagene  QuikChange  Mutagenesis,  kit,  as  detailed  in  section 
2.2.5.  This  figure  shows  the  sequences  of  the  oligonucleotides  used  to  generate  each  of 
the  CD23a  mutant  proteins.  The  nucleic  acids  detailed  in  blue  represent  the  unique  tail 
section  in  each  isoform.  and  the  specific  base  mutations  have  been  shown  in  red.  The 
resultant  mutant  proteins  are  also  shown,  with  the  altered  amino  acids  highlighted  in 
colour.  The  proteins  were  named  according  to  the  amino  acid  changes  incorporated  and 
this  nomenclature  is  also  given. 
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IWI) FIGuRE  4.2  GENERATION  OF  MuTANT  GFP-CD23B  FusION  PROTEINS 
Each  of  the  CD23  mutant  constructs  were  generated  using  specificafly  designed 
oUgnucleotides  and  the  Stratagene  QuikChange  Mutagenesis  kit,  as  described  in  section 
2.2.5.  This  figure  shows  the  sequences  of  the  oligonucleotides  used  to  generate  each  of 
the  CD23b  mutant  proteins.  The  nucleic  acids  detailed  in  blue  represent  the  unique  tail 
section  in  each  isoform  and  the  specific  base  mutations  have  been  shown  in  red.  The 
resultant  mutant  proteins  are  also  shown,  with  the  altered  amino  acids  highlighted  in 
colour.  The  proteins  were  named  according  to  the  amino  acid  changes  incorporated  and 
this  nomenclature  is  also  given. 
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__A FIGtw  4.3  AmiNo  AciD  SIDE  CHAiNs  -  THE  RELEVANCE  OF  EACH  OF 
THE  MUTATIONs  GENERATED 
This  figure  illustrates  the  side  chains  of  each  of  the  amino  acids  that  have  been  altered 
in  the  wild-type  CD23  proteins  in  order  to  generate  the  10  mutant  CD23  proteins.  In 
each  case  the  original  amino  acid  is  shown,  as  well  as  the  amino  acid  it  has  been 
replaced  with  in  the  mutant.  Sites  of  potential  phosphorylation  have  been  highlighted  in 
blue. 
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At  el FIGuRE  4.4  HEK  293  CELLS  STABLY  ExPREss  ALL  OF  THE,  GFP-CD23 
MUTANT  FUSION  PROTEINS  AT  THE  PLASMA  MEMBRANE  -  CD23BP3R 
APPEARS  TO  BE  THE  EXCEPTION  TO  THE  RuLE 
G418-resistant  HEK  293  cells  stably  transfected  with  each  of  the  mutant  GFP-CD23 
constructs  were  subjected  to  flow  cytometry.  The  presence  of  CD23  was  detected  by  an 
anti-CD23  PE  antibody  (FL-2),  Whilst  the  presence  of  the  GFP  tag  was  detected 
directly,  from  its  green  fluorescence  (FL-1).  The  data  has  been  presented  as  a  number  of 
dot-plots  enabling  the  percentage  of  double  positive  cells  to  be  calculated. 
Although  the  percentage  of  double  positives  in  the  GFP-CD23aY6F  is  also  relatively 
small  the  following  figure  illustrates  that  this  mutant  is  indeed  expressed  at  the  plasma 
membrane. 
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GFP FIGuRE  4.5  CELLuLAR  LOCALISATION  OF  EACH  OF  THE  GFP-CD23 
MUTANT  FUSION  PROTEINS  IN  HEK  293  -  GFP-CD23BP3R  DOES  NOT 
REACH  THE  PLASMA  MEMBRANE 
G418-resistant  HEK  293  cells  stably  transfected  with  each  of  the  GFP-CD23  mutant 
proteins  were  propagated  for  48  hours  on  polya-D-Iysine  (PDL)  coated  coverslips  before 
being  harvested,  washed  in  KRH  buffer  and  subjected  to  confocal  analysis.  The  images 
demonstrate  the  localisation  of  each  of  the  mutant  proteins  in  the  basal  state,  and 
indicate  that  the  bP3R  mutant  appears  to  be  the  only  CD23  protein  studied  that  is  unable 
to  target  to  the  plasma  membrane. 
144 GFP-CD23a  Mutants GFP-CD23b  Mutants FIGuRE  4.6  GFP-CD23AS7A  PROTEIN  Co-LOCALISES  WITH 
TRANsFERRiN-MODIFIED  TExAs  RED  (TF-TxR)  iN  HEK  293  CELLS 
Coverslips  bearing  G418-resistant  HEK  293  cells  expressing  the  GFP-CD23aS7A 
protein  were  pre-incubated  with  20pg  Tf-TxR  prior  to  confocal  analysis.  The  cells  were 
exposed  to  (B)  no  stimulus,  (L)  IýLg  NIP-specific  IgE  or  (XL)  Igg  NIP-specific  IgE 
followed  by  the  addition  of  I  pg  NIPo-BSA  and  examined  by  confocal  microscopy  over 
a  45  minute  period.  The  images  shown  demonstrate  the  typical  staining  pattems 
observed  for  this  mutant  in  each  of  the  (B)  basal,  (L)  loaded  and  (XL)  cross-linked 
states  respectively. 
The  basal  and  loaded  states  demonstrate  diffuse  staining  throughout  the  cytoplasm  of 
the  HEK  293  ceUs.  GFP-CD23aS7A  fusion  proteins  were  found  to  enter  the  cell  via 
directed  uptake  and  co-localise  with  Tf-TxR  and  thus  the  early  endosomal  system,  but 
only  after  being  loaded  with  NIP-specific  IgE  and  then  cross-linked  with  NIP-BSA. 
145 GFP-aS7A FIGuRE  4.7  GFP-CD23AS7D  PROTEIN  Co-LOCALISES  wrrH 
TRANSFERRIN-MODMED  TEXAS  RED  (TF-TxR)  iN  HEK  293  CELLS 
Coverslips  bearing  G418-resistant  HEK  293  cells  expressing  the  GFP-CD23aS7D 
protein  were  pre-incubated  with  20jig  Tf-TxR  prior  to  confocal  analysis.  The  cells  were 
exposed  to  (B)  no  stimulus,  (L)  I  gg  NIP-specific  IgE  or  (XL)  I  gg  NIP-specific  IgE 
followed  by  the  addition  of  I  jig  NIPjo-BSA  and  examined  by  confocal  microscopy  over 
a  45  minute  period.  The  images  shown  demonstrate  the  typical  staining  patterns 
observed  for  this  mutant  in  each  of  the  (B)  basal,  (L)  loaded  and  (XL)  cross-linked 
states  respectively. 
GFP-CD23aS7D  fusion  proteins  were  found  to  enter  the  cell  via  directed  uptake  and  co- 
localise  with  Tf-TxR  and  thus  the  early  endosomal  system  in  all  three,  basal,  loaded  and 
cross-linked  states. 
146 GFP-aS7D FIGURE  4.8  GFP-CD23AY6F  PROTEIN  Co-LOCALISES  WITTI 
TRANSFERRIN-MODIFIED  TEXAS  RED  (TF-TxR)  iN  HEK  293  CELLS 
Coverslips  bearing  G418-resistant  HEK  293  cells  expressing  the  GFP-CD23aY6F 
protein  were  pre-incubated  with  20ýtg  Tf-TxR  prior  to  confocal  analysis.  The  cells  were 
examined  in  the  basal  state  and  it  was  observed  that  this  mutant  protein  was  expressed 
at  very  low  levels  in  these  stably  transfected  cells.  Other  GFP-CD23  aYff-expressing 
cell  lines  were  made,  but  with  the  same  end  result  of  low  protein  expression.  The 
images  shown  are  representative  of  the  data  obtained  for  each  of  the  GFP-CD23aY6F 
cell  lines.  The  cells  were  not  exposed  to  either  NIP-specific  IgE  or  the  NIPjo-BSA  as  to 
the  fact  the  CD23  receptor  was  present  at  such  low  levels  its  trafficking  patterns  could 
not  be  assessed  as  per  the  rest  of  the  GFP-CD23  mutant  proteins. 
The  GFP-CD23aY6F  fusion  proteins  were  found  to  reach  the  plasma  membrane  and 
there  was  some  evidence  of  a  punctate  distribution  at  the  cell  surface  in  the  basal  state. 
Evidence  of  co-localisation  was  observed  with  Tf-TxR  indicating  that  this  protein  was 
able  to  travel  via  the  endosomal  pathway  within  HEK  293  cells  in  an  unoccupied  state. 
The  GFP-CD23aY6F  fusion  proteins  were  expressed  in  insufficient  amounts  to 
facilitate  the  usual  trafficking  studies  under  loaded  and  cross-linked  conditions. 
147 GFP-aY6F FIGuRE  4.9  GFP-CD23AYS67FA  PROTEIN  CO-LOCALISES  WITH 
TRANSFERRIN-MODIFIED  TEXAS  RED  (TF-TxR)  IN  HEK  293  CELLS 
Coverslips  bearing  G418-resistant  HEK  293  cells  expressing  the  GFP-CD23aYS67FA 
protein  were  pre-incubated  with  20gg  Tf-TxR  prior  to  confocal  analysis.  The  cells  were 
exposed  to  (B)  no  stimulus,  (L)  l[Lg  NIP-specific  IgE  or  (XL)  Iýtg  NIP-specific  IgE 
followed  by  the  addition  of  IýLg  NIPjo-BSA  and  examined  by  confocal  microscopy  over 
a  45  minute  period.  The  images  shown  demonstrate  the  typical  staining  patterns 
observed  for  this  mutant  in  each  of  the  (B)  basal,  (L)  loaded  and  (XL)  cross-linked 
states  respectively. 
GFP-CD23aYS67FA  fusion  proteins  were  found  to  enter  the  cell  via  directed  uptake 
and  co-localise  with  Tf-TxR  and  thus  the  early  endosomal  system  in  all  three,  basal, 
loaded  and  cross-linked  states.  The  punctate  morphology  is  pronounced  in  the  loaded 
state  where  the  aYS67FA  mutant  was  also  observed  to  co-localise  extensively  with  the 
Tf-TxR  probe.  Co-localisation  was  also  evident,  to  a  far  lesser  extent,  within  the  cell.  In 
the  cross-linked  state,  the  aYS67FA  mutant  was  found  to  have  a  very  punctate 
morphology,  so  much  so  that  practically  every  cell  was  surrounded  by  concentrated  foci 
of  green  fluorescence,  separated  by  patches  of  no  fluorescence.  Co-localisation  was 
observed,  but  much  less  so  than  in  the  loaded  state. 
148 GFP-aYS67FA FIGuRE  4.10  THE  GFP-CD23BS5A  PROTEIN  Co-LOCALISES  WITH 
TRANSFERRIN-MODIFIED  TEXAS  RED  (TF-TxR)  IN  HEK  293  CELLS 
AFTER  CROSs-LINKING  WITH  NIP-BSA 
Coverslips  bearing  G418-resistant  HEK  293  cells  expressing  the  GFP-CD23bSSA 
protein  were  pre-incubated  with  20gg  Tf-TxR  prior  to  confocal  analysis.  The  cells  were 
exposed  to  (B)  no  stimulus,  (L)  1ýtg  NIP-specific  IgE  or  (XL)  I  Vg  NIP-specific  IgE 
Mowed  by  the  addition  of  I  [ig  NIP10-13SA  and  examined  by  confocal  microscopy  over 
a  45  minute  period.  The  images  shown  demonstrate  the  typical  staining  patterns 
observed  for  this  mutant  in  each  of  the  (B)  basal,  (L)  loaded  and  (XL)  cross-linked 
states  respectively. 
Two  distinct  populations,  as  defined  by  their  very  different  fluorescent  staining  patterns, 
were  observed  in  this  stably-transfected  cell  line.  The  first  population  (the  first  page  of 
images)  was  found  to  demonstrate  diffuse  staining  throughout  the  cytoplasm  of  the 
HEK  293  cells  in  the  basal  and  loaded  states.  In  this  population  the  GFP-CD23bS5A 
fusion  proteins  were  only  found  to  enter  the  cell  via  directed  uptake  and  co-localise  with 
Tf-TxR  and  thus  the  early  endosomal  systen-4  after  being  loaded  with  NIP-specific  IgE 
and  then  cross-linked  with  NIP-BSA.  In  contrast  to  this,  the  second  cell  population 
(second  set  of  images)  was  found  to  show  co-localisation  with  Tf-TxR  in  all  three  basal, 
loaded  and  cross-linked  states.  A  small  amount  of  diffuse  staining  was  also  observed 
within  the  cytoplasm  of  these  cells,  however  much  of  the  fluorescence  was  contained 
along  the  plasma  membrane  or  within  distinct  foci  of  fluorescence  within  the  cell. 
149 GFP-bS5A GFP-bS5A FIGuRE  4.11  THE  GFP-CD23BS5D  PROTEIN  CO-LOCALISES  WITH 
TRANsFERRiN-MODIMD  TEXAS  RED  (TF-TxR)  IN  HEK  293  CELLS 
UNDER  ALL  THREE  BASAL,  LOADED  AND  CROSS-LINKED  CONDITIONS 
Coverslips  bearing  G418-resistant  HEK  293  cells  expressing  the  GFP-CD23bS5D 
protein  were  pre-incubated  with  20gg  Tf-TxR  prior  to  confocal  analysis.  The  cells  were 
exposed  to  (B)  no  stimulus,  (L)  I  gg  NIP-specific  IgE  or  (XL)  I  gg  NIP-specific  IgE 
followed  by  the  addition  of  Ipg  NIPjo-BSA  and  examined  by  confocal  microscopy  over 
a  45  minute  period.  The  images  shown  demonstrate  the  typical  staining  patterns 
observed  for  this  mutant  in  each  of  the  (B)  basal,  (L)  loaded  and  (XL)  cross-linked 
states  respectively. 
GFP-CD23bS5D  fusion  proteins  were  found  to  enter  the  cell  via  directed  uptake  and  co- 
localise  with  Tf-TxR  and  thus  the  early  endosomal  ýystem  in  all  three,  basal,  loaded  and 
cross-  .e  states. 
150 GFP-bS5D FIGuRE  4.12  THE  GFP-CD23BS5F  PROTEIN  CO-LOCALISES  WITH 
TRANsFERRiN-MODMED  TEXAS  RED  (TF-TXR)  IN  HEK  293  CELLS 
UNDER  ALL  THREE  BASAL,  LOADED  AND  CROSS-LWKED  CONDITIONS 
Coverslips  bearing  G418-resistant  HEK  293  cells  expressing  the  GFP-CD23bS5F 
protein  were  pre-incubated  with  20ýtg  Tf-TxR  prior  to  confocal  analysis.  The  cells  were 
exposed  to  (B)  no  stimulus,  (L)  1ýtg  NIP-specific  IgE  or  (XL)  Iýtg  NIP-specific  IgE 
followed  by  the  addition  of  I  gg  NIP10-13SA  and  examined  by  confocal  microscopy  over 
a  45  minute  period.  The  images  shown  demonstrate  the  typical  staining  patterns 
observed  for  this  mutant  in  each  of  the  (B)  basal,  (L)  loaded  and  (XL)  cross-linked 
states  respectively. 
GFP-CD23bS5F  fusion  proteins  were  found  to  enter  the  cell  via  directed  uptake  and  co- 
localise  with  Tf-TxR  and  thus  the  early  endosomal  system  in  all  three,  basal,  loaded  and 
cross-linked  states. 
151 GFP-bS5F FIGuRE  4.13  THE  GFP-CD23BP3R  PROTEiN  DOES  NOT  TARGET  TO  THE 
PLASMA  MEMBRANE  iN  HEK  293  CELLS 
Coverslips  bearing  G418-resistant  HEK  293  cells  expressing  the  GFP-CD23bP3R 
protein  were  pre-incubated  with  20gg  Tf-TxR  prior  to  confocal  analysis.  The  cells  were 
examined  in  the  basal  state  and  it  was  observed  that  this  mutant  protein  was  unable  to 
target  to  the  plasma  membrane  in  HEK  293  cells.  The  cells  were  not  exposed  to  either 
NIP-specific  IgE  or  the  NIP,  o-BSA  as  there  was  little  point  due  to  the  fact  the  CD23 
receptor  was  not  at  the  cell  surface  and  its  trafficking  patterns  could  not  be  assessed  as 
per  the  rest  of  the  GFP-CD23  mutant  proteins. 
GFP-CD23bP3R  fusion  proteins  were  unable  to  target  to  the  plasma  membrane  and  no 
co-localisation  was  observed  with  Tf-TxR  indicating  that  this  protein  was  trapped 
within  the  cell  in  compartments  which  were  not  early  endosomes. 
152 GFP-bP3R FIGuRE  4.14  THE  GFP-CD23BP4R  PROTEIN  CO-LOCALISES  WITH 
TRANSFERRIN-MODIFIED  TEXAS  RED  (TF-TxR)  IN  HEK  293  CELLS 
UNDER  ALL  THREE  BASAL,  LOADED  AND  CROSS-LINKED  CONDITIONS 
Coverslips  bearing  G418-resistant  HEK  293  cells  expressing  the  GFP-CD23bP4R 
protein  were  pre-incubated  with  20gg  Tf-TxR  prior  to  confocal  analysis.  The  cells  were 
exposed  to  (13)  no  stimulus,  (L)  Igg  NIP-specific  IgE  or  (XL)  Igg  NIP-specific  IgE 
followed  by  the  addition  of  I  [ig  NIP10-13SA  and  examined  by  confocal  microscopy  over 
a  45  minute  period.  The  images  shown  demonstrate  the  typical  staining  pattems 
observed  for  this  mutant  in  each  of  the  (B)  basaL  (L)  loaded  and  (XL)  cross-linked 
states  respectively. 
GFP-CD23bP4R  fusion  proteins  were  found  to  enter  the  cell  via  directed  uptake  and  co- 
localise  with  Tf-TxR  and  thus  the  early  endosomal  system  in  all  three,  basal,  loaded  and 
cross-linked  states. 
153 GFP-bP4R FIGuRE  4.15  THE  GFP-CD23BN2K  PROTEIN  CO-LOCALISES  NVITH 
TRANSFERRIN-MODMED  TExAs  RED  (TF-TxR)  IN  HEK  293  CELLS 
UNDER  ALL  THREE  BASAL,  LOADED  AND  CROSS-LINKED  CONDITIONS 
Coverslips  bearing  G418-resistant  HEK  293  cells  expressing  the  GFP-CD23bN2K 
protein  were  pre-incubated  with  20jig  Tf-TxR  prior  to  confocal  analysis.  The  cells  were 
exposed  to  (B)  no  stimulus,  (L)  Igg  NIP-specific  IgE  or  (XL)  Igg  NIP-specific  IgE 
followed  by  the  addition  of  I  jig  NIPo-BSA  and  examined  by  confocal  microscopy  over 
a  45  minute  period.  The  images  shown  demonstrate  the  typical  staining  patterns 
observed  for  this  mutant  in  each  of  the  (B)  basal,  (L)  loaded  and  (XL)  cross-linked 
states  respectively. 
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co-localise  with  Tf-TxR  and  thus  the  early  endosomal  system  in  all  three,  basal,  loaded 
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154 GFP-bN2K FIGuREs  4.16  MUTATION  OF  THE  CYTOPLASMIC  N-TERMINUS  OF  CD23 
AFFEcTs  PROTEOLYTIC  CLEAVAGE  FROM  THE  CELL  SURFACE 
G418-resistant  HEK  293  cells  expressing  each  of  the  GFP-CD23  mutant  proteins  were 
cultured  for  4  days  in  complete  DMEM  media.  The  supernatants  were  collected  and 
assayed  for  the  presence  of  soluble  CD23  protein  using  the  sCD23  ELISA  described  in 
section  2.23H.  This  figure  illustrates  the  amount  of  soluble  CD23  detected  in  each  of 
the  supernatants,  indicating  that  many  of  the  mutations  caused  significant  differences  in 
the  amount  of  CD23  shed  from  the  cell  surface  in  comparison  to  the  data  collected  from 
supernatants  collected  from  cells  expressing  each  of  the  wild-type  CD23  isoforms. 
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U')  q4t FIGURE  4.17  RAii  A  CELLS  STABLY  EXPRESS  BOTH  OF  THE  GFP-CD23 
ISOFORm  FUSION  PROTEINS  AT  THE  PLASMA  MEMBRANE, 
G418-resistant  RaJi  A  cells  stably-transfected  with  each  of  the  wild-type  GFP-CD23 
constructs  were  subjected  to  flow  cytometry.  The  presence  of  CD23  was  detected  by  an 
anti-CD23  PE  antibody  (FL-2),  whilst  the  presence  of  the  GFP  tag  was  detected 
directly,  from  its  green  fluorescence  (FL-1).  The  data  have  been  presented  as  a  number 
of  dot-plots  where  the  upper  right  quadrant  shows  the  double  positive  cells  in  each  case. 
Untransfected  (UT)  Raji  cells  were  also  assayed  for  the  presence  of  endogenous  CD23 
protein. 
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GFP FIGURE  4.18  CONFOCAL  ANALYSIS  CONFIRMS  CELL  SURFACE 
EXPRESSION  OF  ]BOTH  OF  THE  GFP-CD23  ISOFORM  FUSION  PROTEINS  IN 
RAii  A  CELLS 
G418-resistant  RaJi  A  cells  stably-transfected  with  each  of  the  wild-type  GFP-CD23 
isoforms  were  propagated  for  48  hours  on  glass  coverslips  before  being  harvested, 
washed  in  KRH  buffer  and  subjected  to  confocal  analysis.  The  images  demonstrate  the 
localisation  of  each  of  the  GFP-tagged  isoforms  in  the  basal  state,  and  indicate  that  both 
CD23  isoforms  appear  to  be  targeted  to  the  plasma  membrane. 
157 FIGURE  4.19  SCHEMATIC  DIAGRAM  ILLUSTRATES  THE  ENHANCED  NIP 
SYSTEM  USING  AN  ADDITIONAL  PROTEIN  CONJUGATE  -  NIP-INSULIN 
Figure  3.5  is  shown  again  in  the  upper  diagram,  illustrating  how  the  NIP-system 
facilitates  the  study  of  GFP-CD23  trafficking  in  an  unoccupied  or  "Basar'  state,  a 
"Loaded"  state  following  the  addition  of  NIP-specific  chimaeric  IgE  antibody  and  a 
"Cross-linked"  state  following  the  addition  of  NIP-BSA  to  cell  pre-loaded  with  NIP- 
specific  IgE.  In  addition  to  this  the  lower  diagram  illustrates  the  effect  of  adding  NIP- 
Insulin  proteins.  Like  the  NIP-BSA,  the  NIP-Insulin  will  serve  to  bind  specifically  to 
the  NIP-specific  IgE  antibody  molecules  but  will  be  unable  to  Tgate'  more  than  one 
CD23  molecule  at  the  cell  surface.  The  addition  of  this  protein  conjugate,  and  the 
comparison  between  this  state  and  the  NIP-BSA  cross-linked  state  facilitates 
investigation  of  the  importance  of  CD23  oligomerisation  for  directed  uptake  and 
internalisation.  As  before,  the  green  star  in  each  instance  represents  the  GFP  tag  at  the 
N-terminus  of  each  CD23  fusion  protein. 
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02 FIGuRE  4.20  GFP-CD23B  ENTERS  THE  ENDocyTic  PATHWAY  IN  RAii  A 
CELLS 
Coverslips  bearing  G418-resistant  Raji  A  cells  expressing  the  GFP-CD23b  protein  were 
pre-incubated  with  20ýLg  Tf-TxR  prior  to  confocal  analysis.  The  cells  were  exposed  to 
(i)  no  stimulus,  (ii)  Igg  NIP-specific  IgE,  (iii)  Iýtg  NIP-specific  IgE  followed  by  the 
addition  of  either  I[Lg  NIPjo-BSA  or  (iv)  NIPI-Insulin  and  examined  by  confocal 
microscopy  over  a  45  minute  period.  The  images  shown  demonstrate  the  typical 
staining  patterns  observed  for  this  isoform.  in  each  of  the  (i)  basal,  (ii)  loaded,  (iii)  cross- 
linked  and  (iv)  ligated  states  respectively. 
In  the  basal  state  the  majority  of  the  CD23  protein  is  located  at  the  plasma  membrane, 
with  the  addition  of  IgE  resulting  in  concentrated  foci  of  fluorescence  along  the 
membrane  and  the  initiation  of  uptake  from  the  cell  surface.  Evidence  of  co-localisation 
with  Tf-TxR  is  also  present.  Cross-linking  with  NIPIO-BSA  causes  an  increase  in 
directed  uptake  from  the  cell  surface  and  an  extensive  punctate  distribution.  In  contrast 
to  this,  whUst  figating  with  NIPI-Insulin  does  results  in  CD23  uptake,  it  occurs  less  so 
than  in  the  aforementioned  cross-linked  state,  with  the  majority  of  the  CD23  retained 
within  the  plasma  membrane.  Some  co-localisation  was  noted,  both  on  the  membrane 
and  within  the  cell. 
159 FIGuRE  4.21GFP-CD23B  ENTERS  THE  PHAGOCYTIC  PATHWAY  iN  RAJI  A 
CELLS 
Coverslips  bearing  G418-resistant  Raji  A  cells  expressing  the  GFP-CD23b  protein  were 
pre-incubated  with  5OnM  LysoTracker  Red  prior  to  confocal  analysis.  Ile  cells  were 
exposed  to  (i)  no  stimulus,  (ii)  Igg  NIP-specific  IgE,  (iii)  Iýtg  NIP-specific  IgE 
followed  by  the  addition  of  either  I  gg  NIPjo-BSA  or  (iv)  NIP,  -Insulin  and  examined  by 
confocal  microscopy  over  a  45  minute  period.  The  images  shown  demonstrate  the 
typical  staining  patterns  observed  for  this  isoform  in  each  of  the  (i)  basal,  (ii)  loaded  and 
(iii  &  iv)  cross-linked  states  respectively. 
In  the  basal  state  the  majority  of  the  CD23  protein  was  located  at  the  plasma  membrane, 
with  the  addition  of  IgE  resulting  in  concentrated  foci  of  fluorescence  along  the 
membrane  and  some  uptake  from  the  cell  surface  demonstrating  evidence  of  co- 
localisation  with  LysoTracker  Red.  Cross-linking  with  NIP1o-BSA  caused  an  increase  in 
directed  uptake  from  the  cell  surface  and  also  an  extensive  punctate  morphology.  In 
contrast  to  this,  cross-linking  with  NIP,  -Insulin  resulted  in  little  uptake,  with  the 
majority  of  the  CD23  retained  within  distinct  patches  along  the  plasma  membrane. 
160 FIGuRE  4.22  RAii  A  CELLS  STABLy  ExPREss  EACH  OF  THE  GFP-CD23A 
MuTANT  FUSION  PROTEINS 
G418-resistant  RaJi  A  cells  stably-transfected  with  each  of  the  GFP-CD23a  mutant 
constructs  were  subjected  to  flow  cytometry.  The  presence  of  CD23  was  detected  by  an 
anti-CD23  PE  antibody  (FL-2),  whilst  the  presence  of  the  GFP  tag  was  detected 
directly,  from  its  green  fluorescence  (FL-1).  The  data  has  been  presented  as  a  number  of 
dot-plots,  with  the  upper  right  quadrant  in  each  case  illustrating  cells  expressing  GFP- 
CD23a  proteins  on  their  plasma  membrane. 
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GFP-aYS67FA FIGuRE  4.23  RAii  A  CELLS  STABLY  EXPRESS  EACH  OF  THE  GFP-CD23B 
MUTANT  FUSION  PROTEINS 
G418-resistant  RaJi  A  cells  stably-transfected  with  each  of  the  GFP-CD23b  mutant 
constructs  were  subjected  to  flow  cytometry.  The  presence  of  CD23  was  detected  by  an 
anti-CD23  PE  antibody  (FL-2),  Whilst  the  presence  of  the  GFP  tag  was  detected 
directly,  from  its  green  fluorescence  (FL-1).  The  data  has  been  presented  as  a  number  of 
dot-plots,  with  the  upper  right  quadrant  in  each  case  illustrating  cells  expressing  the 
GFP-CD23b  proteins  on  their  plasma  membrane. 
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ClFP-bS5F FIGURE  4.24  CELLULAR  LOCALISATION  OF  EACH  OF  THE  GFP-CD23A 
MUTANT  FUSION  PROTEINS  IN  RAii  A  CELLS 
G418-resistant  Raji  A  cells  stably  transfected  with  each  of  the  GFP-CD23a  mutant 
proteins  were  propagated  for  48  hours  on  glass  coverslips  before  being  harvested, 
washed  in  KRH  buffer  and  subjected  to  confocal  analysis.  The  images  demonstrate  the 
fluorescent  signal  from  each  of  the  GFP-tagged  mutant  proteins  in  the  basal  state  as 
well  as  bright  field  images  indicating  the  location  of  each  of  the  cells  in  the  field  of 
view. 
The  aY6F  and  aYS67FA  proteins  were  observed  to  have  a  predominantly  plasma 
membrane  location,  with  suggestions  of  a  punctate  distribution  in  the  basal  state.  The 
aS7A  and  aS7D  mutant  proteins  were  also  able  to  target  to  the  plasma  membrane,  but  In 
contrast  to  the  aY6F  and  aYS67FA  mutants,  there  was  substantially  more  GFP-tagged 
protein  located  within  the  cells,  suggesting  much  higher  expression  levels  of  these 
mutant  proteins. 
163 FIGuRE  4.25  CELLuLAR  LOCALISATION  OF  EACH  OF  THE  GFP-CD23B 
MUTANT  FUSION  PROTEINS  IN  RAii  A  CELLS 
G418-resistant  Raji  A  ceRs  stably-transfected  with  each  of  the  GFP-CD23b  mutant 
proteins  were  propagated  for  48  hours  on  glass  coverslips  before  being  harvested, 
washed  in  KRH  buffer  and  subjected  to  confocal  analysis.  The  images  demonstrate  the 
fluorescent  signal  from  each  of  the  GFP-tagged  mutant  proteins  in  the  basal  state  as 
well  as  bright  field  images  indicating  the  location  of  each  of  the  cells  in  the  field  of 
view. 
The  GFP-CD23  bS5A,  bS5D,  bS5F,  bP4R  and  bN2K  mutants  were  all  able  to  target  to 
the  plasma  membrane  in  Raii  A  cells,  with  the  majority  of  the  stably-transfected  cell 
lines  containing  few  cells  having  reasonable  protein  expression  levels.  The  bP3k 
mutant  was  expressed  at  lower  levels  than  these  mutants  and  the  limited  data  collected 
for  this  mutant  is  shown  in  the  next  figure. 
164 FIGuRE  4.26  THE  GFP-CD23BP3R  MUTANT  DEMONSTRATED  TWo 
DISTINCT  PATTERNS  OF  ExPRESSION 
The  stably-transfected  cell  line  expressing  the  GFP-CD23  bP3R  mutant  protein  was 
found  to  result  in  two  types  of  cell;  those  expressing  little  protein  which  in  the  most  part 
seemed  to  be  contained  within  the  cell  (A)  and  those  expressing  higher  levels  of  the 
protein,  and  demonstrating  a  plasma  membrane  localisation.  This  mutant  was  found  not 
to  be  able  to  target  the  plasma  membrane  in  HEK  293  cells,  but  this  appears  not  to  be 
the  case  in  this  lyinphocytic  cell  line.  These  findings  seem  to  suggest  that  the  bP3R 
mutant  does  reach  the  plasma  membrane  in  Raji  A  cells  (supported  by  the  FACs 
analysis  in  Figure  4.23),  all  be  it  at  low  levels. 
165 FIGURE  4.27  BOTH  GFP-CD23A  S7A  AND  S7D  MUTANTS  APPEAR  TO  CO- 
LOCALISE  WITH  TEXAS  RED-MODIFIED  TRANsFERRIN  (TF-TXR)  IN  THE 
BASAL  STATE  IN  RAm  A  CELLS 
CoversUps  bearing  G418-resistant  Raji  A  ceRs  expressing  either  of  the  GFP-CD23 
aS7A  or  aS7D  mutant  proteins  were  pre-incubated  with  20gg  Tf-TxR  prior  to  confocal 
analysis.  The  cells  were  exposed  to  no  stimulus  and  basal  trafficking  was  monitored  by 
confocal  microscopy  over  a  45  minute  period.  The  images  shown  demonstrate  the 
typical  basal  staining  patterns  observed  for  these  mutants.  Much  of  the  GFP-CD23 
fluorescence  was  located  within  the  plasma  membrane  of  these  cells,  however  there 
were  patches  of  co-localisation  present  within  the  cells  for  both  mutant  proteins,  as  weR 
as  at  the  cell  surface  in  the  aS7D  mutant. 
166 FIGuRE  4.28  BASAL  LOCAISATION  iN  RAii  A-  GFP-CD23AY6F  AND 
4 
AYS67FA  MUTANTs 
Coverslips  bearing  G418-resistant  Raji  A  cells  expressing  either  of  the  GFP-CD23 
a,  Y6F  or  aYS67FA  mutant  proteins  were  pre-incubated  with  20pg  Tf-TxR  prior  to 
confocal  analysis.  The  cells  were  exposed  to  no  stimulus  and  basal  trafficking  was 
monitored  by  confocal  microscopy  over  a  45  minute  period.  The  images  shown 
demonstrate  the  typical  basal  staining  patterns  observed  for  these  mutants. 
Both  of  these  mutants  were  expressed  at  low  levels  in  the  stably-transfected  Raji  A 
cells,  with  much  of  the  GFP-CD23  fluorescence  located  within  the  plasma  membrane  of 
these  cells.  Evidence  of  a  punctate  morphology  was  observed  for  both  mutants.  A 
couple  of  small  patches  of  co-localisation  were  noted,  in  a  few  cells. 
167 FIGuRE  4.29  BASAL  LOCALISATION  IN  RAii  A-  GFP-CD23BS5A,  S5D 
AND  S5F  MUTANTS 
Coverslips  bearing  G418-resistant  Raji  A  cells  expressing  either  of  the  GFP- 
CD23bS5A,  bS5D  or  bS5F  mutant  proteins  were  pre-incubated  with  20ýtg  Tf-TxR  prior 
to  confocal  analysis.  The  cells  were  exposed  to  no  stimulus  and  basal  trafficking  was 
monitored  by  confocal  microscopy  over  a  45  minute  period.  The  images  shown 
demonstrate  the  typical  basal  staining  patterns  observed  for  these  mutants. 
All  of  these  mutants  were  located  predominantly  at  the  plasma  membrane,  and  showed  a 
punctate  distribution  (particularly  the  bS5D  mutant).  Patches  of  co-localisation  with  Tf- 
TxR  were  also  observed  in  each  of  these  stably-transfected  cell  lines,  and  was 
predominantly  located  at  the  cell  surface. 
168 FIGuRE  4.30  BASAL  LOCALISATION  iN  RAii  A-  GFP-CD23BN2K  AND 
P4R  MuTANTs 
CoversUps  bearing  G418-resistant  Raji  A  ceUs  expressing  either  of  the  GFP- 
CD23bN2K  or  bP4R  mutant  proteins  were  pre-incubated  with  20gg  Tf-TxR  prior  to 
confocal  analysis.  The  cells  were  exposed  to  no  stimulus  and  basal  trafficking  was 
monitored  by  confocal  microscopy  over  a  45  minute  period.  The  images  shown 
demonstrate  the  typical  basal  staining  patterns  observed  for  these  mutants. 
Both  of  these  mutants  were  expressed  at  reasonable  levels  in  the  stably-transfected  Raji 
A  cells,  with  much  of  the  GFP-CD23  fluorescence  located  within  the  plasma  membrane 
of  these  cells.  Concentrated  patches  of  the  GFP-CD23bN2K  mutant  were  observed  at 
the  cell  surface.  The  GFP-CD23bP4R  mutant  was  demonstrated  to  have  distinct  foci  of 
green  fluorescence  within  the  cell.  Patches  of  co-localisation  with  Tf-TxR  were 
observed  within  the  cells  expressing  each  of  these  mutant  proteins. 
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IDENTIFICATION  OF  CD23  N-TERMINAL  TAIL  BINDING 
PARTNERS  USING  THE  YEAST  Two-HYBRID  SYSTEM 
170 5.1  INTRODUCTION 
Many  biological  processes  are  based  upon  specific  interactions  that  occur  between 
proteins  so  it  is  not  surprising  that  considerable  effort  has  been  made  to  identify  species 
that  bind  to  known  proteins  of  interest.  Historically  these  protein-protein  interactions 
have  been  detected  using  physical  or  indeed  classical  biochemical  approaches,  such  as 
co-immunoprecipitation  and  cross-linking.  The  main  disadvantage  of  these  systems  is 
that  they  result  only  in  the  identification  of  the  apparent  molecular  weight  of  the 
associated  interacting  protein;  obtaining  the  cloned  gene  is  often  a  difficult  and  complex 
process.  In  one  approach,  this  problem  was  circumvented  by  the  use  of  purified  proteins 
as  probes  against  bacterial  expression  libraries,  where  a  positive  signal  for  an  interacting 
protein  is  accompanied  by  the  corresponding  gene  [Nelbock  et  al.,  19901. 
A  number  of  these  so  called  'library-based'  methods  have  developed  including  protein- 
probing  [Young  &  Davies,  1983]  and  phage  display  [Smith,  19851.  Protein  probing 
utilises  a  labelled  protein  to  screen  an  expression  library,  with  the  interactions  between 
the  immobilised  protein  and  the  labelled  protein  probe  occurring  on  nitrocellulose 
filters.  The  main  disadvantage  of  this  system  is  that  proteins  encoded  in  the  library  must 
be  capable  of  folding  correctly  in  Ecoli,  generally  as  fusion  proteins,  and  of 
maintaining  their  structure  on  nitrocellulose.  Phage  display  utilises  an  Ecoli 
filamentous  phage,  such  as  M13,  bearing  the  protein  of  interest  as  a  fusion  to  coat 
proteins  on  the  cell  surface.  Random  sequences  can  be  inserted  into  the  coat  protein 
genes,  enabling  the  generation  of  a  library  of  fusion  phage.  Binding  partners  are 
detected  by  a  series  of  affinity  purifications.  The  main  disadvantages  of  this  system 
echo  the  previous  discussion,  with  both  systems  taking  place  in  Exo1i  cells.  Phage 
display  is  primarily  limited  to  small  peptides,  with  larger  inserts  generally  interfering 
with  the  function  of  the  coat  proteins.  The  exception  to  this  being  25kDa  ScFv  antibody 
phage  display  libraries. 
The  yeast  two-hybrid  system,  originally  described  by  Fields  &  Song,  1989,  is  another 
library-based  method  by  which  protein-protein  interactions  can  be  identified  in  vivo 
through  the  reconstitution  of  the  activity  of  a  transcriptional  activator.  The  method  is 
based  on  the  fact  that  most  eukaryotic  transcriptional  activators  are  composed  of  two 
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BD)  which  recognises  and  binds  to  a  sequence  upstream  of  the  responsive  genes 
(upstream  activating  sequence,  UAS)  and  an  activation  domain  (AD)  which  interacts 
with  other  components  of  the  transcriptional  machinery  required  to  initiate  transcription. 
Both  these  domains  are  necessary  to  initiate  transcription  of  the  response  gene(s),  and 
must  be  in  close  enough  proximity  to  one  another  to  do  so,  as  neither  domain  is  able  to 
initiate  transcription  alone  [Brent  &  Ptashne,  1985;  Ma  &  Ptashne,  1987].  Figure  5AA 
details  a  schematic  representation  of  the  general  yeast  two-hybrid  strategy,  and 
illustrates  how  it  functions  to  detect  interacting  proteins. 
The  feasibility  of  the  yeast  two-hybrid  system  was  originally  demonstrated  by  using  it 
to  detect  an  interaction  between  the  yeast  proteins  SNFI,  a  protein  kinase,  and  SNF4,  a 
protein  associated  with  the  kinase  [Fields  &  Song,  19891.  Since  then  the  technique  has 
been  further  developed  by  many  research  groups  and  indeed  there  are  now  several 
versions  of  the  yeast  two-hybrid  system  commercially  available.  Most  systems  contain 
either  the  yeast  GAL4  or  the  Ecoli  LexA  protein  as  the  DNA-BD,  and  the  GAL4  or 
herpes  simplex  virus  VP  16  protein  as  the  AD,  respectively. 
The  yeast  two-hybrid  system  has  been  used  in  this  chapter  to  investigate  possible 
interactions  between  the  N-terminus  of  CD23  and proteins  encoded  by  a  human 
leukocyte  cDNA  library.  The  Clontech  MATCHMAKER  two-hybrid  3  assay  based 
upon  the  GAL4  system,  shown  to  consist  of  separable  domains  responsible  for  DNA- 
binding  and  transcriptional  activation  [Keegan  et  al.,  1986],  was  the  system  utilised  for 
this  work.  Briefly,  the  bait  gene  (the  N-terminal  cytoplasmic  domain  of  CD23)  is 
expressed  as  a  fusion  to  the  GAL4  DNA-binding  domain,  while  proteins  encoded  by  the 
Clontech  human  leukocyte  MATCHMAKER  cDNA  library  are  expressed  as  fusions  to 
the  GAL4  activation  domain,  Figure  5.1  B. 
The  MATCHMAKER  two-hybrid  system  3  has  been  developed  to  incorporate  many 
features  serving  to  reduce  the  incidence  of  false  positive  results  and  enable  quick 
identification  of  true  protein-protein  interactions.  The  yeast  two-hybrid  systems  provide 
a  sensitive  method  for  detecting  relatively  weak  and  transient  interactions,  so  much  so 
172 that  occasionally  these  interactions  may  not  be  biochemically  detectable,  but  may  still 
be  critical  for  correct  functioning  of  complex  biological  systems  [Guarente,  1993; 
Estojak  et  al.,  1995].  The  sensitivity  of  the  MATCHMAKER  GAL4  two-hybrid  system 
3  is  primarily  attributable  to  the  amplification  of  positive  signals  in  vivo  (i.  e., 
transcriptional,  translational  and  enzymatic).  In  addition,  because  the  two-hybrid  assay 
is  performed  in  vivo,  the  proteins  are  more  likely  to  be  in  their  native  conformations, 
which  may  lead  to  increased  sensitivity  and  accuracy  of  detection. 
The  MATCHMAKER  yeast  two-hybrid  system  3  also  features  a  new  yeast  strain, 
AH109,  which  utilises  3  reporters  -  ADE2,  HIS3  and  MELI  (or  lacZ)  -  under  the 
control  of  distinct  GAL4  upstream  activating  sequences  (UASs)  and  TATA  boxes 
(Figure  5-2).  The  simultaneous  use  of  these  different  reporter  genes  that  share  minimal 
sequence  overlap  in  their  promoters  has  improved  the  specificity  of  detection,  thus 
helping  to  reduce  the  number  of  false  positives  detected.  The  ADE2  reporter  alone 
provides  strong  nutritional  selection:  the  option  of  using  HIS3  selection  allows  the 
stringency  of  selection  to  be  controlled  and  can  reduce  the  incidence  of  false  positives 
[James  et  al.,  1996].  MELI  is  an  endogenous  gene  found  in  several  yeast  strains  and 
encodes  a-galactosidase,  a  secreted  enzyme  that  enables  direct  enzyme  assay  on  X-a- 
Gal  indicator  plates,  employing  a  blue/white,  positive/negative  screening.  It  should  be 
noted  at  this  stage  however  that  some  false  positives  will  always  arise  due  to  the  ability 
of  certain  target  clones  to  activate  transcription  in  the  absence  of  a  DNA  binding 
domain,  as  well  as  for  other  unknown  reasons  [Barte'l  et  al.,  1993].  The  tight  regulation 
of  the  GAL  UASs  by  GAU  makes  it  a  valuable  tool  for  manipulating  expression  of  the 
reporter  genes  in  two-hybrid  systems  that  are  dependent  on  the  GAL4  DNA-BD.  The 
yeast  strain  must  also  carry  deletions  that  ensure  the  endogenous  GAL4  gene  is  not 
expressed.  In  addition,  GAL80  is  also  mutated  as  its  product  inhibits  the  function  of 
GAL  4.  The  yeast  strain  must  also  contain  auxotrophic  markers  for  the  selection  of 
yeast  transformed  with  target  and/or  bait  plasmids.  The  genotype  of  the  AH109  yeast 
strain  is  also  detailed  in  Figure  5.2. 
The  Yeast  two-hybrid  assay  does  however  hold  some  disadvantages  that  largely  depend 
upon  the  nature  of  the  proteins  being  assayed.  The  assay  is  limited  to  proteins  that  can 
173 be  located  to  and  stably  expressed  in  the  nucleus  and  therefore  this  may  exclude  some 
membrane  and  extracellular  proteins.  Certain  post-translational  modifications  required 
for  some  protein-protein  interactions  in  higher  eukaryotes,  such  as  tyrosine 
phosphorylation,  glycosylation,  disulphide  bond  formation  and  acetylation  do  not  occur 
in  yeast  and  this  may  also  limit  the  proteins  which  can  be  used/detected.  However  it 
should  also  be  noted  that  the  yeast  cell  system  does  provide  more  post-translational 
modifications  than  any  bacterial  cell  system.  Since  the  proteins  are  expressed  as  fusion 
proteins,  the  GAL4  domains  may  interfere  with  the  ability  of  the  test  proteins  to  interact 
[van  Aelst  et  al.,  1993]  although  this  is  generally  not  found  to  be  a  common  problem.  It 
has  also  be  noted  that  some  proteins,  including  those  not  normally  involved  in 
transcription,  are  able  to  activate  transcription  when  fused  to  the  DNA-BD  [Ma  & 
Ptashne,  1987]  or  may  be  lethal  or  harmful  when  expressed  in  yeast  [Allen  et  al.,  19951, 
preventing  their  use  as  bait  proteins.  These  factors  must  all  be  considered  when 
Choosing  the  bait  protein. 
The  yeast  two-hybrid  system  identifies  protein-protein  interactions  purely  on  a  physical 
basis,  therefore  interactions  could  be  detected  between  proteins  that  never  come  into 
contact  with  each  other  in  a  natural  scenario.  It  is  therefore  paramount  that  all  potential 
interactors  be  checked  out  by  further  biochemical  analysis  and  cell/tissue  distribution 
tests  before  the  interaction  can  be  confirmed  to  be  true. 
In  summary,  the  yeast  two-hybrid  system  is  a  very  attractive  tool  as  it  is  not  only 
capable  of  identifiýring  individual  proteins  encoded  in  large  cDNA  libraries  able  to 
interact  with  a  known  protein,  but  it  also  results  in  the  immediate  availability  of  the 
cloned  gene  for  these  interacting  species.  The  N-terminal  tail  of  CD23  is  relatively  short 
in  comparison  to  most  cell  surface  receptors  and  it  does  not  contain  any  of  the  well- 
characterised  consensus  sites  required  for  some  of  the  more  common  protein-protein 
interactions  associated  with  receptor  signalling  such  as  Src  homology  domains  and  the 
usual  tyrosine-based  sorting  motifs.  It  has  therefore  been  hypothesised  that  CD23  may 
indeed  be  required  to  bind  to  some  sort  of  'adapter-Eke'  protein  thus  enabling 
recruitment  of  the  necessary  signalling  molecules  to  promote  its  function.  The  work 
detailed  in  this  chapter  utilises  the  yeast  two-hybrid  system  in  an  attempt  to  identify 
174 proteins  that  bind  to  the  cytoplasn&  N-terminal  tail  of  CD23  in  order  to  investigate  this 
theory. 
5.2  REsuLTs 
5.2.1  GENERATION  OF  THE  GAM  DNA-BD-CD23  FUSION  CONSTRUCTS 
DNA  encoding  full  length  CD23  was  amplified  using  PCR  and  the  ofigonucleotides 
detailed  within  Figure  5.3A,  in  order  to  generate  DNA  fragments  containing  the  N- 
terminal  tail  of  either  the  CD23a  or  CD23b  isoforrn  enclosed  by  additional 
endonuclease  restriction  sites.  Both  single  (,  )  and  triple  (t)  CD23  bait  constructs  were 
generated,  containing  either  one  or  three  sequential  copies  of  the  CD23  N-terminal.  tail, 
respectively.  The  transmembrane  domain  was  not  included  as  it  was  likely  to  have 
posed  expression/sorting  problems  due  to  the  nature  of  the  amino  acids  involved.  These 
PCR  fragments  were  digested  with  the  appropriate  restriction  endonuclease  enzymes 
and  directionally  cloned  in-frame  into  the  multiple  cloning  site  (MCS)  of  the  DNA-BD 
vector,  pGBKT7  (Figure  5.3B),  to  create  pCD23a,,  pCD23at  pCI)23bý  and  pCD23bt 
respectively.  Figure  5.3c  illustrates  the  cloning  strategy  involved  in  the  generation  of 
each  of  the  CD23a  and  CD23b  single  and  triple  bait  fragments  and  the  restriction  sites 
utilised  in  order  to  clone  these  baits  into  the  pGBKT7  MCS.  Figure  5.3D  illustrates  the 
resultant  bait  constructs,  highlighting  any  additional  amino  acids  incorporated  as  a 
result  of  the  cloning  strategy.  Endonuclease  restriction  digestion  was  performed  to 
check  that  each  of  the  bait  inserts  had  been  cloned  correctly,  Figure  5.3E  shows  the 
fragment  banding  produced.  Each  construct  was  analysed,  and  the  CD23  N-terminal  tail 
fragments  were  confirmed  to  have  been  correctly  inserted  in-frame  (data  not  shown). 
pGBKT7  generates  a  fusion  of  the  GAL4  DNA-BD  and  the  bait  protein  and  facilitates 
the  growth  of  yeast  cells  expressing  this  plasmid  on  SD/-Trp  selection  medium. 
5.2.2  ExPRESSION  OF  THE  GAL4  DNA-BD-CD23  FUSION  BAIT  PROTEINS 
IN  AM  09  YEAST  CELLS 
The  four  GAL4  DNA-BD-CD23  bait  constructs  were  individually  transformed  into 
AH109  yeast  ceUs  and  tested  for  toxicity  and  autonomous  activation  of  the  MEW 
reporter  gene.  Toxicity  was  assessed  by  comparing  the  growth  rate  and  colony  number 
175 of  yeast  transformed  with  each  of  the  bait  constructs  and  yeast  transformed  with  the 
empty  pGBKT7  plasmid,  on  SD/-Trp  agar.  The  colony  growth  was  found  to  be  very 
similar  in  each  instance,  indicating  that  the  expression  of  the  CD23a,,  CD23at,  CD23bs 
and  CD23bt  proteins  was  non-toxic  in  yeast,  since  no  significant  reduction  in  colony 
number  or  growth  rate  was  observed.  Figure  5.4  shows  the  resultant  growth  of  AH109 
yeast  cells  containing  each  of  the  bait  vectors,  on  SD/-Trp  agar. 
Autonomous  activation  of  the  MELI  reporter  gene  was  assayed  by  growing  colonies 
expressing  each  of  the  bait  constructs  +/-  the  empty  pACT2  vector  on  SD/-Trp-Leu  or 
SD/-Trp  agar  containing  X-cc-Gal,  respectively.  Had  the  bait  plasmids  been  able  to 
activate  MEW  activity,  the  cc-galactosidase  enzyme  produced  would  have  been  able  to 
metabolise  the  X-cc-Gal  substrate  resulting  in  the  formation  of  blue  colonies.  This  was 
found  not  to  be  the  case,  indicating  that  none  of  the  bait  plasmids  are  able  to  self 
activate  MELI,  either  alone  or  in  the  presence  of  the  empty  GAL4  AD  vector,  pACT2 
(data  not  shown). 
Having  demonstrated  each  of  the  bait  plasmids  to  be  non-toxic  and  non-self  activating, 
it  was  then  vital  to  confirm  each  of  the  proteins  were  in  fact  being  expressed  correctly 
and  that  the  negative  findings  discussed  above  were  indeed  real.  Protein  expression  was 
analysed  by  direct  lysis  of  AH109  yeast  cells  transformed  with  each  of  the  four  bait 
constructs  using  the  TCA  protein  extraction  method  detailed  in  section  2.2.10B.  The 
proteins  were  detected  using  antibodies  specific  to  the  c-Myc  tag,  resulting  in  the 
identification  of  a  strong  band  at  the  30  and  36kDa  position  in  yeast  cells  transformed 
with  pC1323aýpC1323b,  and  pCD23at/pCD23bt  respectively  (Figure  5.5).  These  bands 
correspond  to  the  expression  of  each  of  the  CD23  N-terminal  tail  bait  proteins  as  fusion 
proteins  linked  to  the  GAL4  DNA-BD  and  a  c-Myc  tag.  Collectively  these  results 
clearly  demonstrate  that  each  bait  protein  is  not  only  being  expressed  correctly,  but  that 
each  protein  is  also  a  suitable  candidate  for  screening  using  this  yeast  two-hybrid 
system. 
176 5.2.3  SUCCEssFuL  AmpLiFiCATION  OF  THE  MATCHMAKER  HUMAN 
LEUKOCYTE  cDNA  LIBRARY 
A  human  leukocyte  MATCHMAKER  cDNA  library,  generated  from  normal  human 
leukocyte  mRNA  pooled  from  550  male/feniale  caucasians  ages  18-40,  was  obtained 
from  Clontech.  The  cDNA  had  been  Xho  I-(dT)15  primed  and  uni-directionally  cloned 
into  the  Eco  RI-Xho  I  sites  in  the  multiple  cloning  site  of  pACT2,  Figure  5.6A.  The 
library  had  been  prepared  using  oligo(dT)  priming,  used  to  eliminate  the  synthesis  of 
lengthy  poly(dT)  regions  and  ensure  that  fiffl  length  clones  and  3'  ends  would  be  well- 
represented  within  the  library  [Chenchik  et  al.,  1994;  Borson  et  al.,  1992;  Moqadarn  & 
Siebert,  1994]. 
The  pACT2  vector  generates  a  fusion  of  the  GAL4-AD  (amino  acids  768-881),  an  HA 
epitope  tag,  and  the  protein  encoded  by  the  CDNA  in  the  fusion  library.  The  expressed 
protein  is  targeted  to  the  yeast  nucleus  by  the  nuclear  localisation  sequence  from  the 
simian  virus  40  large  T-antigen  (SV40  T  antigen)  [Chien  et  al.,  1991]  that  has  been 
cloned  into  the  5'  end  of  the  GAL4  AD  sequence.  pACT2  also  contains  the  LEU2 
nutritional  gene  that  allows  yeast  auxotrophs,  to  grow  on  limiting  synthetic  media. 
The  information  provided  along  with  the  library  demonstrated  it  to  contain 
approximately  3.5  x  106  independent  clones,  with  insert  sizes  ranging  from  0.4  -  4.  Okb, 
the  average  size  being  2.  Okb.  The  library  was  re-titred  in-house  and  found  to  contain  4x 
108  colony  forming  units  (cfii)/ml  (Figure  5.6B),  using  the  method  detailed  in  section 
2.2.8A. 
The  library  sample  had  to  be  amplified,  see  section  2.2-9,  in  order  to  ensure  enough 
DNA  was  available  for  screening  purposes.  The  resultant  DNA  was  used  to  transform 
JM109  bacterial  cells.  10  individual  colonies  were  randomly  picked  and  subjected  to 
endonuclease  restriction  digestion.  All  10  plasmids  were  shown  to  contain  inserts  of 
varying  lengths.  These  results  indicate  that  the  amplification  step  had  not  caused  an 
obvious  loss  in  library  representation  and  indeed  that  the  DNA  sample  contained 
plasn-Ms  expressing  a  variety  of  cDNA  insert  sizes,  Figure  5.6c. 
177 5.2.4  01"FIMISATION  OF  TRANSFORMATION  EFFICIENCY  &  FIRST  PILOT- 
SCALE  SCREEN 
It  is  vitally  important  to  maximise  plasmid  uptake  in  order  to  be  able  to  effectively 
screen  the  largest  number  of  clones  possible  per  gg  of  library  DNA  added.  A  number  of 
transfon-nation  reactions  were  carried  out  in  order  to  establish  the  most  appropriate 
amount  of  library  DNA  to  add,  i.  e.  the  amount  of  DNA  producing  the  greatest  number 
of  colonies/ýtg  DNA. 
Table  5.1  shows  the  results  for  each  of  the  CD23a  bait  vectors,  as  the  number  of  double 
transformants  grown  on  each  of  the  SD/-Trp/-Leu  agar  plates.  The  findings  indicate  the 
addition  of  I  ýtg  of  library  DNA  to  give  the  best  transformation  efficiency  with  the 
pCD23a,  vector.  Addition  of  more  DNA  than  this  resulted  in  the  generation  of  less 
transfbrmants/ýtg  DNA,  thus  demonstrating  a  reduction  in  transformation  efficiency. 
The  transformation  efficiencies  using  the  pCD23b  baits  were  generally  found  to  be  less 
than  those  observed  for  the  pCD23a  baits  in  each  instance  (data  not  shown). 
Table  5.1  Optimisation  of  Transfonnation  Efficiency, 
recorded  as  number  of  cfu  per  SD/-Trp/-Leu  agar  plate 
Library  DNA  (pg)  pCD23&,  pCD23at 
0  0  0 
0.1  4  57 
1.0  397  24 
2.0  74  76 
5.0  232  267 
In  the  first  pilot-scale  yeast  two-hybrid  screen,  the  pCD23a,  and  pCD23at  bait 
constructs  were  employed.  In  each  case  the  bait  vector  was  initially  transformed  into 
competent  AH109  cells  prior  to  transformation  of  the  library  DNA.  The  resultant 
transformation  mixes  were  plated  onto  SD/-Trp/-Leu  agar  in  order  to  calculate  the 
efficiency  of  the  transformation  reaction  in  each  case,  calculated  using  the  formula 
given  in  section  2.2.10H.  These  plates  were  then  used  to  replica-plate  the  colonies  onto 
178 triple  dropout  agar  (SD/-Trp/-Leu/-His).  In  screening  less  than  IX  103  transformants 
this  experiment  was  too  small  to  identify  any  real  positive  interactors,  but  was  rather 
performed  as  run-through/test  experiment  of  this  new  technique.  The  pCI)23aý  bait  was 
found  to  give  higher  colony  growth  each  time  and  was  thus  chosen  as  the  bait  for  all 
initial  screening  work. 
5.2.5  FIRST  SMALL-SCALE  SCREEN  USING  THE  HumAN  LEUKOCYTE 
cDNA  LiBRARY 
Approximately  IX  105  yeast  transformants  were  screened,  resulting  in  the  growth  of 
hundreds  of  tiny  colonies  on  many  of  the  SD/-Trp/-Leu/-His  agar  plates.  The  largest, 
most  promising  of  these  colonies  were  picked  and  streaked  onto  fresh  agar,  identffying 
in  excess  of  40  colonies  that  grew  on  triple  selection  agar.  Triple  drop-out  agar  selects 
for  yeast  expressing  both  the  DNA-BD  and  AD  plasmids  as  well  as  activation  of  the 
HIS3  reporter  gene  and  therefore,  yeast  potentially  containing  interacting  proteins. 
Replica  plating  was  used  to  transfer  these  colonies  onto  quadruple  drop  out  agar  (SD/- 
Trp/-Leu/-His/-Ade),  reducing  the  number  of  colonies  to  38.  These  38  clones  were 
screened  for  expression  of  the  second  reporter  gene,  MELI  using  the  cc-galactosidase 
assay  (section  2.2.10G).  Of  these,  19  were  found  to  grow  repeatedly  on  quadruple 
dropout  agar  and  shown  to  express  a-galactosidase,  as  indicated  by  the  growth  of  blue 
colonies  on  agar  plates  containing  the  X-a-Gal  substrate.  Figure  5.7  shows  sample 
plates  containing  a  number  of  'positive'  clones  able  to  activate  MEL  I  reporter  gene 
activity,  inducing  cc-galactosidase  enzyme  activity  and  having  the  capability  to 
metabolise  the  X-cc-Gal  substrate.  The  non-reactive  (white)  colonies  were  discarded  at 
this  stage  as  false  positives.  This  library  screen  was  found  to  identify  19  'positive' 
clones  that  were  found  to  be  able  to  activate  the  ADE2,  HIS3  and  MELI  reporter  genes. 
The  plasmids  were  isolated  from  each  of  the  'positive'  yeast  clones  using  the  protocol 
detailed  in  section  2.2.10A.  The  resultant  DNA  preparations  were  used  to  transform 
electrocompetent  KC8  Exo1i  cells  (section  2.2.10C),  facilitating  the  isolation  of  each  of 
the  AD  plasmids.  The  AD  plasmids  were  then  subjected  to  endonuclease  restriction 
digestion  to  analyse  the  inserts  contained  in  each.  The  AD  plasmids  were  sequenced 
179 immediately,  using  the  pACT2  forward  and  reverse  insert  screening  primers,  detailed  in 
section  2.1.8c. 
Several  clones  (74%  of  those  analysed)  were  identified  as  containing  cDNA  inserts  with 
strong  nucleic  acid  sequence  homology  to  metallothionein  II  (MT-11).  However  each  of 
these  cDNA  inserts  were  found  to  contain  the  nucleic  acid  sequence  for  MT-II  in  the 
same,  incorrect  open  reading  frame  (ORF).  Figure  5.8  details  one  of  the  cDNA 
fragments  which  was  identified  many  times.  The  purple  box  and  text  indicate  the 
location  and  protein  sequence  of  MT-11,  incorporated  in  ORF  3  (Figure  5.8).  The  insert 
sequence  was  translated  using  the  correct  ORF  utilised  by  the  AD  vector  and  the 
resultant  protein  sequence  is  shown  as  pink  text.  All  of  the  'positive'  clones  identified  in 
this  small-scale  screen  were  deemed  to  be  false  positives  (for  a  variety  of  reasons)  and 
were  not  investigated  further. 
5.2.6  LARGE  SCALE  SCREEN  WITH  INCREASED  SELECTION  STRINGENCY 
After  two  unsuccessful  screens  identifying  only  false  positive  species,  the  stringency  of 
the  final  screen  was  increased,  (Figure  2.4)  by  plating  all  transformants  directly  onto 
quadruple  dropout  agar  (SD/-Ade/-His/-Trp/-Leu).  The  main  aim  of  this  strategy  was  to 
reduce  the  number  of  false  positives  identified,  as  theoretically  anything  which  could 
grow  under  these  higher  stringency  conditions  is  much  more  likely  to  be  a  truly  positive 
interactor.  The  drawback  is  that  proteins  which  interact  either  weakly  or  transiently  with 
the  CD23  bait  protein  may  not  be  detected  under  these  conditions. 
5.2.6A  IDENTIFICATION  OF  EIGHT  POTENTIALLY  POSITIVE  INTERACTORS 
Approximately  2x  106  independent  clones  were  screened.  50  x  150mm  plates  were  each 
spread  with  150pl  of  the  transformation  mix  and  the  plates  were  incubated  at  30'C  for 
up  to  15  days.  Colonies  were  picked  as  and  when  they  appeared.  A  total  of  14  colonies 
appeared  and  were  re-streaked  twice  onto  quadruple  drop  out  agar  plates,  the  second 
time  onto  agar  containing  the  X-cc-gal  substrate  in  order  to  test  for  MEW  activation. 
Just  8  clones  were  found  to  grow  consistently  on  the  quadruple  drop  out  agar  and  to 
have  the  ability  to  metabolise  the  X-cc-Gal  substrate  (data  not  shown). 
180 5.2.611  SEQUENCE  ANALYSIS  OF  THE  INTERACTING  LIBRARY  PROTEINS 
The  plasmids  were  isolated  from  each  of  the  8  'positive'  yeast  clones  and  the  resultant 
DNA  preparations  used  to  transform  electrocompetent  KC8  Exo1i  cells  (section 
2.2.10C),  facilitating  the  isolation  of  the  AD  plasmids  in  each  case.  The  plasmids  were 
subjected  to  restriction  endonuclease  digestion,  in  order  to  determine  the  size  of  the 
insert  each  vector  contained,  Figure  5.9.  Each  of  the  eight  AD  plasmids  were  then 
sequenced  immediately,  using  the  pACT2  forward  and  reverse  insert  screening  primers, 
detailed  in  section  2.1.8c. 
The  sequence  data  was  checked  and  manipulated  using  the  Macintosh-based  Edit  View 
and  Gene  Jockey  11  programs,  respectively.  Sequence  homology  searches  were 
performed  by  comparison  of  these  sequences  with  both  nucleic  acid  and  amino,  acid 
sequences  listed  in  the  GenBank,  EMBL  and  other  databases  using  a  number  of  BLAST 
searches  on  the  worldwide  web  (http:  //www.  ncbi.  nhu.  nih.  gov/BLAST)  in  order  to 
identify  the  interacting  library  cDNAs. 
Figure  5.10  summarises  the  sequence  data  obtained.  The  nucleic  acid  sequences  of  each 
of  the  cDNA  inserts  have  also  been  translated  in  the  correct  open  reading  frame  utilised 
by  the  AD  vector,  thus  illustrating  the  actual  amino  acid  sequence  of  each  of  the 
expressed  proteins.  In  the  correct  ORF,  clone  8  contains  a  cDNA  insert  encoding  a  very 
short  protein  of  only  4  amino  acids,  should  the  first  stop  codon  be  utilised,  and  is 
therefore  likely  to  be  a  false  positive.  Clones  2  and  4  may  also  be  interesting,  however 
the  sequence  data  obtained  from  these  samples  was  not  very  good  and  contained  a 
number  of  Ns  or  unknown  bases.  These  samples  would  have  to  be  re-sequenced  before 
being  investigated  further  and  this  could  not  performed  within  the  timescale  of  this 
project. 
Clones  7&9  gave  the  most  interesting  leads  with  each  of  the  cDNA  inserts  showing 
nucleic  acid  homology  to  a  number  of  the  human  filamin  proteins.  Clone  7  was  found  to 
contain  a  relatively  large  cDNA  insert  with  extensive  homology  to  a  carboxy  terminal 
segment  of  human  filamin  A.  The  cDNA  inserts  were  examined  further  and  translated 
according  to  the  open  reading  fi-ame  used  by  the  pACT2  vector.  The  cDNA  insert 
181 contained  within  clone  9  was  found  to  be  inserted  in  the  wrong  open  reading  frame  for 
the  pACT2  vector,  i.  e.  the  actual  expressed  protein  would  not  be  a  segment  of  human 
filan-fin.  However  the  cDNA  insert  fragment  of  clone  7  was  found  to  be  in  the  correct 
open  reading  frame  (ORF)  with  the  translation  indicating  the  expression  of  a  sizable 
segment  of  human  filamin  A  protein. 
5.2.6C  CONFIRMATION  OF  THE  INTERACTIONS  IN  YEAST 
The  AD  plasmid  preparations  were  used  to  re-transform  AH109  yeast  cells  along  with 
either  the  empty  GAL4  DNA-BD  vector,  pGBKT7  or  one  of  the  four  CD23  bait  vectors 
in  order  to  (i)  confirm  the  interaction  with  pCD23a,,  (ii)  identify  any  false  interactions, 
highlighted  by  activation  of  reporter  gene  expression  in  the  presence  of  the  empty  bait 
vector,  and  (iii)  investigate  whether  any  of  the  library  proteins  could  in  fact  interact  with 
any  of  the  other  CD23  bait  constructs.  Table  5.2  illustrates  the  colony  growth  observed. 
Table  5.2  Confirmation  of  Interaction  in  AH109  Cells 
Re-transforniation  of  Isolated  AD  Constructs 
Clone\Plasmid  pCD23a,  PCD23b,  pCD23a,  PCD23bt  pGBKT7 
2  +  +  + 
3  ii  +  +++ 
4  +  +  +  + 
5 
7  ++  ++  ++  ++ 
8  +  ++  +  + 
9  +  +  +  + 
10 
Key:  +=  1-25  colonies,  ++  =  25-200,  and  ...  =  >200  colonies. 
These  results  indicate  that  clones  2,3,5,8  and  9  contained  plasmids  expressing  proteins 
able  to  activate  reporter  gene  expression  in  the  absence  of  bait  protein  (i.  e. 
autonomously),  thus  demonstrating  these  proteins  to  be  false  positives.  Clone  3  was 
found  to  contain  a  cDNA  insert  displaying  homology  to  a  number  of  zinc  finger-like 
proteins  and,  according  to  the  sequence  data  should  express  this  protein  in  transformed 
182 yeast  cells.  These  proteins  are  known  for  their  ability  to  bind  DNA  and  it  may  indeed  be 
the  case  that  this  protein  is  able  to  bind  to  the  GAL4  DNA,  thus  stimulating  reporter 
gene  expression  without  any  protein-protein  interaction  occurring  with  the  bait  vector, 
explaining  the  results  observed  above.  Clone  10  was  also  demonstrated  to  be  a  false 
positive  as  re-transformation  into  fresh  yeast  was  unable  to  facilitate  any  colony  growth 
on  the  selection  agar.  The  colony  growth  in  the  presence  of  the  empty  pGBKT7  bait 
vector  is  shown  in  Figure  5.11. 
Clones  4  and  7  were  demonstrated  to  be  able  to  activate  transcription  of  the  reporter 
genes  in  the  presence  of  all  four  bait  constructs,  but  not  when  transfected  with  the 
empty  bait  vector,  indicating  that  these  cDNAs  encode  proteins  able  to  interact  with  the 
N-terminal  tail  section  of  both  the  CD23  isoforms.  Figure  5.12  shows  the  colony  growth 
obtained  with  either  clone  4  or  clone  7  and  each  of  the  CD23  bait  constructs. 
Activation  of  the  ADE2  and  MELI  reporter  genes  was  assayed  by  streaking  a  sample  of 
each  of  these  newly  transformed  yeast  cells  onto  SD  quadruple  drop  out  agar  plates 
containing  the  X-cc-Gal  substrate.  Clones  2,3,5,8  and  9  were  all  able  to  activate  MELI 
expression  in  the  presence  of  the  empty  bait  vector.  Whilst  clones  4  and  7  were  found 
only  to  be  able  to  activate  MELI  in  the  presence  of  a  CD23  bait  construct,  (data  not 
shown). 
5.2.61)  ANALYSIS  OF  HA-TAGGED  PROTEIN  ExPRESSION  FROM  EACH  OF  THE 
ISOLATED  AD  CONSTRUCTS 
Protein  expression  was  analysed  by  direct  lysis  of  AH109  yeast  cells  transformed  with 
the  AD  plasmids  of  clones  2,3,4,5,7,8,9  and  10  using  the  TCA  protein  extraction 
method  detailed  in  section  2.2.1  OB.  The  pACT2  AD  vector  expresses  proteins  as  fusions 
of  the  GAL4-AD  with  an  incorporated  haemagglutinin  (HA)  epitope  tag.  The  proteins 
were  therefore  detected  using  an  antibody  specific  for  the  HA-tag.  Figure  5.13  shows 
these  results.  HA-tagged  proteins  were  clearly  detected  in  AH109  cells  expressing 
clones  3,7,9  and  10.  No  obvious  HA-tagged  proteins  were  detected  from  AH109  cells 
expressing  clones  2,4,5  and  8  or  from  the  empty  pACT`2  vector  (should  have  expressed 
183 the  GAL4  AD  with  an  HA  tag).  For  this  reason  it  was  difficult  to  estimate  the  sizes  of 
each  of  the  proteins  detected,  as  it  was  impossible  to  subtract  the  size  of  the  GAL4  AD 
segment  and  the  IIA  tag. 
Collectively  these  results  suggest  that  clone  7  expresses  a  protein  of  real  interest,  due  to 
the  fact  that  it  does  not  show  autonomous  activation,  yet  did  activate  reporter  gene 
activity  in  the  presence  of  the  CD23  bait.  According  to  the  sequence  homology  searches 
it  seems  that  this  clone  corresponds  to  a  sizable  section  of  the  carboxy  terminus  of 
human  filamin  A,  and  that  it  is  encoded  in  the  correct  open  reading  frame  utilised  by  the 
vector,  suggesting  the  N-tenninus  of  CD23  may  bind  to  filamin  A.  Further  biochemical 
testing  is  required  to  prove  the  existence  of  this  protein-protein  interaction  in  native 
cells. 
Clone  4  also  gave  interesting  results,  as  it  to  was  able  to  activate  reporter  gene 
expression  in  the  presence  of  CD23  but  not  autonomously.  However  the  sequence  data 
obtained  for  this  clone  was  sub-standard,  containing  lots  of  unknowns  and  was  therefore 
redundant  when  trying  to  predict  the  protein  sequence  encoded  in  ORFl.  Further 
sequencing  would  have  to  be  performed  prior  to  further  analysis  of  this  clone.  This  was 
not  performed  during  the  timescale  of  this  project. 
5.2.7  THE  CD23-FiLAmiN  INTERACTION 
The  yeast  two-hybrid  system  screens  only  for  physical  properties  of  interacting  proteins, 
and  cannot  reveal  anything  about  the  biological  significance  of  the  detected  partners. 
CD23  and  filarnin  A  must  therefore  be  proven  to  interact  in  a  natural  scenario,  i.  e.  in 
cells  that  would  nornially  express  both  proteins,  before  this  interaction  can  be  concluded 
to  be  of  biological  significance. 
5.2.7A  FILAMIN  A 
The  positive  clone  isolated  from  the  yeast  two-hybrid  screen  encodes  a  large  segment  of 
the  carboxy  terminus  of  human  filamin  A.  The  first  question  to  be  asked  must  be  one  of 
184 tissue/cellular  distribution,  in  an  attempt  to  address  whether  or  not  CD23  and  filarnin  A 
may  ever  meet  in  a  natural  environment.  Human  filarnin  exists  in  three  forms,  A,  B  and 
C.  Previous  reports  have  demonstrated  filamin  A  to  be  present  in  a  wide  range  of 
different  cell  types  encompassing  a  variety  of  cells  of  the  human  immune  system, 
including  B  cells  [as  reviewed  by  Stossel  et  al,  20011.  These  reports  certainly  suggest 
this  may  be  a  feasible  reaction,  based  purely  on  the  possibility  of  the  two  proteins  being 
able  to  come  into  contact  with  one  another.  Table  5.3,  adapted  from  this  review  paper, 
details  the  nomenclature  used  for  the  human  filamin  proteins  as  well  as  information  on 
the  expression  patterns  of  each. 
Table  5.3  Proposed  Nomenclature  for  the  Human  Filamin  Proteins. 
Proposed  Previous  Names  No.  of  Expression 
name  Repeats 
hsFLNa  ABP,  ABP-280,  FLNI,  24  Widely  expressed  abundantly  in  a 
non-muscle  FLN,  variety  of  human  tissues  [Gorlin  el 
(xFLN  al.,  1990;  Gorlin  el  al.,  1993; 
Maestnni  el  al.,  19931 
hsFLNb  PFLN,  FHI,  FLN3  24  Broad  distribution  [Zhang  el  al., 
1998;  Takafua  el  al.,  1998;  Xu  el 
al.,  1998;  Brocker  el  al.,  1999; 
Chakarova  el  al.,  2000]  less 
abundant  than  FLNa 
hsFLNc  7FLN,  ABP-L,  FLN2  24  Predominant  in  muscle 
5.2.7B  HUMAN  FILAMIN  MAV  IMMUNO-PRECIPITATE  WITH  CD23  FROM  THE  RMPI 
8866  B  CELL  LINE 
Proteins  expressed  together  in  the  infonnative,  yet  still  artificial,  yeast  two-hybird 
system  may  never  in  fact  naturally  come  into  contact  with  one  another  in  a  host  cell,  if 
for  example  if  they  were  to  be  expressed  in  different  sub-cellular  compartments  or  at 
different  stages  of  development.  The  biological  significance  of  any  identified  protein- 
protein  interaction  must  therefore  be  proven  and  co-immunoprecipitation  or 
immuno  fluorescence  assays  are  the  usual  choice,  enabling  the  confirmation  of  the 
mteraction  in  a  relevant  host  cell.  In  an  attempt  to  confirm  the  interaction  between 
CD23  and  filamin  Aa  co-immunoprecipitation  experiment  was  performed.  The  RPMI 
8866  B  cell  fine  was  chosen  due  to  the  fact  that  it  is  known  to  naturally  express  good 
185 levels  of  CD23  protein.  An  initial  experiment  was  performed  in  an  attempt  to  establish 
whether  or  not  filamin  A  is  expressed  in  this  cell  line,  however  the  results  obtained  were 
inconclusive.  The  co-immunoprecipitation  experiment  was  then  performed,  following 
the  protocol  detailed  in  section  2.2.7. 
RPMI  8866  cells  were  exposed  to  (i)  no  stimulus,  (ii)  I  pg  NIP-specific  IgE  antibody  or 
(iii)  I  tig  NIP-specific  IgE  antibody  followed  by  I  gg  NIP-BSA.  Two  experiments  were 
performed  in  parallel  using  either  anti-CD23  or  anti-filamin  antibodies  to  immuno- 
precipitate  the  proteins  of  interest.  The  samples  were  then  separated  by  SDS-PAGE, 
transferred  to  nitroceRulose  and  immuno-blotted  with  anti-filanin  or  anti-CD23 
antibodies,  respectively.  Figure  5.14  shows  the  results  of  the  first  and  only 
CD23/filamin  co-immunoprecipitation  experiment  performed  at  the  end  of  this  project. 
The  results  were  promising  and  indicated  the  presence  of  bands  of  approximately  the 
correct  sizes.  Filamin  A  is  a  210kDa  protein,  and  may  be  present  at  the  top  of  the  anti- 
FLN  blot  (Figure  5.14).  The  samples  from  the  filamin  immunoprecipitation  were  run 
again  on  a  10%  SDS-PAGE  gel,  facilitating  better  separation  of  the  proteins  and  thus  a 
better  estimate  of  the  size  of  the  resultant  bands  when  blotted  with  an  anti-CD23 
antibody.  The  results  suggest  that  the  bands  of  interest  may  indeed  be  CD23  as  they  are 
expressed  at  approximately  the  correct  45kDa  size  (Figure  5.15).  It  should  be  noted  than 
this  experiment  was  only  done  once,  due  to  the  lack  of  time,  and  cannot  be  used  to  state 
categorically  that  CD23  and  filan-dn  A  do  not  interact,  but  rather  provide  encouraging 
evidence  to  the  contrary,  suggesting  that  they  rnight  bind.  Further  investigation  is 
required  to  unequivocaRy  prove  this  interaction. 
5.3  DiscusSION 
Binding  partners  for  the  cytoplasmic  N-terminal  tail  of  CD23  were  investigated  using 
the  yeast  two-hybrid  assay  and  a  human  leukocyte  cDNA  library.  The  yeast  two-hybrid 
assay  has  several  advantages  over  other  methods  as  it  is  performed  in  vivo  (in  the  yeast 
nucleus)  and  therefore  the  proteins  involved  are  more  likely  to  be  expressed  in  their 
natural  conformation,  unlike  in  the  more  biochemical  methods  where  bait  proteins  are 
generally  bound  to  affinity  columns  or  nitrocellulose  membranes,  and  therefore  not 
necessarily  displayed  in  their  natural  conformation.  The  conditions  of  the  yeast  two- 
186 hybrid  assay  are  also  more  likely  to  mimic  those  observed  in  the  natural  scenario  in 
comparison  to  those  of  a  typical  in  vitro  biochemical  assay.  Finally,  another  advantage 
is  that  the  yeast  two-hybrid  system  is  highly  sensitive,  with  the  ability  to  detect  both 
weak  and  transient  interactions  that  may  be  typical  of  large  protein  complexes 
[Guarente,  1993]. 
There  are  however,  several  disadvantages  to  the  yeast  two-hybrid  systen-4  including  the 
completion  of  processes  that  usually  require  non-yeast  proteins,  such  as  protein  folding. 
The  other  main  disadvantage  is  that  not  all  post-translational  modifications  occur  in 
yeast,  for  example  tyrosine  phosphorylation  rarely  occurs  in  S.  cerevisiae  [Gartner  et  al., 
1992;  Lim  et  al.,  1993].  However  it  has  been  shown  that  more  post-translational 
modifications  do  occur  in  yeast  than  in  bacterial  protein  expression  systems  [Phizichy  & 
Fields,  1995].  The  cytoplasmic  tail  of  CD23a  does  theoretically  have  the  potential  to  be 
phosphorylated,  although  the  functional  role  of  this  modification,  should  it  occur,  is  not 
Yet  known  and  should  it  occur,  it  may  or  may  not  affect  protein  binding.  The 
mammalian  two-hybrid  system  would  offer  one  simple  advantage  over  the  yeast  system, 
possibly  removing  all  these  disadvantages,  in  that  it  would  allow  CD23,  protein 
interactions  to  occur  in  their  native  environment  [Dang  et  al.,  1991;  Fearson  et  al., 
1992].  However,  this  assay  is  not  practical  for  screening  large  numbers  of  transfectants 
[Osborne  et  al.,  1997],  a  process  necessary  for  initially  identffying  interacting  clones 
from  the  many  cDNAs  encoded  within  a  large  expression  library. 
In  summary,  the  results  detailed  within  this  chapter  have  identified  human  filamin  A  as 
a  potential  binding  partner  for  the  cytoplasmic  N-terminal  tail  of  CD23.  Filamins  are 
large  actin-binding  proteins  that  serve  to  stabilise  delicate  three-dimentional  actin  webs, 
link  these  to  cellular  membranes,  and  have  been  shown  to  integrate  architectural  and 
signalling  functions  [as  reviewed  by  Stossel  et  al,  2001].  Due  to  the  fact  that  different 
members  of  this  family  were  discovered  using  a  variety  of  techniques  and  approaches 
there  is  a  distinct  lack  of  consistency  in  the  nomenclature.  A  uniform  naming  system 
has  since  been  proposed  and  is  shown  in  Table  5.3  [Stossel  et  al,  2001].  The  minimal 
requirement  for  membership  of  the  filamin  family  is  a  string  of  the  characteristic 
repeated  P-sheet  units.  The  amino  acid  sequences  of  the  human  filamin  members  show 
187 approximately  60-80%  overall  sequence  homology,  with  the  greatest  variation  occurring 
in  the  carboxy-terminal,  self-association  domains. 
5.3.1  THE  STRUCTURE  OF  HumAN  FILAMN  A  (FLNA) 
The  amino-terminal  actin-binding  domain  contains  sequence  motifs  found  in  many 
actin-filament  binding  proteins  [Lebart  et  al.,  1994]  with  the  remainder  of  the  protein 
consisting  of  24  repeats  of  -96  amino  acids  each,  interrupted  by  one  or  two  short  hinge 
segments.  Secondary  structure  algorithm  modelling  of  these  domains  indicates  the  P- 
sheets  to  overlap  in  an  anti-parallel  manner  to  form  a  rod  shape  [Gorlin  et  al.,  19901, 
and  dimerisation  has  been  shown  to  occur  via  the  24th  repeat.  Figure  5.16  illustrates  the 
structure  of  FLNa  and  indicates  where  CD23  is  thought  to  bind  to  this  molecule. 
Although  the  exact  amino  acids  involved  in  the  interaction  between  CD23  and  FLNa 
have  not  yet  been  established,  it  is  proposed  that  filamin  may  indeed  interact  with  the 
common  tail  region  as  it  was  found  to  interact  with  all  four  of  the  CD23  bait  species. 
Although  the  work  presented  in  this  chapter  has  not  categorically  proven  the  interaction 
between  CD23  and  filamin  A  in  native  cells,  I  firmly  believe  this  interaction  does  occur 
in  nature.  A  variety  of  information  supports  this  theory,  not  least  of  which  being  that 
filamin  A  has  been  shown  to  interact  with  a  number  of  other  transmembrane  proteins, 
not  dissimilar  to  CD23,  and  is  involved  in  a  number  of  functions  also  relevant  to  the 
biological  activity  of  CD23. 
The  biological  relevance  of  any  newly  identified  protein-protein  interaction  can  be 
difficult  to  define,  and  certainly  the  function  of  the  interaction  between  CD23  and 
filamin  can  only  be  speculated  at  this  current  time,  however  it  seems  likely  that  FLNa 
may  act  as  an  adaptor  protein,  Ihiking  CD23  to  the  necessary  signalling  pathways 
required  for  its  function.  Recent  studies  support  this  theory,  having  shown  that  FLNa 
can  and  does  function  as  a  docking  protein  for  various  cell  surface  receptors  and 
intracellular  proteins  involved  in  signalling  and  endocytosis,  these  proteins  include 
GPIba/pIX  [Andrews  &  Fox,  1991,1992],  FcyRI  [Ohta  et  al.,  1991;  Harrison  et  al., 
1994],  SEK-1  [Marti  et  al.,  1997],  P2-integrin  [Sharma  et  al.,  1995],  PI  -integrin  [Loo  et 
al.,  1998],  Mn  [Liu  et  al.,  1997],  TNF  receptor-associated  factor  2  (TRAF-2) 
[Leonardi  et  al.,  2000]  and  the  small  GTPases  Rac,  Rho,  Cdc42  and  RaIA  [Ohta  et  al., 
188 1999].  Table  5.4  lists  a  number  of  proteins  demonstrated  to  interact  with  filamin,  and 
details  the  functional  significance  of  these  interactions.  Further  analysis  is  required  to 
unequivocally  define  the  biological  purpose  of  the  interaction  between  CD23  and  FLNa- 
Table  5.4  Some  of  the  Binding  Partners  Identified  for  the  Human  Filamins 
Protein  Filamin  Filamin  Reference  Functional  I 
Repeat  Significance 
Transtnembrane 
Proteins 
GP-Ibcc  (member  FLN-a/b  17-19  Meyer  el  al.,  Promotes  cell 
of  Von  Willebrand  1997  spreading 
receptor  complex) 
PIA,  PID,  P2,  P3,  FLN-a/b  20-24  Calderwood  el  Mechanoprotection 
and  P7  integrins  al.,  2000 
Tissue  factor  FLN-a  23-24  Ott  el  al.,  1998  Cell  adhesion  and 
migration 
Fc7RI  FLN-a  ?  Ohta  el  al.,  1991  1? 
Furin  Receptor  FLN-a  13-14  Liu  el  al.,  1997  Directs  intracellular 
trafficking  of  furin 
Androgen  receptor  FLN-a/c  16-19  Ozanne  el  al.,  Translocation  of 
2000  androgen  receptor  to 
nucleus 
Lnk  adaptor  protein  FLN-a  19-23  He  el  al.,  2000  1? 
(ABP-280) 
Signalling  Proteins 
RhoA,  Rae  1,  FLN-a  21-24  Ohta  et  al.,  1999  9 
Cdc42 
Ral-A  FLN-a  24  Ohta  el  al.,  1999  Promotes  fiormation 
offilopodia 
TRAF2  FLN-a  15-19  Leonardi  ei  al.,  Involved  in  SAPK 
2000  or  NF-03  activation 
A  number  of  false  positive  species  were  also  identified  during  the  course  of  these 
studies,  (as  is  usually  the  case  in  a  yeast  two-hybrid  assay),  however  one  of  these 
proteins  was  isolated  several  times.  Although  results  on  false  positive  interactions  are 
generally  not  reported,  it  is  known  that  some  proteins  are  continually  re-isolated  using 
unrelated  bait  proteins,  these  include  ribosomal,  mitochondrial,  ferritin,  ubiquitin.  some 
189 proteosome  subunits  and  certain  cytoskeletal  proteins  [Golemis,  1995;  Golemis  & 
Brent,  1997].  The  detection  of  some  false  positive  clones  can  be  due  to  the  biological 
properties  of  the  proteins,  others  are  for  as  yet  unknown  reasons.  For  example,  frequent 
isolation  of  ribosomal  proteins  could  be  due  to  the  extensive  hydrophobic  or  charged 
residues  that  can  interact  with  corresponding  regions  on  a  bait  protein  [Golemis  & 
Brent,  1997].  There  may  be  a  similar  argument  for  the  isolation  of  such  a  high  number 
of  clones  expressing  cDNAs  with  nucleic  acid  homology  to  MT-11,  if  the  actual  protein 
expressed  contains  domains/motifs  recognised  by  the  CD23  bait  protein.  However  this 
information  could  only  be  obtained  once  it  is  known  what  proteins,  and  indeed  the 
particular  regions  of  these  proteins,  that  CD23  binds  to. 
Collectively,  these  data  have  shown  the  yeast  two-hybrid  system  to  be  a  valuable  tool 
for  identifying  potential  binding  partners  of  the  N-terminal  tail  of  CD23.  This  project 
has  effectively  opened  the  door  for  a  range  of  future  experiments,  not  only  to  further 
characterise  the  protein-protein  interaction  that  occurs  between  CD23  and  filamin  but 
also  to  address  the  question  of  which  other  proteins  bind  to  the  CD23/filamin  complex, 
should  filamin  be  acting  as  an  adaptor  protein,  facilitating  the  downstream  signalling  of 
or  function  of  CD23.  The  yeast  two-hybrid  system  should  also  be  used  to  identify  other 
proteins  of  interest,  particularly  as  the  entire  cDNA  library  was  not  screened  during  the 
course  of  this  project,  and  to  establish  if  any  differences  do  indeed  exist  between  the 
signalling  pathways  employed  by  each  of  the  CD23  isoforms,  something  which  has 
been  speculated  many  times  before  but  has  yet  not  been  proven  conclusively. 
190 FIGURE  5.1A  SCHEMATIC  REPRESENTATION  OF  THE  PRINCIPLE  BEHM 
THE  YEAST  Two-HyiBRiD  SYSTEM 
(i)  In  the  native  scenario  the  GAL4  protein  contains  both  DNA-binding  and  activating 
regions  and  induces  GAL  I  -lacZ  transcription. 
This  system  has  been  adapted  to  enable  the  identification  of  novel  protein  interactions. 
(ii)  Hybrids  containing  either  the  DNA-binding  domain  (upper)  or  activating  region 
(lower)  are  unable  to  induce  transcription  alone. 
(iii)  When  bait  and  library  fusion  proteins  interact,  the  DNA-131)  and  AD  are  brought 
into  proximity,  thus  activating  transcription  of  the  reporter  genes. 
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ý*Transcription FIGuRE  5.111  SCHEMATIC  REPRESENTATION  OF  THE  PRINCIPLE  BEHIND 
THE  MATCHMAKER  3  YEAST  Two-HYBRiD  SYSTEM 
The  DNA-BD  is  amino  acids  1-147  of  the  yeast  GAL4  protein  and  it  binds  to  the  GAL 
upstream  activating  sequence  (UAS)  upstream  of  the  reporter  genes,  ADE2,  HIS3, 
MEW  and  lacZ.  The  AD  is  amino  acids  768-881  of  the  GAL4  protein  and  it  functions 
as  the  transcriptional  activator. 
The  bait  protein  is  the  N-terminal  cytoplasmic  tail  of  human  CD23,  either  presented  as  a 
single  or  triple  repeat  protein,  fused  to  the  GAL4  DNA-BD.  Screening  for  binding 
partners  will  be  against  proteins  encoded  by  a  human  leukocyte  cDNA  library  that  has 
been  made  as  fusions  to  the  GAL4  AD  sequence.  Interaction  of  CD23  with  a  protein 
encoded  within  the  cDNA  library  will  result  in  the  transcriptional  activation  of  the 
reporter  genes,  ADE2,  HIS3,  MELI  and  lacZ,  detected  by  nutritional  selection  and 
enzymatic  assay. 
192 Z 
en 
c:  >,  m  <  cl  0  *0" 
Z<  $0  uz FIGuRE  5.2  THE  AH109  YEAST  STRAIN 
The  AH109  strain  is  a  derivative  of  PJ69-2A  yeast  and  includes  the  ADE2  and  HIS3 
markers  [James  et  aL,  1996].  MEW  is  an  endogenous  GAM-responsive  gene.  The  lacZ 
reporter  gene  was  introduced  into  PJ69-2A  to  create  AH109  [Holtz,  A.  unpublished]. 
MELI  and  lacZ  encode  cc-galactosidase  and  P-galactosidase  respectively,  with  (x- 
galactosidase  being  a  secreted  enzyme  that  can  be  assayed  directly  on  X-a-Gal  indicator 
plates  which  employ  blue/white  screening.  The  HIS3,  ADE3  and  MELI/lacZ  reporter 
genes  are  under  the  control  of  three  completely  heterologous  GAL4-responsive  UAS 
and  promoter  elements  (TATA  boxes)  -  GALI,  GAL2  and  MELI  respectively,  serving 
to  minimise  the  detection  of  false  positives,  particularly  those  that  interact  directly  with 
the  sequences  flanking  the  GAM  binding  site  and  those  that  interact  with  transcription 
factors  bound  to  specific  TATA  boxes. 
The  AH 109  genotype  is  listed  in  the  table. 
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AH  109  Yeast  Strain  Genotvoe 
Strain  Genotype  Reference 
AH109  MATa,  trpl-901,  leu2-3,112,  ura3-52,  his3-200,  ga14A,  ga180A.  James  el  al., 
LYS2  -  GALIjjAs-GALI  TATA-HIS3, 
GAL2jIAS-GAL2'FATA-  1996 
ADE2,  URA3  -  -.  MELII  IAS-MELI 
TATA-IacZ FIGURE  5.3  GENERATION  OF  THE  CD23  BAIT  CONSTRUCTS 
The  ofigonucleotides  used  to  generate  each  of  the  CD23  tail  fragments  flanked  by 
additional  restriction  sites  are  detailed  in  A,  for  easy  insertion  into  the  pGBKT7 
multiple  cloning  site,  plasmid  map  shown  in  B,  with  the  cloning  strategy  explained  in 
the  schematic  diagram  C.  D  illustrates  the  resultant  proteins,  highlighting  the  additional 
amino  acids  incorporated  due  to  the  cloning  strategy  used.  Each  of  the  constructs  were 
subjected  to  restriction  digestion  analysis  with  (i)  Nde  I  -Not  I  and  (ii)  Hind  III  and  the 
banding  patterns  produced  are  shown  in  E  in  lanes  2,4,6,  &8  and  lanes  3,5,7,  &9 
respectively.  Key;  CD23a,  -  lanes  2&3,  CD23at  -  lanes  4&5,  CD23b,  -  lanes  6&7, 
CD23h  -  lanes  8&9. 
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ARE  NoN-Toxic  IN  YEAST  AH109  CELLS 
Four  allquots  of  competent  AH109  yeast  were  transformed  with  IVI  of  each  of  the 
CD23  N-terminal  bait  plasmids.  Resultant  colony  growth  for  each  of  these  four 
transformants  was  compared  with  yeast  transformed  with  the  empty  DNA-BD  vector 
pGBKT7.  Scans  of  each  agar  plate  clearly  show  that  colony  growth  is  not  restricted  by 
any  of  the  CD23  N-terminal  bait  proteins,  indicating  that  these  constructs  are  not  toxic 
to  the  AH  109  yeast  cells. 
Key  to  scans;  A,  =  pCD23a,,  B,  =  pCD23b,,  At  =  pCD23at,  Bt  =  pCD23bt.  Growth  for 
yeast  containing  empty  DNA-BD  vector  not  shown. 
195 FIGURE  5.5  ExPRESSION  OF  THE  CD23  N-TERMINAL  TAIL  AS  A  C-MYC 
FUSION  PROTEIN  IN  AM  09  YEAST 
Each  of  the  CD23  N-terminal  baits  were  independently  transfected  into  AH109  yeast 
cells  and  selected  on  SD/-Trp  agar.  An  overnight  culture  of  each  sarnple  was  subjected 
to  TCA  protein  extraction,  with  15gl  of  the  final  protein  product  loaded  onto  a  10% 
SDS-PAGE  gel.  The  separated  proteins  were  then  transferred  to  nitrocellulose 
membrane  and  immunoblotted  with  anti-cMyc  antibody.  The  blot  was  visualised  using 
the  BioRad  ECL  detection  kit.  The  pGBKT7  vector  expresses  each  protein  as  a  fusion 
of  the  GAIA  DNA-BD  and  the  c-Myc  tag. 
Key;  Lane  I-  empty  pGBKT7  vector,  Lane  2-  pCD23a,,  Lane  3-  pCD23at,  Lane  4- 
pCD23b,,  Lane  5-  pCD23bt. 
196 FIGuRE  5.6  SUCCEssFuL  AmpLiFICATION  OF  THE  HumAN  LEUKOCYTE 
CDNA  LIBRARY 
The  Clontech  Human  Leukocyte  cDNA  library  had  been  Xho  I-(dT)15  primed  and 
unidirectionally  cloned  into  the  multiple  cloning  site  (MCS)  of  the  pACT2  vector, 
generating  library  fusion  proteins  with  the  GAL4  AD  and  haemagglutinin  (HA)  epitope 
tag.  Figure  A  shows  the  plasmid  map,  and  restriction  sites  incorporated  in  the  MCS,  for 
pACT2.  The  library  sample  was  titred  'in-house'  prior  to  arnplification  and  found  to 
contain  4.4  x  108  colony  forming  unitsha  B  using  the  method  described  in  2.2.8A. 
After  amplification  10  random  colonies  were  chosen  and  subjected  to  restriction 
endonuclease  digestion  with  Bgl  II,  in  order  to  analyse  the  cDNA  insert  contained 
within  each,  Figure  C  illustrates  the  results. 
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103  X  103  X  103 
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3.97  x  10' 
4,4  x  10' 
4.4  x  108 FIGuRE  5.7  X-a-GAL  TEST  FOR  MEM  ACTIVATION 
This  figure  shows  sample  plates  containing  a  number  of  'positive'  clones  able  to 
activate  MEL  I  reporter  gene  activity,  inducing  a-galactosidase  enzyme  activity  and 
therefore  the  ability  to  metabolise  the  X-a-Gal  substrate.  Plate  A  shows  the  results  of  a 
number  of  samples  which  had  been  simply  picked  and  then  seeded  directly  onto  the 
agar  in  a  single  swab.  Plate  B  shows  the  results  of  a  number  of  the  same  samples 
streaked  out  onto  the  agar  plate  in  order  to  generate  single  colonies  in  each  case.  The 
method  shown  in  B  was  by  far  the  more  reliable  way  to  test  for  MELI  activation,  with 
those  clones  demonstrating  single  colonies  able  to  activate  MELI  activity  possessing 
real  ability  to  metabolise  the  X-cc-Gal  substrate. 
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* FIGLTRE  5.8  THE  RECURRING  cDNA  CLONE  -  IDENTIFIED  To  ENCODE 
METALLOTHIONEIN-11  (MT-11)  IN  OPEN  READING  FRAME  (ORF)  3 
This  figure  details  one  of  the  cDNA  fragments  that  was  identified  many  times  in  the 
first  small-scale  screen.  The  insert  sequence  was  translated  using  the  correct  ORF 
utilised  by  the  AD  vector  and  the  resultant  protein  sequence  is  shown  as  pink  text.  The 
purple  box  indicates  the  location  of  the  DNA  sequence  with  homology  to  MT-11  and 
the  purple  text  indicates  the  protein  sequence  of  MT-11,  incorporated  in  ORF  3. 
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u FIGURE  5.9  RESTRICTION  ANALYSIS  OF  THE  8  'POSITIVES'  IDENTIFIED  IN 
THE  HIGHER  STRINGENCY  YEAST  Two-HYBRm  SCREEN 
Yeast  DNA  preparations  were  performed  as  per  2.2.10A  and  used  to  transform  KC8 
E.  coli  cells,  embling  the  isolation  of  each  of  the  AD  plasmids.  The  AD  plasmids  were 
subjected  to  restriction  endonuclease  digestion  with  BgI  II  to  clip  the  cDNA  inserts  from 
the  MCS  in  the  PACT2  vector.  The  results  showed  the  presence  of  inserts  of  varying 
sizes,  indicating  that  the  same  cDNA  insert  had  not  been  identified  8  times. 
200 FIGURE  5.10  SUMMARY  OF  THE  SEQUENCE  DATA  OBTAINED  FOR  THE 
EIGIff  POSITIVE  CLONES  IDENTIFIED  IN  THE  FINAL  YEAST  Two-HYBRW 
SCREEN 
The  DNA  sequences  for  each  of  the  cDNA  inserts  have  been  listed,  with  the  identified 
nucleic  acid  homology  also  shown.  The  open  reading  frame  (ORF)  used  by  the  pACT2 
vector  is  ORFI,  and  the  ORF  for  each  of  the  homologies  identified  has  also  been  - 
shown.  In  each  instance  the  cDNA  encoded  in  each  vector  has  been  translated  in  ORF1 
demonstrating  the  protein  which  would  be  generated  by  the  cells  expressing  each  of 
these  vectors.  These  results  indicate  that  clones  3,  and  7  are  the  only  clones  to  express  a 
cDNA  insert  with  homology  for  a  given  protein  in  the  correct  reading  frame  for  the 
expression  of  that  same  protein.  The  data  from  clones  2,4  and  5  are  inconclusive  with 
regards  to  ORF,  due  to  the  poor  sequence  information  obtained. 
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00 FIGURE  5.11  CLONES  2,3,5ý  8  AND  9  ARE  ABLE  To  ACTIVATE  HIS3 
ExPREssioN  IN  THE  PRESENCE  OF  THE  Emffy  BAiT  VECTOR 
Each  of  the  KC8  DNA  preparations  were  used  to  re-transform  AH109  yeast  cells  along 
with  either  the  empty  pGBKT7  bait  vector  or  one  of  the  CD23  bait  constructs  and 
grown  on  triple  selection  media  (SD/-Trp/-Leu/-His).  The  AD  plasmids  isolated  from 
clones  2,3,5,8  and  9  were  able  to  activate  reporter  gene  expression  (His3)  in  the 
presence  of  the  empty  pGBKT7,  bait  vector  and  grow  on  triple  selection  agar.  The  AD 
plasmids  isolated  from  clones  4,7  and  10  were  found  to  be  unable  to  grow  on  triple 
selection  medium  in  the  presence  of  the  empty  bait  vector. 
202 FIGURE  5.12  CLONES  4  AND  7  ARE  ABLE  To  ACTIVATE  HIS3  ExPRESSION 
ONLY  IN  THE  PRESENCE  OF  THE  CD23  BAIT  VECTORS 
Clone  10  was  unable  to  grow  in  the  presence  of  any  of  the  CD23  bait  constructs  (data 
not  shown),  however  the  AD  plasmids  isolated  from  clones  4  and  7  were  found  to  be 
able  to  activate  reporter  gene  expression  with  the  CD23  bait  constructs  but  not  in  the 
presence  of  the  empty  bait  vector,  as  shown  in  the  previous  figure.  Clone  7  was  found  to 
have  better  growth  than  clone  4,  demonstrating  a  greater  number  of  colonies  on  each 
plate.  Clone  7  also  seemed  to  interact  better  with  the  single  bait  vectors,  producing  more 
transformants  with  these  in  comparison  to  the  triple  bait  vectors. 
Key;  (i)  pCD23a,  (h)  pCD23N  (ifi)  pCD23at  (iv)  pCD23bt 
203 FIGURE  5.13  PROTEIN  EXPRESSION  FROM  THE  ISOIATED  AD  VECTORS 
Yeast  cells  were  transformed  with  each  of  the  AD  plasmids  isolated  from  the  8  clones, 
in  order  to  assess  protein  expression  from  each  vector.  TCA  protein  extractions  were 
performed  as  per  2.2.10B  and  15ýtl  of  each  sample  was  separated  on  a  10%  SDS-PAGE 
electrophoresis  gel.  The  protein  samples  were  transferred  to  nitrocellulose  membrane 
and  immunoblotted  with  antibody  specific  for  the  HA  epitope  tag. 
The  results  indicate  strong  protem  expression  of  HA-fusion  proteins  from  clones  3,7,9 
and  10.  However  HA-tagged  protein  expression  was  not  observed  from  the  empty  bait 
vector,  making  it  impossible  to  estimate  the  sizes  of  each  of  these  expressed  proteins 
without  the  HA-tag  and  GAL4  AD  protein. 
204 FIGuRE  5.14  CD23  MAY  INTERACT  WITH  FLNA  IN  RPMI  8866  CELLS 
The  B  cell  line  RPMI  8866  were  cultured  in  complete  RPMI  media  and  harvested  on  the 
day  of  experimentation.  The  cells  were  counted,  resuspended  in  l2ný  of  RPMI  medium 
at  1.5  x  107  cells/ml  and  split  equally  amongst  the  wells  of  a6  well  plate.  The  three 
duplicate  samples  were  treated  with  (i)  no  addition,  (ii)  IgE  anti-NIP  antibodies  or  (iii) 
IgE  anti-NIP  antibodies,  followed  by  NIPIO-BSA  for  10  minutes  at  37'C  before  they 
were  subjected  to  lysis  with  OGP  buffer  and  immunoprecipitated  with  either  anti-CD23 
or  anti-filamin  antibody.  The  proteins  bound  to  sepharose-protein  G  beads  were 
harvested,  separated  on  6%  SDS-PAGE  and  immunoblotted  with  the  opposite  antibody. 
The  blot  was  visualised  using  the  BioRad  ECL  detection  kit.  The  flow  chart  summarises 
this  experiment  and  the  numbers  attached  to  each  sample  corresponds  with  the  numbers 
labelling  the  ECL  gel  scan.  UB  denotes  the  unbound  samples  from  the  appropriately 
labelled  tubes. 
5ýtg  IgE  anti-NIP 
Treatment  5ýtg  IgE  anti-NIP 
+  5n  NIP-BSA 
f_ý  f_ý  f_ý 
142536 
Immunoprecipitation  Anti-Filamin  Anti-CD23 
Antibody 
Blotting 
Anti-CD23  Anti-Filamin  Antibody 
205 Anti-FLN  Blot 
23456  UB4  UB5  UB6 
Anti-CD23  Blot FIGURE  5.15  CD23  MAY  INTERACr  wrrH  FLNA  IN  RPMI  8866  CELLS  (2) 
Those  samples  shown  on  the  lower  blot  of  the  previous  figure  were  run  again  on  a  10% 
SDS  PAGE  gel  in  order  to  enhance  protein  separation,  and  immunoblotted  with  anti- 
CD23  antibody.  The  blot  was  visualised  using  the  BioRad  ECL  detection  kit.  The  flow 
chart  shown  on  the  previous  figure  summarises  the  experimental  conditions,  and  details 
the  contents  of  each  lane.  UB  denotes  the  unbound  samples  from  the  appropriately 
labelled  tubes. 
206 Anti-CD23  Blot 
206  kDa 
va  124  kDa 
42  kDa 
32  kDa 
19  kDa 
23456  UBI  UB2  U113 FIGURE  5.16  SCHEmATic  DIAGRAM  ILLUSTRATING  THE  PROPOSED 
STRUCTURE  OF  HUMAN  FLNA 
The  diagram  illustrates  the  structural  model  for  human  filamin  a,  (FLNa).  FLNa 
contains  24  repeats  of  -96  amino  acids  each.  These  domains  are  thought  to  fold  into 
anti-parallel  P-pleated  sheet  structures  that  overlap,  generating  the  rod  arrangement 
illustrated  in  the  diagram.  Dimerisation  is  thought  to  occur  through  the  24h  repeat.  The 
amino-terminal  actin-binding  domain  contains  sequence  motifs  common  to  many  actin- 
filament-binding  proteins. 
The  arrow  demonstrates  were  the  N-terminal  tail  of  CD23  is  thought,  to  bind  FLNa, 
based  upon  the  clone  purified  from  the  yeast  two-hybrid  screen  detailed  within  this 
chapter.  Clone  7  encodes  at  least  repeat  20,  with  the  remainder  of  the  insert  having  to  be 
sequenced. 
Ms  diagram  was  adapted  from  Stossel  et  al.,  2001. 
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GENERAL  CONCLUSIONS  &  DISCUSSION 
208 6.1  CURRENT  UNDERSTANDING  OF THE  HumAN  CD23  ISOFORMS 
CD23  is  a  45kDa  leukocyte  cell  surface  antigen  expressed  on  various  cells  of  the 
haernatopoietic  lineage  including  B  cells,  T  cells  and  monocytes  [Capron  et  al.,  1986; 
Sarfati  et  al.,  1986;  Bieber  et  al.,  1989;  Billaud  et  al.,  1989].  CD23  is  a  multifunctional 
receptor/figand  and  cytokine,  playing  a  role  in  antigen  presentation,  macrophage 
activation  and  cell  adhesion.  The  principal  function  of  the  full-lengtb/membrane 
associated  form  is  as  the  low  affinity  receptor  for  IgE  (FccRII)  [Bonnefoy  et  al.,  1987; 
Yukawa,  et  al.,  19871. 
Early  evidence  suggested  two  distinct  roles  for  CD23,  one  being  a  stage-dependent 
involvement  in  B  cell  growth  and  Oferentiation  [Gordon,  et  al.,  1987;  Kolb,  et  al., 
1990],  the  second  involving  the  effector  phase(s)  of  IgE-mediated  immunity,  including 
allergy  and  the  response  to  parasitic  infections  [Kehry  &  Yamashita,  1989;  Luo,  et  al., 
1991].  Two  species  of  human  CD23  were  originally  hypothesised  by  Yokota  and 
colleagues  and  then  later  identified  and  termed  CD23a  and  CD23b  [Yokota  et  al., 
1988].  The  human  CD23  gene  has  been  mapped  to  an  II  exon  gene  on  chromosome  19, 
encoding  both  the  CD23  isoforms  [Ludin,  et  al.,  1987;  Suter,  et  al.,  1987;  Wendel- 
Hansen,  et  al.,  19901  which  arise  from  use  of  different  transcription  start  sites  and 
differential  RNA  splicing.  The  isoforms  have  been  demonstrated  to  differ  only  in  a 
short  amino  acid  stretch  in  the  cytoplasmic  tail  region  where  the  N-terminal  7  amino 
acids  of  CD23a  (MEEGQYS)  are  distinct  from  the  alternative  6  amino  acids  of  CD23b 
(MNPPSQ),  see  Figure  1.4.  The  presence  of  both  cell  type-specific  and  stimulus- 
specific  expression  of  the  two  CD23  variants  suggests  that  each  isoform.  has  a  different 
cellular  function,  despite  having  identical  extracellular  domains. 
Early  studies  of  CD23a  and  CD23b  indicated  that  the  two  isoforms;  may  be  intcrnalised 
via  distinct  pathways,  with  CD23a  shown  to  enter  the  cell  via  receptor-mediated 
endocytosis  in  Y2  cells  whilst  CD23b  was  demonstrated  to  have  a  more  phagocytic 
route  of  cellular  entry  in  J774  cells  [Yokota,  et  al.,  1992].  The  aromatic  tyrosine  residue 
at  position  6  and  the  Asn-Pro  residues  at  positions  2-4  were  thought  to  be  important  for 
CD23a  endocytosis,  and  the  phagocytosis  of  CD23b  respectively.  These  findings  suggest 
endocytosis,  and  phagocytosis  to  be  separate  functions  that  appear  to  be  attributable  to 
209 distinct  amino  acid  residues.  The  studies  presented  here  employed  a  single  model  to 
analyse  the  intracellular  trafficking  patterns  of  each  of  the  CD23  isoforms  in  the  same 
cell  systen-4  with  emphasis  on  a  number  of  potentially  key  residues  located  in  the  unique 
cytoplasmic  N-terminal  tail  of  each  protein. 
With  respect  to  downstream  signalling,  current  understanding  generally  links  the  CD23a 
isoform  to  a  cAMP  pathway  with  the  CD23b  isoform  thought  to  function  generally  via 
inositol-1,4,5-trisphosphate  and  Caý+  mobilisation  [as  reviewed  by  Mossalayi  et  al., 
1997].  Much  of  this  understanding  is  speculative  with  no  conclusive  proof  of  protein- 
protein  interactions  physically  linking  CD23  to  any  of  these  signalling  pathways.  CD23 
has  however  been  demonstrated  to  associate  with  a  src  family  tyrosine  kinase  p59fyn,  as 
identified  using  co-immunoprecipitation  experiments  [Sugie  et  al.,  1991].  The  fact  that 
CD23  appears  able  to  transmit  a  signal  in  a  variety  of  cells,  together  with  the  fact  that  it 
has  a  very  short  cytoplasmic  tail  strongly  suggest  that  CD23  may  associate  with  other 
molecules  in  order  to  exert  its  function.  The  later  part  of  the  work  presented  herein 
addresses  the  gaps  in  this  knowledge  and  the  conclusions  of  these  studies  are  discussed 
herewith. 
6.1.1  MAIN  CONCLUSIONS 
The  main  findings  of  the  research  presented  in  this  thesis  are  two  fold.  The  results 
firstly  demonstrate  that  the  two  human  CD23  isoforms  do  indeed  traffic  differently  in 
the  same  cell.  model.  The  second  section  of  research  provides  an  insight  into  a  potential 
mechanism  enabling  CD23  function,  identifying  a  protein-protein  interaction  which 
may  explain  how  CD23  and  its  short  cytoplasmic  tail  facilitates  signalling. 
6.2  INTRACELLULAR  TRAFFICKING  OF  CD23 
The  research  presented  in  this  thesis  demonstrates  that  there  are  indeed  fundamental 
differences  between  the  intraceffular  trafficking  of  each  of  the  CD23  isoforms, 
something  which  had  been  suggested  before  [Yokota  et  al.,  1992]  but  never  proven 
using  the  same  stimulation  method  and  cell  system  to  analyse  both  protein  isoforms. 
The  HEK  293  system  reported  here  has  the  obvious  advantages  of  not  expressing 
210 endogenous  CD23  in  the  first  instance,  enabling  the  use  of  fluorescent  antibodies  to 
detected  and  monitor  the  transfected  CD23  proteins,  by  confocal  microscopic  analysis 
in  a  readily  adherent  cell  line.  This  system  facilitated  the  comparison  of  wild-type  CD23 
(identified  using  a  fluorescently  labelled  antibody)  with  GFP-tagged  CD23  fusions 
proteins.  Firstly  the  presented  results  demonstrate  the  usefulness  of  GFP-fusion  proteins 
in  CD23  intracellular  trafficking  studies,  facilitating  the  investigation  of  the  unoccupied 
or  'basal'  receptor,  a  phenomena  uncharacterised  prior  to  this  research.  There  are  also  a 
number  of  technical  advantages  as  GFP-fusion  proteins  have  been  found  to  give  greater 
sensitivity  and  resolution  in  comparison  to  staining  with  fluorescently  labelled 
antibodies,  exhibiting  low  background  fluorescence  and  greater  resistance  to  photo 
bleaching  [Wang  &  Hazelrigg,  19941.  The  use  of  the  GFP  tag  is  also  well  characterised 
in  kinetic  studies  of  protein  localisation  and  trafficking  [Flach  et  al.,  1994,  Wang  & 
Hazelrigg,  1994],  with  chimeric  genes  encoding  either  N-  or  C-terminal  GFP-fusions 
retaining  the  normal  biological  activity  of  the  heterologous  partner,  as  well  as 
maintaining  fluorescent  properties  similar  to  native  GFP  [Flach  et  al.,  1994;  Wang  & 
Hazelrigg,  1994;  Marshall  et  al.,  1995;  Stems,  1995].  The  studies  presented  within 
certainly  illustrate  this  to  be  the  case  for  CD23,  with  basal  GFP-CD23  acting  as  per 
FITC-labelled  wild-type  CD23  proteins,  demonstrating  that  the  addition  of  the  GFP  tag 
does  not  to  affect  CD23  trafficking,  an  important  consideration  in  any  study  utilising 
fusion  proteins. 
Secondly,  the  results  also  demonstrate  the  usefulness  of  the  NIP-system,  a  single  model 
system  facilitating  the  investigation  of  CD23  trafficking  in  the  'basal',  'loaded'  and 
ccross-linked'  state,  again,  something  which  had  not  been  investigated  prior  to  the 
initiation  of  this  research.  The  combination  of  the  GFP-tag  and  the  NIP-system 
generates  an  elegant  methodology  facilitating  the  investigation  of  CD23  trafficking  in  a 
situation  minimally  perturbed  from  that  which  would  be  present  in  the  native  state. 
In  summary  the  findings  from  the  HEK  293  study  demonstrate  that  both  the  CD23a  and 
CD23b  molecules  show  a  degree  of  re-cycling  in  the  basal,  unligated  state  and  that, 
following  the  cross-linking  of  GFP-CD23  molecules  or  loading  of  CD23  with  anti- 
CD23  antibodies,  only  the  CD23a  isoform  is  able  to  demonstrate  rapid  directed  uptake 
and  co-localisation  with  Tf-TxR  and  thus  sorting  into  the  endosomal  system.  The 
211 CD23b  isoform  was  internalised,  but  did  not  enter  the  endosomal  pathway  under  any 
conditions  in  HEK  293  cells.  These  findings  demonstrate  that  the  two  isoforms  appear 
to  traffic  differentially,  but  that  each  isoform  requires  ligation  with  IgE  as  stimulus  for 
the  receptors  to  collect  at  particular  areas  along  the  plasma  membrane,  prior  to  uptake 
from  the  cell  surface.  Cross-linking  with  NIPIo-BSA  stimulated  a  definite  increase  in 
the  extent  of  directed  uptake  from  the  cell  surface,  and  this  was  found  to  be  true  for  both 
CD23  isoforms.  Wild-type  GFP-CD23b  was  also  studied,  and  was  demonstrated  to  use 
both  the  endocytic  and  phagocytic  pathways  in  RaJi  A  cells  as  judged  by  co-localisation 
with  both  Tf-TxR  and  LysoTracker  dyes,  respectively.  No  data  were  generated  for  the 
GFP-CD23a  isoform  as  the  expression  levels  were  too  low  to  work  with.  The  data 
suggest  that  the  CD23b  isoform  requires  extensive  oligomerisation  at  the  cell  surface, 
achieved  in  these  experimental  conditions  only  after  cross-linking  with  NIPIO-BSA 
protein  conjugates,  as  stimulus  for  directed  uptake  into  the  endosomal  system,  but 
readily  enters  the  phagocytic  pathway  on  loading  with  IgE  and  antigen.  These  findings 
suggest  that  cross-linking  of  CD23  at  the  plasma  membrane  is  required  to  drive  directed 
movement  into  the  endosomal  system  and,  potentially,  towards  the  antigen  processing 
machinery  of  the  cell.  This  requirement  parallels  mast  cell  and  basophil  degranulation,  a 
process  triggered  by  cross-finking  of  the  high  affinity  IgE  receptors.  The  requirement 
for  cross-linking  may  also  reflect  a  situation  where  antigens  for  which  high  levels  of 
IgE  exist  are  most  readily  internalised  via  a  CD23-dependent  mechanism  for  processing 
and  presentation  to  T  cells  for  negative  regulation  of  the  IgE  response.  Data  from  CD23* 
/-  mice  support  a  role  for  IgE  in  negative  regulation  of  the  IgE  response  [Yu  Ct  al., 
1994].  CD23  has  also  been  shown  to  be  spatially  associated  with  IILA-DR  molecules 
on  the  B  cell  surface  [Bonnefoy  et  al.,  1988]  and  this  interaction  facilitates  a  well 
characterised  function  of  membrane  bound  CD23  in  B  cells,  the  enhancement  of  the 
IgE-dependent  antigen  presentation  to  T  cells  [Pirron  et  al.,  1990;  van  der  IleiJden  el 
al.,  1993;  Squire  et  al.,  1994;  Gustavsson  et  al.,  1994;  Fujiwara  et  al.,  1994;  Muddc  et 
al.,  1995;  Oshiba  et  al.,  1997;  Karagiannis  et  al.,  2001].  This  requires  the  binding  of 
antigen-IgE  antibody  complexes  to  CD23,  internalisation  of  the  complexes  and 
transport  to  compartments  of  the  endosomal  network  containing  proteolytic  enzymes 
and  major  histocompatibility  (MHC)  class  II  antigens. 
212 The  findings  from  the  mutagenesis  study  suggest  that  there  may  be  a  number  of  key 
residues  which  affect  the  trafficking  patterns  of  the  CD23  proteins.  The  results  suggest 
that  the  phosphorylation  state  of  the  serine  residue,  present  in  both  isoforms,  may  play  a 
regulatory  role  in  CD23  uptake  from  the  cell  surface.  Two  expression  patterns  were 
observed  for  bS5A  in  HEK  293  cells.  If  the  first  population  to  be  described 
(demonstrating  a  diffuse  intracellular  staining  with  a  limited  amount  located  on  the 
plasma  membrane  in  the  basal  state)  was  correct,  then  when  the  serine  is  not 
phosphorylated,  and  unable  to  be  phosphorylated,  cross-linkffig  is  required  before 
directed  uptake  is  observed,  as  was  shown  to  be  the  case  for  serine  mutations  in  both 
CD23  isoforms.  Mutation  of  these  residues  to  aspartate  or  phenylalanine  resulted  in 
proteins  able  to  undergo  directed  uptake  from  the  cell  surface  in  all  three  states, 
regardless  of  receptor  occupancy  or  ofigomerisation  state.  The  second  population 
demonstrated  a  more  usual  staining  pattern,  with  much  of  the  protein  associated  with 
the  plasma  membrane,  however  this  population  was  observed  to  show  extensive  co- 
localisation  with  Tf-TXR  in  all  three  basal,  loaded  and  cross-linked  states.  If  this  second 
population  was  found  to  be  the  true  case,  the  results  become  more  complicated  and 
harder  to  explain.  Further  investigation  is  required  to  establish  which  of  the  two 
expression  patterns  was  true  for  the  bS5A  mutant  protein,  before  any  definitive 
conclusions  as  to  the  importance  of  this  residue  can  be  drawn. 
The  other  point  to  consider  is  that  a  number  of  different  residues  were  observed  to  have 
an  effect  on  CD23  trafficking,  therefore  it  seems  likely  that  the  modification  of  a  single 
residue  may  not  solely  explain  the  requirements  for  sorting,  but  rather  that  a  number  of 
key  residues  may  play  a  role  in  the  vesicular  transport  of  the  receptor  from  the  cell 
surface  into  the  cell.  However,  collectively,  the  results  do  strongly  suggest  that  the 
phosphorylation  state  of  this  residue  does  play  an  important  role  in  CD23  trafficking. 
The  preliminary  results  obtained  from  the  mutagenesis  studies  performed  in  Raji  A 
cells,  were  generally  supportive  of  the  findings  observed  in  the  HEK  293  cells.  The 
basal  staining  pattern  observed  for  the  bS5A  mutant  protein  in  Raji  A  cells  was  similar 
to  that  of  the  second  population  observed  in  the  HEK  293  cells.  This  observation 
"muddies  the  water'  on  the  simple  theory  of  the  phosphorylation  state  of  the  scrine 
residue  having  a  regulatory  role  on  CD23  protein  trafficking.  Loaded  and  cross-linked 
states  were  not  examined  using  the  Raji  A  cells,  as  a  direct  result  of  the  poorer 
213 expression  levels  observed  in  this  cell  type,  therefore  comparisons  can  only  be  drawn 
between  the  basal  data  sets  from  each  cell  line. 
The  NNP  tri-peptide  motif  located  within  the  N-terminal  tail  of  the  CD23b  isoform.  has 
previously  been  linked  to  CD23  sorting  into  a  phagocytic  route  in  J774  cells  [Yokota,  et 
al.,  1992],  therefore  these  residues  were  also  targeted  for  manipulation  in  this  study. 
The  bP3R  mutant  was  found  to  remain  trapped  within  distinct  regions  of  the  cytoplasm 
in  HEK  293  cells,  unable  to  reach  the  plasma  membrane,  as  determined  by  both  flow 
cytomertrie  and  confocal  analysis.  No  co-localisation  was  observed  with  Tf-TxR 
indicating  that  this  protein  is  located  in  areas  or  vesicles  distinct  from  either  the  early 
endosomes  or  indeed  the  endocytic  pathway.  In  contrast  to  this  the  bP3R  protein  was 
observed  to  have  a  different  expression  pattern  in  Raji  A  cells,  with  some  of  the  protein 
recorded  at  the  cell  membrane,  both  by  flow  cytometric  and  confocal  analysis.  This 
situation  was  found  to  be  similar  for  that  of  the  bS5A  protein  in  HEK  293  cells,  as  two 
different  expression  patterns  were  also  observed  for  the  bP3R  proteins,  this  time  in  Raji 
A  cells.  The  most  likely  explanation  in  this  instance  is  that  the  differences  were  a  result 
of  protein  expression  levels;  with  cells  that  expressed  lower  amounts  of  the  CD23 
protein  not  clearly  demonstrating  its  presence  at  the  plasma  membrane,  however  cell 
surface  CD23  was  detected  in  cells  expressing  higher  amounts  of  the  bP3R  protein. 
Collectively  these  results  suggest  there  to  be  a  difference  in  expression  patterns  between 
the  two  cell  types  investigated.  This  observation  may  be  explained  with  respect  to  the 
cell  types  and  their  abilities  to  utilise  differential  trafficking  pathways.  Raji  A  cells  are 
capable  of  trafficking  proteins  via  a  phagocytic  route,  whereas  IIEK  293  cells  are 
unable  to  use  this  pathway.  This  finding  suggests  the  two  cells  possess  different  sorting 
machinery,  therefore  it  is  conceivable  that  this  protein,  thought  to  traffic  by 
phagocytosis,  may  be  processed  differently  in  cells  capable  of  this  sorting  route  to  those 
not  able  to  use  it.  HEK  293  cells,  unlike  Raji  A  cells,  do  not  express  MIIC  class  11 
proteins,  therefore  the  CD23  trafficking  observed  in  HEK  293  cells  is  intrinsic  to  the 
CD23  protein  itself 
The  bP4R  and  bN2K  mutants  were  found  to  demonstrate  both  directed  uptake  and  co- 
localisation  with  Tf-TxR  in  HEK  293  cells.  It  was  initially  proposed  that  these  mutants 
may  have  been  forced  to  use  the  endocytic  route  of  entry  as  a  default  pathway  as  it  was 
214 the  only  one  available  to  them  in  this  cell  type.  This  theory  was  supported  by  the  fact 
that  the  bP4R  and  bN2K  mutants  were  not  observed  to  co-localise  with  Tf-TxR  in  Raii 
A  cells.  The  wild-type  GFP-CD23b  proteins  were  observed  to  use  the  phagocytic  route 
of  entry  in  Raji  A  cells.  The  bN2K  mutant  was  also  observed  to  co-localise  with 
LysoTracker  dye,  in  all  three  states  in  Raji  A  cells,  (data  not  shown)  Whilst  the  bP4R 
mutant  was  not  studied  in  the  presence  of  LysoTracker  Red.  Yokota  and  colleagues 
reported  that  altering  the  proline  at  position  4  to  an  argffiffie  caused  a  decrease  in  the 
extent  of  CD23  uptake  by  phagocytosis  in  J774  cells  [Yokota,  et  al.,  1992],  the 
quantitative  difference  (if  any)  of  uptake  of  wild-type  CD23b  and  bN2K  proteins  was 
not  determined  from  the  confocal  images  recorded  in  this  investigation.  The  best  way  to 
address  this  question  would  have  been  to  use  1125  labelled  IgE/CD23,  measuring  the 
amount  internalised  into  the  cell  after  a  certain  time  point  under  the  various  conditions 
of  interest.  However,  bearing  in  mind  that  the  Raji  A  transfectants  were  made  towards 
the  end  of  the  project,  this  experiment  was  not  performed  due  to  the  timescale 
restrictions. 
CD23a  contains  a  tyrosine  residue  at  position  six,  and  two  mutants  were  generated  to 
address  the  potential  role  phosphorylation  of  this  residue  may  play  in  CD23  intracellular 
trafficking.  Unfortunately  the  expression  levels  of  these  proteins  were  low  in  each  of  the 
cell  lines  studied,  limiting  the  conclusions  that  could  be  drawn.  Cytoplasmic  aromatic 
amino  acid  residues  are  known  to  be  important  for  sorting  of  a  variety  of  molecules, 
including  the  low  density  lipoprotein  receptor  [Davis,  et  al.,  1987],  mannose-6- 
phosphate  receptor  [Lobel,  et  al.,  1989],  and  transferrin  receptor  [Jing,  et  al.,  1990].  The 
CD79a  and  CD79b  molecules  contain  cytoplasmic  tyrosine  residues  and  function  as 
transducers  of  B  cell  antigen  receptor  signals  [Gold,  et  al.,  1990]  via  the 
immunoreceptor  tyrosine-based  activation  motif  (ITAM).  Fc  receptor-mediated 
phagocytosis  of  IgG-coated  particles  by  macrophages  is  also  associated  with  localised 
tyrosine  phosphorylation  of  a  variety  of  cytoplasmic  proteins  [Greenberg  et  al.,  1993; 
Greenberg,  1995].  ITAMs  contain  two  conserved  tyrosine  residues  that  can  become 
phosphorylated  upon  receptor  aggregation  [Gold,  et  al.,  1991]  and  bind  distinct 
effectors  via  their  SH2  domains.  CD23  does  not  contain  an  ITAM  motif,  however 
CD23a  does  contain  a  cryptic  tyrosine  motif  (YSEI),  utilising  both  "Unique"  and 
"common7'  elements  of  the  CD23a  cytoplasmic  tail  sequence  that  is  similar  to  the 
215 tyrosine  motif  found  in  lamp-I  (GYSEI)  which  favours  a  phagocytic  sorting  pathway. 
The  lack  of  the  key  preceding  glycine  residue,  suggests  that  this  motif  may  favour 
endocytic  rather  than  lysosomal  uptake  of  CD23a,  as  indeed  was  observed  to  be  the  case 
in  the  experiments  detailed  in  chapter  3.  Further  experimentation  is  required  to  gain 
more  information  as  to  the  potential  importance  of  tyrosine  phosphorylation,  should  it 
occur. 
The  cytoplasmic  domain  of  CD23,  shown  in  figure  1.5,  does  not  contain  any  of  the 
standard  tyrosine  or  di-leucine-based  motifs  described  in  section  1.3.5  of  the 
introduction.  Recently,  an  acidic  dipeptide  motif  (EE)  has  also  been  demonstrated  to  be 
important  for  intracellular  sorting  of  HIV-1  Nef  protein  [Piguet  et  al.,  1999].  Mutation 
of  the  EE  diacidic  motif  of  HIV-1  Nef  abrogates  its  ability  both  to  target  CD4  from  the 
early  to  the  late  endosomal  compartment  and  to  interact  with  P-COP,  yet  it  does  not 
affect  adaptor  protein  complexes  binding  or  indeed  Nef-induced  CD4  endocytosis.  Both 
CD23  isoforms  contain  an  EE  acidic  dipeptide  motif  in  the  common  section  of  their  N- 
terminal  cytoplasmic  tails.  However,  this  motif  was  not  targeted  in  the  research 
discussed  here  as  the  mutagenesis  focused  on  the  residues  which  differ  between  the 
isoforms,  in  the  attempt  to  highlight  differences  responsible  for  their  potential 
differential  functionalities. 
6.2.1  FUTURE  WORK 
This  research  needs  to  be  extended  further,  optimising  the  study  in  lymphocyte  cell 
lines.  The  initial  work  with  Raji  A  cells  is  very  promising,  and  certainly  indicates  these 
cells  to  be  suitable  for  confocal  microscopic  analysis  of  CD23  intracellular  trafficking. 
These  cells  express  endogenous  CD23  proteins  and  therefore  must  possess  all  the 
necessary  equipment  and  protein  intermediates  to  enable  the  GFP-CD23  trafflicking  to 
occur  very  much  as  CD23  trafficking  would  in  the  real  situation.  Secondly,  the  Raji  A 
cell  line  was  isolated  for  its  adhesion  properties  [Nyormoi,  et  al.,  1972],  enabling  this  B 
cell  line  (unlike  Raji),  to  be  routinely  cultured  in  monolayers.  These  cells  therefore 
provide  all  the  advantages  of  aB  lymphocyte  cell  line,  with  the  added  bonus  of  their 
ease  of  use  for  investigation  using  the  confocal  microscope. 
216 The  problem  of  low  protein  expression  in  Raji  A  cells  was  a  limiting  factor  and  must  be 
overcome  to  facilitate  further  analysis  in  this  cell  line.  This  may  be  resolved  by  using 
flow  cytometry  to  separate  cells  expressing  GFP-tagged  proteins  above  a  particular 
level,  thus  supplying  uniform  populations  of  cells  demonstrating  reasonable  expression 
levels.  Another  way  to  target  this  problem  would  be  to  attempt  to  optimise  the 
transfection  and/or  selection  method,  by  altering  the  electroporation  conditions  and 
concentration  of  G418  used,  in  order  to  maximise  the  survival  and  selection  of  cells 
demonstrating  good  expression  levels.  Further  to  the  information  provided  already,  it 
would  also  be  useful  to  perform  experiments  where  the  extent  of  intemalisation  could 
be  calculated,  in  order  to  quantitatively  compare  each  of  the  mutant  proteins  to  the  wild- 
type  isoforms.  Dual  transfection/staining  experiments  could  also  be  performed  using 
different  fluorescent  tags  for  each  of  the  isoforms,  (or  indeed  the  wild-type  and  a  mutant 
protein),  facilitating  the  study  of  both  proteins  in  the  same  cell,  under  exactly  the  same 
experimental  conditions,  investigating  potential  co-localisation  into  the  very  same 
vesicle  within  a  given  pathway. 
6.3  BMING  PARTNERS  FOR  THE  N-TERMINAL  TAIL  OF  CD23 
The  findings  presented  in  this  study  indicate  that  the  N-terminal  tail  of  CD23  may  bind 
to  filarnin.  Filamins  are  a  family  of  high  molecular  mass  actin-binding  proteins  serving 
to  organise  filamentous  actin  into  networks  and  stress  fibres.  Three  filamin  genes  have 
been  identified  in  humans;  FLNa,  FLNb  and  FLNc,  with  the  three  encoded  proteins, 
filamin-A,  -B  and  -C,  found  to  show  strong  homology  (-70%)  over  their  entire 
sequence,  with  the  exception  of  the  flexible-loop  hinge  regions  which  show  only  -45% 
homology  between  sequences.  Furthermore,  filamin-C  contains  an  additional  81  amino 
acid  insertion,  located  in  repeat  20,  not  present  in  filamin-A  or  -B.  The  genomic 
organisation  of  the  three  human  iso-genes  is  highly  conserved,  but  there  is  no  clear 
correlation  between  the  intron-exon  organisation  and  the  repeated  protein  domains 
[Patrosso  et  al.,  1994;  Chakarova  et  al.,  2000].  Several  studies  have  revealed 
overlapping  cellular  and  tissue  expression  patterns  of  human  filamin-A,  -B  and  -C  with 
the  general  conclusion  that  Filamin-A  and  -B  are  the  most  ubiquitously  expressed 
filamin  isoforms  having  been  identified  in  a  wide  variety  of  cell  types  [Gorlin  et  al., 
1990;  Gorlin  et  al.,  1993;  Maestrini  et  al.,  1993;  Zhang  et  al.,  1998;  Takaffia  et  al., 
1998;  Xu  et  al.,  1998;  Brocker  et  al.,  1999;  Chakarova,  et  al.,  2000],  whereas  filamin-C 
217 is  largely  restricted  to  skeletal  and  cardiac  muscle  [Thompson  et  al.,  2000].  As  has  been 
previously  discussed,  it  is  the  filamin-A  protein  which  is  of  relevance  here,  as  this 
protein  was  identified  as  a  binding  partner  for  CD23  using  the  yeast  two-hybrid  systen-L 
The  human  filamins  have  recently  been  demonstrated  to  bind  a  variety  of 
transmembrane  proteins,  serving  to  anchor  these  proteins  to  the  actin  cytoskeleton,  as 
well  as  providing  a  scaffold  for  numerous  cytoplasmic  signalling  proteins  (as  reviewed 
by  Stossel  et  al.,  2001).  As  such,  filamins  have  been  shown  to  stabilise  the  delicate 
three-dimensional  actin  webs  and  link  these  to  cellular  membranes  [Meyer  et  al.,  19981, 
potentially  enabling  them  to  integrate  architectural  and  signalling  functions.  For 
example  bringing  together  receptors  such  as  P-integrins  [Calderwood  et  al.,  2000],  the 
sub-membrane  actin  network  and  intracellular  signalling  components,  filamins  can 
facilitate  the  activation  of  local  cellular  process.  It  seems  likely  that  this  may  also  be  the 
case  with  CD23.  CD23  has  a  relatively  short,  22  amino  acid,  cytoplasmic  tail  devoid  of 
the  common  motifs  known  to  be  required  for  the  binding  of  many  signalling  proteins.  I 
have  therefore  hypothesied  that  filamin-A  is  necessary  for  the  downstream  functionality 
of  CD23,  effectively  acting  as  an  adaptor  protein  enabling  the  recruitment  of  the 
necessary  downstream  signalling  molecules  thereby  enabling  CD23  function.  Figure  6.1 
illustrates  a  schematic  diagram  of  this  proposed  model. 
A  variety  of  transmembrane  receptors  or  signalling  molecules  have  previously  been 
shown  to  bind  the  human  filamin  proteins  via  one  or  more  repeats  in  their  carboxy- 
terminal  tail  (see  Table  5.4).  This  research  indeed  suggests  that  CD23  binds  to  the 
carboxy  terminal  tail  of  filamin-A,  however  the  exact  region(s)  of  the  filamin  molecule 
involved  in  binding  have  not  yet  been  identified,  as  the  clone  isolated  from  the  yeast 
two-hybrid  assay  contained  a  large  segment  of  the  C-terminal  sequence  of  filamin-A.  It 
is  interesting  to  note  that  no  basic  homology  has  been  identified  between  the  diverse 
binding  domains  (from  a  variety  of  different  proteins)  found  to  associate  with  the  same 
or  different  filamin  repeats,  so  theoretical  predictions  of  binding  motifs  cannot  yet  be 
made.  It  is  therefore  impossible  to  predict  which  region  of  the  carboxy-terminal  tail  of 
filamin-A  is  responsible  for  binding  CD23  without  ffirther  investigation  at  the  protein 
level. 
218 In  many  cases  the  regulation  of  these  interactions,  as  well  as  the  factors  that  control  the 
interactions'  specificity  remain  to  be  determined.  Recently,  receptor  occupancy  has 
been  reported  to  influence  the  association  of  filamin  with  transmembrane  receptors.  For 
instance,  occupancy  of  Fc7RI  by  immunoglobulin  decreases  its  interaction  with  filamin 
[Ohta  et  al.,  1991],  leading  to  the  hypothesis  that  Fc7RI  is  linked  by  filamin  to  the 
cortical  actin  cytoskeleton  and  suggests  that  receptor  occupancy  results  in  the  release  of 
receptors  from  their  anchors  facilitating  reorganisation  of  the  cytoskeleton.  In  contrast 
to  this,  ligation  of  tissue  factor  has  been  shown  to  be  necessary  for  filamin-A  binding 
[Ott  et  al.,  1998].  It  therefore  seems  likely  that  the  interaction  between  filamin-A  and 
CD23  may  also  be  affected/regulated  by  the  occupancy  of  CD23  with  IgE.  This 
question  was  addressed  by  one  experiment  performed  near  the  end  of  this  project. 
However,  the  results  were  inconclusive.  It  would  have  been  satisfying  to  have  been  able 
to  characterise  the  CD23-filamin-A  interaction  further,  but  due  to  the  interaction  having 
only  been  identified  in  the  yeast  two-hybrid  system  a  few  months  prior  to  the 
compulsory  completion  of  this  research  this  was  simply  not  possible. 
Interestingly  fyn  was  not  identified  as  a  binding  partner  for  CD23  in  the  yeast  two- 
hybrid  screens  performed  within  this  research.  There  may  be  a  number  of  reasons  for 
this  with  the  phosphorylation  (or  rather  lack  oo  state  of  the  N-termiml  tail  being  the 
most  likely  explanation.  Another,  more  simple  explanation  is  that  the  entire  cDNA 
library  was  never  actually  screened  in  any  one  experiment,  therefore  the  cDNA 
expressing  fyn  may  never  have  been  available  in  the  studies  performed.  Regardless,  this 
research  has  subsequently  opened  a  number  of  potential  avenues  for  further 
investigation. 
6.3.1  FUTURE  WORK 
Firstly  the  CD23-filamin-A  interaction  should  be  demonstrated  unequivocally  in  a 
relevant  cell  line,  which  is  purely  a  matter  of  being  able  to  perform  the  necessary 
experiment  again.  The  primary  question  which  should  be  addressed,  is  that  of  the  nature 
of  the  interaction,  i.  e.  does  it  occur  constitutively?  This  should  be  addressed  by 
investigation  of  the  effects  of  receptor  occupancy  on  filamin  binding  etc. 
219 Filamin  can  be  phosphorylated  and  this  modification  has  also  been  reported  to  affect  its 
interaction  with  several  proteins  including  a  number  of  GTPase  proteins  [Ueda,  et  al., 
1992;  Yada,  et  al.,  1990]  as  well  as  actin  [Zhuang,  et  al.,  1984;  Ohta,  et  al.,  1995]. 
Several  serine/threonine  protein  kinases  phosphorylate  filamins,  including  protein 
kinase  A,  protein  kinase  C,  calciurn/calmodulin-dependent  protein  kinase  II  and  p90 
ribosomal  S6  kinase  [Wallach,  et  al.,  1978;  Chen  &  Stracher,  1989;  Kawamoto  & 
Hidaka,  1984;  Ohta  &  Hartwig,  1996;  Jay,  et  al.,  2000].  Interestingly,  phosphorylation 
of  the  interacting  proteins  has  also  been  implicated  in  the  regulation  of  filamin-protein 
interactions.  Point  mutations  which  mimic  serine  phosphorylation  in  the  cytoplasmic 
tails  of  both  tissue  factor  (Ser  253,248Asp)  [Ott,  et  al.,  1998]  and  the  dopamine  D2 
receptor  (Ser  358Asp)  [Li,  et  al.,  2000]  were  found  to  increase  or  diminish  their 
interaction  with  filamin,  respectively.  Collectively  these  reports  indicate  that  further 
investigation  with  the  N-terminal  CD23  mutants  may  prove  very  useful,  potentially 
providing  insights  as  to  how  the  CD23-filamin  interaction  might  be  regulated.  Other 
mutagenesis  work  should  also  be  performed,  for  example,  construction  of  deletion 
mutants  in  order  to  identify  the  minimal  domain  required  for  an  interaction  [Chien  et 
al.,  1991]  and  point  mutations  to  identify  the  specific  amino  acids  involved  [Li  & 
Fields,  1993],  would  be  one  of  the  obvious  choices  to  further  this  research. 
Abundant  evidence  links  human  filamins  to  a  number  of  cell  signalling  pathways,  and  it 
may  be  that  some  of  these  signalling  proteins  facilitate  CD23  function,  via  binding  to 
filan-An-A  as  an  intermediate.  Another  means  to  expand  this  work  would  therefore  be  to 
analyse  finiher  the  CD23-filamin-A  immuno-precipitations  as  it  is  likely  that  these  other 
proteins  may  also  have  co-immunoprecipitated  within  the  sample  and  may  indeed  be 
detected  by  western  blotting.  For  example,  filamin-A  has  already  been  shown  to  bind  to 
RHO  family  GTPases  and  to  some  regulatory  co-factors  that  are  strongly  implicated  in 
the  regulation  of  actin  assembly  and  myosin  activation  [Bishop  &  Hall,  2000].  Ral  also 
binds  filamin-A  in  a  GTP-dependent  manner,  whereas  Cdc42,  RhoA  and  Racl  bind 
filamin-A  constitutively  [Marti,  et  al.,  1997;  Ohta,  et  al.,  1999].  Trio,  a  guanine 
nucleotide  exchange  factor  for  Rho  GTPases,  binds  filamin-a,  implying  that  switching 
on  and  off  Rho  GTPases  constitutively  bound  to  filamins,  might  regulate  the  spatial 
positioning  of  actin  assembly  [Bellanger,  et  al.,  2000].  By  interacting  directly  with  the 
Rho  signalling  apparatus,  filamins  can  organise  actin  filaments  that  elongate  under  the 
220 influence  of  these  GTPases  into  three-dimensional  configurations  useful  to  the  cell.  This 
line  of  investigation  may  highlight  those  proteins  involved  in  the  initial  steps  of  the 
downstream  signalling  pathways  of  CD23,  and  may  even  provide  conclusive  proof  as  to 
whether  or  not  the  two  isoforms  do  indeed  function  via  different  signaRing  pathways. 
It  should  also  be  noted  that  a  full-scale  library  screen  was  never  actually  attempted 
during  the  course  of  this  project  and  that  all  the  screens  discussed  in  this  chapter  used 
either  the  pCD23A.,  or  pCD23At  bait  vectors  to  initially  identify  positive  interactors. 
The  plasmids  containing  the  cDNA  fragments  encoding  'positive'  proteins  were  then 
isolated  and  used  to  transform  AH109  cells  in  conjunction  with  the  CD23b  bait  vectors. 
This  simple  test  was  able  to  indicate  whether  the  interaction  was  specific  to  the  CD23a 
isoforin  or  indeed  whether  the  protein  could  also  interact  with  CD23b.  Ideally  if  time 
had  not  been  a  limiting  factor  it  would  have  been  informative  to  have  performed  two 
library  scale  screens  using  the  cytoplasmic  N-terminal  tail  of  each  of  the  CD23  isoforms 
as  the  bait  protein,  in  order  to  investigate  the  possibility  of  other  novel  protein 
interactions.  Again  this  line  of  investigation  may  provide  information  as  to  whether  the 
two  isoforms  do  actually  bind  different  proteins  in  order  to  achieve  their  functions. 
A  commercially  produced  vector,  for  use  in  the  yeast  two-hybrid  assay,  has  also  now 
been  released  which  facilitates  the  expression  of  phosphorylated  proteins  in  yeast. 
CD23a  contains  tyrosine  and  serine  residues  at  positions  6  and  7  whilst  the  CD23b 
isoform  contains  a  serine  at  position  5.  The  phosphorylation  state  of  these  residues  may 
be  an  extremely  important  factor  as  to  whether  or  not  certain  proteins  bind.  It  would  be 
very  interesting  to  complete  a  screen  with  our  bait  proteins  in  this  vector,  thus 
investigating  whether  or  not  a  separate  range  of  protein  interactors  would  be  identified. 
This  research  has  effectively  proven  the  validity  of  the  yeast  two-hybrid  system  for  the 
identification  of  protein  interactions  at  the  N-terminal  cytoplasmic  tail  of  CD23.  Whilst 
the  results  discussed  provide  an  appetiser  for  what  must  yet  remain  to  be  discovered,  the 
project  has  opened  many  potential  avenues  for  investigation  that  should  be  exploited  in 
future  studies,  hopefully  providing  more  crucial  information  helping  to  elucidate  how 
the  two  human  CD23  isoforms  function. 
221 FIGuRE  6.1  PROPOSED  MODEL  FOR  THE  CD23-FiLAmiN  INTERACTION 
This  schematic  diagram  illustrates  a  proposed  model  showing  the  potential  method  of 
downstream  activation  after  the  cytoplasmic  N-terminal  tail  of  CD23  binds  to  the  C- 
terminus  of  filamin  A.  The  box  focuses  in  on  the  area  of  protein-protein  interaction, 
with  the  key  highlighting  the  areas  of  importance. 
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246 SOLUTIONS  AND  BUFFERS 
Unless  otherwise  stated  the  quantities  shown  correspond  to  IL  stock  solutions. 
E.  COLI  &  YEAST  CELL  CULTURE  MEDIAS  &  AGARS 
Solution/Buffer  Composition 
LB  Broth  lOg  Bacto-Tryptone,  5g  Bacto-Yeast  extract,  10g  NaCl,  pH  7.5. 
Supplement  with  0.05mg/ml  Ampicillin  or  0.03mg/mL 
Kanamycin 
LB  Agar  IL  LB  Broth,  15g  Bacto-Agar.  Supplement  with  0.05mg/ml 
Ampicillin  or  0.03mg/ml  Kanamycin 
SOC  Media  2g  Bacto-tryptone,  0.5g  Bacto-yeast,  0.01M  NaCl,  0.01M  M902, 
0.01M  MgS04,0.02M  Glucose 
YPD  20g  Difco  Peptone,  I  Og  Yeast  Extract.  Autoclave,  add  Glucose 
(final  concentration  2%)  once  cooled  to  500C. 
YPDA  YPD  made  as  above.  Add  Adenine  to  final  concentration  of  0.003 
%  once  media  cooled  to  50'C. 
M9  DO  leu  13.5g  Na2HP04,6g  KH2PO4,2g  NH40,  lg  NaCl,  0.7g  DO  leu 
supplement,  made  up  to  2L  with  water  and  autoclaved.  Cooled  to 
50T,  added  2ml  1M  MgS04  (or  M902),  100ýLl  IM  CaC12, 
ImIlM  thiamine,  500ýd  100ýtg/ml  Ampicillin,  10ml  40%  Glucose 
M9  Agar  IL  M9  Media,  9g  Bacto-Agar 
E.  CoU  COMPETENT  CELL  PREPARATIONS 
Buffer/Solution  Composition 
Psi  Broth  5g  Bacto  yeast  extract,  20g  Bacto  Tryptone,  5g  Magnesium  Sulphate 
TfbI  30mM  Potassium  Acetate,  I  OOmM  Rubidium  Chloride,  I  OmM  Calcium 
Chloride,  50mM  Magnesium  Chloride,  15%  v/v  Glycerol 
TfbII  lOmM  MOPS,  75mM  Calcium  Chloride,  lOmM  Rubidium  Chloride,  15 
%  v/v  Glycerol 
DNA  ANALYSIS 
DNA  Purification  Buffers  (E.  coli)  Composition 
Solution  I  5OmM  Glucose,  25mM  Tris-HCI,  pH8.0,  I  OmM 
EDTA 
Solution  2  0.2M  NaOH,  1%  (w/v)  SDS, 
Solution  3  3M  Potassium  acetate,  3M  Acetic  acid 
247 DNA  Purification  Buffers  Composition 
(Yeast) 
Buffer  S  lOmM  K2HP04,  pH7.2,  lOmM  EDTA,  50mM  2- 
mercaptoethanol,  50mg/ml  zymolase 
Lysis  Buffer  25mM  Tris-HCI,  25mM  EDTA,  25%  (w/v)  SDS 
DNA  Purification  Buffers  Composition 
(Kit) 
QiagenPlResuspension  50mMTris-HCI(pH8),  IOmMEDTA,  100gg/mIRNaseA 
Buffer 
Qiagen  P2  Lysis  Buffer  200mM  NaOH,  1%  (w/v)  SDS 
Qiagen  P3  Neutralisation  3M  potassium  acetate,  pH  4.8 
Buffer 
Qiagen  QBT  750mM  NaCl,  50mM  MOPS,  pH  7.0,15%  isopropanol,  0.15% 
Equilibriation  Buffer  Tritoe  X-100 
Qiagen  QC  Wash  Buffer  1M  NaCl,  5OmM  MOPS  (pH  7),  15%  (v/v)  Isopropanol 
Qiagen  QF  Elution  1.25mM  NaCl,  5OmM  Tris-HCI  (pH  8.5),  15%  (v/v) 
Buffer  Isopropanol 
Promega  Resuspension  5OmM  Tris-HCI  (pH  7.5),  lOmM  EDTA,  100gg/ml  RNase  A 
Buffer 
Promega  Lysis  Buffer  0.2mM  NaOH,  I%  SDS 
Promega  Neutralisation  4.09M  guanidine  hydrochloride,  0.759M  potassium  acetate, 
Buffer  2.12M  glacial  acetic  acid,  pH  4.2 
Promega  Column  Wash  60mM  potassium  acetate,  I  OmM  Tris-HCI  (pH  7.5),  60% 
Buffer  Lr  ethanol 
- 
Buffers/Dyes  Composition 
DNA  Loading  Dye 
(5x) 
0.25%  (w/v)  Bromophenol  blue,  0.25  %  (w/v)  xylene  cyanol  FF 
and  15%  Ficoll 
50X  TAE  Buffer  242g  Tris,  18.6g  EDTA,  57ml.  of  Glacial  Acetic  acid,  dH20  to  IL 
TE  Buffer  lOmM  Tris-HCI  (pH  8),  lmM  EDTA 
248 PROTEIN  ANALYSIS 
SDS  PAGE  Gels  Composition  11 
6%  SDS-PAGE  6%  (w/v)  Acrylamide/Bis  Acrylamide,  0.375M  Tris-HCI  (pH  8.8), 
Separation  Gel  0.1%  (w/v)  SDS,  0.05%  (w/v)  Ammonium  Persulphate,  0.0003% 
(v/v)  TEMED 
10%  SDS-PAGE  10%  (w/v)  Acrylamide/Bis  Acrylamide,  0.375M  Tris-HCI  (PH  8.8), 
Separation  Gel  0.1%  (w/v)  SDS,  0.05%  (w/v)  Ammonium  Persulphate,  0.0003% 
(v/v)  TEMED 
12%  SDS-PAGE  12%  (w/v)  Acrylamide/Bis  Acrylamide,  0.375M  Tris-HCI  (pH  8.8), 
Separation  Gel  0.1%  (w/v)  SDS,  0.05%  (w/v)  Ammonium  Persulphate,  0.0003% 
(v/v)  TEMED 
5%  SDS-PAGE  5%  (w/v)  Acrylamidc/Bis  Acrylamide,  0.13M  Tris-HCI  (pH  6.8), 
Stacking  Gel  0.1%  (w/v)  SDS,  0.1%  (w/v)  Ammonium  Persulphate,  0.0007%  (v/v) 
I  TEMED 
Solutions  Composition 
Protein  Transfer  48mM  Tris,  39mM  Glycine,  1.3mM  SDS,  20%  (v/v)  Methanol 
Buffer 
4x  Protein  200mM  Tris-HCI  pH  8,8%  (w/v)  SDS,  OA%  (w/v)  Bromophenol 
Loading  Buffer  blue,  40%  (v/v)  Glycerol,  20%  (v/v)  P-Mercaptoethanol 
2x  Non  Reducing  25mM  Tris  pH  6.8,20%  glycerol,  10%  SDS,  5mM  EDTA, 
Loading  Buffer  brornophenol  blue 
I  Ox  Phosphate  1.37M  NaCl,  26.8M  KCI,  42mM  Na2HP04,14.7mM  KH2PO4,  pH 
Buffered  Saline  7.2 
(PBS) 
RIPA  Buffer  50mM  Tris-HCI  (pH  7-4),  1%  (v/v)  NP40,  ImM.  sodium 
deoxycholate,  15  OmM  NaCl,  I  rnM  EGTA,  I  mM  Na3V04,  I  MM 
NaF,  ImM  PMSF,  2[tg/ml  Leupeptin,  0.5mM  DTT 
OGP  Buffer  50rnM  HEPES-KOH,  pH7.4,5mM  CaC12.140mM  NaCl,  1%  octyl- 
P-D-glucopyranoside,  ImM  PMSF,  ImM  Aprotonin,  ImM  Leupeptin 
SDS-PAGE  25mM  Tris-HCI  (pH  8.3),  25OmM  Glycine,  0.1%  (w/v)  SDS 
Running  Buffer  I 
Blocking  Buffer  10%  Marvel,  0.05%  Tween  in  Ix  PBS 
for  Westerns 
Blotto  0.5%  Marvel,  0.05%  Tween  in  lx  PBS 
High  Urea  Buffer  8M  urea,  5%  (w/v)  SDS,  200mM  Tris-HCI  pH  6.8,  O.  ImM  EDTA, 
0.5mg/ml  Brornophenol  blue,  10%  (v/v)  P-mercaptoethanol. 
249 SILVER  STAIN 
Reagent  Composition 
Fix  1  40%  ethanol  10%  acetic  acid 
Fix  2  10%  ethanol  5%  acetic  acid 
Oxidiser  0.02g  sodium-thio-sulphate  in  100  ml  dH20 
Silver 
Stain 
0.2g  AgN03,75  ýd  formaldehyde  inlOO  ml.  dH20 
Developer  6g  sodium  carbonate,  4mg  sodium-thio-sulphate,  50[d  formaldehyde  in 
100mldH20 
Stop  5%  acetic  acid 
sCD23  ELISA 
Antibody/Reagent  Details 
Capture  Antibody  Anti-human  CD23,1:  250  dilution  in  coating  buffer 
Detection  Antibody  Biotinylated  anti-human  CD23,1:  250  dilution  in  assay  diluent 
Enzyme  Reagent  Avidin-Horseradish  Peroxidase  conjugate,  1:  250  dilution 
Standard  Recombinant  Human  CD23 
Buffer/Solution  Composition 
Coating  Buffer  0.2  M  Sodium  Phosphate,  pH  6.5. 
Assay  Diluent  PBS  with  10%  heat  inactivated  Fetal  Bovine  Serum,  pH  7.0 
Wash  Buffer  PBS  0.05%  Tween-20 
Substrate  Solution  Tetrarnethylbenzidine  (TMB)  and  Hydrogen  Peroxide 
Stop  Solution  2N  H2SO4 
PROTEIN  TRAFFICKING  -  CONFOCAL  ANALYSIS 
Buffers/Dyes  Composition  I 
2x  KRH  Buffer  120mM  NaCl,  5mM  KCI,  1.2mM  MgS04,1.2mM  CaC12,20mM 
HEPES,  1.2mM  NaIIP04,  pH  7.4. 
KRH  Working  50%  volume  2x  KRH  with  0.1%  (w/v)  Glucose,  0.18%  (w/v)  BSA 
Stock 
Carbonate  Buffer  39.8ml  IM  NaHC03,3.41ml  IM  Na2CO3,  make  up  to  final  volume  of 
1L,  pH  9.0 
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